<SEC-DOCUMENT>0001821268-24-000261.txt : 20240830
<SEC-HEADER>0001821268-24-000261.hdr.sgml : 20240830
<ACCEPTANCE-DATETIME>20240830170912
ACCESSION NUMBER:		0001821268-24-000261
CONFORMED SUBMISSION TYPE:	N-2/A
PUBLIC DOCUMENT COUNT:		19
FILED AS OF DATE:		20240830
DATE AS OF CHANGE:		20240830

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ADVENT CONVERTIBLE & INCOME FUND
		CENTRAL INDEX KEY:			0001219120
		ORGANIZATION NAME:           	
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		N-2/A
		SEC ACT:		1940 Act
		SEC FILE NUMBER:	811-21309
		FILM NUMBER:		241271011

	BUSINESS ADDRESS:	
		STREET 1:		227 W. MONROE STREET
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606
		BUSINESS PHONE:		312-827-0100

	MAIL ADDRESS:	
		STREET 1:		227 W. MONROE STREET
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADVENT CLAYMORE CONVERTIBLE SECURITIES & INCOME FUND
		DATE OF NAME CHANGE:	20030219

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ADVENT CONVERTIBLE & INCOME FUND
		CENTRAL INDEX KEY:			0001219120
		ORGANIZATION NAME:           	
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		N-2/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-280964
		FILM NUMBER:		241271010

	BUSINESS ADDRESS:	
		STREET 1:		227 W. MONROE STREET
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606
		BUSINESS PHONE:		312-827-0100

	MAIL ADDRESS:	
		STREET 1:		227 W. MONROE STREET
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADVENT CLAYMORE CONVERTIBLE SECURITIES & INCOME FUND
		DATE OF NAME CHANGE:	20030219
<IS-FILER-A-NEW-REGISTRANT>N
<IS-FILER-A-WELL-KNOWN-SEASONED-ISSUER>N
<FILED-PURSUANT-TO-GENERAL-INSTRUCTION-A2>Y
<IS-FUND-24F2-ELIGIBLE>N
</SEC-HEADER>
<DOCUMENT>
<TYPE>N-2/A
<SEQUENCE>1
<FILENAME>gug87916avk-n2a.htm
<DESCRIPTION>AVK
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:fnd="http://xbrl.sec.gov/fnd/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:AVK="http://guggenheiminvestments.com/20240719">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_CEF%2D2023%2D(with%2DFND) -->
<!-- Field: Set; Name: xdx; ID: xdx_03F_AVK_guggenheiminvestments.com_20240719 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20240723_20240723 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DEntityCentralIndexKey_0001219120 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-07-23" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-07-23" id="Fact000004" name="dei:EntityCentralIndexKey">0001219120</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-07-23" id="Fact000014" name="dei:DocumentType">N-2/A</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-07-23" id="xdx2ixbrl0046" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="avk-20240719.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-07-23">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001219120</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-23</xbrli:startDate>
        <xbrli:endDate>2024-07-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-232024-07-23_dei_BusinessContactMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001219120</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-23</xbrli:startDate>
        <xbrli:endDate>2024-07-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-02-012024-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001219120</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-02-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-11-012024-01-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001219120</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-11-01</xbrli:startDate>
        <xbrli:endDate>2024-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-08-012023-10-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001219120</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-08-01</xbrli:startDate>
        <xbrli:endDate>2023-10-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001219120</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-012023-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001219120</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-11-012023-01-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001219120</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-11-01</xbrli:startDate>
        <xbrli:endDate>2023-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-08-012022-10-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001219120</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-08-01</xbrli:startDate>
        <xbrli:endDate>2022-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012022-07-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001219120</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2022-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-012022-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001219120</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001219120</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-232024-07-23_custom_RiskIntroductionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001219120</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">AVK:RiskIntroductionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-23</xbrli:startDate>
        <xbrli:endDate>2024-07-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-232024-07-23_custom_DistributionRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001219120</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">AVK:DistributionRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-23</xbrli:startDate>
        <xbrli:endDate>2024-07-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-232024-07-23_custom_RisksAssociatedWithOfferingsOfAdditionalCommonSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001219120</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">AVK:RisksAssociatedWithOfferingsOfAdditionalCommonSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-23</xbrli:startDate>
        <xbrli:endDate>2024-07-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-232024-07-23_custom_AdditionalRisksofRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001219120</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">AVK:AdditionalRisksofRightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-23</xbrli:startDate>
        <xbrli:endDate>2024-07-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Ratio">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000055" toRefs="Footnote000065"/>
  <ix:relationship fromRefs="Fact000056" toRefs="Footnote000065"/>
  <ix:relationship fromRefs="Fact000057" toRefs="Footnote000066"/>
  <ix:relationship fromRefs="Fact000061" toRefs="Footnote000067"/>
  <ix:relationship fromRefs="Fact000062" toRefs="Footnote000069"/>
  <ix:relationship fromRefs="Fact000063" toRefs="Footnote000070"/>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="text-decoration: none">As filed with
the Securities and Exchange Commission on August 30, 2024</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: right">Securities Act File No.&#160;<span id="xdx_904_edei--EntityFileNumber_c20240723__20240723_zQtJkMZaBjTg"><ix:nonNumeric contextRef="AsOf2024-07-23" id="Fact000010" name="dei:EntityFileNumber">333-280964</ix:nonNumeric></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="text-decoration: none">Investment Company
Act File No.&#160;<span id="xdx_907_edei--InvestmentCompanyActFileNumber_c20240723__20240723_zkat0c6OjNsf"><ix:nonNumeric contextRef="AsOf2024-07-23" id="Fact000011" name="dei:InvestmentCompanyActFileNumber">811-21309</ix:nonNumeric></span></span></p>

<hr style="height: 2px; width: 100%"/>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 12pt; text-align: center">UNITED STATES<br/>
SECURITIES AND EXCHANGE COMMISSION<br/>
Washington, D.C. 20549<br/>
</p>



<p style="font: bold 9pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 12pt; text-align: center"><span style="font-size: 20pt">_______________</span></p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0; text-align: center"><span style="font-size: 20pt">FORM&#160;<span id="xdx_90B_edei--EntityInvCompanyType_c20240723__20240723_zKQfJTRaBT3b"><ix:nonNumeric contextRef="AsOf2024-07-23" id="Fact000012" name="dei:EntityInvCompanyType">N-2</ix:nonNumeric></span></span></p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 12pt; text-align: center"><span style="font-size: 20pt">_______________&#160;</span></p>



<p style="font: bold 9pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 12pt; text-align: center"><span style="font-size: 20pt"></span><br/></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: 0.5in"><span id="xdx_90A_edei--DocumentRegistrationStatement_c20240723__20240723_zfZrOKKMRmI7"><ix:nonNumeric contextRef="AsOf2024-07-23" format="ixt:booleantrue" id="Fact000013" name="dei:DocumentRegistrationStatement">[X]</ix:nonNumeric></span> <span style="font-size: 9pt">Registration
Statement under the Securities Act of 1933</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: 0.25in"><span id="xdx_905_edei--DocumentType_dxH_c20240723__20240723_zBFdtyeOMJwb" title="::XDX::N-2%2FA">[X] <span style="font-size: 9pt">Pre-Effective
Amendment No. 1</span></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-indent: 0.5in">[_] <span style="font-size: 9pt">Post-Effective
Amendment No. </span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 0 2.25in; text-indent: 0.5in">and/or</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in"><span id="xdx_908_edei--InvestmentCompanyActRegistration_c20240723__20240723_zJtzCc7RpsTj"><span id="xdx_906_edei--InvestmentCompanyRegistrationAmendment_c20240723__20240723_zkZS73MHsHWg"><ix:nonNumeric contextRef="AsOf2024-07-23" format="ixt:booleantrue" id="Fact000015" name="dei:InvestmentCompanyActRegistration"><ix:nonNumeric contextRef="AsOf2024-07-23" format="ixt:booleantrue" id="Fact000016" name="dei:InvestmentCompanyRegistrationAmendment">[X]</ix:nonNumeric></ix:nonNumeric></span></span> <span style="font-size: 9pt">Registration Statement under
the Investment Company Act of <span id="xdx_90E_edei--InvestmentCompanyRegistrationAmendmentNumber_c20240723__20240723_zJq684Huzvpb"><ix:nonNumeric contextRef="AsOf2024-07-23" id="Fact000017" name="dei:InvestmentCompanyRegistrationAmendmentNumber">1940</ix:nonNumeric></span></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 0 1.75in">[X] <span style="font-size: 9pt">Amendment No.&#160;9</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 2.5in">&#160;</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><span style="font-size: 9pt">_______________________________</span></p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><span style="font-size: 9pt"><span id="xdx_90A_edei--EntityRegistrantName_c20240723__20240723_zuiRDQXfaFcl"><ix:nonNumeric contextRef="AsOf2024-07-23" id="Fact000018" name="dei:EntityRegistrantName">ADVENT CONVERTIBLE
AND INCOME FUND</ix:nonNumeric></span></span><br/>
<span style="font-size: 9pt; font-weight: normal">(Registrant&#8217;s Exact Name as Specified in Charter)</span></p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><span style="font-size: 9pt; font-weight: normal">______________________________&#160;</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 2.5in">&#160;</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">888 Seventh Ave., 31<sup>st</sup> Floor<br/>
<span id="xdx_904_edei--EntityAddressCityOrTown_c20240723__20240723_zkZZDL3qWVe1"><ix:nonNumeric contextRef="AsOf2024-07-23" id="Fact000019" name="dei:EntityAddressCityOrTown">New York</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressStateOrProvince_c20240723__20240723_zhjIpZorzoXk"><ix:nonNumeric contextRef="AsOf2024-07-23" format="ixt-sec:stateprovnameen" id="Fact000020" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span> <span id="xdx_909_edei--EntityAddressPostalZipCode_c20240723__20240723_zXSaZwi8NSHc"><ix:nonNumeric contextRef="AsOf2024-07-23" id="Fact000021" name="dei:EntityAddressPostalZipCode">10019</ix:nonNumeric></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">(Address of Principal Executive Offices)</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b><span id="xdx_90D_edei--CityAreaCode_c20240723__20240723_zU63u6A6zU61"><ix:nonNumeric contextRef="AsOf2024-07-23" id="Fact000022" name="dei:CityAreaCode">(212)</ix:nonNumeric></span> <span id="xdx_900_edei--LocalPhoneNumber_c20240723__20240723_zrk9c7BBWYbd"><ix:nonNumeric contextRef="AsOf2024-07-23" id="Fact000023" name="dei:LocalPhoneNumber">482-1600</ix:nonNumeric></span></b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in">(Registrant&#8217;s Telephone
Number, including Area Code)</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><span id="xdx_907_edei--ContactPersonnelName_c20240723__20240723__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zKduGWJ9Zxvf"><ix:nonNumeric contextRef="From2024-07-232024-07-23_dei_BusinessContactMember" id="Fact000024" name="dei:ContactPersonnelName">Robert J. White</ix:nonNumeric></span><br/>
888 Seventh Ave., <span id="xdx_908_edei--EntityAddressAddressLine1_c20240723__20240723__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_ztIgTDleGSv5"><ix:nonNumeric contextRef="From2024-07-232024-07-23_dei_BusinessContactMember" id="Fact000025" name="dei:EntityAddressAddressLine1">31</ix:nonNumeric></span><sup><span id="xdx_90F_edei--EntityAddressAddressLine2_c20240723__20240723__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zcuUZUSy5Qnc"><ix:nonNumeric contextRef="From2024-07-232024-07-23_dei_BusinessContactMember" id="Fact000026" name="dei:EntityAddressAddressLine2">st</ix:nonNumeric></span></sup> <span id="xdx_902_edei--EntityAddressAddressLine3_c20240723__20240723__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zyBZPnAdqByf"><ix:nonNumeric contextRef="From2024-07-232024-07-23_dei_BusinessContactMember" id="Fact000027" name="dei:EntityAddressAddressLine3">Floor</ix:nonNumeric></span><br/>
<span id="xdx_90F_edei--EntityAddressCityOrTown_c20240723__20240723__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zwg2pia7Bm1h"><ix:nonNumeric contextRef="From2024-07-232024-07-23_dei_BusinessContactMember" id="Fact000028" name="dei:EntityAddressCityOrTown">New York</ix:nonNumeric></span>, <span id="xdx_90C_edei--EntityAddressStateOrProvince_c20240723__20240723__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_z5E5cuqMcRRg"><ix:nonNumeric contextRef="From2024-07-232024-07-23_dei_BusinessContactMember" format="ixt-sec:stateprovnameen" id="Fact000029" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span> <span id="xdx_905_edei--EntityAddressPostalZipCode_c20240723__20240723__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zU1mixHaNiml"><ix:nonNumeric contextRef="From2024-07-232024-07-23_dei_BusinessContactMember" id="Fact000030" name="dei:EntityAddressPostalZipCode">10019</ix:nonNumeric></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: center"><span style="font-size: 9pt">(Name and Address of
Agent for Service)<br/>
</span><span style="text-decoration: underline">________________________________</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center"><i>Copies to</i>:</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Kevin T. Hardy, Esq.</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Skadden, Arps, Slate, Meagher &amp; Flom LLP</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>320 South Canal Street</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Chicago, Illinois 60606</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">Approximate date of proposed public offering: <b><span id="xdx_900_edei--ApproximateDateOfCommencementOfProposedSaleToThePublic_c20240723__20240723_zp0FlnRB9PWg"><ix:nonNumeric contextRef="AsOf2024-07-23" id="Fact000031" name="dei:ApproximateDateOfCommencementOfProposedSaleToThePublic">From time to time
after the effective date of this Registration Statement.</ix:nonNumeric></span></b></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 9pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span id="xdx_90F_edei--DividendOrInterestReinvestmentPlanOnly_c20240723__20240723_zQMLGRBXesYk"><ix:nonNumeric contextRef="AsOf2024-07-23" format="ixt:booleanfalse" id="Fact000032" name="dei:DividendOrInterestReinvestmentPlanOnly">[_]</ix:nonNumeric></span></td><td><span style="font-size: 9pt">Check box if the only securities being registered on this Form are being offered pursuant to dividend
or interest reinvestment plans.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span id="xdx_90C_edei--DelayedOrContinuousOffering_c20240723__20240723_zE2SnrfMlYMl"><ix:nonNumeric contextRef="AsOf2024-07-23" format="ixt:booleantrue" id="Fact000033" name="dei:DelayedOrContinuousOffering">[X]</ix:nonNumeric></span></td><td><span style="font-size: 9pt">Check box if any securities being registered on this Form will be offered on a delayed or continuous
basis in reliance on Rule&#160;415 under the Securities Act of 1933 (&#8220;Securities Act&#8221;), other than securities offered in connection
with a dividend reinvestment plan.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span id="xdx_906_ecef--PrimaryShelfFlag_c20240723__20240723_zgWWGPeW32Ka"><ix:nonNumeric contextRef="AsOf2024-07-23" format="ixt:booleantrue" id="Fact000034" name="cef:PrimaryShelfFlag">[X]</ix:nonNumeric></span></td><td><span style="font-size: 9pt">Check box if this Form is a registration statement pursuant to General Instruction A.2 or a post-effective
amendment thereto.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span id="xdx_908_edei--EffectiveUponFiling462e_c20240723__20240723_zqkhuG3ayqu4"><ix:nonNumeric contextRef="AsOf2024-07-23" format="ixt:booleanfalse" id="Fact000035" name="dei:EffectiveUponFiling462e">[_]</ix:nonNumeric></span></td><td><span style="font-size: 9pt">Check box if this Form is a registration statement pursuant to General Instruction B or a post-effective
amendment thereto that will become effective upon filing with the Commission pursuant to Rule&#160;462(e) under the Securities Act.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span id="xdx_90D_edei--AdditionalSecuritiesEffective413b_c20240723__20240723_zFqvM1k9hjX5"><ix:nonNumeric contextRef="AsOf2024-07-23" format="ixt:booleanfalse" id="Fact000036" name="dei:AdditionalSecuritiesEffective413b">[_]</ix:nonNumeric></span></td><td><span style="font-size: 9pt">Check box if this Form is a post-effective amendment to a registration statement filed pursuant to General
Instruction B to register additional securities or additional classes of securities pursuant to Rule&#160;413(b) under the Securities
Act.</span></td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>It is proposed that this filing will become effective (check appropriate
box):</b></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span id="xdx_905_edei--EffectiveWhenDeclaredSection8c_c20240723__20240723_zsqbaVmzMUyh"><ix:nonNumeric contextRef="AsOf2024-07-23" format="ixt:booleanfalse" id="Fact000037" name="dei:EffectiveWhenDeclaredSection8c">[_]</ix:nonNumeric></span></td><td><span style="font-size: 9pt">When declared effective pursuant to Section&#160;8(c) of the Securities Act.</span></td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>If appropriate, check the following box:</b></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span id="xdx_909_edei--NewEffectiveDateForPreviousFiling_c20240723__20240723_z8cQTeErq16l"><ix:nonNumeric contextRef="AsOf2024-07-23" format="ixt:booleanfalse" id="Fact000038" name="dei:NewEffectiveDateForPreviousFiling">[_]</ix:nonNumeric></span></td><td><span style="font-size: 9pt">This [post-effective] amendment designates a new effective date for a previously filed [post-effective
amendment] [registration statement].</span></td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in; text-indent: -0.25in"><span id="xdx_903_edei--AdditionalSecurities462b_c20240723__20240723_zMBCjDqQ4yke"><ix:nonNumeric contextRef="AsOf2024-07-23" format="ixt:booleanfalse" id="Fact000039" name="dei:AdditionalSecurities462b">[_]</ix:nonNumeric></span><span style="font-size: 9pt">	This
Form is filed to register additional securities for an offering pursuant to Rule&#160;462(b) under the Securities Act, and the Securities
Act registration statement number of the earlier effective registration statement for the same offering is <span style="text-decoration: underline">		</span>.</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in; text-indent: -0.25in"><span id="xdx_90C_edei--NoSubstantiveChanges462c_c20240723__20240723_znIzwXNnkc5i"><ix:nonNumeric contextRef="AsOf2024-07-23" format="ixt:booleanfalse" id="Fact000040" name="dei:NoSubstantiveChanges462c">[_]</ix:nonNumeric></span><span style="font-size: 9pt">	This
Form is a post-effective amendment filed pursuant to Rule&#160;462(c) under the Securities Act, and the Securities Act registration statement
number of the earlier effective registration statement for the same offering is <span style="text-decoration: underline">	</span>.</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in; text-indent: -0.25in"><span id="xdx_908_edei--ExhibitsOnly462d_c20240723__20240723_z7YzZaXWity2"><ix:nonNumeric contextRef="AsOf2024-07-23" format="ixt:booleanfalse" id="Fact000041" name="dei:ExhibitsOnly462d">[_]</ix:nonNumeric></span><span style="font-size: 9pt">	This
Form is a post-effective amendment filed pursuant to Rule&#160;462(d) under the Securities Act, and the Securities Act registration statement
number of the earlier effective registration statement for the same offering is <span style="text-decoration: underline">	</span>.</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Check each box that appropriately characterizes the Registrant:</b></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span id="xdx_90F_ecef--RegisteredClosedEndFundFlag_c20240723__20240723_zmCn3ghlDgs3"><ix:nonNumeric contextRef="AsOf2024-07-23" format="ixt:booleantrue" id="Fact000042" name="cef:RegisteredClosedEndFundFlag">[X]</ix:nonNumeric></span></td><td><span style="font-size: 9pt">Registered Closed-End Fund (closed-end company that is registered under the Investment Company Act of
1940 (&#8220;Investment Company Act&#8221;)).</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span id="xdx_90B_ecef--BusinessDevelopmentCompanyFlag_c20240723__20240723_zOMYntnOrah2"><ix:nonNumeric contextRef="AsOf2024-07-23" format="ixt:booleanfalse" id="Fact000043" name="cef:BusinessDevelopmentCompanyFlag">[_]</ix:nonNumeric></span></td><td><span style="font-size: 9pt">Business Development Company (closed-end company that intends or has elected to be regulated as a business
development company under the Investment Company Act).</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span id="xdx_906_ecef--IntervalFundFlag_c20240723__20240723_z2XMq2ZG4EAb"><ix:nonNumeric contextRef="AsOf2024-07-23" format="ixt:booleanfalse" id="Fact000044" name="cef:IntervalFundFlag">[_]</ix:nonNumeric></span></td><td><span style="font-size: 9pt">Interval Fund (Registered Closed-End Fund or a Business Development Company that makes periodic repurchase
offers under Rule&#160;23c-3 under the Investment Company Act).</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span id="xdx_90D_ecef--PrimaryShelfQualifiedFlag_c20240723__20240723_z5l1m21PciUi"><ix:nonNumeric contextRef="AsOf2024-07-23" format="ixt:booleantrue" id="Fact000045" name="cef:PrimaryShelfQualifiedFlag">[X]</ix:nonNumeric></span></td><td><span style="font-size: 9pt">A.2 Qualified (qualified to register securities pursuant to General Instruction A.2 of this Form).</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span id="xdx_90C_edei--EntityWellKnownSeasonedIssuer_dxL_c20240723__20240723_z1lFSR4zqGwl" title="::XDX::No"><span style="-sec-ix-hidden: xdx2ixbrl0046">[_]</span></span></td><td><span style="font-size: 9pt">Well-Known Seasoned Issuer (as defined by Rule&#160;405 under the Securities Act).</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span id="xdx_909_edei--EntityEmergingGrowthCompany_c20240723__20240723_zJ1TmXLtAVze"><ix:nonNumeric contextRef="AsOf2024-07-23" format="ixt:booleanfalse" id="Fact000047" name="dei:EntityEmergingGrowthCompany">[_]</ix:nonNumeric></span></td><td><span style="font-size: 9pt">Emerging Growth Company (as defined by Rule&#160;12b-2 under the Securities Exchange Act of 1934 (&#8220;Exchange
Act&#8221;)).</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">[_]</td><td><span style="font-size: 9pt">If an Emerging Growth Company, indicate by check mark if the registrant has elected not to use the extended
transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;7(a)(2)(B) of
Securities Act.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span id="xdx_908_ecef--NewCefOrBdcRegistrantFlag_c20240723__20240723_zHw6Axbs1c36"><ix:nonNumeric contextRef="AsOf2024-07-23" format="ixt:booleanfalse" id="Fact000048" name="cef:NewCefOrBdcRegistrantFlag">[_]</ix:nonNumeric></span></td><td><span style="font-size: 9pt">New Registrant (registered or regulated under the Investment Company Act for less than 12 calendar months
preceding this filing).</span></td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in; text-indent: -0.25in">&#160;</p>


<!-- Field: Page; Sequence: 2 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Registrant hereby amends this Registration Statement on such date
or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states
that the Registration Statement shall thereafter become effective in accordance with Section&#160;8(a) of the Securities Act of 1933 or
until the Registration Statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said
Section&#160;8(a), may determine.</p>


<!-- Field: Page; Sequence: 3 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: red"><b>The information in this Prospectus
is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange
Commission is effective. This Prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities
in any state where the offer or sale is not permitted.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: red"><b>Subject To Completion Preliminary Prospectus
dated August 30, 2024</b></p>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>&#160;</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b></b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>BASE PROSPECTUS</b></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 8pt; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font: 9pt Times New Roman, Times, Serif; width: 50%; padding-top: 3pt">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 50%; padding-top: 3pt; text-align: right">&#160;</td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: center"><b>$150,000,000</b></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: center"><b>ADVENT CONVERTIBLE AND INCOME FUND</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Common Shares</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Subscription Rights for Common Shares</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b><i>The Fund</i>.</b> Advent Convertible and Income Fund (the &#8220;Fund&#8221;)
is a diversified, closed-end management investment company.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b><i>Investment Objective</i>. </b>The Fund&#8217;s investment objective
is to provide total return through a combination of capital appreciation and current income. There can be no assurance that the Fund will
achieve its investment objective, and you could lose some or all of your investment.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 0"><b><i>Investment Strategy</i>.</b> Under normal market conditions,
the Fund invests at least 80% of its Managed Assets (as defined in this Prospectus) in a diversified portfolio of convertible securities
and non-convertible income producing securities. Under normal market conditions, the Fund will invest at least 30% of its Managed Assets
in convertible securities and may invest up to 70% of its Managed Assets in non-convertible income securities. The Fund may invest without
limitation in foreign securities. The Fund also uses a strategy of writing (selling) covered call options on up to 25% of the securities
held in the portfolio, thus generating option writing premiums. &#8220;Managed Assets&#8221; means the total assets of the Fund, including
assets attributable to the Fund&#8217;s use of leverage, minus the sum of its accrued liabilities (other than liabilities incurred for
the purpose of creating leverage).</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b><i>Offering.</i></b> The Fund
may offer, from time to time, up to $150,000,000 aggregate initial offering price of common shares of beneficial interest, par value
$0.001 per share (&#8220;common shares&#8221;), and subscription rights to purchase Common Shares (&#8220;Rights,&#8221; and collectively
with the common shares, &#8220;Securities&#8221;) in one or more offerings in amounts, at prices and on terms set forth in one or more
supplements to this Prospectus (each a &#8220;Prospectus Supplement&#8221;). You should read this Prospectus and any related Prospectus
Supplement carefully before you decide to invest in the Securities.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund may offer Securities (1) directly to one or more purchasers,
(2) through agents that the Fund may designate from time to time or (3) to or through underwriters or dealers. The Prospectus Supplement
relating to a particular offering of Securities will identify any agents or underwriters involved in the sale of Securities, and will
set forth any applicable purchase price, fee, commission or discount arrangement between the Fund and agents or underwriters or among
underwriters or the basis upon which such amount may be calculated. The Fund may not sell Securities through agents, underwriters or dealers
without delivery of this Prospectus and a Prospectus Supplement. See &#8220;Plan of Distribution.&#8221;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Investing in the Fund&#8217;s Securities involves certain risks.
Shares of closed-end funds listed for trading on a securities exchange frequently trade at a discount from net asset value. An investment
in the Fund is subject to investment risk, including the possible loss of the entire principal amount that you invest. The Fund utilizes
leverage, which is subject to numerous risks. <span style="font-family: Times-Bold,serif">See &#8220;Risks&#8221; beginning on page 19
of this Prospectus and &#8220;Risks&#8221; in the Fund&#8217;s most recent Annual Report on Form&#160;N-CSR and in any of the Fund&#8217;s
other filings with the Securities and Exchange Commission (&#8220;SEC&#8221;) incorporated herein by reference.</span> You should carefully
consider these risks together with all of the other information contained in this Prospectus before making a decision to purchase the
Fund&#8217;s Securities.</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 0"><b>Neither the SEC nor any state securities commission has approved
or disapproved of these securities or determined if this Prospectus is truthful or complete. Any representation to the contrary is a criminal
offense.</b></p>

<!-- Field: Rule-Page --><div style="margin: 1pt 2.25in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Prospectus dated September [], 2024</b></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><b><i>Adviser</i>. </b>Advent Capital Management, LLC (&#8220;Advent&#8221;
or the &#8220;Adviser&#8221;) serves as the investment adviser to the Fund and is responsible for the day-to-day management of the Fund&#8217;s
portfolio of securities, which includes buying and selling securities for the Fund.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b><i>Common Shares</i>.</b> The Fund&#8217;s outstanding common
shares are, and the common shares offered by this Prospectus will be, subject to notice of issuance, listed on the New York Stock Exchange
(&#8220;NYSE&#8221;) under the symbol &#8220;AVK.&#8221; As of August 23, 2024, the net asset value of the Fund&#8217;s common shares
was $12.36 per share and the last reported sale price for the Fund&#8217;s common shares on the NYSE was $12.69 per share, representing
a premium to net asset value of 2.67%. See &#8220;Market and Net Asset Value Information.&#8221;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b><i>Distributions</i>.</b> The Fund intends to pay substantially
all of its net investment income to Common Shareholders through monthly distributions. In addition, the Fund intends to distribute any
net long-term capital gains to Common Shareholders at least annually. The Fund expects that distributions paid on the Common Shares will
consist primarily of (i) investment company taxable income, which includes, among other things, ordinary income, net short-term capital
gain and income from certain hedging and interest rate transactions, (ii) net capital gain (which is the excess of net long-term capital
gain over net short-term capital loss), and/or (iii) return of capital. Distributions paid by the Fund for any particular month may be
comprised of more or less than the amount of net investment income from that monthly period. As a result, all or a portion of a distribution
may be deemed a return of capital (which is in effect a partial return of the amount a Common Shareholder invested in the Fund) up to
the amount of the Common Shareholder&#8217;s tax basis in their Common Shares, which would reduce such tax basis. The Fund&#8217;s distributions
have historically included, and may in the future include, a significant portion of return of capital. For the fiscal year ended October&#160;31,
2023, the Fund&#8217;s distributions were comprised of approximately 28.04% ordinary income and 71.96% return of capital. Accordingly,
shareholders should not assume that the source of a distribution from the Fund is net income or profit, and the Fund&#8217;s distributions
should not be used as a measure of performance or confused with yield or income. Return of capital is the return of a portion of the
shareholder&#8217;s original investment up to the amount of the Common Shareholder&#8217;s tax basis in their Common Shares, which would
reduce such tax basis. Although a return of capital may not be taxable, it will generally increase the Common Shareholder&#8217;s potential
gain or reduce the Common Shareholder&#8217;s potential loss on any subsequent sale or other disposition of Common Shares, which may
increase taxes payable by a Common Shareholder or reduce a Common Shareholder&#8217;s loss deduction in connection with such sale or
other disposition. Common Shareholders should not assume that the source of a distribution from the Fund is net income or profit, and
Common Shareholders who receive distributions that include return of capital should not assume that such return of capital is derived
from the Fund&#8217;s investments.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b><i>Leverage</i>.</b> As part of its investment strategy, the Fund
utilizes leverage to finance the purchase of additional securities that provide increased income and potentially greater appreciation
potential to common shareholders than could be achieved from a portfolio that is not leveraged. <span style="background-color: white">The
Fund may utilize leverage up to the limits imposed by the Investment Company Act of 1940, as amended (the &#8220;1940 Act&#8221;). Under
the 1940 Act, the Fund may utilize leverage in the form of indebtedness in an aggregate amount up to 33&#160;<sup>1&#160;</sup>/<sub>&#160;3</sub>%
of the Fund&#8217;s Managed Assets (including the proceeds of such leverage) immediately after incurring such indebtedness. Under the
1940 Act, the Fund may utilize leverage in the form of preferred shares in an aggregate amount of up to 50% of the Fund&#8217;s total
assets (including the proceeds of such leverage) immediately after such issuance. The Fund may also invest in reverse repurchase agreements
to the maximum extent permitted by the SEC and/or SEC staff rules, guidance or positions.</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund has entered into a senior secured credit agreement dated December&#160;15,
2017, as amended from time to time through the date hereof, with a financial institution (the &#8220;Credit Agreement&#8221;) pursuant
to which the Fund may borrow up to $158 million. As of April 30, 2024, outstanding borrowings under the Credit Agreement were approximately
$157 million, <span style="background-color: white">which represented approximately 21.5% of the Fund&#8217;s Managed Assets as of such
date. In addition, as of April 30, 2024, the Fund had reverse repurchase agreements outstanding representing leverage equal to approximately
21.5% of the Fund&#8217;s Managed Assets as of such date. As of April 30, 2024, the Fund&#8217;s total financial leverage, </span>through
indebtedness under the Credit Agreement and reverse repurchase agreements, <span style="background-color: white">represented approximately
43.0% of the Fund&#8217;s Managed Assets.</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><span style="background-color: white">In addition, the Fund may engage
in certain derivatives transactions that have economic characteristics similar to leverage to the extent permitted by the SEC and/or SEC
staff rules, guidance or positions.</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The use of leverage is a speculative technique that involves special
risks. There can be no assurance that the Fund&#8217;s leveraging strategy will be successful. See &#8220;Use of Leverage&#8221; in this
Prospectus and &#8220;Investment Objective, Policies and Principal Risks&#8212;Principal Risks&#8212;Leverage Risk&#8221; in the Fund&#8217;s
Annual Report.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: center">* * *</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">You should read this Prospectus and the documents incorporated herein
by reference, which contain important information about the Fund that you should know before deciding whether to invest, and retain it
for future reference. A Statement of Additional Information, dated September [], 2024, containing additional information about the Fund,
has been filed with the SEC and is incorporated by reference in its entirety into this Prospectus.</p>


<!-- Field: Page; Sequence: 5 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>The Fund&#8217;s Securities do not represent a deposit or obligation
of, and are not guaranteed or endorsed by, any bank or other insured depository institution and are not federally insured by the Federal
Deposit Insurance Corporation, the Federal Reserve Board or any other government agency.</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">As permitted by regulations adopted by the SEC, paper copies of the
Fund&#8217;s annual and semi-annual shareholder reports will no longer be sent by mail, unless you specifically request paper copies of
the reports from the Fund or from your financial intermediary, such as a broker-dealer or bank. Instead, the reports will be made available
on the Fund&#8217;s website (www.guggenheiminvestments.com/cef/fund/avk), and you will be notified by mail each time a report is posted
and provided with a website link to access the report.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">You may elect to receive all future reports in paper free of charge.
If you own these shares through a financial intermediary, such as a broker-dealer or bank, you may contact your financial intermediary
to request that you continue to receive paper copies of your shareholder reports. If you invest directly with the Fund, you can inform
the Fund that you wish to continue receiving paper copies of your shareholder reports by calling (800) 345-7999. Your election to receive
reports in paper will apply to all funds held with the fund complex if you invest directly with the Fund or to all funds held in your
account if you invest through your financial intermediary.</p>


<!-- Field: Page; Sequence: 6 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 8pt; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: bold 9pt Times New Roman, Times, Serif; padding: 12pt 5.4pt; width: 100%; text-align: center">TABLE OF CONTENTS</td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: right">	Page</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>



<table cellpadding="0" cellspacing="0" style="width: 100%">
  <tr style="font: 9pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 90%; text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in">ABOUT THIS PROSPECTUS</td>
    <td style="width: 10%; text-align: right; padding-top: 0in; padding-bottom: 0in">i</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in">WHERE YOU CAN FIND MORE INFORMATION</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0in">ii</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in">INCORPORATION BY REFERENCE</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0in">ii</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in">PROSPECTUS SUMMARY</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0in">1</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in">SUMMARY OF FUND EXPENSES</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0in">6</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in">FINANCIAL HIGHLIGHTS</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0in">7</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in">THE FUND</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0in">8</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in">USE OF PROCEEDS</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0in">8</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in">MARKET AND NET ASSET VALUE INFORMATION</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0in">8</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in">INVESTMENT OBJECTIVE AND POLICIES</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0in">9</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in">THE FUND&#8217;S INVESTMENTS</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0in">9</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in">USE OF LEVERAGE</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0in">15</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in">RISKS</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0in">19</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in">MANAGEMENT OF THE FUND</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0in">20</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in">NET ASSET VALUE</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0in">21</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in">DISTRIBUTIONS</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0in">22</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in">DIVIDEND REINVESTMENT PLAN</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0in">23</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in">DESCRIPTION OF CAPITAL STRUCTURE</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0in">23</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in">DESCRIPTION OF SUBSCRIPTION RIGHTS THAT MAY BE ISSUED</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0in">25</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in">ANTI-TAKEOVER PROVISIONS IN THE FUND&#8217;S GOVERNING DOCUMENTS</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0in">27</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in">CERTAIN PROVISIONS OF DELAWARE LAW, THE DECLARATION OF TRUST AND BY-LAWS</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0in">28</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in">CLOSED-END FUND STRUCTURE</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0in">30</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in">TAX MATTERS</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0in">31</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in">PLAN OF DISTRIBUTION</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0in">37</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in">SERVICING AGENT, TRANSFER AGENT, CUSTODIAN AND ADMINISTRATOR</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0in">39</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in">LEGAL MATTERS</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0in">39</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in">INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0in">39</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in">FISCAL YEAR END AND REPORTS TO SHAREHOLDERS</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0in">39</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in">PRIVACY PRINCIPLES OF THE FUND</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0in">41</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in">TABLE&#160; OF CONTENTS OF STATEMENT OF ADDITIONAL INFORMATION</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0in">42</td></tr>
</table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 7 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">ABOUT THIS PROSPECTUS</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">This Prospectus
is part of a registration statement on Form&#160;N-2 that the Fund filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;)
using a &#8220;shelf&#8221; registration process. Under this process, the Fund may offer, from time to time, up to $150,000,000 aggregate
initial offering price of Securities in one or more offerings in amounts, at prices and on terms set forth in one or more Prospectus
Supplements. The Prospectus Supplement may also add, update or change information contained in this Prospectus. You should carefully
read this Prospectus and any accompanying Prospectus Supplement, together with the additional information described under the heading
&#8220;Where You Can Find More Information.&#8221;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">This Prospectus, any accompanying Prospectus Supplement and the Statement
of Additional Information, contain (or will contain) or incorporate (or will incorporate) by reference forward-looking statements, within
the meaning of the federal securities laws, that involve risks and uncertainties. These statements describe the Fund&#8217;s plans, strategies,
and goals and the Fund&#8217;s beliefs and assumptions concerning future economic and other conditions and the outlook for the Fund, based
on currently available information. In this Prospectus and any accompanying Prospectus Supplement, words such as &#8220;anticipates,&#8221;
&#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;objectives,&#8221; &#8220;goals,&#8221; &#8220;future,&#8221; &#8220;intends,&#8221;
&#8220;seeks,&#8221; &#8220;will,&#8221; &#8220;may,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; and similar expressions, and the
negative of such terms, are used in an effort to identify forward-looking statements, although some forward-looking statements may be
expressed differently. By their nature, all forward-looking statements involve risks and uncertainties, and actual results could differ
materially from those contemplated by any forward looking statements. Although the Fund believes that the expectations expressed in these
forward-looking statements are (or will be) reasonable, actual results could differ materially from those projected or assumed in these
forward-looking statements. The Fund&#8217;s future financial condition and results of operations, as well as any forward-looking statements,
are subject to change and are subject to inherent risks and uncertainties, such as those disclosed in the &#8220;Risks&#8221; sections
of this Prospectus and the Fund&#8217;s most recent Annual Report, which describe certain currently known risk factors that could cause
actual results to differ materially from the Fund&#8217;s expectations, and, if applicable, additional risk considerations described in
an accompanying Prospectus Supplement. The Fund urges you to review carefully that section for a more detailed discussion of the risks
associated with an investment in the Fund&#8217;s securities. All forward-looking statements contained or incorporated by reference in
this Prospectus and any accompanying Prospectus Supplement are made as of the date of this Prospectus and any accompanying Prospectus
Supplement. The Fund does not intend, and undertakes no obligation, to update any forward-looking statement. The Fund is not entitled
to the safe harbor for forward-looking statements pursuant to Section&#160;27A of the Securities Act of 1933 (the &#8220;Securities Act&#8221;).</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">You should rely only on the information contained
or incorporated by reference in this Prospectus and any accompanying Prospectus Supplement. The Fund has not authorized any other person
to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it.
The Fund is not making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should not
assume that the information in this Prospectus and any accompanying Prospectus Supplement is accurate as of any date other than the date
of this Prospectus and any accompanying Prospectus Supplement. The Fund&#8217;s business, financial condition and results of operations
may have changed since that date. The Fund will amend this Prospectus and any accompanying Prospectus Supplement if, during the period
that this Prospectus and any accompanying Prospectus Supplement is required to be delivered, there are any subsequent material changes.</p>

<p style="font: 9pt Times New Roman, Times, Serif; text-align: center; margin-top: 12pt; margin-bottom: 12pt">i</p>


<!-- Field: Page; Sequence: 8 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 9pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt"><b>&#160;</b></p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">WHERE YOU CAN FIND MORE INFORMATION</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund is subject to the informational requirements of the Securities
Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and the 1940 Act and in accordance therewith files, or will file, reports and other
information with the SEC. Reports, proxy statements and other information filed by the Fund with the SEC pursuant to the informational
requirements of the Exchange&#160;Act and the 1940 Act can be inspected and copied at the public reference facilities maintained by the
SEC, 100&#160;F&#160;Street, N.E., Washington,&#160;D.C. 20549. The SEC maintains a web site at www.sec.gov containing reports, proxy
and information statements and other information regarding registrants, including the Fund, that file electronically with the SEC</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">This Prospectus constitutes part of a Registration Statement filed by
the Fund with the SEC under the Securities Act, and the 1940 Act. This Prospectus omits certain of the information contained in the Registration
Statement, and reference is hereby made to the Registration Statement and related exhibits for further information with respect to the
Fund and the common shares offered hereby. Any statements contained herein concerning the provisions of any document are not necessarily
complete, and, in each instance, reference is made to the copy of such document filed as an exhibit to the Registration Statement or otherwise
filed with the SEC. Each such statement is qualified in its entirety by such reference. The complete Registration Statement may be obtained
from the SEC upon payment of the fee prescribed by its rules and regulations or free of charge through the SEC&#8217;s website (www.sec.gov).</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><span style="background-color: white">The Fund will provide without
charge to each person, including any beneficial owner, to whom this Prospectus is delivered, upon written or oral request, a copy of any
and all of the information that has been incorporated by reference in this Prospectus or any accompanying Prospectus Supplement. You may
request such information </span>by calling (800) 345-7999 or by writing to Guggenheim Funds Distributors, LLC at 227 West Monroe Street,
7<sup>th</sup> Floor, Chicago, Illinois, 60606, or you may obtain a copy (and other information regarding the Fund) from the SEC&#8217;s
website (www.sec.gov). Free copies of the Fund&#8217;s Prospectus, Statement of Additional Information and any incorporated information
will also be available from the Fund&#8217;s website at www.guggenheiminvestments.com/cef/fund/avk. <span style="background-color: white">Information
contained on the Fund&#8217;s website is not incorporated by reference into this Prospectus or any Prospectus Supplement and should not
be considered to be part of this Prospectus or any Prospectus Supplement.</span></p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">INCORPORATION BY REFERENCE</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><span style="background-color: white">This Prospectus is part of a registration
statement that the Fund has filed with the SEC. The Fund is permitted to &#8220;incorporate by reference&#8221; the information that it
files with the SEC, which means that the Fund can disclose important information to you by referring you to those documents. The information
incorporated by reference is an important part of this Prospectus, and later information that the Fund files with the SEC will automatically
update and supersede this information. </span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><span style="background-color: white">The documents listed below, and
any reports and other documents subsequently filed by the Fund with the SEC pursuant to Rule&#160;30(b)(2) under the 1940 Act and Sections&#160;13(a),
13(c), 14 or 15(d) of the Exchange Act, prior to the termination of the offering, and any reports and other documents subsequently filed
by the Fund with the SEC pursuant to Rule&#160;30(b)(2) under the 1940 Act and Sections&#160;13(a), 13(c), 14 or 15(d) of the Exchange
Act after the date of the initial registration statement and prior to the effectiveness of the registration statement, are incorporated
by reference into this Prospectus and deemed to be part of this Prospectus from the date of the filing of such reports and documents:</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the Fund&#8217;s
                                            Statement of Additional Information, dated September [], 2024, filed with this Prospectus
                                            (&#8220;SAI&#8221;);</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><span style="background-color: white">the
                                            Fund&#8217;s Annual Report on Form&#160;<a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm">N-CSR</a>
                                            for the fiscal year ended October&#160;31, 2023, filed with the SEC on December&#160;29,
                                            2023 (&#8220;Annual Report&#8221;);</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><span style="background-color: white">the
                                            Fund&#8217;s Semi-Annual Report on Form <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126824000124/gug87515avk-ncsr.htm">N-CSRS</a>
                                            for the period ended April 30, 2024, filed with the SEC on July 3, 2024 (&#8220;Semi-Annual
                                            Report&#8221;); </span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><span style="background-color: white">the
                                            financial highlights contained within the Fund&#8217;s Annual Report on Form <a href="https://www.sec.gov/Archives/edgar/data/1219120/000089180419000003/gug75351-ncsr.htm">N-CSR</a>
                                            for the fiscal year ended October 31, 2018, filed with the SEC on January 4, 2019;</span></td></tr></table>


<p style="font: 9pt Times New Roman, Times, Serif; text-align: center; margin-top: 12pt; margin-bottom: 12pt"><span style="background-color: white">ii&#160;</span></p>
<!-- Field: Page; Sequence: 9 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"><br/></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><span style="background-color: white">the
                                            Fund&#8217;s definitive proxy statement on <a href="https://www.sec.gov/Archives/edgar/data/1219120/000182126824000183/gug87836avk.htm">Schedule&#160;14A</a>
                                            for its 2024 annual meeting of shareholders, filed with the SEC on August&#160;2, 2024 (&#8220;Proxy
                                            Statement&#8221;); and</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><span style="background-color: white">the
                                            Fund&#8217;s description of common shares contained in its Registration Statement on <a href="https://www.sec.gov/Archives/edgar/data/1219120/000095017203001191/s426975.txt">Form&#160;8-A</a>
                                            (File No.&#160;001-31663) filed with the SEC on April&#160;10, 2003.</span></td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><span style="background-color: white">To obtain
copies of these filings, see &#8220;Where You Can Find More Information.&#8221;&#160;</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; text-align: center; margin-top: 12pt; margin-bottom: 12pt"><span style="background-color: white">iii&#160;</span></p>


<!-- Field: Page; Sequence: 10 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">PROSPECTUS SUMMARY</p>

<table cellspacing="0" cellpadding="0" style="font-size: 8pt; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font: 9pt Times New Roman, Times, Serif; width: 33%; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-indent: 0in"><b>The Fund 	</b></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 67%; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-indent: 0in">Advent Convertible and Income Fund is a diversified, closed-end management investment company registered under the 1940 Act. The Fund was organized as a Delaware statutory trust on February&#160;18, 2003. The common shares commenced trading on the NYSE on April&#160;29, 2003. The Fund&#8217;s principal office is located at <span id="xdx_90E_edei--EntityAddressAddressLine1_c20240723__20240723_ze5N8PL7Skl6"><ix:nonNumeric contextRef="AsOf2024-07-23" id="Fact000049" name="dei:EntityAddressAddressLine1">888 Seventh Ave., 31st Floor</ix:nonNumeric></span>, <span id="xdx_90C_edei--EntityAddressAddressLine2_c20240723__20240723_zZJs79n8DHgc"><ix:nonNumeric contextRef="AsOf2024-07-23" id="Fact000050" name="dei:EntityAddressAddressLine2">New York, New York 10019</ix:nonNumeric></span>, and its telephone number is (212) 482-1600.</td></tr>
  <tr style="vertical-align: top">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-indent: 0in"><b>The Offering 	</b></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">The Fund may offer, from time to time, up to $150,000,000
    aggregate initial offering price of Securities, including common shares and Rights, in one or more offerings in amounts, at prices
    and on terms set forth in one or more Prospectus Supplements. You should read this Prospectus and any related Prospectus Supplement
    carefully before you decide to invest in the Securities.</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0in">The Fund may offer Securities (1) directly to one
    or more purchasers, (2) through agents that the Fund may designate from time to time or (3) to or through underwriters or dealers. The
    Prospectus Supplement relating to a particular offering of Securities will identify any agents or underwriters involved in the sale of
    Securities, and will set forth any applicable purchase price, fee, commission or discount arrangement between the Fund and agents or underwriters
    or among underwriters or the basis upon which such amount may be calculated. The Fund may not sell Securities through agents, underwriters
    or dealers without delivery of this Prospectus and a Prospectus Supplement. See &#8220;Plan of Distribution.&#8221;</p></td></tr>
  <tr style="vertical-align: top">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-indent: 0in"><b>Use of Proceeds	</b></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-indent: 0in">The
    Fund registered $150,000,000 aggregate initial offering price of Securities pursuant to the registration statement of which this
    Prospectus is a part. Unless otherwise specified in a Prospectus Supplement, the Fund intends to invest the net proceeds of an offering
    of Securities in accordance with its investment objective and policies as stated in this Prospectus. It is currently anticipated
    that the Fund will be able to invest substantially all of the net proceeds of an offering of Securities in accordance with its investment
    objective and policies within three months after the completion of such offering. Pending the full investment of the proceeds of
    an offering, it is anticipated that all or a portion of the proceeds will be invested in U.S. Government securities or high grade,
    short-term money market instruments, which have returns substantially lower than those the Fund anticipates earning once it has fully
    invested the proceeds of an offering in accordance with its investment objective. A delay in the anticipated use of proceeds could
    lower returns and reduce the Fund&#8217;s distribution to common shareholders.</td></tr>

<tr style="vertical-align: top">
    <td style="font: 9pt Times New Roman, Times, Serif; width: 33%; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-indent: 0in"><b>Investment Objective and <br/>
Policies 	</b></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 67%; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-indent: 0in"><br/>
Under normal market conditions, the Fund invests at least 80% of its Managed Assets (as defined in this Prospectus) in a diversified portfolio of convertible securities and non-convertible income producing securities. Under normal market conditions, the Fund will invest at least 30% of its Managed Assets in convertible securities and may invest up to 70% of its Managed Assets in non-convertible income securities. The Fund may invest without limitation in foreign securities. The Fund also uses a strategy of writing (selling) covered call options on up to 25% of the securities held in the portfolio, thus generating option writing premiums. </td></tr>
</table>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 11; Options: NewSection -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font-size: 8pt; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-indent: 0in; width: 33%"/>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-indent: 0in; width: 67%"><br/> See &#8220;Investment Objective and Policies&#8221; and &#8220;The Fund&#8217;s Investments&#8221; in this Prospectus. </td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font-size: 8pt; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-indent: 0in; width: 33%"><b>Risks 	</b></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-indent: 0in; width: 67%">See &#8220;Risks&#8221; in this Prospectus and the information contained under the heading &#8220;Investment Objective, Policies and Principal Risks&#8212;Principal Risks&#8221; in the Fund&#8217;s Annual Report. Investors should consider the specific risk factors and special considerations associated with investing in the Fund. An investment in the Fund is subject to investment risk, including the possible loss of your entire investment. A Prospectus Supplement relating to an offering of the Fund&#8217;s securities may identify additional risk associated with such offering.</td></tr>
  <tr style="vertical-align: top">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-indent: 0in"><b>Use of Leverage 	</b></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">As part of its investment strategy, the Fund utilizes leverage to
    finance the purchase of additional securities that provide increased income and potentially greater appreciation potential to common shareholders
    than could be achieved from a portfolio that is not leveraged. <span style="background-color: white">The Fund may utilize leverage up
    to the limits imposed by the Investment Company Act of 1940, as amended (the &#8220;1940 Act&#8221;). Under the 1940 Act, the Fund may
    utilize leverage in the form of indebtedness in an aggregate amount up to 33&#160;<sup>1&#160;</sup>/<sub>&#160;3</sub>% of the Fund&#8217;s
    Managed Assets (including the proceeds of such leverage) immediately after incurring such indebtedness. Under the 1940 Act, the Fund may
    utilize leverage in the form of preferred shares in an aggregate amount of up to 50% of the Fund&#8217;s total assets (including the proceeds
    of such leverage) immediately after such issuance. The Fund may also invest in reverse repurchase agreements to the maximum extent permitted
    by the SEC and/or SEC staff rules, guidance or positions.</span></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">The Fund has entered into a senior secured credit agreement dated
    December&#160;15, 2017, as amended from time to time through the date hereof, with a financial institution (the &#8220;Credit Agreement&#8221;)
    pursuant to which the Fund may borrow up to $158 million. As of April 30, 2024, outstanding borrowings under the Credit Agreement were
    approximately $157 million, <span style="background-color: white">which represented approximately 21.5% of the Fund&#8217;s Managed Assets
    as of such date. In addition, as of April 30, 2024, the Fund had reverse repurchase agreements outstanding representing leverage equal
    to approximately 21.5% of the Fund&#8217;s Managed Assets as of such date. As of April 30, 2024, the Fund&#8217;s total financial leverage,
    </span>through indebtedness under the Credit Agreement and reverse repurchase agreements, <span style="background-color: white">represented
    approximately 43.0% of the Fund&#8217;s Managed Assets.</span></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt"><span style="background-color: white">In addition, the Fund may engage
    in certain derivatives transactions that have economic characteristics similar to leverage to the extent permitted by the SEC and/or SEC
    staff rules, guidance or positions.</span></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">The use of leverage is a speculative technique that involves special
    risks. There can be no assurance that the Fund&#8217;s leveraging strategy will be successful. See &#8220;Use of Leverage&#8221; in this
    Prospectus and &#8220;Investment Objective, Policies and Principal Risks&#8212;Principal Risks&#8212;Leverage Risk&#8221; in the Fund&#8217;s
    Annual Report.</p></td></tr>
  </table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font-size: 8pt; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font: 9pt Times New Roman, Times, Serif; width: 33%; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-indent: 0in"><b>Management of the Fund 	</b></td>
    <td style="width: 67%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">Advent is responsible for the daily management of the Fund&#8217;s
portfolio of investments, which includes buying and selling securities for the Fund, as well as investment research. Advent is a registered
investment adviser, based in New York, which specializes in convertible and high-yield securities for institutional and individual investors.
The firm was established by Tracy V. Maitland, a former Director in the Convertible Securities sales and trading division of Merrill
Lynch. Advent&#8217;s </p></td></tr>
  </table>

<!-- Field: Page; Sequence: 12 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<table cellspacing="0" cellpadding="0" style="font-size: 8pt; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-indent: 0in; width: 33%"/>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 67%">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt"> investment discipline emphasizes capital structure research, encompassing equity fundamentals as well as credit research,
    with a focus on cash flow and asset values while seeking to maximize total return. As of May 31, 2024 Advent managed more than $7.8 billion
    in assets.</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">The Adviser receives an annual fee from the Fund based on the average
    value of the Fund&#8217;s Managed Assets. If the average value of the Fund&#8217;s Managed Assets (calculated monthly) is greater than
    $250 million, the fee will be a maximum amount equal to 0.54% of the average value of the Fund&#8217;s Managed Assets.</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">The fee paid to the Adviser is calculated on the basis of the Fund&#8217;s
    Managed Assets, including proceeds from leverage, so the fees paid to the Adviser will be higher when leverage is utilized. The Fund bears
    the portion of the management fee attributable to assets purchased with the proceeds of leverage and therefore common shareholders effectively
    bear the entire management fee.</p></td></tr>
</table>

<table cellspacing="0" cellpadding="0" style="font-size: 8pt; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font: 9pt Times New Roman, Times, Serif; width: 33%; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-indent: 0in"><b>Distributions 	</b></td>
    <td style="width: 67%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0in">The Fund intends to pay substantially all of its
    net investment income to Common Shareholders through monthly distributions. In addition, the Fund intends to distribute any net long-term
    capital gains to Common Shareholders at least annually. The Fund expects that distributions paid on the Common Shares will consist primarily
    of (i) investment company taxable income, which includes, among other things, ordinary income, net short-term capital gain and income
    from certain hedging and interest rate transactions, (ii) net capital gain (which is the excess of net long-term capital gain over net
    short-term capital loss), and/or (iii) return of capital. Distributions paid by the Fund for any particular month may be comprised of
    more or less than the amount of net investment income from that monthly period. As a result, all or a portion of a distribution may be
    deemed a return of capital (which is in effect a partial return of the amount a Common Shareholder invested in the Fund) up to the amount
    of the Common Shareholder&#8217;s tax basis in their Common Shares, which would reduce such tax basis.</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0in"><b>The Fund&#8217;s distributions have
historically included, and may in the future include, a significant portion of return of capital. For the fiscal year ended October&#160;31,
2023, the Fund&#8217;s distributions were comprised of approximately 28.04% ordinary income and 71.96% return of capital. </b>Accordingly,
shareholders should not assume that the source of a distribution from the Fund is net income or profit, and the Fund&#8217;s distributions
should not be used as a measure of performance or confused with yield or income. Return of capital is the return of a portion of the
shareholder&#8217;s original investment up to the amount of the Common Shareholder&#8217;s tax basis in their Common Shares, which would
reduce such tax basis. Although a return of capital may not be taxable, it will generally increase the Common Shareholder&#8217;s potential
gain or reduce the Common Shareholder&#8217;s potential loss on any subsequent sale or other disposition of Common Shares, which may
increase taxes payable by a Common Shareholder or reduce a Common Shareholder&#8217;s loss deduction in connection with such sale or
other disposition. Common Shareholders should not assume that the source of a distribution from the Fund is net income or profit, and
Common Shareholders who receive distributions that include return of capital should not assume that such return of capital is derived
from the Fund&#8217;s investments.</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0in">Alternatively, the Fund may also distribute less than its net investment
income in a particular period. The undistributed net investment income may be available to supplement future common share distributions.
Undistributed net investment income is included in the Common Shares&#8217;</p></td></tr>
</table>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 13 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<table cellspacing="0" cellpadding="0" style="font-size: 8pt; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-indent: 0in; width: 33%"><b> 	</b></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 67%">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0in">net asset value, and, correspondingly, distributions
from net investment income will reduce the Common Shares&#8217; net asset value.</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0in">With each distribution that does not consist solely of
net investment income, the Fund will issue a notice to shareholders that will provide estimated information regarding the amount and
composition of the distribution. The amounts and sources of distributions reported in each notice will be estimated, are likely to change
over time and are not provided for tax reporting purposes. The final determination of such amounts will be made and reported to shareholders
after the end of the calendar year when the Fund determines its earnings and profits for the year. The actual amounts and sources of
the amounts for accounting and tax reporting purposes will depend upon the Fund&#8217;s investment experience during its full fiscal
year and may be subject to changes based on tax regulations. The Fund will send each shareholder a Form&#160;1099-DIV for the calendar
year that will tell shareholders how to report distributions for federal income tax purposes.</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0in">The Fund&#8217;s distribution rate is not constant
    and the amount of distributions, when and if declared by the Fund&#8217;s Board of Trustees, is subject to change based on the performance
    of the Fund.</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0in">See &#8220;Distributions&#8221; in this Prospectus.</p></td></tr>
</table>

<p style="margin: 0"></p>

<p style="margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font-size: 8pt; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-indent: 0in; width: 33%"><b>Listing and Symbol 	</b></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; width: 67%">The Fund&#8217;s currently outstanding common shares are, and common shares offered by this Prospectus will be, listed on the NYSE under the symbol &#8220;AVK.&#8221;</td></tr>
  <tr style="vertical-align: top">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-indent: 0in"><b>Anti-Takeover Provisions <br/>
in the Fund&#8217;s Governing Documents 	</b></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0in"><br/>
    <br/>
    The Fund presently has provisions in its Governing Documents which could have the effect of limiting, in each case, (i) the ability of
    other entities or persons to acquire control of the Fund, (ii) the Fund&#8217;s freedom to engage in certain transactions or (iii) the
    ability of the Fund&#8217;s Board of Trustees or shareholders to amend the Governing Documents or effectuate changes in the Fund&#8217;s
    management. See &#8220;Anti-Takeover Provisions in the Fund&#8217;s Governing Documents&#8221; in this Prospectus.</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: justify">In addition, as a Delaware statutory trust, the
    Fund is subject to the control share acquisition statute (the &#8220;Control Share Statute&#8221;) contained in Subchapter III of the
    Delaware Statutory Trust Act (the &#8220;DSTA&#8221;), which became automatically applicable to listed closed-end funds, such as the Fund,
    upon its effective date of August&#160;1, 2022 (the &#8220;Effective Date&#8221;). The Control Share Statute provides that an acquirer
    of shares above a series of voting power thresholds has no voting rights under the DSTA or the governing documents of the Fund with respect
    to shares acquired in excess of that threshold (<i>i.e.</i>, the &#8220;control shares&#8221;) unless approved by shareholders. See &#8220;Certain
    Provisions of Delaware Law, the Declaration of Trust and By-Laws&#8212;Delaware Control Share Statute.</p></td></tr>
  <tr style="vertical-align: top">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-indent: 0in"><b>Tax Matters 	</b></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">The Fund has elected to be treated and intends to continue to qualify each year as a regulated investment company (&#8220;RIC&#8221;) under subchapter M of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;). See &#8220;Tax Matters.&#8221;</td></tr>
  </table>

<!-- Field: Page; Sequence: 14 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font-size: 8pt; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font: 9pt Times New Roman, Times, Serif; width: 33%; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-indent: 0in"><b>Administrator 	</b></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 67%; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-indent: 0in">MUFG Investor Services (US), LLC serves as the Fund&#8217;s Administrator. Pursuant to an administration agreement with the Fund, MUFG provides certain administrative, bookkeeping and accounting services to the Fund.</td></tr>
  <tr style="vertical-align: top">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-indent: 0in"><b>Servicing Agent 	</b></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-indent: 0in">Guggenheim Funds Distributors, LLC acts as servicing agent to the Fund. The Servicing Agent is located at 227 West Monroe Street, Chicago, IL 60606. Pursuant to a servicing agreement with the Fund, the Servicing Agent provides the Fund a variety of services, including (i) replying to requests for information concerning the Fund from shareholders or prospective shareholders, brokers or the public; (ii) aiding in the secondary market support of the Fund through regular written and oral communications with the Fund&#8217;s NYSE designated market maker, the closed-end fund analyst community and various information providers specializing in the dissemination of closed-end fund information; (iii) coordinating and overseeing activities of the Fund&#8217;s administrator; (iv) developing and maintaining a website for the Fund and (v) overseeing, in consultation with, and as agreed by, Advent matters relating to the conduct and administration of meetings of the Board of Trustees and committees thereof.</td></tr>
  <tr style="vertical-align: top">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-indent: 0in"><b>Custodian 	</b></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-indent: 0in">All securities owned by the Fund and all cash, including proceeds from the sale of securities in the Fund&#8217;s investment portfolio, are held by The Bank of New York Mellon, as custodian (the &#8220;<span style="font-weight: normal">Custodian</span>&#8221;). The Custodian is responsible for holding all securities, other investments and cash, receiving and paying for securities purchased, delivering against payment securities sold, receiving and collecting income from investments, making all payments covering expenses and performing other administrative duties, all as directed by authorized persons.</td></tr>
  <tr style="vertical-align: top">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-indent: 0in"><b>Transfer Agent 	</b></td>
    <td style="font: 9pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-indent: 0in">Computershare Trust Company, N.A. serves as the Fund&#8217;s transfer agent.</td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"></p>


<!-- Field: Page; Sequence: 15 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt"><b>&#160;</b></p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">SUMMARY OF FUND EXPENSES</p>

<p id="xdx_986_ecef--PurposeOfFeeTableNoteTextBlock_c20240723__20240723_zqZjWHlCoQua" style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 4pt"><ix:nonNumeric contextRef="AsOf2024-07-23" escape="true" id="Fact000051" name="cef:PurposeOfFeeTableNoteTextBlock">The following table contains information about the costs and expenses
that common shareholders will bear directly or indirectly. The table is based on the capital structure of the Fund as of April 30, 2024
(except as noted below). The purpose of the table and the example below is to help you understand the fees and expenses that you, as a
common shareholder, would bear directly or indirectly.</ix:nonNumeric></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 10pt 0"><b>Shareholder Transaction Expenses</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"></p>

<ix:nonNumeric contextRef="AsOf2024-07-23" escape="true" id="Fact000053" name="cef:ShareholderTransactionExpensesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_881_ecef--ShareholderTransactionExpensesTableTextBlock_dD_z3KBRlDp5omd" summary="xdx: Disclosure - Shareholder Transaction Expenses" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left; background-color: rgb(204,238,255)">
  <td style="width: 80%">	Sales load paid by common shareholders (as a percentage of offering
price)</td>
  <td style="text-align: right; width: 20%">-<span id="xdx_909_ecef--SalesLoadPercent_d0_c20240723__20240723_fKDEp_zZ6toKgp8uKl"><ix:nonFraction name="cef:SalesLoadPercent" contextRef="AsOf2024-07-23" id="Fact000055" format="ixt:zerodash" decimals="INF" sign="-" unitRef="Ratio">-</ix:nonFraction></span>%<sup>(1)</sup></td></tr>
<tr style="vertical-align: top; text-align: left; background-color: White">
  <td>	Offering expenses borne by the Fund (as a percentage of offering price)</td>
  <td style="text-align: right">-<span id="xdx_90B_ecef--OtherTransactionExpensesPercent_d0_c20240723__20240723_fKDEp_zbfML4Jbsyzg"><ix:nonFraction name="cef:OtherTransactionExpensesPercent" contextRef="AsOf2024-07-23" id="Fact000056" format="ixt:zerodash" decimals="INF" sign="-" unitRef="Ratio">-</ix:nonFraction></span>%<sup>(1)</sup></td></tr>
<tr style="vertical-align: top; text-align: left; background-color: rgb(204,238,255)">
  <td>	Dividend Reinvestment Plan fees</td>
  <td style="text-align: right"><span id="xdx_906_ecef--DividendReinvestmentAndCashPurchaseFees_dn_c20240723__20240723_fKDIp_zShu8yFN6pX5"><ix:nonFraction name="cef:DividendReinvestmentAndCashPurchaseFees" contextRef="AsOf2024-07-23" id="Fact000057" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">None</ix:nonFraction></span><sup>(2)</sup></td></tr>
</table></ix:nonNumeric>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="AsOf2024-07-23" escape="true" id="Fact000059" name="cef:AnnualExpensesTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_881_ecef--AnnualExpensesTableTextBlock_dD_zsixZZo5XI2j" summary="xdx: Disclosure - Annual Expenses" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>As a Percentage of <br/>
Net Assets Attributable to Common Shares</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt"><b>Annual Expenses</b></span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 0.25in"><span style="font-size: 9pt">Management fees<sup>(3) </sup>	</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 9pt"><span id="xdx_902_ecef--ManagementFeesPercent_c20240723__20240723_fKDMp_zeAmj4lATutc"><ix:nonFraction name="cef:ManagementFeesPercent" contextRef="AsOf2024-07-23" id="Fact000061" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.95</ix:nonFraction>%</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 0.25in"><span style="font-size: 9pt">Interest Expense<sup>(4)</sup> 	</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 9pt"><span id="xdx_900_ecef--InterestExpensesOnBorrowingsPercent_c20240723__20240723_fKDQp_zrsKgdU6Gk02"><ix:nonFraction name="cef:InterestExpensesOnBorrowingsPercent" contextRef="AsOf2024-07-23" id="Fact000062" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">4.21</ix:nonFraction>%</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 76%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other Expenses<sup>(5)</sup> 	</span></td>
    <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 9pt"><span id="xdx_904_ecef--OtherAnnualExpensesPercent_c20240723__20240723_fKDUp_z7qNvSNtAGwd"><ix:nonFraction name="cef:OtherAnnualExpensesPercent" contextRef="AsOf2024-07-23" id="Fact000063" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.83</ix:nonFraction>%</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 0.25in"><span style="font-size: 9pt">Total annual expenses 	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 9pt"><span id="xdx_90D_ecef--TotalAnnualExpensesPercent_c20240723__20240723_zrjvigGKazve"><ix:nonFraction name="cef:TotalAnnualExpensesPercent" contextRef="AsOf2024-07-23" id="Fact000064" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">5.99</ix:nonFraction>%</span></span></td></tr>
  </table></ix:nonNumeric>
<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><sup>____________</sup></td><td/></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 4pt"><tr style="vertical-align: top">
<td style="width: 0"/><td id="xdx_F0F_zlzpHIKmu8jl" style="width: 0.25in">(1)</td><td id="xdx_F13_z5Yg9vTbHeWa"><ix:footnote id="Footnote000065" xml:lang="en-US">If common shares are sold to or through underwriters, a prospectus or prospectus supplement will set forth any applicable sales load
and the estimated offering expenses borne by the Fund.</ix:footnote></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 4pt"><tr style="vertical-align: top">
<td style="width: 0"/><td id="xdx_F0A_ziXZ8JdTNMud" style="width: 0.25in">(2)</td><td id="xdx_F1E_zlkpFmnYyNA4"><ix:footnote id="Footnote000066" xml:lang="en-US">Common shareholders will incur brokerage charges if they direct Computershare Trust Company, N.A., as Plan Agent for the common shareholders,
to sell their common shares held in a dividend reinvestment account.</ix:footnote></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 4pt"><tr style="vertical-align: top">
<td style="width: 0"/><td id="xdx_F01_zAciPIhtYCAc" style="width: 0.25in">(3)</td><td id="xdx_F1A_z1uRVYZ3UxGf"><ix:footnote id="Footnote000067" xml:lang="en-US">The Fund pays the Adviser an annual management fee, payable monthly in arrears, in an amount equal to 0.54% of the Fund&#8217;s average
daily Managed Assets. Common shareholders bear the portion of the investment advisory fee attributable to the assets purchased with the
proceeds of leverage, which means that common shareholders effectively bear the entire management fee. <span id="xdx_907_ecef--ManagementFeeNotBasedOnNetAssetsNoteTextBlock_c20240723__20240723_zZkZOhKRxHZh"><ix:nonNumeric contextRef="AsOf2024-07-23" escape="true" id="Fact000068" name="cef:ManagementFeeNotBasedOnNetAssetsNoteTextBlock">The contractual management fee
rate of 0.54% of the Fund&#8217;s Managed Assets represents an effective management fee rate of 0.95% of net assets attributable to common
shares, assuming leverage of 43.0% of the Fund&#8217;s Managed Assets (the Fund&#8217;s outstanding leverage as of April 30, 2024)</ix:nonNumeric></span>.</ix:footnote></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 4pt"><tr style="vertical-align: top">
<td style="width: 0"/><td id="xdx_F06_zxkmVOuOgDK8" style="width: 0.25in">(4)</td><td id="xdx_F1D_zmw5QakTWDI9"><ix:footnote id="Footnote000069" xml:lang="en-US">Includes interest payments on borrowed funds and interest expense on reverse repurchase agreements. Interest payments on borrowed
funds is based upon the Fund&#8217;s outstanding borrowings under the Credit Agreement as of April 30, 2024, in an amount equal to 21.5%
of the Fund&#8217;s Managed Assets, at an annual interest rate cost to the Fund of 5.97% (the weighted average interest rate paid by the
Fund during the six months ended April 30, 2024). Interest expenses on reverse repurchase agreements is based on the Fund&#8217;s outstanding
reverse repurchase agreements as of April 30, 2024, representing 21.5% of the Fund&#8217;s Managed Assets at an annual interest rate cost
to the Fund of 4.80% (the weighted average interest rate cost incurred by the Fund during the six months ended April 30, 2024). The actual
amount of interest expense incurred by the Fund will vary over time in accordance with the amount of borrowings and reverse repurchase
agreements and variations in market interest rates.</ix:footnote></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 4pt"><tr style="vertical-align: top">
<td style="width: 0"/><td id="xdx_F01_zL0RRrnXr7lf" style="width: 0.25in">(5)</td><td id="xdx_F1E_zdN5KrGEQ2o2"><ix:footnote id="Footnote000070" xml:lang="en-US">&#8220;<span id="xdx_908_ecef--OtherExpensesNoteTextBlock_c20240723__20240723_zojKjAEkfRF2"><ix:nonNumeric contextRef="AsOf2024-07-23" escape="true" id="Fact000071" name="cef:OtherExpensesNoteTextBlock">Other Expenses&#8221; are based on estimated amounts for the six months ended April 30, 2024.</ix:nonNumeric></span></ix:footnote></td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: justify"><b>Example</b></p>
<div id="xdx_98B_ecef--ExpenseExampleTableTextBlock_c20240723__20240723_z0eUSfUNmdI6"><ix:nonNumeric contextRef="AsOf2024-07-23" escape="true" id="Fact000072" name="cef:ExpenseExampleTableTextBlock">
<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 10pt">The following example illustrates the expenses that you would pay
on a $1,000 investment in common shares, assuming (1) total annual expenses of 5.99% of net assets attributable to common shares, and
(2) a 5% annual return. The example assumes that the estimated Total Annual Expenses set forth in the Annual Expenses table are accurate
and that all dividends and distributions are reinvested at net asset value per common share. Actual expenses may be greater or less than
those assumed. Moreover, the Fund&#8217;s actual rate of return may be greater or less than the hypothetical 5% return shown in the example.</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>1 Year</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 31%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>3 Years</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>5 Years</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>10 Years</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><span id="xdx_90B_ecef--ExpenseExampleYear01_c20240723__20240723_zihIgongleEg">$<ix:nonFraction name="cef:ExpenseExampleYear01" contextRef="AsOf2024-07-23" id="Fact000073" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60</ix:nonFraction></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><span id="xdx_908_ecef--ExpenseExampleYears1to3_c20240723__20240723_zwpMArH0TKL2">$<ix:nonFraction name="cef:ExpenseExampleYears1to3" contextRef="AsOf2024-07-23" id="Fact000074" format="ixt:numdotdecimal" decimals="0" unitRef="USD">177</ix:nonFraction></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><span id="xdx_90B_ecef--ExpenseExampleYears1to5_c20240723__20240723_zQ9oDX08wgX5">$<ix:nonFraction name="cef:ExpenseExampleYears1to5" contextRef="AsOf2024-07-23" id="Fact000075" format="ixt:numdotdecimal" decimals="0" unitRef="USD">292</ix:nonFraction></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><span id="xdx_90D_ecef--ExpenseExampleYears1to10_c20240723__20240723_zaAFgg8cJFac">$<ix:nonFraction name="cef:ExpenseExampleYears1to10" contextRef="AsOf2024-07-23" id="Fact000076" format="ixt:numdotdecimal" decimals="0" unitRef="USD">570</ix:nonFraction></span></span></td></tr>
  </table>
</ix:nonNumeric></div>
<!-- Field: Page; Sequence: 16 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 10pt 0 6pt">The Example should not be considered a representation of future
expenses or returns. Actual expenses may be higher or lower than those assumed. Moreover, the Fund&#8217;s actual rate of return may be
higher or lower than the hypothetical 5% return shown in the example.</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">FINANCIAL HIGHLIGHTS</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span style="background-color: white">The financial highlights table
is intended to help you understand the Fund&#8217;s financial performance for the periods presented.</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span style="background-color: white">The financial highlights
for the six-month period ended April 30, 2024 are incorporated by reference to the Fund&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126824000124/gug87515avk-ncsr.htm">Semi-Annual Report</a> to Shareholders to the period ended April 30, 2024, as contained in the Fund&#8217;s Form N-CSRS filed with the SEC on July
3, 2024.</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span style="background-color: white">The financial highlights
for the fiscal years ended October&#160;31, 2023, 2022, 2021, 2020 and 2019 are incorporated by reference to the Fund&#8217;s Annual
Report to shareholders for the year ended October 31, 2023, as contained in the Fund&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm">Form N-CSR</a> filed with the SEC on December 29, 2023, and has been audited by </span>PricewaterhouseCoopers LLP<span style="background-color: white">,
independent registered public accounting firm for the Fund. The report of </span>PricewaterhouseCoopers LLP i<span style="background-color: white">s
included in the Fund&#8217;s Annual Report to shareholders for the year ended October 31, 2023, as contained in the Registrant&#8217;s
Form N-CSR filed with the SEC on December 29, 2023, and is incorporated herein by reference. </span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span style="background-color: white">The financial highlights
for the fiscal years ended October 31, 2018, 2017, 2016, 2015 and 2014 are incorporated by reference to the Fund&#8217;s Annual Report
to shareholders for the year ended October 31, 2018, as contained in the Registrant&#8217;s <a href="https://www.sec.gov/Archives/edgar/data/1219120/000089180419000003/gug75351-ncsr.htm">Form N-CSR</a> filed with the SEC on January 4, 2019.</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><b>SENIOR SECURITIES</b></p>
<ix:nonNumeric contextRef="AsOf2024-07-23" escape="true" id="Fact000078" name="cef:SeniorSecuritiesTableTextBlock"><div id="xdx_88C_ecef--SeniorSecuritiesTableTextBlock_dD_zAYOTBTY2Xlg"><p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">The
                                            following table sets forth information about the Fund&#8217;s outstanding senior securities
                                            as of the end of each fiscal set forth below. The information in this table for the fiscal
                                            years ended <span style="background-color: white">October&#160;31, 2023, 2022, 2021, 2020
                                            and 2019 has been audited by </span>PricewaterhouseCoopers LLP<span style="background-color: white">,
                                            independent registered public accounting firm for the Fund. The report of </span>PricewaterhouseCoopers
                                            LLP i<span style="background-color: white">s included in the Fund&#8217;s Annual Report to
                                            shareholders for the year ended October 31, 2023, as contained in the Registrant&#8217;s
                                            <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm">Form N-CSR</a> filed with the SEC on December 29, 2023, and is incorporated herein by reference.</span></span></p></div>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span style="background-color: white"><b>Senior Securities Representing
Indebtedness</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 27%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt"><b>Fiscal Year Ended</b></span></td>
    <td style="width: 38%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>Principal <br/>
Amount Outstanding(1)(2)</b></span></td>
    <td style="width: 35%; padding-right: 5.4pt; padding-left: 0.25in; text-align: center"><span style="font-size: 9pt"><b>Asset Coverage <br/>
Per $1,000 of Principal Amount</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">October&#160;31, 2023</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$173,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center"><span style="font-size: 9pt">$3,159</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">October&#160;31, 2022</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$173,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center"><span style="font-size: 9pt">$3,480</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">October&#160;31, 2021</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$168,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center"><span style="font-size: 9pt">$5,139</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">October&#160;31, 2020</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$168,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center"><span style="font-size: 9pt">$4,300</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">October&#160;31, 2019</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$210,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center"><span style="font-size: 9pt">$3,686</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">October&#160;31, 2018</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$235,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center"><span style="font-size: 9pt">$3,381</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">October&#160;31, 2017</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$150,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center"><span style="font-size: 9pt">$3,356</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">October&#160;31, 2016</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$170,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center"><span style="font-size: 9pt">$3,256</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">October&#160;31, 2015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$170,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center"><span style="font-size: 9pt">$3,374</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">October&#160;31, 2014</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$170,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center"><span style="font-size: 9pt">$3,635</span></td></tr>
  </table></ix:nonNumeric>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(1)</td><td>Principal amount outstanding represents the principal amount owed by the Fund to lenders under credit facility arrangements in place
at the time.</td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(2)</td><td>For each fiscal year listed above, the Fund also had outstanding leverage through reverse repurchase agreements.</td></tr></table>


<!-- Field: Page; Sequence: 17 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt/115% Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 10pt"><b>THE FUND</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Advent Convertible and Income Fund is a diversified, closed-end management
investment company registered under the 1940 Act. The Fund was organized as a Delaware statutory trust on February&#160;18, 2003. The
common shares commenced trading on the NYSE on April&#160;29, 2003. The Fund&#8217;s principal office is located at 888 Seventh Ave.,
31<sup>st</sup> Floor, New York, New York 10019, and its telephone number is (212) 482-1600.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Advent Capital Management, LLC serves as the Fund&#8217;s investment
adviser and is responsible for the management of the Fund.</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">USE OF PROCEEDS</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt">The Fund registered $150,000,000 aggregate initial offering price
of Securities pursuant to the registration statement of which this Prospectus is a part. Unless otherwise specified in a Prospectus Supplement,
the Fund intends to invest the net proceeds of an offering of Securities in accordance with its investment objective and policies as
stated in this Prospectus. It is currently anticipated that the Fund will be able to invest substantially all of the net proceeds of
an offering of Securities in accordance with its investment objective and policies within three months after the completion of such offering.
Pending the full investment of the proceeds of an offering, it is anticipated that all or a portion of the proceeds will be invested
in U.S. Government securities or high grade, short-term money market instruments, which have returns substantially lower than those the
Fund anticipates earning once it has fully invested the proceeds of an offering in accordance with its investment objective. A delay
in the anticipated use of proceeds could lower returns and reduce the Fund&#8217;s distribution to common shareholders.</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">MARKET AND NET ASSET VALUE INFORMATION</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 4pt">The Fund&#8217;s currently outstanding common shares are, and the
common shares offered pursuant to this Prospectus Supplement and the accompanying Prospectus will be, subject to notice of issuance, listed
on the NYSE. The common shares commenced trading on the NYSE on April&#160;29, 2003.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 4pt">The Fund&#8217;s common shares have traded both at a premium and
at a discount to the Fund&#8217;s net asset value per share. There can be no assurance that the common shares will trade at a premium
or discount to net asset value after the offering. Shares of closed-end investment companies frequently trade at a discount to net asset
value. The Fund&#8217;s net asset value will be reduced immediately following an offering of the common shares due to the costs of such
offering, which will be borne entirely by the Fund. The sale of common shares by the Fund (or the perception that such sales may occur)
may have an adverse effect on prices of common shares in the secondary market. An increase in the number of common shares available for
sale may result in downward pressure on the market price for common shares. See &#8220;Risks&#8212;Market Discount Risk&#8221; in the
Fund&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm">Annual Report</a>, which
is incorporated by reference herein.</p>

<ix:nonNumeric contextRef="AsOf2024-07-23" escape="true" id="Fact000081" name="cef:SharePriceTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_880_ecef--SharePriceTableTextBlock_dD_zbG3ufhqacEc" summary="xdx: Disclosure - Share Prices" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>Market
    Price</b></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>Corresponding
    Net Asset Value Per Common Share</b></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>Corresponding
    Premium/(Discount) as a Percentage of <br/>
    Net Asset Value</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt"><b><span style="text-decoration: underline">Fiscal Quarter Ended</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>High</b></span></td>
    <td style="border-top: Black 1pt solid; width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>Low</b></span></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>High</b></span></td>
    <td style="border-top: Black 1pt solid; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>Low</b></span></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>High</b></span></td>
    <td style="border-top: Black 1pt solid; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>Low</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">July 31, 2024</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$12.85</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$11.58</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$12.28</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$12.06</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">4.64%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">-3.98%</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">April&#160;30, 2024</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_900_ecef--HighestPriceOrBid_c20240201__20240430_z4uMbWGvVjva" style="font-size: 9pt">$<ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2024-02-012024-04-30" id="Fact000083" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.10</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_905_ecef--LowestPriceOrBid_c20240201__20240430_zMhcbO0z9rCk" style="font-size: 9pt">$<ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2024-02-012024-04-30" id="Fact000084" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.23</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90B_ecef--HighestPriceOrBidNav_c20240201__20240430_zHxUBXxDy2A2" style="font-size: 9pt">$<ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2024-02-012024-04-30" id="Fact000085" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.59</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_905_ecef--LowestPriceOrBidNav_c20240201__20240430_zj6EJuQQ4Co8" style="font-size: 9pt">$<ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2024-02-012024-04-30" id="Fact000086" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.95</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_901_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_c20240201__20240430_zfkX7NzVc3dd" style="font-size: 9pt">-<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-02-012024-04-30" id="Fact000087" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">3.89</ix:nonFraction>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_900_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_c20240201__20240430_z35rfiYeAHMg" style="font-size: 9pt">-<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-02-012024-04-30" id="Fact000088" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">6.03</ix:nonFraction>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">January&#160;31, 2024</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_904_ecef--HighestPriceOrBid_c20231101__20240131_zWfReKqL3klb" style="font-size: 9pt">$<ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2023-11-012024-01-31" id="Fact000089" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.71</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90C_ecef--LowestPriceOrBid_c20231101__20240131_znc7p8uAHF8h" style="font-size: 9pt">$<ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2023-11-012024-01-31" id="Fact000090" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.64</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_907_ecef--HighestPriceOrBidNav_c20231101__20240131_z7bFOUe30hS7" style="font-size: 9pt">$<ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2023-11-012024-01-31" id="Fact000091" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.39</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_907_ecef--LowestPriceOrBidNav_c20231101__20240131_zJy8rAP6b1C7" style="font-size: 9pt">$<ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2023-11-012024-01-31" id="Fact000092" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.86</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90B_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_c20231101__20240131_zN2Phtro7wsd" style="font-size: 9pt">-<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-11-012024-01-31" id="Fact000093" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">5.49</ix:nonFraction>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90A_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_c20231101__20240131_zQ638F4tdPVg" style="font-size: 9pt">-<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-11-012024-01-31" id="Fact000094" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">11.23</ix:nonFraction>%</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">October&#160;31, 2023</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_907_ecef--HighestPriceOrBid_c20230801__20231030_z65QkuS88VB3" style="font-size: 9pt">$<ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2023-08-012023-10-30" id="Fact000095" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.96</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_904_ecef--LowestPriceOrBid_c20230801__20231030_zDK9JC2rNn1g" style="font-size: 9pt">$<ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2023-08-012023-10-30" id="Fact000096" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.27</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90B_ecef--HighestPriceOrBidNav_c20230801__20231030_z6BvqeDy95Lk" style="font-size: 9pt">$<ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2023-08-012023-10-30" id="Fact000097" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.79</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_902_ecef--LowestPriceOrBidNav_c20230801__20231030_zhgGpBQl1ixf" style="font-size: 9pt">$<ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2023-08-012023-10-30" id="Fact000098" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.81</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90D_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_c20230801__20231030_zDdlKEujvbbf" style="font-size: 9pt">-<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-08-012023-10-30" id="Fact000099" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">6.49</ix:nonFraction>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_905_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_c20230801__20231030_zGTyfs99uxee" style="font-size: 9pt">-<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-08-012023-10-30" id="Fact000100" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">14.25</ix:nonFraction>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">July&#160;31, 2023</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_902_ecef--HighestPriceOrBid_c20230501__20230731_zcJTdQQBDwQk" style="font-size: 9pt">$<ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2023-05-012023-07-31" id="Fact000101" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.96</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_902_ecef--LowestPriceOrBid_c20230501__20230731_zlXhILcSeh69" style="font-size: 9pt">$<ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2023-05-012023-07-31" id="Fact000102" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.01</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_905_ecef--HighestPriceOrBidNav_c20230501__20230731_zZZJausECy4a" style="font-size: 9pt">$<ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2023-05-012023-07-31" id="Fact000103" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.89</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90E_ecef--LowestPriceOrBidNav_c20230501__20230731_zSjfqiH7PGxb" style="font-size: 9pt">$<ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2023-05-012023-07-31" id="Fact000104" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.99</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_905_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_c20230501__20230731_zKFoYz9DvGKl" style="font-size: 9pt">-<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-05-012023-07-31" id="Fact000105" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">7.21</ix:nonFraction>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_903_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_c20230501__20230731_z18wYAu0BHD9" style="font-size: 9pt">-<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-05-012023-07-31" id="Fact000106" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">8.17</ix:nonFraction>%</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">April&#160;30, 2023</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_906_ecef--HighestPriceOrBid_c20230201__20230430_z2V2E7YqaGb1" style="font-size: 9pt">$<ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2023-02-012023-04-30" id="Fact000107" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.13</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90D_ecef--LowestPriceOrBid_c20230201__20230430_zi70uPkYnFue" style="font-size: 9pt">$<ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2023-02-012023-04-30" id="Fact000108" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.06</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_906_ecef--HighestPriceOrBidNav_c20230201__20230430_z3hnkZi7Dh2" style="font-size: 9pt">$<ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2023-02-012023-04-30" id="Fact000109" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.60</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90E_ecef--LowestPriceOrBidNav_c20230201__20230430_zjvk11eDzIz2" style="font-size: 9pt">$<ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2023-02-012023-04-30" id="Fact000110" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.90</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_902_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_c20230201__20230430_z5Vj2U3Qycs2" style="font-size: 9pt">-<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-02-012023-04-30" id="Fact000111" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">3.46</ix:nonFraction>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90C_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_c20230201__20230430_zCULwQIbe6Of" style="font-size: 9pt">-<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-02-012023-04-30" id="Fact000112" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">7.06</ix:nonFraction>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">January&#160;31, 2023</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90F_ecef--HighestPriceOrBid_c20221101__20230131_zHHLbUA8I0m5" style="font-size: 9pt">$<ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2022-11-012023-01-31" id="Fact000113" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.57</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90E_ecef--LowestPriceOrBid_c20221101__20230131_zFG46Luy6HB1" style="font-size: 9pt">$<ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2022-11-012023-01-31" id="Fact000114" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.81</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90C_ecef--HighestPriceOrBidNav_c20221101__20230131_z6bw4cyXe5Hc" style="font-size: 9pt">$<ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2022-11-012023-01-31" id="Fact000115" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.23</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_908_ecef--LowestPriceOrBidNav_c20221101__20230131_z51NAzC5gLZ5" style="font-size: 9pt">$<ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2022-11-012023-01-31" id="Fact000116" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.22</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_906_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_c20221101__20230131_zYiCA5rP8FBi" style="font-size: 9pt">-<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2022-11-012023-01-31" id="Fact000117" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">4.99</ix:nonFraction>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90C_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_c20221101__20230131_zdcvoNQssIT1" style="font-size: 9pt">-<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2022-11-012023-01-31" id="Fact000118" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">11.54</ix:nonFraction>%</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">October&#160;31, 2022</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90E_ecef--HighestPriceOrBid_c20220801__20221031_zzMDlbzJKwrb" style="font-size: 9pt">$<ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2022-08-012022-10-31" id="Fact000119" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">14.70</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90B_ecef--LowestPriceOrBid_c20220801__20221031_z6si7MtqHu3c" style="font-size: 9pt">$<ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2022-08-012022-10-31" id="Fact000120" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.43</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_901_ecef--HighestPriceOrBidNav_c20220801__20221031_zmtMhP0AMLWj" style="font-size: 9pt">$<ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2022-08-012022-10-31" id="Fact000121" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">14.15</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90B_ecef--LowestPriceOrBidNav_c20220801__20221031_zEdoV40X7MH" style="font-size: 9pt">$<ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2022-08-012022-10-31" id="Fact000122" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.73</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90D_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_c20220801__20221031_z7NK3Q6diEP7" style="font-size: 9pt"><ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2022-08-012022-10-31" id="Fact000123" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">3.89</ix:nonFraction>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_901_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_c20220801__20221031_zrU5Fqruq8M1" style="font-size: 9pt">-<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2022-08-012022-10-31" id="Fact000124" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">11.08</ix:nonFraction>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">July&#160;31, 2022</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90F_ecef--HighestPriceOrBid_c20220501__20220731_zw5L6wOQvZtc" style="font-size: 9pt">$<ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2022-05-012022-07-31" id="Fact000125" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">14.53</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90A_ecef--LowestPriceOrBid_c20220501__20220731_zrnlgPKJSQEi" style="font-size: 9pt">$<ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2022-05-012022-07-31" id="Fact000126" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.75</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_906_ecef--HighestPriceOrBidNav_c20220501__20220731_z2VmpkWqG0g3" style="font-size: 9pt">$<ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2022-05-012022-07-31" id="Fact000127" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.08</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_904_ecef--LowestPriceOrBidNav_c20220501__20220731_zSIa2K58vfmc" style="font-size: 9pt">$<ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2022-05-012022-07-31" id="Fact000128" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.38</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_900_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_c20220501__20220731_zJOr16qWOvci" style="font-size: 9pt">-<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2022-05-012022-07-31" id="Fact000129" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">3.65</ix:nonFraction>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90B_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_c20220501__20220731_zTQT2G5R8Wxl" style="font-size: 9pt">-<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2022-05-012022-07-31" id="Fact000130" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">5.09</ix:nonFraction>%</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">April&#160;30, 2022</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_900_ecef--HighestPriceOrBid_c20220201__20220430_z73PEurZSRne" style="font-size: 9pt">$<ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2022-02-012022-04-30" id="Fact000131" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">16.87</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_900_ecef--LowestPriceOrBid_c20220201__20220430_zRbSehzl8Go4" style="font-size: 9pt">$<ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2022-02-012022-04-30" id="Fact000132" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">14.18</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_905_ecef--HighestPriceOrBidNav_c20220201__20220430_zFsEgRxXhcp3" style="font-size: 9pt">$<ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2022-02-012022-04-30" id="Fact000133" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">16.73</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_907_ecef--LowestPriceOrBidNav_c20220201__20220430_zpm3Ij8V6ICb" style="font-size: 9pt">$<ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2022-02-012022-04-30" id="Fact000134" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">14.99</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_904_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_c20220201__20220430_zOVwTdAsv3Qj" style="font-size: 9pt"><ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2022-02-012022-04-30" id="Fact000135" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.84</ix:nonFraction>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_907_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_c20220201__20220430_zak2vfZ39uI4" style="font-size: 9pt">-<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2022-02-012022-04-30" id="Fact000136" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">5.40</ix:nonFraction>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">January&#160;31, 2022</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90F_ecef--HighestPriceOrBid_c20211101__20220131_z4xnNJ9lTUFl" style="font-size: 9pt">$<ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2021-11-012022-01-31" id="Fact000137" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">19.39</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90D_ecef--LowestPriceOrBid_c20211101__20220131_zKOh415XjV4f" style="font-size: 9pt">$<ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2021-11-012022-01-31" id="Fact000138" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.59</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90C_ecef--HighestPriceOrBidNav_c20211101__20220131_zWBDlLHwhkbh" style="font-size: 9pt">$<ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2021-11-012022-01-31" id="Fact000139" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">20.31</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_901_ecef--LowestPriceOrBidNav_c20211101__20220131_zYL6SkJTdeX1" style="font-size: 9pt">$<ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2021-11-012022-01-31" id="Fact000140" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">16.62</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90B_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_c20211101__20220131_zneeC22xEuk4" style="font-size: 9pt">-<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2021-11-012022-01-31" id="Fact000141" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">4.53</ix:nonFraction>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_902_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_c20211101__20220131_zVzRt3pRA7D7" style="font-size: 9pt">-<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2021-11-012022-01-31" id="Fact000142" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">6.20</ix:nonFraction>%</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  </table></ix:nonNumeric>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 4pt">As of August 23, 2024,
34,600,881 common shares were outstanding. The last reported sales price, net asset value per share and percentage premium to net
asset value per share on August 23, 2024 was $12.69, $12.36 and 2.67%,</p>


<!-- Field: Page; Sequence: 18 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 4pt">respectively. The Fund cannot predict whether its common shares
will trade in the future at a premium to or discount from net asset value, or the level of any premium or discount. Shares of closed-end
investment companies frequently trade at a discount from net asset value.</p>

<p id="xdx_98C_ecef--InvestmentObjectivesAndPracticesTextBlock_c20240723__20240723_gBFIOAPTB-IV_zOFJQKqbvnX6" style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center"><ix:nonNumeric contextRef="AsOf2024-07-23" continuedAt="ConU000157-01" escape="true" id="Fact000157" name="cef:InvestmentObjectivesAndPracticesTextBlock">INVESTMENT OBJECTIVE AND POLICIES</ix:nonNumeric></p>

<div id="xdx_C00_gBFIOAPTB-IV_zvxoAHf9gwpi"><ix:continuation continuedAt="ConU000157-02" id="ConU000157-01"><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The information contained
                                            under the headings &#8220;Investment Objective, Policies and Principal Risks&#8212;Investment
                                            Objective and Policies,&#8221; &#8220;About the Fund Manager&#8212;Investment Philosophy&#8221;
                                            and &#8220;About the Fund Manager&#8212;Investment Process&#8221; in the Fund&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm">Annual Report</a> is incorporated herein by reference.</p></ix:continuation></div>

<div id="xdx_C0A_gBFIOAPTB-IV_zbPiexj7RPn3"><ix:continuation continuedAt="ConU000157-03" id="ConU000157-02"><p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">THE FUND&#8217;S INVESTMENTS</p></ix:continuation></div>

<div id="xdx_C04_gBFIOAPTB-IV_z6nDTT7g3zxf"><ix:continuation continuedAt="ConU000157-04" id="ConU000157-03"><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund&#8217;s investment portfolio may consist of investments in
the following types of securities. There is no guarantee that the fund will buy all of the types of securities or use all of the investment
techniques that are described herein.</p></ix:continuation></div>

<div id="xdx_C00_gBFIOAPTB-IV_zMCF1VVItgTc"><ix:continuation continuedAt="ConU000157-05" id="ConU000157-04"><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Convertible and Non-Convertible Securities Allocation</i>. Under
normal market conditions, the Fund invests at least 80% of its Managed Assets (as defined in this Prospectus) in a diversified portfolio
of convertible securities and non-convertible income producing securities. Under normal market conditions, the Fund will invest at least
30% of its Managed Assets in convertible securities and may invest up to 70% of its Managed Assets in non-convertible income securities.
The Fund may invest without limitation in convertible securities.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in"><span style="text-decoration: underline">Convertible Securities</span>. A convertible security is a
bond, debenture, note, stock or other similar security that may be converted into or exchanged for a prescribed amount of common stock
or other equity security of the same or a different issuer within a particular period of time at a specified price or formula. A convertible
security may also be structured so that it is convertible at the option of the holder or the issuer, or subject to mandatory conversion.
Before conversion, convertible securities have characteristics similar to nonconvertible debt securities in that they ordinarily provide
a stream of income with generally higher yields than those of common stock of the same or similar issuers. Convertible securities are
senior in rank to common stock in a corporation&#8217;s capital structure and, therefore, generally entail less risk than the corporation&#8217;s
common stock, although the extent to which such risk is reduced depends in large measure upon the degree to which the convertible security
sells above its value as a fixed income security.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in">The Fund believes that the characteristics of convertible
securities make them appropriate investments for an investment company seeking a high level of total return on its assets. These characteristics
include the potential for capital appreciation if the value of the underlying common stock increases, the relatively high yield received
from dividend or interest payments as compared to common stock dividends and decreased risks of decline in value, relative to the underlying
common stock due to their fixed income nature. As a result of the conversion feature, however, the interest rate or dividend preference
on a convertible security is generally less than would be the case if the securities were not convertible. During periods of rising interest
rates, it is possible that the potential for capital gain on a convertible security may be less than that of a common stock equivalent
if the yield on the convertible security is at a level that causes it to sell at a discount.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in">Every convertible security may be valued, on a theoretical
basis, as if it did not have a conversion privilege. This theoretical value is determined by the yield it provides in comparison with
the yields of other securities of comparable character and quality that do not have a conversion privilege. This theoretical value, which
may change with prevailing interest rates, the credit rating of the issuer and other pertinent factors, often referred to as the &#8220;investment
value,&#8221; represents the security&#8217;s theoretical price support level.</p>

</ix:continuation></div><div id="xdx_C01_gBFIOAPTB-IV_zNUeM3Yx6knj"><ix:continuation continuedAt="ConU000157-06" id="ConU000157-05"><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in">&#8220;Conversion value&#8221; is the amount a convertible
security would be worth in market value if it were to be exchanged for the underlying equity security pursuant to its conversion privilege.
Conversion value fluctuates directly with the price of the underlying equity security, usually common stock. If, because of low prices
for the common stock, the conversion value is substantially below the investment value, the price of the convertible security is governed
principally by the factors described in the preceding paragraph. If the conversion value rises near or above its investment value, the
price of the convertible security generally will rise above its investment value and, in addition, will sell at some premium over its
conversion value. This premium represents the price investors are willing to pay for the privilege of</p></ix:continuation></div>


<!-- Field: Page; Sequence: 19 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C03_gBFIOAPTB-IV_zea66JBB8uCl"><ix:continuation continuedAt="ConU000157-07" id="ConU000157-06"><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in">purchasing a fixed-income security with a possibility of capital
appreciation due to the conversion privilege. Accordingly, the conversion value of a convertible security is subject to equity risk, that
is, the risk that the price of an equity security will fall due to general market and economic conditions, perceptions regarding the industry
in which the issuer participates or the issuing company&#8217;s particular circumstances. If the appreciation potential of a convertible
security is not realized, its conversion value premium may not be recovered.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in"><span style="text-decoration: underline">Non-Convertible Income Securities</span>. The Fund may also
invest in income securities other than convertible securities that are expected to periodically accrue or generate income for their holders.
Such income securities include (i) fixed income securities such as bonds, debentures, notes, preferred stock, short-term discounted Treasury
Bills or certain securities of the U.S. government sponsored instrumentalities, as well as money market mutual funds that invest in those
securities, which, in the absence of an applicable exemptive order, will not be affiliated with the Adviser, and (ii) common and preferred
stocks of issuers that have historically paid periodic dividends. Fixed income securities obligate the issuer to pay to the holder of
the security a specified return, which may be either fixed or reset periodically in accordance with the terms of the security. Fixed income
securities generally are senior to an issuer&#8217;s common stock and their holders generally are entitled to receive amounts due before
any distributions are made to common stockholders. Common stocks, on the other hand, generally do not obligate an issuer to make periodic
distributions to holders.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in">The market value of fixed income securities, especially those
that provide a fixed rate of return, may be expected to rise and fall inversely with interest rates and in general is affected by the
credit rating of the issuer, the issuer&#8217;s performance and perceptions of the issuer in the market place. The market value of callable
or redeemable fixed income securities may also be affected by the issuer&#8217;s call and redemption rights. In addition, it is possible
that the issuer of fixed income securities may not be able to meet its interest or principal obligations to holders. Further, holders
of non-convertible fixed income securities do not participate in any capital appreciation of the issuer.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in">The Fund may also invest in obligations of government sponsored
instrumentalities. Unlike non-U.S. government securities, obligations of certain agencies and instrumentalities of the U.S. government,
such as the Government National Mortgage Association, are supported by the &#8220;full faith and credit&#8221; of the U.S. government;
others, such as those of the Export-Import Bank of the U.S., are supported by the right of the issuer to borrow from the U.S. Treasury;
others, such as those of the Federal National Mortgage Association, are supported by the discretionary authority of the U.S. government
to purchase the agency&#8217;s obligations; and still others, such as those of the Student Loan Marketing Association, are supported only
by the credit of the instrumentality. No assurance can be given that the U.S. government would provide financial support to U.S. government
sponsored instrumentalities if it is not obligated to do so by law. Although the Fund may invest in all types of obligations of agencies
and instrumentalities of the U.S. government, the Fund currently intends to invest only in obligations that are supported by the &#8220;full
faith and credit&#8221; of the U.S. government.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in">The Fund also may invest in common stock of issuers that have
historically paid periodic dividends or otherwise made distributions to common stockholders. Unlike fixed income securities, dividend
payments generally are not guaranteed and so may be discontinued by the issuer at its discretion or because of the issuer&#8217;s inability
to satisfy its liabilities. Further, an issuer&#8217;s history of paying dividends does not guarantee that it will continue to pay dividends
in the future. In addition to dividends, under certain circumstances the holders of common stock may benefit from the capital appreciation
of the issuer.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in">Common stocks represent the residual ownership interest in
the issuer and holders of common stock are entitled to the income and increase in the value of the assets and business of the issuer after
all of its debt obligations and obligations to preferred shareholders are satisfied. Common stocks generally have voting rights.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in">Common stocks fluctuate in price in response to many factors
including historical and prospective earnings of the issuer, the value of its assets, general economic conditions, interest rates, investor
perceptions and market liquidity.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in"><span style="text-decoration: underline">Synthetic Convertible Securities</span>. The Fund may also
invest in &#8220;synthetic&#8221; convertible securities, which, for purposes of its investment policies, the Fund considers to be convertible
securities. A synthetic convertible</p></ix:continuation></div>


<!-- Field: Page; Sequence: 20 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C07_gBFIOAPTB-IV_zemKXVsLHuK5"><ix:continuation continuedAt="ConU000157-08" id="ConU000157-07"><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in">security may be created by the Fund or by a third party by
combining separate securities that possess the two principal characteristics of a traditional convertible security: an income producing
component and a convertible component. Synthetic convertible securities differ from convertible securities whose conversion privilege
may be evidenced by warrants attached to the security or acquired as part of a unit with the security. The income-producing component
is achieved by investing in non-convertible, income-producing securities such as bonds, preferred stocks and money market instruments.
The convertible component is achieved by investing in securities or instruments such as warrants or options to buy common stock at a certain
exercise price, or options on a stock index. Unlike a traditional convertible security, which is a single security having a single market
value, a synthetic convertible comprises two or more separate securities, each with its own market value. Because the &#8220;market value&#8221;
of a synthetic convertible security is the sum of the values of its income producing component and its convertible component, the value
of a synthetic convertible security may respond differently to market fluctuations than a traditional convertible security. The Fund also
may purchase synthetic convertible securities created by other parties, including convertible structured notes. Convertible structured
notes are income-producing debentures linked to equity. Convertible structured notes have the attributes of a convertible security; however,
the issuer of the convertible note (typically an investment bank), rather than the issuer of the underlying common stock into which the
note is convertible, assumes credit risk associated with the underlying investment and the Fund in turn assumes credit risk associated
with the issuer of the convertible note.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Covered Call Option Strategy</i>. The Fund may use a strategy of
writing (selling) covered call options on the securities held in the portfolio, thus generating option writing premiums. The objective
of this strategy is to generate current gains from option premiums to enhance distributions payable to common shareholders. The Fund may
write (sell) covered call options on up to 25% of the securities held in its portfolio.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Options</i>. An option on a security is a contract that gives the
holder of the option, in return for a premium, the right to buy from (in the case of a call) or sell to (in the case of a put) the writer
of the option the security underlying the option at a specified exercise or &#8220;strike&#8221; price. The writer of an option on a security
has the obligation upon exercise of the option to deliver the underlying security upon payment of the exercise price or to pay the exercise
price upon delivery of the underlying security. Certain options, known as &#8220;American style&#8221; options may be exercised at any
time during the term of the option. Other options, known as &#8220;European style&#8221; options, may be exercised only on the expiration
date of the option.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">If an option written by the Fund expires unexercised, the Fund realizes
on the expiration date a capital gain equal to the premium received by the Fund at the time the option was written. If an option purchased
by the Fund expires unexercised, the Fund realizes a capital loss equal to the premium paid. Prior to the earlier of exercise or expiration,
an exchange-traded option may be closed out by an offsetting purchase or sale of an option of the same series (type, underlying security,
exercise price and expiration). There can be no assurance, however, that a closing purchase or sale transaction can be effected when the
Fund desires. The Fund may sell put or call options it has previously purchased, which could result in a net gain or loss depending on
whether the amount realized on the sale is more or less than the premium and other transaction costs paid on the put or call option when
purchased. The Fund will realize a capital gain from a closing purchase transaction if the cost of the closing option is less than the
premium received from writing the option, or, if it is more, the Fund will realize a capital loss. If the premium received from a closing
sale transaction is more than the premium paid to purchase the option, the Fund will realize a capital gain or, if it is less, the Fund
will realize a capital loss. Net gains from the Fund&#8217;s option strategy will be short-term capital gains which, for U.S. federal
income tax purposes, will constitute net investment company taxable income.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">As part of its strategy, the Fund may not sell &#8220;naked&#8221; call
options on individual securities, (<i>i.e.</i>, options representing more shares of the stock than are held in the portfolio). A call
option written by the Fund on a security is &#8220;covered&#8221; if the Fund owns the security or instrument underlying the call or has
an absolute and immediate right to acquire that security or instrument without additional cash consideration (or, if additional cash consideration
is required, cash or other assets determined to be liquid by the Adviser (in accordance with procedures established by the Board of Trustees)
in such amount are segregated by the Fund&#8217;s custodian) upon conversion or exchange of other securities held by the Fund. A call
option is also covered if the Fund holds a call on the same security as the call written where the exercise price of the call held is
(i) equal to or less than the exercise price of the call written, or (ii) greater than the exercise price of the call written, provided
the difference is maintained by the Fund in segregated assets determined to be liquid by the Adviser as described above.</p></ix:continuation></div>


<!-- Field: Page; Sequence: 21 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C0E_gBFIOAPTB-IV_zcf5pnBJX6X5"><ix:continuation continuedAt="ConU000157-09" id="ConU000157-08"><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Put options are contracts that give the holder of the option, in return
for a premium, the right to sell to the writer of the option the security underlying the option at a specified exercise price at a specific
time or times during the term of the option. These strategies may produce a considerably higher return than the Fund&#8217;s primary strategy
of covered call writing, but involve a higher degree of risk and potential volatility.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund will write (sell) put options on individual securities only
if the put option is &#8220;covered.&#8221; A put option written by the Fund on a security is &#8220;covered&#8221; if the Fund segregates
or earmarks assets determined to be liquid by the Adviser, as described above, equal to the exercise price. A put option is also covered
if the Fund holds a put on the same security as the put written where the exercise price of the put held is (i) equal to or greater than
the exercise price of the put written, or (ii) less than the exercise price of the put written, provided the difference is maintained
by the Fund in segregated or earmarked assets determined to be liquid by the Adviser, as described above.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund may sell put and call options on indices of securities. Options
on an index differ from options on securities because (i) the exercise of an index option requires cash payments and does not involve
the actual purchase or sale of securities, (ii) the holder of an index option has the right to receive cash upon exercise of the option
if the level of the index upon which the option is based is greater, in the case of a call, or less, in the case of a put, than the exercise
price of the option and (iii) index options reflect price-fluctuations in a group of securities or segments of the securities market rather
than price fluctuations in a single security.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Illiquid Securities</i>. The Fund may invest no more than 20% of
its Managed Assets in illiquid securities. Illiquid securities include securities legally restricted as to resale, such as commercial
paper issued pursuant to Section&#160;4(a)(2) of the Securities Act and securities eligible for resale pursuant to Rule&#160;144A thereunder.
Section&#160;4(a)(2) and Rule&#160;144A securities may, however, be treated as liquid by the Adviser pursuant to procedures adopted by
the Board of Trustees, which require consideration of factors such as trading activity, availability of market quotations and number of
dealers willing to purchase the security. If the Fund invests in Rule&#160;144A securities, the level of portfolio illiquidity may be
increased to the extent that eligible buyers become uninterested in purchasing such securities.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">It may be difficult to sell such securities at a price representing
the fair value until such time as such securities may be sold publicly. Where registration is required, a considerable period may elapse
between a decision to sell the securities and the time when it would be permitted to sell. Thus, the Fund may not be able to obtain as
favorable a price as that prevailing at the time of the decision to sell. The Fund may also acquire securities through private placements
under which it may agree to contractual restrictions on the resale of such securities. Such restrictions might prevent their sale at a
time when such sale would otherwise be desirable.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">As described below, the Fund may invest a portion of its assets in privately
offered convertible securities or similar instruments that may be illiquid.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Foreign Securities</i>. The Fund may invest without limitation in
foreign securities. Investing in foreign securities may provide increased diversification by adding securities from various foreign countries
(i) that offer different investment opportunities, (ii) that generally are affected by different economic trends and (iii) whose stock
markets may not be correlated with U.S. markets. At the same time, these opportunities and trends involve risks that may not be encountered
in U.S. investments.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The following considerations comprise both risks and opportunities not
typically associated with investing in U.S. securities: fluctuations in exchange rates of foreign currencies; possible imposition of exchange
control regulations or currency restrictions that would prevent cash from being brought back to the United States; less public information
with respect to issuers of securities; less government supervision of stock exchanges, securities brokers and issuers of securities; lack
of uniform accounting, auditing and financial reporting standards; lack of uniform settlement periods and trading practices; less liquidity
and frequently greater price volatility in foreign markets than in the United States; possible imposition of foreign taxes; the possibility
of expropriation or confiscatory taxation, seizure or nationalization of foreign bank deposits or other assets; the adoption of foreign
government restrictions and other adverse political, social or diplomatic developments that could affect investment; difficulty in obtaining
or enforcing a court judgment abroad; sometimes less advantageous legal, operational and financial protections applicable to foreign sub-custodial
arrangements; and the historically lower level of responsiveness of foreign management to shareholder concerns (such as dividends and
return on investment).</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund may purchase sponsored American Depository Receipts (&#8220;ADRs&#8221;)
or U.S. dollar denominated securities of foreign issuers. ADRs are receipts issued by U.S. banks or trust companies in respect of securities
of foreign issuers held on deposit for use in the U.S. securities markets.</p></ix:continuation></div>


<!-- Field: Page; Sequence: 22 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C0C_gBFIOAPTB-IV_zaAgKuGASI7a"><ix:continuation continuedAt="ConU000157-10" id="ConU000157-09"><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><span style="background-color: white">The risks described above for
foreign securities, including the risks of nationalization and expropriation of assets, are typically increased to the extent that the
Fund invests in companies headquartered in developing, or emerging market, countries. Investments in securities of companies headquartered
in such countries may be considered speculative and subject to certain special risks. The political and economic structures in many of
these countries may be in their infancy and developing rapidly, and such countries may lack the social, political and economic characteristics
of more developed countries. Certain of these countries have in the past failed to recognize private property rights and have at times
nationalized and expropriated the assets of private companies. Some countries have inhibited the conversion of their currency to another.
The currencies of certain emerging market countries have experienced devaluation relative to the U.S. dollar, and future devaluations
may adversely affect the value of the Fund&#8217;s assets denominated in such currencies. Some emerging market countries have experienced
substantial rates of inflation for many years. Continued inflation may adversely affect the economies and securities markets of such countries.
In addition, unanticipated political or social developments may affect the value of the Fund&#8217;s investments in these countries and
the availability of the Fund of additional investments in these countries. The small size, limited trading volume and relative inexperience
of the securities markets in these countries may make the Fund&#8217;s investments in such countries illiquid and more volatile than investments
in more developed countries, and the Fund may be required to establish special custodial or other arrangements before making investments
in these countries. There may be little financial or accounting information available with respect to companies located in these countries,
and it may be difficult as a result to assess the value or prospects of an investment in such companies.</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Equity Securities</i>. Equity securities, such as common stock, generally
represent an ownership interest in a company. The Fund may invest up to 20% of its Managed Assets in non-convertible equity securities.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Lower Grade Securities</i>. The Fund may invest a significant portion
of its assets in securities rated below investment grade, such as those rated Ba or lower by Moody&#8217;s Investors Service, Inc. (&#8220;Moody&#8217;s&#8221;)
and BB or lower by Standard &amp; Poor&#8217;s (&#8220;S&amp;P&#8221;) or securities comparably rated by other rating agencies or in unrated
securities determined by Advent to be of comparable quality. Lower grade securities are commonly referred to as &#8220;junk bonds.&#8221;
Both the convertible securities and the income-producing securities in which the Fund will invest may be lower grade securities.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Prices of&#160;lower&#160;grade&#160;securities are more sensitive to
negative developments, such as a decline in the issuer&#8217;s revenues or a general economic downturn, than are the prices of higher
grade&#160;securities.&#160;Lower grade&#160;securities tend to be less liquid than investment grade securities. The market value&#160;of&#160;lower
grade&#160;securities may be more volatile than the market value of investment grade securities and generally tends to reflect the market&#8217;s
perception of the creditworthiness of the issuer and short-term market developments to a greater extent than investment grade securities,
which primarily reflect fluctuations in general levels of interest rates.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Ratings are relative and subjective, and not absolute standards of quality.
Securities ratings are based largely on the issuer&#8217;s historical financial condition and the rating agencies&#8217; analysis at the
time of rating. Consequently, the rating assigned to any particular security is not necessarily a reflection of the issuer&#8217;s current
financial condition.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund may purchase securities of companies that are experiencing
significant financial or business difficulties, including companies involved in bankruptcy or other reorganization and liquidation proceedings.
Although such investments may result in significant financial returns to the Fund, they involve a substantial degree of risk. The level
of analytical sophistication, both financial and legal, necessary for successful investments in issuers experiencing significant business
and financial difficulties is unusually high. There can be no assurance that the Fund will correctly evaluate the value of the assets
collateralizing its investments or the prospects for a successful reorganization or similar action. In any reorganization or liquidation
proceeding relating to a portfolio investment, the Fund may lose all or part of its investment or may be required to accept collateral
with a value less than the amount of the Fund&#8217;s initial investment.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">As a part of its investments&#160;in&#160;lower&#160;grade&#160;securities,
the Fund may invest in the securities of issuers in default. By investing in the securities of issuers in default, the Fund bears the
risk that these issuers will not continue to honor their obligations or emerge from bankruptcy protection or that the value of these securities
will not otherwise appreciate.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">In addition to using statistical rating agencies and other sources,
the Adviser will also perform its own analysis of issuers in seeking investments that it believes to be underrated (and thus higher yielding)
in light of the financial condition of the issuer. Its analysis of issuers may include, among other things, current and anticipated cash
flow and borrowing requirements, value of assets in relation to historical cost, strength of management, responsiveness to</p></ix:continuation></div>


<!-- Field: Page; Sequence: 23 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C0E_gBFIOAPTB-IV_z88e4JAtpRo9"><ix:continuation continuedAt="ConU000157-11" id="ConU000157-10"><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">business conditions, credit standing and current anticipated results
of operations. In selecting investments for the Fund, the Adviser may also consider general business conditions, anticipated changes in
interest rates and the outlook for specific industries.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Subsequent to its purchase by the Fund, an issue of securities may cease
to be rated or its rating may be reduced. In addition, it is possible that statistical rating agencies might change their ratings of a
particular issue to reflect subsequent events on a timely basis. Moreover, such ratings do not assess the risk of a decline in market
value. None of these events will require the sale of the securities by the Fund, although the Adviser will consider these events in determining
whether the Fund should continue to hold the securities.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The market&#160;for&#160;lower&#160;grade&#160;and comparable unrated
securities has at various times, particularly during times of economic recession, experienced substantial reductions in market value and
liquidity. Past recessions have adversely affected the value of such securities as well as the ability of certain issuers of such securities
to repay principal and pay interest thereon or to refinance such securities. The market for those securities could react in a similar
fashion in the event of any future economic recession.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Preferred Stock</i>. The Fund may invest in preferred stock. The
preferred stock in which the Fund typically will invest will be convertible securities. Preferred shares are equity securities, but they
have many characteristics of fixed income securities, such as a fixed dividend payment rate and/or a liquidity preference over the issuer&#8217;s
common shares. However, because preferred stocks are equity securities, they may be more susceptible to risks traditionally associated
with equity investments than the Fund&#8217;s fixed income securities.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Private Securities</i>. The Fund may invest up to 15% of its Managed
Assets in privately offered convertible securities, privately offered non-convertible income securities and any attached or related privately
offered warrants or equity-linked securities (collectively, &#8220;private securities&#8221;), which may include securities of private
companies and privately issued securities of public companies. Advent does not expect to invest more than 2.5% of the Fund&#8217;s Managed
Assets in any single private security at the time of investment. The Fund invests primarily in private securities to seek to enhance the
Fund&#8217;s current income. Therefore, the Fund will invest in a private security only if the expected yield on such security at the
time of investment exceeds the yield of specified public convertible and high yield bond benchmarks (currently the ICE BofAML All U.S.
Convertibles Index and ICE BofAML US High Yield Total Return Index). The Fund is not required to dispose of private securities in the
event that relative yields change after the time of investment. Any private securities investments will increase the percentage of the
Fund&#8217;s assets invested in illiquid securities. In order to provide for further diversification, Advent intends to limit the number
of private securities transactions the Fund makes in any given year and deploy the Fund&#8217;s overall allocation to private securities
over the course of several years.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Derivative Transactions</i>. The Fund may purchase and sell derivative
instruments such as exchange-listed and over-the-counter put and call options on securities, financial futures, equity, fixed-income and
interest rate indices, and other financial instruments, purchase and sell financial futures contracts and options thereon, enter into
various interest rate transactions such as swaps, caps, floors or collars and enter into various currency transactions such as currency
forward contracts, currency futures contracts, currency swaps or options on currency or currency futures or credit transactions and credit
default swaps. The Fund also may purchase derivative instruments that combine features of these instruments and purchase securities for
delayed settlement. See &#8220;The Fund&#8217;s Investments&#8212;Derivatives&#8221; in the Statement of Additional Information.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Other Investment Companies</i>. The Fund may invest in the securities
of other investment companies to the extent that such investments are consistent with the Fund&#8217;s investment objective and policies
and permissible under the 1940 Act. The Fund may invest in mutual funds, closed-end funds and exchange-traded funds. Under the 1940 Act,
the Fund generally may invest only up to 10% of its total assets in the aggregate in shares of other investment companies and only up
to 5% of its total assets in any one investment company, provided the investment does not represent more than 3% of the voting stock of
the acquired investment company at the time such shares are purchased. However, pursuant to certain exemptions set forth in the 1940 Act,
the Fund may invest in excess of this limitation provided that certain conditions are met. Investments in other investment companies involve
operating expenses and fees at the other investment company level that are in addition to the expenses and fees borne by the Fund and
are borne indirectly by common shareholders. For purposes of the Fund&#8217;s policy of investing at least 80% of its Managed Assets in
convertible securities and other income producing securities, the Fund will include the value of its investments in other investment companies
that invest primarily in convertible securities and/or other income producing securities.</p></ix:continuation></div>


<!-- Field: Page; Sequence: 24 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C05_gBFIOAPTB-IV_zgqoON0Ex31e"><ix:continuation continuedAt="ConU000157-12" id="ConU000157-11"><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Defensive and Temporary Investments</i>. Under unusual market or
economic conditions or for temporary defensive purposes, the Fund may invest up to 100% of its total assets in securities issued or guaranteed
by the U.S. government or its instrumentalities or agencies, certificates of deposit, bankers&#8217; acceptances and other bank obligations,
commercial paper rated in the highest category by a nationally recognized statistical rating organization or other fixed income securities
deemed by the Adviser to be consistent with a defensive posture, or may hold cash, including money market funds.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Repurchase Agreements</i>. The Fund may enter into repurchase agreements
with broker-dealers, member banks of the Federal Reserve System and other financial institutions. Repurchase agreements may be seen as
loans by the Fund collateralized by underlying debt securities. Under the terms of a typical repurchase agreement, the Fund would acquire
an underlying debt obligation for a relatively short period (usually not more than one week) subject to an obligation of the seller to
repurchase, and the Fund to resell, the obligation at an agreed price and time. This arrangement results in a fixed rate of return to
the Fund that is not subject to market fluctuations during the holding period. The Fund bears a risk of loss in the event that the other
party to a repurchase agreement defaults on its obligations and the Fund is delayed in or prevented from exercising its rights to dispose
of the collateral securities, including the risk of a possible decline in the value of the underlying securities during the period in
which it seeks to assert these rights. The Adviser, acting under the supervision of the Board of Trustees, reviews the creditworthiness
of those banks and dealers with which the Fund enters into repurchase agreements to evaluate these risks, and monitors on an ongoing basis
the value of the securities subject to repurchase agreements to ensure that the value is maintained at the required level. The Fund will
not enter into repurchase agreements with the Adviser or any of its affiliates.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Lending of Portfolio Securities</i>. The Fund may lend portfolio
securities to registered broker-dealers or other institutional investors deemed by the Adviser to be of good standing under agreements
which require that the loans be secured continuously by collateral in cash, cash equivalents or U.S. Treasury bills maintained on a current
basis at an amount at least equal to the market value of the securities loaned. The Fund continues to receive the equivalent of the interest
or dividends paid by the issuer on the securities loaned as well as the benefit of an increase and the detriment of any decrease in the
market value of the securities loaned and would also receive compensation based on investment of the collateral. The Fund would not, however,
have the right to vote any securities having voting rights during the existence of the loan, but would call the loan in anticipation of
an important vote to be taken among holders of the securities or of the giving or withholding of consent on a material matter affecting
the investment. As with other extensions of credit, there are risks of delay in recovery or even loss of rights in the collateral should
the borrower of the securities fail financially. At no time would the value of the securities loaned exceed 35% of the value of the Fund&#8217;s
total assets.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Portfolio Turnover Rate</i>. Portfolio turnover rate is not considered
a limiting factor in the execution of investment decisions for the Fund.</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">USE OF LEVERAGE</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund may utilize leverage up to the limits imposed by the 1940 Act.
Under the 1940 Act, the Fund may utilize financial leverage in the form of indebtedness in an aggregate amount up to 33 <span style="background-color: white"><sup>1&#160;</sup>/<sub>&#160;3</sub></span>%
of the Fund&#8217;s Managed Assets (including the proceeds of such leverage) immediately after incurring such indebtedness. Under the
1940 Act, the Fund may utilize leverage in the form of preferred shares in an aggregate amount of up to 50% of the Fund&#8217;s total
assets (including the proceeds of such leverage) immediately after such issuance. The Fund may also invest in reverse repurchase agreements
to the maximum extent permitted by the SEC and/or SEC staff rules, guidance or positions. <span style="background-color: white">In addition,
the Fund may engage in certain derivatives transactions that have economic characteristics similar to leverage to the extent permitted
by the SEC and/or SEC staff rules, guidance or positions.</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">Borrowings</td><td/></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund is authorized to borrow or issue debt securities
for financial leveraging purposes and for temporary purposes such as the settlement of transactions. The Fund may utilize indebtedness
to the maximum extent permitted under the 1940 Act. Under the 1940 Act, a fund generally is not permitted to issue commercial paper or
notes or engage in other borrowings unless, immediately after the borrowing, the fund would have asset coverage (as defined in the 1940
Act) of at least 300%, <i>i.e.</i>, the value of the fund&#8217;s total assets less liabilities other than the principal amount represented
by commercial paper, notes or other borrowings, is at least 300% of such principal amount. In</p></ix:continuation></div>


<!-- Field: Page; Sequence: 25 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C0E_gBFIOAPTB-IV_zENU6SYmv8m1"><ix:continuation continuedAt="ConU000157-13" id="ConU000157-12"><p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">addition, other than with respect to privately arranged borrowings,
the Fund is not permitted to declare any cash dividend or other distribution on the common shares unless, at the time of such declaration,
the value of the Fund&#8217;s total assets, less liabilities other than the principal amount represented by borrowings, is at least 300%
of such principal amount after deducting the amount of such dividend or other distribution. If the Fund borrows, the Fund intends, to
the extent possible, to prepay all or a portion of the principal amount of any outstanding commercial paper, notes or other borrowings
to the extent necessary to maintain the required asset coverage.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The terms of any such borrowings may require a Fund
to pay a fee to maintain a line of credit, such as a commitment fee, or to maintain minimum average balances with a lender. Any such requirements
would increase the cost of such borrowings over the stated interest rate. Such lenders would have the right to receive interest on and
repayment of principal of any such borrowings, which right will be senior to those of the common shareholders. Any such borrowings may
contain provisions limiting certain activities of the Fund, including the payment of dividends to common shareholders in certain circumstances.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Certain types of borrowings subject the Fund to covenants
in credit agreements relating to asset coverage and portfolio composition requirements. Certain borrowings also may subject the Fund to
certain restrictions on investments imposed by guidelines of one or more rating agencies, which may issue ratings for such borrowings.
Such guidelines may impose asset coverage or portfolio composition requirements that are more stringent than those imposed by the 1940
Act.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The 1940 Act grants to the holders of senior securities
representing indebtedness, other than with respect to privately arranged borrowings, certain voting rights in the event of default in
the payment of interest on or repayment of principal. Failure to maintain certain asset coverage requirements under the 1940 Act could
result in an event of default and entitle the debt holders to elect a majority of the Board of Trustees.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Credit Agreement</i>. The Fund has entered into
a senior secured credit agreement, dated December&#160;15, 2017, as amended from time to time through the date hereof, between the Fund
and Soci&#233;t&#233; G&#233;n&#233;rale, New York Branch (the &#8220;Credit Agreement&#8221;). Under the terms of the Credit
Agreement, the Fund may borrow up to the following amounts:</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>1.88% fixed rate 5-year maturity (December 15, 2025)	$19,000,000</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>SOFR + 0.95% floating rate			$139,000,000</td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">An undrawn commitment fee of 0.30% per annum is charged
on the difference between the $139,000,000 floating rate loan commitment and the amount borrowed. In the event that the Fund terminates
a credit agreement prior to the contractually agreed-upon date, the Fund may be charged a breakage fee by the counterparty to compensate
for the early termination.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund&#8217;s borrowings under the Credit Agreement
are collateralized by portfolio assets. The Credit Agreement includes usual and customary covenants. These covenants impose on the Fund
asset coverage requirements, collateral requirements, investment strategy requirements, and certain financial obligations. These covenants
place limits or restrictions on the Fund&#8217;s ability to (i) enter into additional indebtedness with a party other than Soci&#233;t&#233;
G&#233;n&#233;rale, (ii) change its fundamental investment policies, or (iii) pledge to any other party, other than to the counterparty,
securities owned or held by the Fund over which the counterparty has a lien. In addition, the Fund is required to deliver financial information
to the counterparty within established deadlines, maintain an asset coverage ratio (as defined in Section&#160;18(g) of the 1940 Act)
of at least 300%, comply with the rules of the stock exchange on which its shares are listed, and maintain its classification as a &#8220;closed-end
management investment company&#8221; as defined in the 1940 Act.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">As of April 30, 2024, there was $157 million outstanding
in connection with the Credit Agreement. The average daily amount of borrowings under the credit agreement during the six months ended
April 30, 2024 was $160,868,132, with a related weighted average interest rate of 5.97%. The maximum amount outstanding during the six
months ended April 30, 2024 was $173,000,000.</p></ix:continuation></div>


<!-- Field: Page; Sequence: 26 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C07_gBFIOAPTB-IV_z4XyoAeag3p1"><ix:continuation continuedAt="ConU000157-14" id="ConU000157-13"><p style="font: bold 9pt Times New Roman, Times, Serif; margin: 10pt 0 0 0.5in; text-indent: -0.5in">Reverse Repurchase Agreements</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Under a reverse repurchase agreement, the Fund sells a portfolio instrument
to another party, such as a bank or broker-dealer, in return for cash. At the same time, the Fund agrees to repurchase the instrument
at an agreed-upon time and price, which reflects an interest payment. Such agreements have the economic effect of borrowings. Proceeds
of the sale will be invested in additional instruments for the Fund, and the income from these investments will generate income for the
Fund. If such income does not exceed the income, capital appreciation and gain or loss that would have been realized on the securities
sold as part of the reverse repurchase transaction, the use of this technique will diminish the investment performance of the Fund compared
with what the performance would have been without the use of reverse repurchase transactions. With respect to any reverse repurchase agreement,
the Fund&#8217;s Managed Assets shall include any proceeds from the sale of an asset of the Fund to a counterparty in such a transaction,
in addition to the value of the underlying asset as of the relevant measuring date.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Reverse repurchase agreements involve the risks that the interest income
earned on the investment of the proceeds will be less than the interest expense and expenses associated with the repurchase agreement,
that the market value of the securities sold by the Fund may decline below the price at which the Fund is obligated to repurchase such
securities and that the securities may not be returned to the Fund. There is no assurance that reverse repurchase agreements can be successfully
employed. In connection with reverse repurchase agreements, the Fund will also be subject to counterparty risk with respect to the purchaser
of the securities. If the broker/dealer to whom the Fund sells securities becomes insolvent, the Fund&#8217;s right to purchase or repurchase
securities may be restricted.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">For the six months ended April 30, 2024, the average daily balance for
which reverse repurchase agreements were outstanding amounted to $157,000,000 (exclusive of interest payable), with a related weighted
average interest rate of 4.80%. As of April 30, 2024, there were $157,021,361 (inclusive of interest payable) in reverse repurchase agreements
outstanding.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Rule&#160;18f-4 under the 1940 Act (the &#8220;Derivatives Rule&#8221;)
permits the Fund to enter into derivatives transactions and certain other transactions notwithstanding the restrictions on the issuance
of &#8220;senior securities&#8221; under Section&#160;18 of the 1940 Act. The Derivatives Rule requires registered investment companies
that enter into derivatives transactions and certain other transactions that create future payment or delivery obligations to, among other
things, (i) comply with a value-at-risk leverage limit, and (ii) adopt and implement a derivatives risk management program. The Fund has
elected to treat reverse repurchase agreements as derivatives for purposes of complying with Rule&#160;18f-4.</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 10pt 0 0 0.5in; text-indent: -0.5in">Preferred Shares</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund&#8217;s Declaration of Trust (as defined herein) provides that
the Board of Trustees may authorize and issue preferred shares with rights as determined by the Board of Trustees, by action of the Board
of Trustees without prior approval of common shareholders.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Common shareholders have no preemptive right to purchase any preferred
shares that might be issued. Any such preferred share offering would be subject to the limits imposed by the 1940 Act. Any preferred shares
issued by the Fund would have special voting rights and a liquidation preference over the common shares. Issuance of preferred shares
would constitute leverage and would entail special risks to the common shareholders.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Under the 1940 Act, the Fund may not issue preferred shares unless,
immediately after such issuance, it has an &#8220;asset coverage&#8221; of at least 200% of the liquidation value of the outstanding preferred
shares (<i>i.e.</i>, such liquidation value may not exceed 50% of the value of the Fund&#8217;s total assets). For these purposes, &#8220;asset
coverage&#8221; means the ratio of (i) total assets less all liabilities and indebtedness not represented by &#8220;senior securities&#8221;
to (ii) the amount of &#8220;senior securities representing indebtedness&#8221; plus the &#8220;involuntary liquidation preference&#8221;
of the preferred shares. &#8220;Senior security&#8221; generally means any bond, note, or similar security evidencing indebtedness and
any class of shares having priority over any other class as to distribution of assets or payment of dividends. &#8220;Senior security
representing indebtedness&#8221; means any &#8220;senior security&#8221; other than equity shares. The &#8220;involuntary liquidation
preference&#8221; of the preferred shares is the amount that holders of preferred shares would be entitled to receive in the event of
an involuntary liquidation of the Fund in preference to the common shares.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">If preferred shares are outstanding, two of the Fund&#8217;s Trustees
will be elected by the holders of preferred shares, voting separately as a class. The remaining Trustees of the Fund will be elected by
common shareholders and preferred shareholders voting together as a single class. In the unlikely event the Fund failed to pay dividends
on preferred shares for two years, preferred shareholders would be entitled to elect a majority of the Trustees of the Fund.</p></ix:continuation></div>


<!-- Field: Page; Sequence: 27 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C04_gBFIOAPTB-IV_zND9cH23nuHf"><ix:continuation id="ConU000157-14"><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund is not permitted to declare any dividend (except a dividend
payable in common shares), or to declare any other distribution on the common shares, or to purchase any common shares, unless the preferred
shares have at the time of the declaration of any such dividend or other distribution, or at the time of any such purchase of common shares,
an asset coverage of at least 200% after deducting the amount of such dividend, distribution or purchase price.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">In addition, the Fund may be subject to certain restrictions imposed
by guidelines of one or more rating agencies that may issue ratings for preferred shares issued by the Fund. These guidelines may impose
asset coverage or portfolio composition requirements that are more stringent than those imposed on the Fund by the 1940 Act.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 0; background-color: white">If preferred shares are issued, the terms
of any preferred shares issued are expected to include asset coverage maintenance provisions which will require the redemption of the
preferred shares in the event&#160;of&#160;non-compliance&#160;by&#160;the Fund and may also prohibit dividends and other distributions
on the common shares in such circumstances. In order to meet redemption requirements, the Fund may have to liquidate portfolio securities.
Such liquidations and redemptions would cause the Fund to incur related transaction costs and could result in capital losses to the Fund.
Prohibitions on dividends and other distributions on the common shares could impair the Fund&#8217;s ability to qualify as a regulated
investment company under the Code.</p>

<table cellpadding="0" cellspacing="0" style="font: bold 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">Derivatives</td><td/></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund may engage in certain derivatives transactions that have economic
characteristics similar to leverage.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">To the extent the terms of such transactions obligate the Fund to make
payments, the Fund earmarks or segregates cash or liquid securities in an amount at least equal to the current value of the amount then
payable by the Fund under the terms of such transactions or otherwise cover such transactions in accordance with applicable interpretations
of the staff of the SEC. To the extent the terms of such transactions obligate the Fund to deliver particular securities to extinguish
the Fund&#8217;s obligations under such transactions, the Fund may &#8220;cover&#8221; its obligations under such transactions by either
(i) owning the securities or collateral underlying such transactions or (ii) having an absolute and immediate right to acquire such securities
or collateral without additional cash consideration (or, if additional cash consideration is required, having earmarked or segregated
cash or liquid securities). Such segregation or cover is intended to provide the Fund with available assets to satisfy its obligations
under such transactions. As a result of such segregation or cover, the Fund&#8217;s obligations under such transactions will not be considered
senior securities representing indebtedness for purposes of the 1940 Act, or included in calculating the aggregate amount of the Fund&#8217;s
financial leverage.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Rule&#160;18f-4 under the 1940 Act, the Derivatives Rule, permits the
Fund to enter into derivatives transactions and certain other transactions notwithstanding the restrictions on the issuance of &#8220;senior
securities&#8221; under Section&#160;18 of the 1940 Act. The Fund has adopted a derivatives risk management program which includes value-at-risk
modeling, stress tests, backtests, and additional disclosures to the SEC in compliance with Rule&#160;18f-4 under the 1940 Act. The requirements
of the rule and the Fund&#8217;s derivatives risk management program may restrict the Fund&#8217;s ability to engage in certain derivatives
transactions and/or increase the cost of such transactions, which could adversely affect the performance of the Fund.</p></ix:continuation></div>

<p id="xdx_981_ecef--EffectsOfLeverageTextBlock_c20240723__20240723_gBFEOLTB-XMD_zWVEN4VWO4Nk" style="font: bold 9pt Times New Roman, Times, Serif; margin: 10pt 0 0 0.5in; text-indent: -0.5in"><ix:nonNumeric contextRef="AsOf2024-07-23" continuedAt="ConU000161-01" escape="true" id="Fact000161" name="cef:EffectsOfLeverageTextBlock">Effects of Leverage</ix:nonNumeric></p>

<div id="xdx_C08_gBFEOLTB-XMD_zlOc9Aw37AS7"><ix:continuation continuedAt="ConU000161-02" id="ConU000161-01"><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Assuming that the Fund utilizes leverage representing approximately
43.0% of the Fund&#8217;s Managed Assets (the Fund&#8217;s outstanding leverage as of April 30, 2024) and that the Fund will bear expenses
relating to that leverage at an average annual rate of 5.38%, the income generated by the Fund&#8217;s portfolio (net of estimated expenses)
must exceed 2.32% in order to cover the expenses specifically related to the Fund&#8217;s estimated use of leverage. Of course, these
numbers are merely estimates used for illustration. Actual leverage expenses will vary frequently and may be significantly higher or lower
than the rate estimated above.</p></ix:continuation></div>

<div id="xdx_C01_gBFEOLTB-XMD_zty1TJWdFJIc"><ix:continuation continuedAt="ConU000161-03" id="ConU000161-02"><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The following table is furnished in response to requirements of the
SEC. It is designed to illustrate the effect of leverage on common share total return, assuming investment portfolio total returns (comprised
of income and changes in the value of securities held in the Fund&#8217;s portfolio) of (10)%, (5)%, 0%, 5% and 10%. These assumed investment
portfolio returns are hypothetical figures and are not necessarily indicative of the investment portfolio returns experienced or expected
to be experienced by the Fund. The table further reflects the use of leverage representing 43.0% of the Fund&#8217;s total managed assets
and the Fund&#8217;s currently projected annual leverage expense of 5.38%.</p></ix:continuation></div>


<!-- Field: Page; Sequence: 28 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<div id="xdx_C09_gBFEOLTB-XMD_zqkbEPGGx1m4"><ix:continuation id="ConU000161-03">
<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 55%; padding-left: 21.75pt">Assumed Portfolio Total Return (net of expenses)</td>
    <td style="width: 10%; text-align: center">(10.00)%</td>
    <td style="width: 10%; text-align: center">(5.00)%</td>
    <td style="width: 9%; text-align: center">0.00%</td>
    <td style="width: 7%; text-align: center">5.00%</td>
    <td style="width: 9%; text-align: center">10.00%</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 21.75pt">Common Share Total Return</td>
    <td style="text-align: center">(21.63)%</td>
    <td style="text-align: center">(12.85)%</td>
    <td style="text-align: center">(4.07)%</td>
    <td style="text-align: center">4.71%</td>
    <td style="text-align: center">13.49%</td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Common Share Total Return is composed of two elements: the common share
distributions paid by the Fund (the amount of which is largely determined by the net investment income of the Fund) and gains or losses
on the value of the securities the Fund owns. As required by SEC rules, the table assumes that the Fund is more likely to suffer capital
losses than to enjoy capital appreciation. For example, a total return of 0% assumes that the tax-exempt interest the Fund receives on
its investments is entirely offset by losses in the value of those securities.</p></ix:continuation></div>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">RISKS</p>

<p id="xdx_98F_ecef--RiskTextBlock_c20240723__20240723__cef--RiskAxis__custom--RiskIntroductionMember_zsiGtisFpKm1" style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><ix:nonNumeric contextRef="From2024-07-232024-07-23_custom_RiskIntroductionMember" escape="true" id="Fact000162" name="cef:RiskTextBlock">The
information contained under the heading &#8220;Investment Objective, Policies and Principal Risks&#8212;Principal Risks&#8221; in the
Fund&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm">Annual Report</a> is
incorporated herein by reference. Investors should consider the specific risk factors and special considerations associated with investing
in the Fund. An investment in the Fund is subject to investment risk, including the possible loss of your entire investment. A Prospectus
Supplement relating to an offering of the Fund&#8217;s securities may identify additional risk associated with such offering.</ix:nonNumeric></p>
<div id="xdx_983_ecef--RiskTextBlock_c20240723__20240723__cef--RiskAxis__custom--DistributionRiskMember_z7bUTSGlqFS5"><ix:nonNumeric contextRef="From2024-07-232024-07-23_custom_DistributionRiskMember" escape="true" id="Fact000163" name="cef:RiskTextBlock">
<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Distribution Risk</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund&#8217;s net investment income can vary significantly over time;
however, the Fund seeks to maintain a more stable monthly distribution per share. The distributions paid by the Fund for any particular
month may be more or less than the amount of net investment income for that monthly period. The Fund may distribute more than the entire
amount of the net investment income earned in a particular period, in which case all or a portion of a distribution may be a return of
capital. <b>The Fund&#8217;s distributions have historically included, and may in the future include, a significant portion of return
of capital. For the fiscal year ended October&#160;31, 2023, the Fund&#8217;s distributions were comprised of approximately 28.04% ordinary
income and 71.96% return of capital. </b>Accordingly, shareholders should not assume that the source of a distribution from the Fund is
net income or profit, and the Fund&#8217;s distributions should not be used as a measure of performance or confused with yield or income.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Return of capital is the return of a portion of the shareholder&#8217;s
original investment up to the amount of the Common Shareholder&#8217;s tax basis in their Common Shares, which would reduce such tax
basis. Although a return of capital may not be taxable, it will generally increase the Common Shareholder&#8217;s potential gain or reduce
the Common Shareholder&#8217;s potential loss on any subsequent sale or other disposition of Common Shares. In any given year, there
can be no guarantee the Fund&#8217;s investment returns will exceed the amount of distributions which may increase taxes payable by a
Common Shareholder or reduce a Common Shareholder&#8217;s loss deduction in connection with such sale or other disposition. To the extent
the amount of distributions paid to shareholders in cash exceeds the total net investment returns of the Fund, the assets of the Fund
will decline, which may have the effect of increasing the Fund&#8217;s expense ratio. In addition, in order to make such distributions,
the Fund may have to sell a portion of its investment portfolio at a time when independent investment judgment might not dictate such
action.</p></ix:nonNumeric></div>
<div id="xdx_98D_ecef--RiskTextBlock_c20240723__20240723__cef--RiskAxis__custom--RisksAssociatedWithOfferingsOfAdditionalCommonSharesMember_zkiFvCgR3fo4"><ix:nonNumeric contextRef="From2024-07-232024-07-23_custom_RisksAssociatedWithOfferingsOfAdditionalCommonSharesMember" escape="true" id="Fact000164" name="cef:RiskTextBlock">
<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Risks Associated with Offerings of Additional Common Shares</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The voting power of current common shareholders will be diluted to the
extent that current common shareholders do not purchase common shares in any future offerings of common shares or do not purchase sufficient
common shares to maintain their percentage interest. If the Fund is unable to invest the proceeds of such offering as intended, the Fund&#8217;s
per common share distribution may decrease and the Fund may not participate in market advances to the same extent as if such proceeds
were fully invested as planned.</p></ix:nonNumeric></div>
<div id="xdx_98F_ecef--RiskTextBlock_c20240723__20240723__cef--RiskAxis__custom--AdditionalRisksofRightsMember_gBFRTB-C_zqa45z0CkPA5"><ix:nonNumeric contextRef="From2024-07-232024-07-23_custom_AdditionalRisksofRightsMember" continuedAt="ConU000166-01" escape="true" id="Fact000166" name="cef:RiskTextBlock">
<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Additional Risks of Rights</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">There are additional risks associated with an offering of Rights. Shareholders
who do not exercise their Rights may, at the completion of such an offering, own a smaller proportional interest in the Fund than if they
exercised their Rights. As a result of such an offering, a shareholder may experience dilution in net asset value per share if the subscription
price per share is below the net asset value per share on the expiration date. If the subscription price per share is below the net asset
value per share of the Fund&#8217;s common shares on the expiration date, a shareholder will experience an immediate dilution of the aggregate
net asset value of such shareholder&#8217;s common shares if the shareholder does not participate in such an offering and the shareholder
will experience a reduction in the net asset value per share of such shareholder&#8217;s common shares whether or not the shareholder
participates in such an offering. Such a reduction in net asset value per share may have the effect of reducing market price of the common
share. The Fund cannot state precisely the extent of this dilution (if any) if the shareholder does not exercise such shareholder&#8217;s
Rights because the Fund does not know what the net asset value per share will be when the offer expires or what</p></ix:nonNumeric></div>


<!-- Field: Page; Sequence: 29 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C0B_gBFRTB-C_zPq1eXuFuL3k"><ix:continuation id="ConU000166-01"><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">proportion of the Rights will be exercised. If the subscription price
is substantially less than the then current net asset value per common share at the expiration of a rights offering, such dilution could
be substantial. Any such dilution or accretion will depend upon whether (i) such shareholders participate in the Rights offering and (ii)
the Fund&#8217;s net asset value per common share is above or below the subscription price on the expiration date of the Rights offering.
In addition to the economic dilution described above, if a common shareholder does not exercise all of their rights, the common shareholder
will incur voting dilution as a result of this rights offering. This voting dilution will occur because the common shareholder will own
a smaller proportionate interest in the Fund after the rights offering than prior to the rights offering. There is a risk that changes
in market conditions may result in the underlying common shares purchasable upon exercise of the subscription rights being less attractive
to investors at the conclusion of the subscription period. This may reduce or eliminate the value of the subscription rights. If investors
exercise only a portion of the rights, the number of common shares issued may be reduced, and the common shares may trade at less favorable
prices than larger offerings for similar securities. Subscription rights issued by the Fund may be transferable or non-transferable rights.
In a non-transferable rights offering, common shareholders who do not wish to exercise their rights will be unable to sell their rights.
In a transferrable rights offering, the Fund will use its best efforts to ensure an adequate trading market for the rights; however, investors
may find that there is no market to sell rights they do not wish to exercise.</p></ix:continuation></div>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">MANAGEMENT OF THE FUND</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Trustees</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><span style="background-color: white">The Fund&#8217;s business and
affairs are managed under the direction of the Board of Trustees, which has overall responsibility for monitoring and overseeing the Fund&#8217;s
management and operations. The Board of Trustees consists of eight members, seven of whom are not considered &#8220;interested persons&#8221;
of the Fund (as that term is defined in the 1940 Act) (the &#8220;Independent Trustees&#8221;). The Trustees are subject to removal or
replacement in accordance with Delaware law and the Declaration of Trust. </span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><span style="background-color: white">The Board of Trustees, including
a majority of the Independent Trustees, oversees and monitors the Fund&#8217;s investment performance. The Board will review, on an annual
basis, the Investment Advisory Agreement to determine, among other things, whether the fees payable thereunder are reasonable in light
of the services provided.</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Adviser</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Pursuant to an investment advisory agreement between the Fund and Advent
(the &#8220;Investment Advisory Agreement&#8221;), Advent is responsible for the daily management of the Fund&#8217;s portfolio of investments,
which includes buying and selling securities for the Fund, as well as investment research. Advent is a registered investment adviser,
based in New York, which specializes in convertible and high-yield securities for institutional and individual investors. The firm was
established by Tracy V. Maitland, a former Director in the Convertible Securities sales and trading division of Merrill Lynch. Advent&#8217;s
investment discipline emphasizes capital structure research, encompassing equity fundamentals as well as credit research, with a focus
on cash flow and asset values while seeking to maximize total return. Advent is located at 888 Seventh Avenue, 31st Floor, New York, New
York 10019. As of May 31, 2024, Advent managed approximately $7.8 billion in assets.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Adviser receives an annual fee from the Fund based on the average
value of the Fund&#8217;s Managed Assets. The annual fee will be determined as follows:</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.7in; text-indent: -0.2in">(a)&#160;If the average value of the
Fund&#8217;s Managed Assets (calculated monthly) is greater than $250 million, the fee will be a maximum amount equal to 0.54% of the
average value of the Fund&#8217;s Managed Assets.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.7in; text-indent: -0.2in">(b) If the average value of the Fund&#8217;s
Managed Assets (calculated monthly) is $250 million or less, the fee will be a maximum amount equal to 0.55% of the average value of the
Fund&#8217;s Managed Assets.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">In addition, subject to the approval of the Fund&#8217;s Board of Trustees,
a pro rata portion of the salaries, bonuses, health insurance, retirement benefits and similar employment costs for the time spent on
Fund operations (other than the provision of services required under the Investment Advisory Agreement) of all personnel employed by the
Adviser who devote substantial time to Fund operations may be reimbursed by the Fund to the Adviser. For the year ended October&#160;31,
2023, the Adviser was not reimbursed by the Fund for these items.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Portfolio Management</b></p>


<!-- Field: Page; Sequence: 30 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The information contained under &#8220;Item&#160;8. Portfolio Managers
of Closed-End Management Investment Companies&#8221; of the Fund&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm">Annual Report</a> is incorporated herein by reference. <span style="background-color: white">Additional information about the portfolio managers&#8217;
compensation, other accounts managed by the portfolio managers, and other information is provided in the SAI.&#160;</span></p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">NET ASSET VALUE</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><span style="background-color: white">The Fund&#8217;s net asset value
is determined as of the close of regular session trading (normally 4:00&#160;p.m. Eastern Time) on each day the NYSE is open for business.
The Fund&#8217;s net asset value is calculated by taking the market value of the Fund&#8217;s total assets, including interest or dividends
accrued but not yet collected, less all liabilities, and dividing by the total number of common shares outstanding. The result, rounded
to the nearest cent, is the net asset value.</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><span style="background-color: white">The Board of Trustees of the Fund
(the &#8220;Board&#8221;) has adopted policies and procedures for the valuation of the Fund&#8217;s investments (the &#8220;Valuation
Procedures&#8221;). The U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) adopted Rule&#160;2a-5 under the 1940 Act (&#8220;Rule&#160;2a-5&#8221;)
which establishes requirements for determining fair value in good faith and became effective September&#160;8, 2022. Rule&#160;2a-5 also
defines &#8220;readily available market quotations&#8221; for purposes of the 1940 Act and establishes requirements for determining whether
a fund must fair value a security in good faith.</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><span style="background-color: white">Pursuant to Rule&#160;2a-5, the
Board has designated the Investment Adviser as the valuation designee to perform fair valuation determinations for the Fund with respect
to all Fund investments and other assets. As the Fund&#8217;s valuation designee pursuant to Rule&#160;2a-5, the Investment Adviser has
adopted separate procedures (the &#8220;Valuation Designee Procedures&#8221;) reasonably designed to prevent violations of the requirements
of Rule&#160;2a-5 and Rule&#160;31a-4. The Investment Adviser, in its role as valuation designee, utilizes a valuation committee (the
&#8220;Valuation Committee&#8221;), in the fair value of the Fund&#8217;s securities and/or other assets.</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><span style="background-color: white">Valuations of the Fund&#8217;s
securities and other assets are supplied primarily by pricing service providers appointed pursuant to the processes set forth in the Valuation
Procedures. The Investment Adviser, consistent with the monitoring and review responsibilities set forth in the Valuation Procedures,
regularly reviews the appropriateness of the inputs, methods, models and assumptions employed by the pricing service provider.</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><span style="background-color: white">If the pricing service provider
cannot or does not provide a valuation for a particular investment or such valuation is deemed unreliable, such investment is fair valued
by the Investment Adviser.</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><span style="background-color: white">Securities listed on an exchange
or on an over-the-counter market will be valued at the last reported sale price on the primary exchange or market on which they are traded;
provided, however, that securities listed on the National Association of Securities Dealers Automated Quotations (&#8220;NASDAQ&#8221;)
National Market system will be valued at the NASDAQ official closing price, which may not necessarily represent the last sale price.</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><span style="background-color: white">Equity securities that are traded
on an exchange or on the over-the-counter (&#8220;OTC&#8221;) market and for which there are no transactions on a given day are valued
at the mean of the closing bid and asked prices.</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><span style="background-color: white">Open-end investment companies
are valued at their net asset value (&#8220;NAV&#8221;) as of the close of business, on the valuation date. Exchange-traded funds and
closed-end investment companies are generally valued at the last quoted sale price.</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><span style="background-color: white">Generally, trading in foreign
securities markets is substantially completed each day at various times prior to the close of the New York Stock Exchange (&#8220;NYSE&#8221;).
The values of foreign securities are determined as of the close of such foreign markets or the close of the NYSE, if earlier. All investments
quoted in foreign currencies are valued in U.S. dollars on the basis of the foreign currency exchange rates prevailing at the close of
U.S. business at 4:00&#160;p.m. Investments in foreign securities may involve risks not present in domestic investments. The Valuation
Committee will determine the current value of such foreign securities by taking into consideration certain factors which may include those
discussed above, as well as the following factors, among others: the value of the securities traded on other foreign markets, ADR trading,
closed-end fund trading, foreign currency exchange activity, and the trading prices of financial products that are tied to foreign securities.
In addition, under the Valuation Procedures, the Valuation Committee is authorized to use prices and other information supplied by a third-party
pricing vendor in valuing foreign securities.</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><span style="background-color: white">Commercial paper and discount
notes are valued based on prices provided by independent pricing services or, if not available or if the Investment Adviser considers
that price to not represent fair value, by dealers using the mean of</span></p>


<!-- Field: Page; Sequence: 31 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">the closing bid and asked prices for such securities or, if such prices
are not available, at prices for securities of comparable maturity, quality and type. If sufficient market activity is limited or does
not exist, the pricing services or dealers may utilize proprietary valuation models which may, for example, consider market characteristics
such as benchmark yield curves, option adjusted spreads, credit spreads, estimated default rates, coupon rates, anticipated timing of
principal repayments, underlying collateral, or other unique security features in order to estimate relevant cash flows, which are then
discounted to calculate a security&#8217;s fair value. Commercial paper and discount notes with remaining maturities of 60 days or less
at the time of valuation are valued at amortized cost, unless the Investment Adviser concludes that amortized cost does not represent
the fair value of the applicable asset in which case it will be valued using an independent pricing service. Commercial paper and discount
notes which have a term-to-maturity greater than 60 days from the date of purchase are valued at their current market quotations until
maturity or disposition. Convertible securities are valued in the same manner as debt securities.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><span style="background-color: white">Repurchase agreements are generally
valued at amortized cost, provided such amounts approximate market value.</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><span style="background-color: white">Asset-back securities (&#8220;ABS&#8221;)
and other structured finance securities are generally valued using a pricing service provider.</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><span style="background-color: white">Typically, loans are valued using
information provided by an independent third-party pricing service which uses broker quotes, among other inputs. If the pricing service
cannot or does not provide a valuation for a particular loan, or such valuation is deemed unreliable, such investment is valued based
on a quote from a broker-dealer or is fair valued by the Investment Adviser.</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><span style="background-color: white">Exchange-traded options are valued
at the closing price, or if not traded that day at the mean of the bid and ask prices on the principal exchange on which they are traded.</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><span style="background-color: white">Forward foreign currency exchange
contracts are valued daily based on the applicable exchange rate of the underlying currency.</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><span style="background-color: white">Investments for which market quotations
are not readily available are fair valued as determined in good faith by the Investment Adviser. Valuations in accordance with these methods
are intended to reflect each security&#8217;s (or asset&#8217;s or liability&#8217;s) &#8220;fair value.&#8221; Each such determination
is based on a consideration of all relevant factors, which are likely to vary from one pricing context to another. Examples of such factors
may include, but are not limited to market prices; sale prices; broker quotes; and models which derive prices based on inputs such as
prices of securities with comparable maturities and characteristics, or based on inputs such as anticipated cash flows or collateral,
spread over U.S. Treasury securities, and other information analysis.</span></p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">DISTRIBUTIONS</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund intends to pay substantially all of its
net investment income to Common Shareholders through monthly distributions. In addition, the Fund intends to distribute any net long-term
capital gains to Common Shareholders at least annually. The Fund expects that distributions paid on the Common Shares will consist primarily
of (i) investment company taxable income, which includes, among other things, ordinary income, net short-term capital gain and income
from certain hedging and interest rate transactions, (ii) net capital gain (which is the excess of net long-term capital gain over net
short-term capital loss), and/or (iii) return of capital.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund&#8217;s net investment income can vary significantly
over time; however, the Fund seeks to maintain a more stable monthly distribution per share. The distributions paid by the Fund for any
particular month may be more or less than the amount of net investment income for that monthly period.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">In any given year, there can be no guarantee
the Fund&#8217;s investment returns will exceed the amount of distributions. The Fund may distribute more than the entire amount of
the net investment income earned in a particular period, in which case all or a portion of a distribution may be a return of
capital. Return of capital is the return of a portion of the shareholder&#8217;s original investment up to the amount of the Common
Shareholder&#8217;s tax basis in their Common Shares, which would reduce such tax basis. Although a return of capital may not be
taxable, it will generally increase the Common Shareholder&#8217;s potential gain or reduce the Common Shareholder&#8217;s potential
loss on any subsequent sale or other disposition of Common Shares which may increase taxes payable by a Common Shareholder or reduce a Common
Shareholder&#8217;s loss deduction in connection with such sale or other disposition. <b>The Fund&#8217;s distributions have historically included,
and may in the future include, a significant portion of return of capital. For the fiscal year ended October&#160;31, 2023, the
Fund&#8217;s distributions were comprised of approximately 28.04% ordinary income and 71.96% return of capital. </b>Accordingly,
shareholders should not assume that the source of a distribution from the Fund is net</p>


<!-- Field: Page; Sequence: 32 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">income or profit, and the Fund&#8217;s distributions should not
be used as a measure of performance or confused with yield or income. Although a return of capital may not be taxable, it will generally
increase the common shareholder&#8217;s potential gain, or reduce the common shareholder&#8217;s potential
loss, on any subsequent sale or other disposition of common shares. Common shareholders should not assume
that the source of a distribution from the Fund is net income or profit, and common shareholders who receive distributions that include
return of capital should not assume that such return of capital is derived from the Fund&#8217;s investments.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Alternatively, the Fund may also distribute less
than its net investment income in a particular period. The undistributed net investment income may be available to supplement future common
share distributions. Undistributed net investment income is included in the Common Shares&#8217; net asset value, and, correspondingly,
distributions from net investment income will reduce the Common Shares&#8217; net asset value.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">With each distribution that does not consist solely
of net investment income, the Fund will issue a notice to shareholders that will provide estimated information regarding the amount and
composition of the distribution. The amounts and sources of distributions reported in each notice will be estimated, are likely to change
over time and are not provided for tax reporting purposes. The final determination of such amounts will be made and reported to shareholders
after the end of the calendar year when the Fund determines its earnings and profits for the year. The actual amounts and sources of the
amounts for accounting and tax reporting purposes will depend upon the Fund&#8217;s investment experience during its full fiscal year
and may be subject to changes based on tax regulations. The Fund will send each shareholder a Form&#160;1099-DIV for the calendar year
that will tell shareholders how to report distributions for federal income tax purposes.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund&#8217;s distribution rate is not constant
and the amount of distributions, when and if declared by the Fund&#8217;s Board of Trustees, is subject to change based on the performance
of the Fund. The Fund reserves the right to change its distribution policy and the basis for establishing the rate of distributions at
any time and may do so without prior notice to Common Shareholders.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Payment of future distributions is subject to approval
by the Fund&#8217;s Board of Trustees, as well as meeting the covenants of any outstanding Indebtedness or preferred shares and the asset
coverage requirements of the 1940 Act.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The distributions the Fund has paid since April 30,
2024 are as follows:</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="text-decoration: underline">Payment
    Date</span></span></td>
    <td style="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="text-decoration: underline">Record
    Date</span></span></td>
    <td style="text-align: center; width: 33%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="text-decoration: underline">Distribution
    per Common Share</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">May&#160;31,
    2024</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">May&#160;15,
    2024</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$0.1172</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">June
    28, 2024</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">June
    3, 2024</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$0.1172</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">July
    31, 2024</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">July
    1, 2024</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$0.1172</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">August
    30, 2024</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">August
    1, 2024</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$0.1172</span></td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">&#160;</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">DIVIDEND REINVESTMENT PLAN</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The information contained under the heading &#8220;Dividend Reinvestment
Plan&#8221; in the Fund&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm">Annual Report</a> is incorporated herein by reference.</p>

<p id="xdx_98C_ecef--CapitalStockTableTextBlock_c20240723__20240723_gBFCSTTB-S_z6ZYJCjatge4" style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center"><ix:nonNumeric contextRef="AsOf2024-07-23" continuedAt="ConU000174-01" escape="true" id="Fact000174" name="cef:CapitalStockTableTextBlock">DESCRIPTION OF CAPITAL STRUCTURE</ix:nonNumeric></p>

<div id="xdx_C01_gBFCSTTB-S_zLs26kf3p27i"><ix:continuation continuedAt="ConU000174-02" id="ConU000174-01"><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund is a statutory trust organized under the laws of the state
of Delaware. The following is a brief description of the terms of the common shares, indebtedness and preferred shares which may be issued
by the Fund. This description does not purport to be complete and is qualified by reference to the Fund&#8217;s Agreement and Declaration
of Trust (the &#8220;Declaration of Trust&#8221;) and By-Laws (collectively, the &#8220;Governing Documents&#8221;).</p></ix:continuation></div>

<div id="xdx_C02_gBFCSTTB-S_zDWP6AfG65If"><ix:continuation continuedAt="ConU000174-03" id="ConU000174-02"><p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><b>Common Shares</b></p></ix:continuation></div>

<div id="xdx_C0A_gBFCSTTB-S_zou5LSKxxxC1"><ix:continuation continuedAt="ConU000174-04" id="ConU000174-03"><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Pursuant to the Declaration of Trust, the Fund is authorized to issue
unlimited common shares, par value $0.001 per share. Each common share has one vote and, when issued and paid for in accordance with the
terms of this offering, will be fully paid and non-assessable. All common shares are equal as to dividends, assets and voting privileges
and have no conversion, preemptive or other subscription rights.</p></ix:continuation></div>


<!-- Field: Page; Sequence: 33 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C02_gBFCSTTB-S_zrkRAjC6JFZ3"><ix:continuation continuedAt="ConU000174-05" id="ConU000174-04"><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund&#8217;s currently outstanding common shares are, and common
shares offered by this Prospectus will be, listed on the NYSE under the symbol &#8220;AVK.&#8221;</p></ix:continuation></div>

<div id="xdx_C0D_gBFCSTTB-S_zxzRsib8tTUd"><ix:continuation continuedAt="ConU000174-06" id="ConU000174-05"><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund will not issue certificates for common shares.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt"><i>Issuance of Additional Common Shares. </i>Any additional offerings
of common shares will require approval by the Board of Trustees. The provisions of the 1940 Act, including Section&#160;23(b) of the 1940
Act, generally require that the public offering price (less underwriting commissions and discounts) of common shares sold by a closed-end
investment company must equal or exceed the net asset value of such company&#8217;s common shares (calculated within 48 hours of the pricing
of such offering), except, in pertinent part, (i) with the consent of a majority of its common shareholders; or (ii) in connection with
an offering to the holders of one or more classes of its capital stock.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt">The Fund may, from time to time, seek the consent of common shareholders
to permit the issuance and sale by the Fund of common shares at a price below the Fund&#8217;s then-current net asset value, subject to
certain conditions. If such consent is obtained, the Fund may, contemporaneous with and in no event more than one year following the receipt
of such consent, sell common shares at price below net asset value in accordance with any conditions adopted in connection with the giving
of such consent. Additional information regarding any consent of common shareholders obtained by the Fund and the applicable conditions
imposed on the issuance and sale by the Fund of common shares at a price below net asset value will be disclosed in the Prospectus Supplement
relating to any such offering of common shares at a price below net asset value. Until such consent of common shareholders, if any, is
obtained, the Fund may not sell common shares at a price below net asset value. Because the Fund&#8217;s advisory fee is based upon average
Managed Assets, the Adviser&#8217;s interest in recommending the issuance and sale of common shares at a price below net asset value may
conflict with the interests of the Fund and its common shareholders.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt">The Fund may also issue and sell common shares at a price below the
Fund&#8217;s then-current net asset value in connection with an offering to the holders of its common shares pursuant to the issuance
of subscription rights. See &#8220;Description of Subscription Rights.&#8221;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><b>Preferred Shares</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund&#8217;s Declaration of Trust provides that the Board of Trustees
may authorize and issue preferred shares with rights as determined by the Board of Trustees, by action of the Board of Trustees without
prior approval of the holders of the common shares.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Common shareholders have no preemptive right to purchase any preferred
shares that might be issued. Any such preferred share offering would be subject to the limits imposed by the 1940 Act. Any preferred shares
issued by the Fund would have special voting rights and a liquidation preference over the common shares. Issuance of preferred shares
would constitute leverage and would entail special risks to the common shareholders.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Under the 1940 Act, the Fund may not issue preferred shares unless,
immediately after such issuance, it has an &#8220;asset coverage&#8221; of at least 200% of the liquidation value of the outstanding preferred
shares (<i>i.e.</i>, such liquidation value may not exceed 50% of the value of the Fund&#8217;s total assets). For these purposes, &#8220;asset
coverage&#8221; means the ratio of (i) total assets less all liabilities and indebtedness not represented by &#8220;senior securities&#8221;
to (ii) the amount of &#8220;senior securities representing indebtedness&#8221; plus the &#8220;involuntary liquidation preference&#8221;
of the preferred shares. &#8220;Senior security&#8221; generally means any bond, note, or similar security evidencing indebtedness and
any class of shares having priority over any other class as to distribution of assets or payment of dividends. &#8220;Senior security
representing indebtedness&#8221; means any &#8220;senior security&#8221; other than equity shares. The &#8220;involuntary liquidation
preference&#8221; of the preferred shares is the amount that holders of preferred shares would be entitled to receive in the event of
an involuntary liquidation of the Fund in preference to the common shares.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">If preferred shares are outstanding, two of the Fund&#8217;s Trustees
will be elected by the holders of preferred shares, voting separately as a class. The remaining Trustees of the Fund will be elected by
common shareholders and preferred shares voting together as a single class. In the unlikely event the Fund failed to pay dividends on
preferred shares for two years, preferred shares would be entitled to elect a majority of the Trustees of the Fund.</p>

</ix:continuation></div><div id="xdx_C09_gBFCSTTB-S_zVd4wNzaFdeg"><ix:continuation continuedAt="ConU000174-07" id="ConU000174-06"><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund is not permitted to declare any dividend (except a dividend
payable in common shares), or to declare any other distribution on the common shares, or to purchase any common shares, unless the preferred
shares have at the time of the declaration of any such dividend or other distribution, or at the time of any such purchase of common shares,
an asset coverage of at least 200% after deducting the amount of such dividend, distribution or purchase price. In addition, the Fund
may be subject to certain restrictions imposed by guidelines of one or more rating</p></ix:continuation></div>


<!-- Field: Page; Sequence: 34 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C0D_gBFCSTTB-S_zo3kBGXIL8bj"><ix:continuation id="ConU000174-07"><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">agencies that may issue ratings for preferred shares issued by the Fund.
These guidelines may impose asset coverage or portfolio composition requirements that are more stringent than those imposed on the Fund
by the 1940 Act.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><b>Indebtedness</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund is authorized to borrow or issue debt securities
for financial leveraging purposes and for temporary purposes such as the settlement of transactions. The Fund may utilize indebtedness
to the maximum extent permitted under the 1940 Act. Under the 1940 Act, a fund generally is not permitted to issue commercial paper or
notes or engage in other borrowings unless, immediately after the borrowing, the fund would have asset coverage (as defined in the 1940
Act) of at least 300%, <i>i.e.</i>, the value of the fund&#8217;s total assets less liabilities other than the principal amount represented
by commercial paper, notes or other borrowings, is at least 300% of such principal amount. In addition, other than with respect to privately
arranged borrowings, the Fund is not permitted to declare any cash dividend or other distribution on the common shares unless, at the
time of such declaration, the value of the Fund&#8217;s total assets, less liabilities other than the principal amount represented by
borrowings, is at least 300% of such principal amount after deducting the amount of such dividend or other distribution. If the Fund borrows,
the Fund intends, to the extent possible, to prepay all or a portion of the principal amount of any outstanding commercial paper, notes
or other borrowings to the extent necessary to maintain the required asset coverage.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The terms of any such borrowings may require the
Fund to pay a fee to maintain a line of credit, such as a commitment fee, or to maintain minimum average balances with a lender. Any such
requirements would increase the cost of such borrowings over the stated interest rate. Such lenders would have the right to receive interest
on and repayment of principal of any such borrowings, which right will be senior to those of the common shareholders. Any such borrowings
may contain provisions limiting certain activities of the Fund, including the payment of dividends to common shareholders in certain circumstances.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Certain types of borrowings subject the Fund to covenants
in credit agreements relating to asset coverage and portfolio composition requirements. Certain borrowings also may subject the Fund to
certain restrictions on investments imposed by guidelines of one or more rating agencies, which may issue ratings for such borrowings.
Such guidelines may impose asset coverage or portfolio composition requirements that are more stringent than those imposed by the 1940
Act.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The 1940 Act grants to the holders of senior securities representing
indebtedness, other than with respect to privately arranged borrowings, certain voting rights in the event of default in the payment of
interest on or repayment of principal. Failure to maintain certain asset coverage requirements under the 1940 Act could result in an event
of default and entitle the debt holders to elect a majority of the Board of Trustees.</p></ix:continuation></div>

<div><p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt"><b>Capitalization</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt">The following information regarding the Fund&#8217;s authorized shares
is as of April 30, 2024:</p>

<ix:nonNumeric contextRef="AsOf2024-07-23" escape="true" id="Fact000176" name="cef:OutstandingSecuritiesTableTextBlock"><table id="xdx_888_ecef--OutstandingSecuritiesTableTextBlock_ztnItirCHC95" summary="xdx: Disclosure - Outstanding Securities" cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; width: 39%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>Title of Class</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>Amount Authorized</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>Amount Held by Fund for its own Account</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>Amount Outstanding Exclusive of Amounts held by Fund</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><span id="xdx_908_ecef--OutstandingSecurityTitleTextBlock_c20240723__20240723_zbhSl7iwa7Y6"><ix:nonNumeric contextRef="AsOf2024-07-23" escape="true" id="Fact000177" name="cef:OutstandingSecurityTitleTextBlock">Common Shares</ix:nonNumeric></span> </span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">Unlimited</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">None</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><span id="xdx_907_ecef--OutstandingSecurityAuthorizedShares_c20240723__20240723_zUzeIKXNGSh9"><ix:nonFraction name="cef:OutstandingSecurityAuthorizedShares" contextRef="AsOf2024-07-23" id="Fact000178" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">34,593,769</ix:nonFraction></span></span></td></tr>
  </table></ix:nonNumeric></div>
<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">DESCRIPTION OF SUBSCRIPTION RIGHTS THAT MAY
BE ISSUED</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt">The Fund may issue subscription rights to holders of common shares
to purchase additional common shares. Subscription rights may or may not be transferable by the person purchasing or receiving the subscription
rights. In connection with a subscription rights offering to holders of common shares, the Fund would distribute certificates evidencing
the subscription rights and a Prospectus Supplement to our common shareholders as of the record date that we set for determining the shareholders
eligible to receive subscription rights in such subscription rights offering. For complete terms of the subscription rights, please refer
to the actual terms of such subscription rights which will be set forth in the subscription rights agreement or subscription certificate
relating to such subscription rights and described in the Prospectus Supplement.</p>


<!-- Field: Page; Sequence: 35 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt">The Fund generally may not issue and sell common shares at a public
offering price (less underwriting commissions and discounts) less than the net asset value of the Fund&#8217;s common shares (calculated
within 48 hours of the pricing of such offering). However, pursuant to Section&#160;23(b) of the 1940 Act, the Fund may issue and sell
common shares at a public offering price less than the net asset value of the Fund&#8217;s common shares in connection with the issuance
of subscription rights to holders of common shares to purchase additional common shares. See &#8220;Description of Capital Structure.&#8221;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt">The applicable Prospectus Supplement, which would accompany this
Prospectus, would describe the following terms of subscription rights in respect of which this Prospectus is being delivered:</p>

<ul style="margin-top: 0in; list-style-type: disc">

<li style="margin: 0 0 10pt; font-size: 9pt">the period of time the offering would remain open (which will be open a minimum number of
days such that all record holders would be eligible to participate in the offering and will not be open longer than 120 days);</li>

<li style="margin: 0 0 10pt; font-size: 9pt">the title of such subscription rights;</li>

</ul>

<ul style="margin-top: 0in; list-style-type: disc">

<li style="margin: 0 0 10pt; font-size: 9pt">the exercise price for such subscription rights (or method of calculation thereof);</li>

<li style="margin: 0 0 10pt; font-size: 9pt">the number of such subscription rights issued in respect of each share;</li>

<li style="margin: 0 0 10pt; font-size: 9pt">the number of rights required to purchase a single share;</li>

<li style="margin: 0 0 10pt; font-size: 9pt">the extent to which such subscription rights are transferable and the market on which they
may be traded if they are transferable;</li>

<li style="margin: 0 0 10pt; font-size: 9pt">if applicable, a discussion of certain U.S. federal income tax considerations applicable
to the issuance or exercise of such subscription rights;</li>

<li style="margin: 0 0 10pt; font-size: 9pt">the date on which the right to exercise such subscription rights will commence, and the date
on which such right will expire (subject to any extension);</li>

<li style="margin: 0 0 10pt; font-size: 9pt">the extent to which such subscription rights include an over-subscription privilege with
respect to unsubscribed securities and the terms of such over-subscription privilege;</li>

<li style="margin: 0 0 10pt; font-size: 9pt">any termination right the Fund may have in connection with such subscription rights offering;</li>

<li style="margin: 0 0 10pt; font-size: 9pt">the expected trading market, if any, for rights; and</li>

<li style="margin: 0 0 10pt; font-size: 9pt">any other terms of such subscription rights, including exercise, settlement and other procedures
and limitations relating to the transfer and exercise of such subscription rights.</li>

</ul>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt"><b>Exercise of Subscription Rights</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt">Each subscription right would entitle the holder of the subscription
right to purchase for cash such number of shares at such exercise price as in each case is set forth in, or is determinable as set forth
in, the Prospectus Supplement relating to the subscription rights offered thereby. Subscription rights would be exercisable at any time
up to the close of business on the expiration date for such subscription rights set forth in the Prospectus Supplement. After the close
of business on the expiration date, all unexercised subscription rights would become void.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt">Upon expiration of the rights offering and the receipt of payment
and the subscription rights certificate properly completed and duly executed at the corporate trust office of the subscription rights
agent or any other office indicated in the Prospectus Supplement, the Fund would issue, as soon as practicable, the shares purchased as
a result of such exercise. To the extent permissible under applicable law, the Fund may determine to offer any unsubscribed offered securities
directly to persons other than shareholders, to or through agents, underwriters or dealers or through a combination of such methods, as
set forth in the applicable Prospectus Supplement.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Transferable Rights Offering</b></p>


<!-- Field: Page; Sequence: 36 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Subscription rights issued by the Fund may be transferrable. The distribution
to shareholders of transferable rights, which may themselves have intrinsic value, also will afford non-participating shareholders the
potential of receiving cash payment upon the sale of the rights, receipt of which may be viewed as partial compensation for any dilution
of their interests that may occur as a result of the rights offering. In a transferrable rights offering, management of the Fund will
use its best efforts to ensure an adequate trading market in the rights for use by shareholders who do not exercise such rights. However,
there can be no assurance that a market for transferable rights will develop or, if such a market does develop, what the price of the
transferable rights will be. In a transferrable rights offering to purchase common shares at a price below net asset value, the subscription
ratio will not be less than 1-for-3, that is the holders of common shares of record on the record date of the rights offering will receive
one right for each outstanding common share owned on the record date and the rights will entitle their holders to purchase one new common
share for every three rights held (provided that any common shareholder who owns fewer than three common shares as of the record date
may subscribe for one full common share). Assuming the exercise of all rights, such a rights offering would result in an approximately
<span style="background-color: white">33&#160;<sup>1&#160;</sup>/<sub>&#160;3</sub></span>% increase in the Fund&#8217;s common shares
outstanding.</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">ANTI-TAKEOVER PROVISIONS IN THE FUND&#8217;S
GOVERNING DOCUMENTS</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund presently has provisions in its Governing Documents which could
have the effect of limiting, in each case, (i) the ability of other entities or persons to acquire control of the Fund, (ii) the Fund&#8217;s
freedom to engage in certain transactions or (iii) the ability of the Fund&#8217;s Board of Trustees or shareholders to amend the Governing
Documents or effectuate changes in the Fund&#8217;s management. These provisions of the Governing Documents of the Fund may be regarded
as &#8220;anti-takeover&#8221; provisions. The Board of Trustees is divided into three classes, with the terms of one class expiring at
each annual meeting of shareholders. At each annual meeting, one class of Trustees is elected to a three-year term. This provision could
delay for up to two years the replacement of a majority of the Board of Trustees. A Trustee may be removed from office for cause by the
action of a majority of the remaining Trustees followed by a vote of the holders of at least 75% of the shares then entitled to vote for
the election of the respective Trustee.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Declaration of Trust requires the affirmative vote of a majority
of the Board of Trustees followed by the affirmative vote of the holders of at least 75% of the outstanding shares of each affected class
or series of the Fund, voting separately as a class or series, to approve, adopt or authorize certain transactions with 5% or greater
holders of a class or series of shares and their associates, unless the transaction has been approved by at least 80% of the Board of
Trustees, in which case &#8220;a majority of the outstanding voting securities&#8221; (as defined in the 1940 Act) of the Fund shall be
required. For purposes of these provisions, a 5% or greater holder of a class or series of shares (a &#8220;Principal Shareholder&#8221;)
refers to any person who, whether directly or indirectly and whether alone or together with its affiliates and associates, beneficially
owns 5% or more of the outstanding shares of any class or series of shares of beneficial interest of the Fund.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The 5% holder transactions subject to these special approval requirements
are:</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the merger or consolidation of the Fund or any subsidiary of the Fund with or into any Principal Shareholder;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the issuance of any securities of the Fund to any Principal Shareholder for cash (other than pursuant to any automatic dividend reinvestment
plan);</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the sale, lease or exchange of all or any substantial part of the assets of the Fund to any Principal Shareholder, except assets having
an aggregate fair market value of less than $1,000,000, aggregating for the purpose of such computation all assets sold, leased or exchanged
in any series of similar transactions within a twelve-month period; or</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the sale, lease or exchange to the Fund or any subsidiary thereof, in exchange for securities of the Fund, of any assets of any Principal
Shareholder, except assets having an aggregate fair market value of less than $1,000,000, aggregating for the purposes of such computation
all assets sold, leased or exchanged in any series of similar transactions within a twelve-month period.</td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">For the purposes of calculating &#8220;a majority of the outstanding
voting securities&#8221; under the Declaration of Trust, each class and series of the Fund shall vote together as a single class, except
to the extent required by the 1940 Act or the Declaration of Trust with respect to any class or series of shares. If a separate vote is
required, the applicable proportion of shares of the class or series, voting as a separate class or series, also will be required. A &#8220;majority
of</p>


<!-- Field: Page; Sequence: 37 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">the outstanding voting securities&#8221; means the lesser of (i) 67%
or more of the Fund&#8217;s voting securities present at a meeting, if the holders of more than 50% of the Fund&#8217;s outstanding voting
securities are present or represented by proxy; or (ii) more than 50% of the Fund&#8217;s outstanding voting securities.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Board of Trustees has determined that provisions with respect to
the Board and shareholder voting requirements described above, which voting requirements are greater than the minimum requirements under
Delaware law or the 1940 Act, are in the best interest of shareholders generally. Reference should be made to the Declaration of Trust
on file with the SEC for the full text of these provisions. See &#8220;Where You Can Find More Information.&#8221;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">In addition, as a Delaware statutory trust, the Fund is subject to the
Control Share Statute contained in Subchapter III of the DSTA, which became automatically applicable to listed closed-end funds, such
as the Fund, upon its Effective Date of August&#160;1, 2022. The Control Share Statute provides that an acquirer of shares above a series
of voting power thresholds has no voting rights under the DSTA or the governing documents of the Fund with respect to shares acquired
in excess of that threshold (<i>i.e.</i>, the &#8220;control shares&#8221;) unless approved by shareholders. See &#8220;Certain Provisions
of Delaware Law, the Declaration of Trust and By-Laws&#8212;Delaware Control Share Statute.&#8221;</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">CERTAIN PROVISIONS OF DELAWARE LAW, THE DECLARATION
OF TRUST AND BY-LAWS</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Classified Board of Trustees</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Board of Trustees is divided into three classes of trustees serving
staggered three-year terms. Upon expiration of their current terms, Trustees of each class will be elected to serve for three-year terms
and until their successors are duly elected and qualified or the Fund terminates, and each year one class of Trustees will be elected
by the shareholders.&#160;A classified board may render a change in control of the Fund or removal of the Fund&#8217;s incumbent management
more difficult. The Fund believes, however, that the longer time required to elect a majority of a classified Board of Trustees will help
to ensure the continuity and stability of its management and policies.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Election of Trustees</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund&#8217;s Declaration of Trust provides that the affirmative
vote of the holders of a majority of the shares entitled to vote and present or represented by proxy will be required to elect a Trustee.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: justify"><b>Number of Trustees; Vacancies; Removal</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund&#8217;s Declaration of Trust provides that the number of Trustees
will be set by the Board of Trustees. The Fund&#8217;s Declaration of Trust provides that a majority of the Fund&#8217;s Trustees then
in office may at any time increase or decrease the number of Trustees provided there will be at least two Trustees. The Trustees&#8217;
power of appointment is subject to Section&#160;16(a) of the 1940 Act. Whenever a vacancy in the number of Trustees will occur, until
such vacancy is filled as provided, the Trustees in office, regardless of their number, will have all the powers granted to the Trustees
and will discharge all the duties imposed upon the Trustees by the Declaration of Trust.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Action by Shareholders</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Shareholder action can be taken only at an annual or special meeting
of shareholders or by written consent in lieu of a meeting.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Advance Notice Provisions for Shareholder Nominations and Shareholder
Proposals</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund&#8217;s By-laws provide that with respect to an annual meeting
of shareholders, nominations of persons for election to the Board of Trustees and the proposal of business to be considered by shareholders
may be made only (1) pursuant to the Fund&#8217;s notice of the meeting, (2) by the Board of Trustees or (3) by a shareholder of record
who individually or in the aggregate, holds at least 3% of the shares entitled to vote, has held such shares continuously for one year,
continuously holds such shares through and including the time of the annual meeting, and has complied with the advance notice procedures
of the By-laws. With respect to special meetings of shareholders, only the business specified in the Fund&#8217;s notice of the meeting
may be brought before the meeting. Nominations of persons for election to the Board of Trustees at a special meeting may be made only
(1) pursuant to the Fund&#8217;s notice of the meeting, (2) by the Board of Trustees or (3) by a shareholder of record who individually
or in the aggregate, holds at least 3% of the shares entitled to vote, has held such shares continuously for one year, continuously holds
such shares through and including the time of the annual meeting, and has complied with the advance notice procedures of the By-laws.</p>


<!-- Field: Page; Sequence: 38 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Calling of Special Meetings of Shareholders</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund&#8217;s By-laws provide that special meetings of shareholders
may be called at any time by the President or the majority of Trustees of the Fund. By following certain procedures, a special meeting
of shareholders will also be called by any Trustee of the Fund upon the written request of the shareholders entitled to cast not less
than a majority of all the votes entitled to be cast at such meeting.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Additional Provisions of the Declaration of Trust and By-Laws</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"> </p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">The Declaration of Trust provides that the Trustees shall owe to the
Fund and its Shareholders the same fiduciary duties as owed by directors of corporations to such corporations and their stockholders
under the Delaware General Corporation Law. </p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">Under the Declaration of Trust, the Trustees and officers of the Fund
are entitled to indemnification under certain circumstances against liabilities and expenses in connection with any action, suit or other
proceeding in which he or she may be involved while acting as a trustee or officer of the Fund except with respect to any matter as to
which he or she shall not have acted in good faith in the reasonable belief that his or her action was in the best interest of the Fund
or, in the case of any criminal proceeding, as to which he or she shall have had reasonable cause to believe that the conduct was unlawful,
provided, however, that no indemnitee shall be indemnified hereunder against any liability to any person or any expense of such indemnitee
arising by reason of (i) willful misfeasance, (ii) bad faith, (iii) gross negligence, or (iv) reckless disregard of the duties involved
in the conduct of his position. Subject to any limitations provided by the 1940 Act, the Fund has the power and authority to indemnify
and provide for the advance payment of expenses to employees, agents and other persons providing services to the Fund or serving in any
capacity at the request of the Fund to the full extent corporations organized under the Delaware General Corporation Law may indemnify
or provide for the advance payment of expenses for such persons, provided that such indemnification has been approved by a majority of
the Trustees.&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Pursuant to the By-Laws, the Court of Chancery of the State of Delaware
shall be the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the Trust, (ii) any action asserting
a claim of breach of a fiduciary duty owed by any trustee, officer, or employee of the Trust to the Trust or its Shareholders, (iii)
any action asserting a claim against the Trust or any trustee, officer, or employee of the Trust arising pursuant to any provision of
the Delaware Statutory Trust Act or the Trust&#8217;s Declaration or By-Laws, or (iv) any action asserting a claim against the Trust
or any trustee, officer, or employee of the Trust governed by the internal affairs doctrine of the State of Delaware; provided, however,
that, in the event that the Court of Chancery of the State of Delaware lacks jurisdiction over any such action or proceeding, the sole
and exclusive forum for such action or proceeding shall be another state or federal court located within the State of Delaware. The foregoing
exclusive form provision does not apply to any claim under the U.S. federal securities laws. <span style="font-size: 9pt">The exclusive
forum provision may require a shareholders to have to bring a claim subject to the exclusive forum provision in forum that such shareholder
may consider to be less convenient and/or less favorable than other forums in which a shareholder may otherwise seek to bring such claim.
</span></p>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Delaware Control Share Statute</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Because the Fund is organized as a Delaware statutory trust it is subject
to the Control Share Statute contained in Subchapter III of the DSTA, which became automatically applicable to listed closed-end funds,
such as the Fund, upon its Effective Date of August&#160;1, 2022.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Control Share Statute provides for a series of voting power thresholds
above which shares are considered control shares. These thresholds are:</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>10% or more, but less than 15% of all voting power;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>15% or more, but less than 20% of all voting power;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>20% or more, but less than 25% of all voting power;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>25% or more, but less than 30% of all voting power;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>30% or more, but less than a majority of all voting power; or</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>a majority or more of all voting power.</td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Voting power is defined by the Control Share Statute as the power to
directly or indirectly exercise or direct the exercise of the voting power of Fund shares in the election of Trustees. Whether a voting
power threshold is met is determined by aggregating the holdings of the acquirer as well as those of its &#8220;associates,&#8221; as
defined by the Control Share Statute.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Once a threshold is reached, an acquirer has no voting rights under
the DSTA or the governing documents of the Fund with respect to shares acquired in excess of that threshold (<i>i.e.</i>, the &#8220;control
shares&#8221;) unless approved by shareholders. Approval by shareholders requires the affirmative vote of two-thirds of all votes entitled
to be cast on</p>


<!-- Field: Page; Sequence: 39 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">the matter, excluding shares held by the acquirer and its associates
as well as shares held by certain insiders of a Fund. The Control Share Statute provides procedures for an acquirer to request a shareholder
meeting for the purpose of considering whether voting rights shall be accorded to control shares. Further approval by a Fund&#8217;s shareholders
would be required with respect to additional acquisitions of control shares above the next applicable threshold level.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Control Share Statute effectively allows non-interested shareholders
to evaluate the intentions and plans of an acquiring person above each threshold level.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Alternatively, the Board of Trustees is permitted, but not obligated,
to exempt specific acquisitions or classes of acquisitions of control shares, either in advance or retroactively. The Board of Trustees
has considered the Control Share Statute. As of the date hereof, the Board of Trustees has not received notice of the occurrence of a
control share acquisition nor has been requested to exempt any acquisition. Therefore, the Board of Trustees has not determined whether
the application of the Control Share Statute to an acquisition of Fund shares is in the best interest of the Fund and its shareholders
and has not exempted, and has no present intention to exempt, any acquisition or class of acquisitions.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">If the Board of Trustees receives a notice of a control share acquisition
and/or a request to exempt any acquisition, it will consider whether the application of the Control Share Statute or the granting of such
an exemption would be in the best interest of the Fund and its shareholders. The Fund should not be viewed as a vehicle for trading purposes.
It is designed primarily for risk-tolerant long-term investors.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Control Share Statute does not retroactively apply to acquisitions
of shares that occurred prior to the Effective Date. However, such shares will be aggregated with any shares acquired after the Effective
Date for purposes of determining whether a voting power threshold is exceeded, resulting in the newly acquired shares constituting control
shares.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Control Share Statute requires shareholders to disclose to the Fund
any control share acquisition within 10 days of such acquisition and, upon request, to provide any information that the Board of Trustees
reasonably believes is necessary or desirable to determine whether a control share acquisition has occurred.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Some uncertainty around the general application under the 1940 Act of
state control share statutes exists as a result of recent federal and state court decisions that have found that certain control share
by-laws and the opting in to state control share statutes violated the 1940 Act. Additionally, in some circumstances uncertainty may also
exist in how to enforce the control share restrictions contained in state control share statutes against beneficial owners who hold their
shares through financial intermediaries. The Board has considered the Control Share Statute and the uncertainty around the general application
under the 1940 Act of state control share statutes and enforcement of statute control share statutes. The Board intends to continue to
monitor developments relating to the Control Share Statute and state control share statutes generally.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The foregoing is only a summary of certain aspects of the Control Share
Statute. Shareholders should consult their own legal counsel to determine the application of the Control Share Statute with respect to
their shares of the Fund and any subsequent acquisitions of shares.</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">CLOSED-END FUND STRUCTURE</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">Closed-end funds differ from open-end management investment companies
(commonly referred to as &#8220;mutual funds&#8221;) in that closed-end funds generally list their shares for trading on a securities
exchange and do not redeem their shares at the option of the shareholder. By comparison, mutual funds issue securities redeemable at net
asset value at the option of the shareholder and typically engage in a continuous offering of their shares. Mutual funds are subject to
continuous asset in-flows and out-flows that can complicate portfolio management, whereas closed-end funds generally can stay more fully
invested in securities consistent with the closed-end fund&#8217;s investment objective and policies. In addition, in comparison to open-end
funds, closed-end funds have greater flexibility in their ability to make certain types of investments, including investments in illiquid
securities.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">However, shares of closed-end funds listed for trading on a securities
exchange frequently trade at a discount from net asset value, but in some cases trade at a premium. The market price may be affected by
trading volume of the shares, general market and economic conditions and other factors beyond the control of the closed-end fund. The
foregoing factors may result in the market price of the common shares being greater than, less than or equal to net asset value. The Board
of Trustees has reviewed the structure of the Fund in light of its investment objective and</p>


<!-- Field: Page; Sequence: 40 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">policies and has determined that the closed-end structure is in the
best interests of the shareholders. Investors should assume, therefore, that it is unlikely that the Board of Trustees would vote to convert
the Fund to an open-end management investment company.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><b>Repurchase of Common Shares</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Board of Trustees will review periodically the trading range and
activity of the Fund&#8217;s shares with respect to its net asset value and the Board of Trustees may take certain actions to seek to
reduce or eliminate any such discount. Such actions may include open market repurchases or tender offers for the common shares at net
asset value. There can be no assurance that the Board of Trustees will decide to undertake any of these actions or that, if undertaken,
such actions would result in the common shares trading at a price equal to or close to net asset value per common share.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><b>Conversion to Open-End Fund</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">To convert the Fund to an open-end management investment company, the
Declaration of Trust requires the affirmative vote of a majority of the Board of Trustees followed by the affirmative vote of the holders
of at least 75% of the outstanding shares of each affected class or series of shares of the Fund, voting separately as a class or series,
unless such action has been approved by at least 80% of the Board of Trustees, in which case &#8220;a majority of the outstanding voting
securities&#8221; (as defined in the 1940 Act) of the Fund shall be required. The foregoing vote would satisfy a separate requirement
in the 1940 Act that any conversion of the Fund to an open-end management investment company be approved by the shareholders. If approved
in the foregoing manner, conversion of the Fund to an open-end management investment company could not occur until 90 days after the shareholders&#8217;
meeting at which such conversion was approved and would require at least 30 days&#8217; prior notice to all shareholders.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">In the event of conversion, the common shares would cease to be listed
on the NYSE or other national securities exchange or market system. If the Fund were converted to an open-end management investment company,
it is likely that new common shares would be sold at net asset value plus a sales load. Shareholders of an open-end management investment
company may require the company to redeem their shares at any time (except in certain circumstances as authorized by or under the 1940
Act) at their net asset value, less such redemption charge, if any, as might be in effect at the time of a redemption. In the event of
conversion, the Fund would expect to pay all such redemption requests in cash, but would intend to reserve the right to pay redemption
requests in a combination of cash or securities. If such partial payment in securities were made, investors could incur brokerage costs
in converting such securities to cash.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Board of Trustees has reviewed the structure of the Fund in light
of its investment objective and policies and has determined that the closed-end structure is in the best interests of the shareholders.
Any conversion to an open-end management investment company would require material changes to the Fund&#8217;s investment strategy, including
with respect to the use of leverage and investment in illiquid securities, which may adversely impact the Fund&#8217;s ability to achieve
its investment objective. Investors should assume, therefore, that it is unlikely that the Board of Trustees would vote to convert the
Fund to an open-end management investment company.</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">TAX MATTERS</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The following is a summary of certain U.S. federal income tax considerations
generally applicable to the Fund and U.S. Shareholders (as defined below) and Non-U.S. Shareholders (as defined below) that acquire common
shares (collectively, the &#8220;Shareholders&#8221; that acquire &#8220;Shares&#8221;) and that hold such shares as capital assets within
the meaning of the Code (generally, property held for investment). A more complete discussion of the tax rules applicable to the Fund
and its Shareholders can be found in the SAI that is incorporated by reference into this Prospectus. This summary does not discuss the
consequences of an investment in the Rights. The tax consequences of such an investment will be discussed in a relevant Prospectus Supplement.
The discussion is based upon the Code, Treasury Regulations, judicial authorities, published positions of the Internal Revenue Service
(the &#8220;IRS&#8221;) and other applicable authorities, all as in effect on the date hereof and all of which are subject to change or
differing interpretations (possibly with retroactive effect). This summary does not address all of the potential U.S. federal income tax
consequences that may be applicable to the Fund or to all categories of investors, some of which may be subject to special tax rules.
No ruling has been or will be sought from the IRS regarding any matter discussed herein. No assurance can be given that the IRS would
not assert, or that a court would not sustain, a position contrary to any of the tax aspects set forth below. This summary of U.S. federal
income tax consequences is for general information only. <b>Prospective investors should consult their tax advisors as to the U.S. federal
income tax consequences of</b></p>


<!-- Field: Page; Sequence: 41 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>acquiring, holding and disposing of common shares of the Fund, as
well as the effects of state, local and non-U.S. tax laws.</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">For purposes of this summary, the term &#8220;U.S. Shareholder&#8221;
means a beneficial owner of common shares that, for U.S. federal income tax purposes, is one of the following:</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">1.</td><td>an individual who is a citizen or resident of the United States;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">2.</td><td>a corporation or other entity taxable as a corporation created in or organized under the laws of the United States, any state thereof
or the District of Columbia;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">3.</td><td>an estate the income of which is subject to U.S. federal income taxation regardless of its source; or</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">4.</td><td>a trust (x) if a U.S. court is able to exercise primary supervision over the administration of such trust and one or more U.S. persons
have the authority to control all substantial decisions of such trust or (y) that has a valid election in effect under applicable U.S.
Treasury regulations to be treated as a U.S. person.</td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">If a partnership (including any other entity or arrangement treated
as a partnership for U.S. federal income tax purposes) holds common shares, the U.S. federal income tax treatment of a partner in such
partnership generally will depend upon the status of the partner and the activities of the partnership. Partners of partnerships that
hold common shares should consult their tax advisors.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Taxation of the Fund</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund has elected to be treated, and intends to qualify annually,
as a RIC under Subchapter M of the Code. Accordingly, the Fund must, among other things, meet certain income, asset diversification and
distribution requirements:</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">(i)</td><td>The Fund must derive in each taxable year at least 90% of its gross income from the following sources: (a) dividends, interest (including
tax-exempt interest), payments with respect to certain securities loans, and gains from the sale or other disposition of stock, securities
or foreign currencies, or other income (including gain from options, futures and forward contracts) derived with respect to its business
of investing in such stock, securities or foreign currencies; and (b) net income derived from interests in &#8220;qualified publicly traded
partnerships&#8221; (as defined in the Code). Generally, a qualified publicly traded partnership includes a partnership the interests
of which are traded on an established securities market or readily tradable on a secondary market (or the substantial equivalent thereof)
and that derives less than 90% of its gross income from the items described in (a) above.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">(ii)</td><td>The Fund must diversify its holdings so that, at the end of each quarter of each taxable year, (a) at least 50% of the market value
of the Fund&#8217;s total assets is represented by cash and cash items, including receivables, U.S. Government securities, the securities
of other RICs and other securities, with such other securities limited, in respect of any one issuer, to an amount not greater than 5%
of the value of the Fund&#8217;s total assets and not more than 10% of the outstanding voting securities of such issuer and (b) not more
than 25% of the market value of the Fund&#8217;s total assets is invested in the securities (other than U.S. Government securities and
the securities of other RICs) of (I) any one issuer, (II) any two or more issuers that the Fund controls and that are determined to be
engaged in the same business or similar or related trades or businesses or (III) any one or more &#8220;qualified publicly traded partnerships&#8221;
(as defined in the Code).</td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">As long as the Fund qualifies as a RIC, the Fund generally will not
be subject to U.S. federal income tax on income and gains that the Fund distributes to its shareholders; provided that it distributes
each taxable year at least 90% of the sum of (i) the Fund&#8217;s investment company taxable income (which includes, among other items,
dividends, interest, the excess of any net short-term capital gain over net long-term capital loss, and other taxable income, other than
any net capital gain (defined below), reduced by deductible expenses) determined without regard to the deduction for dividends paid and
(ii) the Fund&#8217;s net tax-exempt interest (the excess of its gross tax-exempt interest over certain disallowed deductions) (the &#8220;Annual
Distribution Requirement&#8221;). The Fund intends to distribute substantially all of such income each year. The Fund will be subject
to income tax at regular corporate rates on any taxable income or gains that it does not distribute to its shareholders.</p>


<!-- Field: Page; Sequence: 42 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund will either distribute or retain for reinvestment all or part
of its net capital gain (which consists of the excess of its net long-term capital gain over its net short-term capital loss). If any
such gain is retained, the Fund will be subject to U.S. federal income tax a regular corporate rates on such retained amount. In that
event, the Fund may report the retained amount as undistributed capital gain in a notice to its Shareholders, each of whom (i) will be
required to include in income for U.S. federal income tax purposes as long-term capital gain its share of such undistributed amounts,
(ii) will be entitled to credit its proportionate share of the tax paid by the Fund against its U.S. federal income tax liability and
to claim refunds to the extent that the credit exceeds such liability and (iii) will increase its basis in its shares by the amount of
undistributed capital gain included in such Shareholder&#8217;s gross income net of the tax deemed paid by such Shareholder under clause&#160;(ii).</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Code imposes a 4% nondeductible excise tax on the Fund to the extent
the Fund does not distribute by the end of any calendar year at least the sum of (i) 98% of its ordinary income (not taking into account
any capital gain or loss) for the calendar year and (ii) 98.2% of its capital gain in excess of its capital loss (adjusted for certain
ordinary losses) for a one-year period generally ending on October&#160;31 of the calendar year (unless an election is made to use the
Fund&#8217;s fiscal year) (the &#8220;Excise Tax Avoidance Requirement&#8221;). In addition, the minimum amounts that must be distributed
in any year to avoid the excise tax will be increased or decreased to reflect any under-distribution or over-distribution, as the case
may be, from the previous year. For purposes of the excise tax, the Fund will be deemed to have distributed any income on which it paid
U.S. federal income tax in the taxable year ending within the calendar year. While the Fund intends to distribute any income and capital
gain in the manner necessary to minimize imposition of the 4% nondeductible excise tax, there can be no assurance that sufficient amounts
of the Fund&#8217;s taxable income and capital gain will be distributed to entirely avoid the imposition of the excise tax. In that event,
the Fund will be liable for the excise tax only on the amount by which it does not meet the foregoing distribution requirement.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">If for any taxable year the Fund does not qualify as a RIC, all of its
taxable income (including its net capital gain) will be subject to tax at regular corporate rates without any deduction for distributions
to Shareholders, and such distributions will be taxable to the Shareholders as ordinary dividends to the extent of the Fund&#8217;s current
and accumulated earnings and profits. Such dividends, however, would be eligible (i) to be treated as qualified dividend income in the
case of non-corporate U.S. Shareholders and (ii) for the dividends-received deduction in the case of U.S. Shareholders taxed as corporations,
in each case provided that certain holding period and other requirements are met. The Fund could be required to recognize unrealized gains,
pay taxes and make distributions (which could be subject to interest charges) before requalifying for taxation as a RIC. The remainder
of this discussion assumes that the Fund qualifies as a RIC.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Taxation of the Fund&#8217;s Investments</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Certain of the Fund&#8217;s investment practices are subject to special
and complex U.S. federal income tax provisions that may, among other things, (i) disallow, suspend or otherwise limit the allowance of
certain losses or deductions, (ii) convert lower taxed long-term capital gains or &#8220;qualified dividend income&#8221; into higher
taxed short-term capital gains or ordinary income, (iii) convert an ordinary loss or a deduction into a capital loss (the deductibility
of which is more limited), (iv) cause the Fund to recognize income or gain without a corresponding receipt of cash, (v) adversely affect
the time as to when a purchase or sale of stock or securities is deemed to occur, (vi) adversely alter the characterization of certain
complex financial transactions and (vii) produce income that will not be &#8220;qualified&#8221; income for purposes of the 90% gross
income requirement described above. These U.S. federal income tax provisions could therefore affect the amount, timing and character of
distributions to Shareholders. The Fund intends to structure and monitor its transactions and may make certain tax elections and may be
required to dispose of securities to mitigate the effect of these provisions and prevent disqualification of the Fund as a RIC (which
may adversely affect the net after-tax return to the Fund).</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">If the Fund acquires shares in a &#8220;passive foreign investment company&#8221;
(a &#8220;PFIC&#8221;), the Fund may be subject to U.S. federal income tax on a portion of any &#8220;excess distribution&#8221; or gain
from the disposition of such shares even if such income is distributed as a taxable dividend by the Fund to Shareholders. Additional charges
in the nature of interest may be imposed on the Fund in respect of deferred taxes arising from such distributions or gains. If the Fund
invests in a PFIC and elects to treat the PFIC as a &#8220;qualified electing fund&#8221; (a &#8220;QEF&#8221;) under the Code, in lieu
of the foregoing requirements, the Fund will be required to include in income each year a portion of the ordinary earnings and net capital
gain of the QEF, even if such income is not distributed to the Fund. The Fund&#8217;s ability to make this election will depend on factors
beyond the Fund&#8217;s control. Alternatively, the Fund can elect to mark to market at the end of each taxable year the Fund&#8217;s
shares in a PFIC; in this case, the Fund will recognize as ordinary income any</p>


<!-- Field: Page; Sequence: 43 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">increase in the value of such shares, and as ordinary loss any decrease
in such value to the extent it does not exceed prior increases included in income. Under either election, the Fund may be required to
recognize in a year income in excess of the Fund&#8217;s distributions from PFICs and the Fund&#8217;s proceeds from dispositions of PFIC
stock during that year, and such income will nevertheless be subject to the Annual Distribution Requirement and will be taken into account
for purposes of the 4% excise tax.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">If the Fund holds directly or indirectly 10% or more of the shares in
a foreign corporation that is treated as a &#8220;controlled foreign corporation&#8221; (a &#8220;CFC&#8221;), the Fund may be treated
as receiving a deemed distribution (taxable as ordinary income) each year from such foreign corporation in an amount equal to the Fund&#8217;s
pro rata share of the corporation&#8217;s income for the taxable year (including both ordinary earnings and capital gains), whether or
not the corporation makes an actual distribution during such year. In general, a foreign corporation will be classified as a CFC if more
than 50% of the shares of the corporation, measured by reference to combined voting power or value, is owned (directly, indirectly or
by attribution) by U.S. shareholders. A U.S. shareholder, for this purpose, is any U.S. person that possesses (directly, indirectly or
by attribution) 10% or more of the combined voting power or value of all classes of shares of a corporation. If the Fund is treated as
receiving a deemed distribution from a CFC, the Fund will be required to include such distribution in its investment company taxable income
regardless of whether the Fund receives any actual distributions from such CFC, and the Fund must distribute such income to satisfy the
Annual Distribution Requirement and the Excise Tax Avoidance Requirement.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Taxation of U.S. Shareholders</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Distributions</i>. Distributions paid to U.S. Shareholders by the
Fund from its net capital gains (which is the excess of net long-term capital gain over net short-term capital loss) if any, that the
Fund properly reports as capital gains dividends (&#8220;capital gain dividends&#8221;) are taxable as long-term capital gains, regardless
of how long a U.S. Shareholder has held its shares. All other dividends paid to U.S. Shareholders by the Fund (including dividends from
short-term capital gains) from its current or accumulated earnings and profits (&#8220;ordinary income dividends&#8221;) are generally
subject to tax as ordinary income.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">In the case of corporate U.S. Shareholders, properly reported ordinary
income dividends paid by the Fund generally will be eligible for the dividends received deduction to the extent that the Fund&#8217;s
income consists of dividend income from U.S. corporations and certain holding period requirements are satisfied by both the Fund and the
corporate U.S. Shareholders. In the case of individuals, any properly reported ordinary income dividend that you receive from the Fund
will generally be eligible for taxation at the rates applicable to long-term capital gains to the extent that (i) the ordinary income
dividend is attributable to &#8220;qualified dividend income&#8221; (<i>i.e.</i>, generally dividends paid by U.S. corporations and certain
qualified foreign corporations) received by the Fund, (ii) the Fund satisfies certain holding period and other requirements with respect
to the stock on which such qualified dividend income was paid and (iii) you satisfy certain holding period and other requirements with
respect to your Shares. Qualified dividend income eligible for these special rules are not actually treated as capital gains, however,
and thus will not be included in the computation of your net capital gain and generally cannot be used to offset any capital losses. In
general, you may include as qualified dividend income only that portion of the dividends that may be and are so reported by the Fund as
qualified dividend income. Dividend income from PFICs and, in general, dividend income from real estate investment trusts (&#8220;REITs&#8221;)
is not eligible for the reduced rate for qualified dividend income and is taxed as ordinary income. Due to the nature of the Fund&#8217;s
investments, the Fund does not expect that a significant portion of its distributions will be eligible for the dividends received deduction
or for the reduced rates applicable to qualified dividend income.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Under Treasury regulations, for taxable years beginning before January
1, 2026, properly reported dividends paid by the Fund that are attributable to the Fund&#8217;s &#8220;qualified REIT dividends&#8221;
(generally, ordinary income dividends paid by a REIT, not including capital gain dividends or dividends treated as qualified dividend
income) may be eligible for the 20% deduction described in Section&#160;199A of the Code in the case of non-corporate U.S. Shareholders;
provided that certain holding period and other requirements are met by the Shareholder and the Fund. There can be no assurance as to what
portion, if any, of our distributions will qualify for such deduction. Subject to any future regulatory guidance to the contrary, any
distribution attributable to income from the Fund&#8217;s investments in publicly traded partnerships, if any, will not qualify for the
20% deduction that could be available to a non-corporate U.S. Shareholder were the Shareholder to own such partnership interests directly.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Any distributions you receive that are in excess of the Fund&#8217;s
current and accumulated earnings and profits will be treated as a tax-deferred return of capital to the extent of your adjusted tax basis
in your shares, and thereafter as capital gain from the sale of shares. The amount of any Fund distribution that is treated as a return
of capital will</p>


<!-- Field: Page; Sequence: 44 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">reduce your adjusted tax basis in your shares, thereby increasing your
potential gain, or reducing your potential loss, on any subsequent sale or other disposition of your shares.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Dividends and other taxable distributions are taxable to you even if
they are reinvested in additional Shares of the Fund. Dividends and other distributions paid by the Fund are generally treated as received
by you at the time the dividend or distribution is made. If, however, the Fund pays you a dividend in January that was declared in the
previous October, November or December and you were the U.S. Shareholder of record on a specified date in one of such months, then such
dividend will be treated for U.S. federal income tax purposes as being paid by the Fund and received by you on December&#160;31 of the
year in which the dividend was declared.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund will send you information after the end of each year setting
forth the amount and tax status of any distributions paid to you by the Fund.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Sale of Shares</i>. Except in the case of a redemption (the consequences
of which are described in the SAI under &#8220;Tax Matters&#8221;), the sale or other disposition of common shares of the Fund will generally
result in capital gain or loss to you and will be long-term capital gain or loss if you have held such shares for more than one year.
Any loss upon the sale or other disposition of shares held for six months or less will be treated as long-term capital loss to the extent
of any capital gain dividends received (including amounts credited as an undistributed capital gain) by you with respect to such shares.
Any loss you recognize on a sale or other disposition of common shares will be disallowed if you acquire other common shares (whether
through the automatic reinvestment of dividends or otherwise) within a 61-day period beginning 30 days before and ending 30 days after
your sale or exchange of the shares. In such case, your tax basis in the shares acquired will be adjusted to reflect the disallowed loss.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Current U.S. federal income tax law taxes both long-term and short-term
capital gain of corporations at the rates applicable to ordinary income. For non-corporate taxpayers, short-term capital gain is currently
taxed at rates applicable to ordinary income, while long-term capital gain generally is taxed at reduced maximum rates. The deductibility
of capital losses is subject to limitations under the Code.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Medicare Tax</i>. Certain U.S. Shareholders who are individuals,
estates or trusts and whose income exceeds certain thresholds will be required to pay a 3.8% Medicare tax on all or a part of their &#8220;net
investment income,&#8221; which includes dividends received from the Fund and capital gains from the sale or other disposition of Fund
common shares.</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 0 0 3pt">Taxation of Non-U.S. Shareholders</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The following discussion only applies to Non-U.S. Shareholders. A &#8220;Non-U.S.
Shareholder&#8221; is a holder, other than a partnership (or other entity or arrangement treated as a partnership for U.S. federal income
tax purposes), that is not a U.S. Shareholder for U.S. federal income tax purposes. Whether an investment in Fund shares is appropriate
for a Non-U.S. Shareholder will depend upon that Non-U.S. Shareholder&#8217;s particular circumstances. An investment in shares by a Non-U.S.
Shareholder may have adverse tax consequences. Non-U.S. Shareholders should consult their tax advisors before investing in Fund shares.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Distributions of ordinary income dividends to Non-U.S. Shareholders,
subject to the discussion below, will generally be subject to withholding of U.S. federal tax at a 30% rate (or lower rate provided by
an applicable treaty) to the extent of the Fund&#8217;s current and accumulated earnings and profits. Actual or deemed distributions of
the Fund&#8217;s net capital gain to a Non-U.S. Shareholder, and gain recognized by a Non-U.S. Shareholder upon the sale of Fund shares,
generally will not be subject to U.S. federal withholding tax and will not be subject to U.S. federal income tax. Different tax consequences
may result if the Non-U.S. Shareholder is engaged in a trade or business in the United States or, in the case of an individual, is present
in the United States for 183 days or more during a taxable year and certain other conditions are met. Special certification requirements
apply to a shareholder that is a foreign partnership or a foreign Fund, and such entities are urged to consult their tax advisors.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">No U.S. source withholding taxes will be imposed on dividends paid by
RICs to Non-U.S. Shareholders to the extent the dividends are properly reported as &#8220;interest related dividends&#8221; or &#8220;short-term
capital gain dividends.&#8221; Under this exemption, interest related dividends and short-term capital gain dividends generally represent
distributions of interest or short-term capital gain that would not have been subject to U.S. withholding tax at the source if they had
been received directly by a Non-U.S. Shareholder, and that satisfy certain other requirements. No assurance can be given as to the portion
of the Fund&#8217;s dividends that will constitute interest related or short-term capital gain dividends.</p>


<!-- Field: Page; Sequence: 45 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">If the Fund distributes its net capital gains in the form of deemed
rather than actual distributions (which the Fund may do in the future), a Non-U.S. Shareholder will be entitled to a U.S. federal income
tax credit or tax refund equal to the Non-U.S. Shareholder&#8217;s allocable share of the tax that the Fund pays on the capital gains
deemed to have been distributed. In order to obtain the refund, the Non-U.S. Shareholder must obtain a U.S. taxpayer identification number
and file a U.S. federal income tax return even if the Non-U.S. Shareholder is not otherwise required to obtain a U.S. taxpayer identification
number or file a federal income tax return. For a Non-U.S. Shareholder, distributions (both actual and deemed) and gains realized upon
the sale of shares that are in each case effectively connected with a U.S. trade or business (or, where an applicable treaty applies,
are attributable to a permanent establishment in the United States) will generally be subject to U.S. federal income tax at the rates
applicable to U.S. persons and for a corporate Non-U.S. Shareholder may, under certain circumstances, be subject to an additional &#8220;branch
profits tax&#8221; at a 30% rate (or at a lower rate if provided for by an applicable tax treaty). Accordingly, investment in shares may
not be appropriate for certain Non-U.S. Shareholders.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Certain provisions of the Code referred to as &#8220;FATCA&#8221; require
withholding at a rate of 30% on dividends in respect of shares held by or through certain foreign financial institutions (including investment
funds), unless such institution enters into an agreement with the Treasury to report, on an annual basis, information with respect to
interests in, and accounts maintained by, the institution to the extent such interests or accounts are held by certain U.S. persons and
by certain non-U.S. entities that are wholly or partially owned by U.S. persons and to withhold on certain payments. Accordingly, the
entity through which shares are held will affect the determination of whether such withholding is required. Similarly, dividends in respect
of shares held by an investor that is a non-financial non-U.S. entity that does not qualify under certain exemptions will be subject to
withholding at a rate of 30%, unless such entity either (i) certifies to the applicable withholding agent that such entity does not have
any &#8220;substantial United States owners&#8221; or (ii) provides certain information regarding the entity&#8217;s &#8220;substantial
United States owners,&#8221; which the applicable withholding agent will in turn provide to the Secretary of the Treasury. An intergovernmental
agreement between the United States and an applicable foreign country, or future Treasury regulations or other guidance, may modify these
requirements. The Fund will not pay any additional amounts to Non-U.S. Shareholders in respect of any amounts withheld. Non-U.S. Shareholders
are encouraged to consult their tax advisors regarding the possible implications of the legislation on their investment in shares.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>The foregoing is a general and abbreviated summary of the provisions
of the Code and the Treasury regulations in effect as they directly govern the taxation of the Fund and its U.S. Shareholders and Non-U.S.
Shareholders. These provisions are subject to change by legislative or administrative action, and any such change may be retroactive.
A more complete discussion of the tax rules applicable to the Fund, its U.S. Shareholders and Non-U.S. Shareholders can be found in the
SAI that is incorporated by reference into this Prospectus. Shareholders are urged to consult their tax advisers regarding specific questions
as to U.S. federal, state, local and foreign income or other taxes.</b></p>


<!-- Field: Page; Sequence: 46 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">PLAN OF DISTRIBUTION</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt">The Fund may offer up to $150,000,000 in aggregate initial offering
price of common shares or Rights from time to time under this Prospectus and any related Prospectus Supplement (1) directly to one or
more purchases, including existing shareholders in a Rights offering; (2) through agents; (3) through underwriters; (4) through dealers;
or (5) pursuant to the Fund&#8217;s dividend reinvestment plan. Each Prospectus Supplement relating to an offering of securities will
state the terms of the offering, including:</p>

<ul style="margin-top: 0in; list-style-type: disc">

<li style="margin: 0 0 10pt; font-size: 9pt">the names of any agents, underwriters or dealers;</li>

<li style="margin: 0 0 10pt; font-size: 9pt">any sales loads or other items constituting underwriters&#8217; compensation;</li>

<li style="margin: 0 0 10pt; font-size: 9pt">any discounts, commissions, or fees allowed or paid to dealers or agents;</li>

<li style="margin: 0 0 10pt; font-size: 9pt">the public offering or purchase price of the offered Securities and the net proceeds the
Fund will receive from the sale; and</li>

<li style="margin: 0 0 10pt; font-size: 9pt">any securities exchange on which the offered Securities may be listed.</li>

</ul>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt"><b>Direct Sales</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt">The Fund may sell Securities directly to, and solicit offers from,
institutional investors or others who may be deemed to be underwriters as defined in the Securities Act for any resales of the securities.
In this case, no underwriters or agents would be involved. The Fund may use electronic media, including the Internet, to sell offered
securities directly. The Fund will describe the terms of any of those sales in a Prospectus Supplement.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt"><b>By Agents</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt">The Fund may offer Securities through agents that the Fund may designate.
The Fund will name any agent involved in the offer and sale and describe any commissions payable by the Fund in the Prospectus Supplement.
Unless otherwise indicated in the Prospectus Supplement, the agents will be acting on a best efforts basis for the period of their appointment.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt"><b>By Underwriters</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt">The Fund may offer and sell Securities from time to time to one or
more underwriters who would purchase the Securities as principal for resale to the public, either on a firm commitment or best efforts
basis. If the Fund sells Securities to underwriters, the Fund will execute an underwriting agreement with them at the time of the sale
and will name them in the Prospectus Supplement. In connection with these sales, the underwriters may be deemed to have received compensation
from the Fund in the form of underwriting discounts and commissions. The underwriters also may receive commissions from purchasers of
Securities for whom they may act as agent. Unless otherwise stated in the Prospectus Supplement, the underwriters will not be obligated
to purchase the Securities unless the conditions set forth in the underwriting agreement are satisfied, and if the underwriters purchase
any of the Securities, they will be required to purchase all of the offered Securities. The underwriters may sell the offered Securities
to or through dealers, and those dealers may receive discounts, concessions or commissions from the underwriters as well as from the purchasers
for whom they may act as agent. Any public offering price and any discounts or concessions allowed or reallowed or paid to dealers may
be changed from time to time.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt">In connection with an offering of common shares, if a Prospectus
Supplement so indicates, the Fund may grant the underwriters an option to purchase additional common shares at the public offering price,
less the underwriting discounts and commissions, within 45 days from the date of the Prospectus Supplement, to cover any overallotments.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt"><b>By Dealers</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt">The Fund may offer and sell Securities from time to time to one or
more dealers who would purchase the Securities as principal. The dealers then may resell the offered Securities to the public at fixed
or varying prices to be</p>


<!-- Field: Page; Sequence: 47 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt">determined by those dealers at the time of resale. The Fund will
set forth the names of the dealers and the terms of the transaction in the Prospectus Supplement.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt"><b>General Information</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt">Agents, underwriters, or dealers participating in an offering of
Securities may be deemed to be underwriters, and any discounts and commission received by them and any profit realized by them on resale
of the offered Securities for whom they act as agent, may be deemed to be underwriting discounts and commissions under the Securities
Act.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt">The Fund may offer to sell Securities either at a fixed price or
at prices that may vary, at market prices prevailing at the time of sale, at prices related to prevailing market prices or at negotiated
prices.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt">To facilitate an offering of Securities in an underwritten transaction
and in accordance with industry practice, the underwriters may engage in transactions that stabilize, maintain, or otherwise affect the
market price of the Securities. Those transactions may include overallotment, entering stabilizing bids, effecting syndicate covering
transactions, and reclaiming selling concessions allowed to an underwriter or a dealer.</p>

<ul style="margin-top: 0in; list-style-type: disc">

<li style="margin: 0 0 10pt; font-size: 9pt">An overallotment in connection with an offering creates a short position in the Securities
for the underwriter&#8217;s own account.</li>

<li style="margin: 0 0 10pt; font-size: 9pt">An underwriter may place a stabilizing bid to purchase the Securities for the purpose of
pegging, fixing, or maintaining the price of the Securities.</li>

<li style="margin: 0 0 10pt; font-size: 9pt">Underwriters may engage in syndicate covering transactions to cover overallotments or to
stabilize the price of the Securities by bidding for, and purchasing, Securities in the open market in order to reduce a short position
created in connection with the offering.</li>

<li style="margin: 0 0 10pt; font-size: 9pt">The managing underwriter may impose a penalty bid on a syndicate member to reclaim a selling
concession in connection with an offering when the Securities originally sold by the syndicate member is purchased in syndicate covering
transactions or otherwise.</li>

</ul>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt">Any of these activities may stabilize or maintain the market price
of the Securities above independent market levels. The underwriters are not required to engage in these activities, and may end any of
these activities at any time.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt">In connection with any Rights offering, the Fund may also enter into
a standby underwriting arrangement with one or more underwriters pursuant to which the underwriter(s) will purchase common shares remaining
unsubscribed for after the Rights offering.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt">Any underwriters to whom the offered Securities are sold for offering
and sale may make a market in the offered Securities, but the underwriters will not be obligated to do so and may discontinue any market-making
at any time without notice. There can be no assurance that there will be a liquid trading market for the offered Securities.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt">Under agreements entered into with the Fund, underwriters and agents
may be entitled to indemnification by the Fund and the Adviser against certain civil liabilities, including liabilities under the Securities
Act, or to contribution for payments the underwriters or agents may be required to make.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt">The underwriters, agents, and their affiliates may engage in financial
or other business transactions with the Fund in the ordinary course of business.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt">Pursuant to a requirement of the Financial Industry Regulatory Authority,
Inc. (&#8220;FINRA&#8221;) the maximum compensation to be received by any FINRA member or independent broker-dealer in connection with
an offering of the Fund&#8217;s securities may not be greater than eight percent (8%) of the gross proceeds received by the Fund for the
sale of any securities being registered pursuant to SEC Rule&#160;415 under the Securities Act.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt">To the extent permitted under the 1940 Act and the rules and regulations
promulgated thereunder, the underwriters may from time to time act as brokers or dealers and receive fees in connection with the execution
of portfolio transactions on behalf of the Fund after the underwriters have ceased to be underwriters and, subject to certain restrictions,
each may act as a broker while it is an underwriter.</p>


<!-- Field: Page; Sequence: 48 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">A Prospectus and accompanying Prospectus Supplement in electronic form
may be made available on the websites maintained by underwriters. The underwriters may agree to allocate a number of Securities for sale
to their online brokerage account holders. Such allocations of Securities for internet distributions will be made on the same basis as
other allocations. In addition, Securities may be sold by the underwriters to securities dealers who resell Securities to online brokerage
account holders.</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">SERVICING AGENT, TRANSFER AGENT, CUSTODIAN
AND ADMINISTRATOR</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Servicing Agent</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Guggenheim Funds Distributors, LLC acts as servicing agent to the Fund.
The Servicing Agent is located at 227 West Monroe Street, Chicago, IL 60606. Pursuant to a servicing agreement with the Fund, the Servicing
Agent provides the Fund a variety of services, including (i) replying to requests for information concerning the Fund from shareholders
or prospective shareholders, brokers or the public; (ii) aiding in the secondary market support of the Fund through regular written and
oral communications with the Fund&#8217;s NYSE designated market maker, the closed-end fund analyst community and various information
providers specializing in the dissemination of closed-end fund information; (iii) coordinating and overseeing activities of the Fund&#8217;s
administrator; (iv) developing and maintaining a website for the Fund and (v) overseeing, in consultation with, and as agreed by, Advent
matters relating to the conduct and administration of meetings of the Board and committees thereof.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Transfer Agent</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Computershare Trust Company, N.A. serves as the Fund&#8217;s transfer
agent. Computershare Trust Company, N.A. is located at P.O. Box 30170, College Station, TX 77842.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Custodian</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">All securities owned by the Fund and all cash, including proceeds from
the sale of securities in the Fund&#8217;s investment portfolio, are held by The Bank of New York Mellon, 101 Barclay Street, New York,
New York 10286, as custodian (the &#8220;<span style="font-weight: normal">Custodian</span>&#8221;). The Custodian is responsible for
holding all securities, other investments and cash, receiving and paying for securities purchased, delivering against payment securities
sold, receiving and collecting income from investments, making all payments covering expenses and performing other administrative duties,
all as directed by authorized persons. The Custodian does not exercise any supervisory function in such matters as purchase and sale of
portfolio securities, payment of dividends or payment of expenses.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Administrator</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">MUFG Investor Services (US), LLC serves as the Fund&#8217;s Administrator.
Pursuant to an administration agreement with the Fund, MUFG provides certain administrative, bookkeeping and accounting services to the
Fund. MUFG is located at 805 King Farm Boulevard, Rockville, Maryland 20850.</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">LEGAL MATTERS</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Certain legal matters will be passed on for the Fund by Skadden, Arps,
Slate, Meagher &amp; Flom LLP, Chicago, Illinois, in connection with the offering of the common shares.</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">PricewaterhouseCoopers LLP, 300 Madison Avenue, New York, New York 10017,
is the independent registered public accounting firm of the Fund. The independent registered public accounting firm is expected to render
an opinion annually on the financial statements and financial highlights of the Fund.</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">FISCAL YEAR END AND REPORTS TO SHAREHOLDERS</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund&#8217;s fiscal year end is October&#160;31.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">As soon as practicable after the end of each calendar year, the Fund
will furnish to common shareholders a statement on Form&#160;1099-DIV identifying the sources of the distributions paid by the Fund to
common shareholders for tax purposes.</p>


<!-- Field: Page; Sequence: 49 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">In addition, the Fund will prepare and transmit to common shareholders
a semi-annual report and annual report within 60 days after the close of the period for which the report is being made, or as otherwise
required by the 1940 Act.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">&#160;</p>


<!-- Field: Page; Sequence: 50 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">PRIVACY PRINCIPLES OF THE FUND</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">The Fund is committed to maintaining the privacy of its shareholders and
to safeguarding their non-public personal information. The following information is provided to help you understand what personal information
the Fund collects, how the Fund protects that information and why, in certain cases, the Fund may share information with select other
parties.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">Generally, the Fund does not receive any non-public personal information
relating to its shareholders, although certain non-public personal information of its shareholders may become available to the Fund. The
Fund does not disclose any non-public personal information about its shareholders or former shareholders to anyone, except as permitted
by law or as is necessary in order to service shareholder accounts (for example, to a transfer agent or third-party administrator).</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">The Fund restricts access to non-public personal information about its shareholders
to employees of the Fund&#8217;s Adviser and its affiliates with a legitimate business need for the information. The Fund maintains physical,
electronic and procedural safeguards designed to protect the non-public personal information of its shareholders.</p>


<!-- Field: Page; Sequence: 51 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&#160;</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">TABLE OF CONTENTS OF STATEMENT OF ADDITIONAL
INFORMATION&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 87%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt"><span style="text-decoration: underline">Page</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">The Fund	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">S-2</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Investment Objective and Policies	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">S-2</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Investment Restrictions	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">S-13</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Management of the Fund	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">S-15</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Portfolio Transactions	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">S-18</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Tax Matters 	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">S-18</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">General Information	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">S-25</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Financial Statements	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">S-27</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Appendix&#160;A: Description of Securities
    Ratings	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">A-1</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Appendix&#160;B: Proxy Voting Policies and
    Procedures	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">B-1</span></td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 52 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 14pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">&#160;</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">	</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 2pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 20pt Times New Roman, Times, Serif; margin: 2pt 0; text-align: center"><b>$150,000,000</b></p>

<p style="font: 20pt Times New Roman, Times, Serif; margin: 2pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 20pt Times New Roman, Times, Serif; margin: 2pt 0; text-align: center"><b>Advent Convertible and Income Fund</b></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Common Shares<br/>
Subscription Rights for Common Shares</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">&#160;</p>


<!-- Field: Page; Sequence: 53 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: red"><b>&#160;</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; color: red"><b>The information in this statement of additional information
is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange
Commission is effective. This statement of additional information is not an offer to sell these securities and is not soliciting an offer
to buy these securities in any state where the offer or sale is not permitted.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: red"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: red"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: red"><b>Subject to Completion, dated
August 30, 2024</b></p>
<p style="text-align: center"></p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">ADVENT CONVERTIBLE AND INCOME FUND</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">__________________________<br/>
Statement of Additional Information</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Advent Convertible and Income Fund (the &#8220;Fund&#8221;)
is a diversified, closed-end management investment company.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund&#8217;s investment objective is to provide
total return through a combination of capital appreciation and current income. There can be no assurance that the Fund will achieve its
investment objective, and you could lose some or all of your investment.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">This Statement of Additional Information (&#8220;SAI&#8221;)
is not a Prospectus, but should be read in conjunction with the Prospectus for the Fund dated 	, 2024, and any related supplement to
the Prospectus (each a &#8220;Prospectus Supplement&#8221;). Investors should obtain and read the Prospectus and any related Prospectus
Supplement prior to purchasing Common Shares. A copy of the Prospectus and any related Prospectus Supplement may be obtained, without
charge, by calling the Fund at (800) 345-7999.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Prospectus, any accompanying Prospectus Supplement
and this SAI omit certain of the information contained in the registration statement filed with the Securities and Exchange Commission
(the &#8220;SEC&#8221;). The registration statement may be obtained from the SEC upon payment of the fee prescribed, or inspected at the
SEC&#8217;s office or via its website (www.sec.gov) at no charge. Capitalized terms used but not defined herein have the meanings ascribed
to them in the Prospectus.</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">TABLE OF CONTENTS</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 87%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt"><span style="text-decoration: underline">Page</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">The Fund	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">S-2</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Investment Objective and Policies	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">S-2</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Investment Restrictions	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">S-13</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Management of the Fund	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">S-15</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Portfolio Transactions	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">S-18</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Tax Matters 	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">S-18</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">General Information	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">S-25</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Financial Statements	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">S-27</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Appendix&#160;A: Description of Securities Ratings	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">A-1</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Appendix&#160;B: Proxy Voting Policies and Procedures	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">B-1</span></td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">This Statement of Additional Information
is dated September [ ], 2024.</p>


<!-- Field: Page; Sequence: 54 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">THE FUND</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund is a diversified, closed-end management
investment company organized as a Delaware statutory trust.</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">THE FUND&#8217;S INVESTMENTS</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The following information supplements the discussion
of the Fund&#8217;s investments and techniques that are described in the Prospectus. The Fund may make the following investments, among
others, some of which are part of its principal investment strategies and some of which are not. The principal risks of the Fund&#8217;s
principal investment strategies are discussed in the Prospectus. The Fund may not buy all of the types of securities or use all of the
investment techniques that are described.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>Derivatives</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund may, but is not required to, use various
derivatives transactions for hedging and risk management purposes, to facilitate portfolio management and to earn income or enhance total
return. The use of derivatives transactions to earn income or enhance total return may be particularly speculative. Derivatives are financial
instruments the value of which is derived from a reference instrument. The Fund may engage in a variety of derivatives transactions, including
options, swaps, swaptions, futures contracts, options on futures contracts, forward currency contracts and options on forward currency
contracts. The Fund may purchase and sell exchange-listed, centrally cleared and off-exchange derivatives. If a derivative is centrally
cleared, a central clearing entity stands between the two parties to the trade as counterparty to each. The Fund may utilize derivatives
that reference one or more securities, indices, commodities, currencies or interest rates. In addition, the Fund may utilize new techniques,
transactions, instruments or strategies that are developed or permitted as regulatory changes occur. Derivatives may allow the Fund to
increase or decrease the level of risk to which the Fund is exposed more quickly and efficiently than transactions in other types of instruments.
If the Fund invests in a derivative for speculative purposes, the Fund will be fully exposed to the risks of loss of that derivative,
which may sometimes be greater than the derivative&#8217;s cost. The use of derivatives may involve substantial economic leverage and
consequently substantial volatility.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">There is no assurance that these derivative strategies
will be available at any time, that the Adviser will determine to use them for the Fund or, if used, that the strategies will be successful.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Options.</i> An option on a security is a contract that gives the
holder of the option, in return for a premium, the right to buy from (in the case of a call) or sell to (in the case of a put) the writer
of the option the security underlying the option at a specified exercise or &#8220;strike&#8221; price. The writer of an option on a security
has the obligation upon exercise of the option to deliver the underlying security upon payment of the exercise price or to pay the exercise
price upon delivery of the underlying security. Certain options, known as &#8220;American style&#8221; options may be exercised at any
time during the term of the option. Other options, known as &#8220;European style&#8221; options, may be exercised only on the expiration
date of the option.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">If an option written by the Fund expires unexercised, the Fund realizes
on the expiration date a capital gain equal to the premium received by the Fund at the time the option was written. If an option purchased
by the Fund expires unexercised, the Fund realizes a capital loss equal to the premium paid. Prior to the earlier of exercise or expiration,
an exchange-traded option may be closed out by an offsetting purchase or sale of an option of the same series (type, underlying security,
exercise price and expiration). There can be no assurance, however, that a closing purchase or sale transaction can be effected when the
Fund desires. The Fund may sell put or call options it has previously purchased, which could result in a net gain or loss depending on
whether the amount realized on the sale is more or less than the premium and other transaction costs paid on the put or call option when
purchased. The Fund will realize a capital gain from a closing purchase transaction if the cost of the closing option is less than the
premium received from writing the option, or, if it is more, the Fund will realize a capital loss. If the premium received from a closing
sale transaction is more than the premium paid to purchase the option, the Fund will realize a capital gain or, if it is less, the Fund
will realize a capital loss. Net gains from the Fund&#8217;s option strategy will be short-term capital gains which, for U.S. federal
income tax purposes, will constitute net investment company taxable income.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">As part of its strategy, the Fund may not sell &#8220;naked&#8221; call
options on individual securities, (<i>i.e.</i>, options representing more shares of the stock than are held in the portfolio). A call
option written by the Fund on a security is &#8220;covered&#8221; if the Fund owns the security or instrument underlying the call or has
an absolute and immediate right to acquire that</p>


<!-- Field: Page; Sequence: 55; Options: NewSection; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">security or instrument without additional cash consideration (or, if
additional cash consideration is required, cash or other assets determined to be liquid by the Adviser (in accordance with procedures
established by the Board of Trustees) in such amount are segregated by the Fund&#8217;s custodian) upon conversion or exchange of other
securities held by the Fund. A call option is also covered if the Fund holds a call on the same security as the call written where the
exercise price of the call held is (i) equal to or less than the exercise price of the call written, or (ii) greater than the exercise
price of the call written, provided the difference is maintained by the Fund in segregated assets determined to be liquid by the Adviser
as described above.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Put options are contracts that give the holder of the option, in return
for a premium, the right to sell to the writer of the option the security underlying the option at a specified exercise price at a specific
time or times during the term of the option. These strategies may produce a considerably higher return than the Fund&#8217;s primary strategy
of covered call writing, but involve a higher degree of risk and potential volatility.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund will write (sell) put options on individual securities only
if the put option is &#8220;covered.&#8221; A put option written by the Fund on a security is &#8220;covered&#8221; if the Fund segregates
or earmarks assets determined to be liquid by the Adviser, as described above, equal to the exercise price. A put option is also covered
if the Fund holds a put on the same security as the put written where the exercise price of the put held is (i) equal to or greater than
the exercise price of the put written, or (ii) less than the exercise price of the put written, provided the difference is maintained
by the Fund in segregated or earmarked assets determined to be liquid by the Adviser, as described above.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund may sell put and call options on indices
of securities. Options on an index differ from options on securities because (i) the exercise of an index option requires cash payments
and does not involve the actual purchase or sale of securities, (ii) the holder of an index option has the right to receive cash upon
exercise of the option if the level of the index upon which the option is based is greater, in the case of a call, or less, in the case
of a put, than the exercise price of the option and (iii) index options reflect price-fluctuations in a group of securities or segments
of the securities market rather than price fluctuations in a single security.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Futures and Options on Futures</i>. The Fund may
buy, sell and write futures contracts that relate to: interest rates, credit instruments and related indices, volatility indices, credit-linked
notes and individual stocks and stock indices.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">A futures contract is an agreement between two parties
to buy and sell a security, index or interest rate (each a &#8220;financial instrument&#8221;) for a set price on a future date. Certain
futures contracts, such as futures contracts relating to individual securities, call for making or taking delivery of the underlying financial
instrument. However, these contracts generally are closed out before delivery by entering into an offsetting purchase or sale of a matching
futures contract (same exchange, underlying financial instrument, and delivery month). Other futures contracts, such as futures contracts
on interest rates and indices, do not call for making or taking delivery of the underlying financial instrument, but rather are agreements
pursuant to which two parties agree to take or make delivery of an amount of cash equal to the difference between the value of the financial
instrument at the close of the last trading day of the contract and the price at which the contract was originally written. These contracts
also may be settled by entering into an offsetting futures contract.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Unlike when the Fund purchases or sells a security,
no price is paid or received by the Fund upon the purchase or sale of a futures contract. Initially, the Fund will be required to deposit
with the futures broker, known as a futures commission merchant (&#8220;FCM&#8221;), an amount of cash or securities equal to a varying
specified percentage of the contract amount. This amount is known as initial margin. The margin deposit is intended to ensure completion
of the contract. Minimum initial margin requirements are established by the futures exchanges and may be revised. In addition, FCMs may
establish margin deposit requirements that are higher than the exchange minimums. Cash held in the margin account generally is not income
producing. However, coupon-bearing securities, such as Treasury securities, held in margin accounts generally will earn income. Subsequent
payments to and from the FCM, called variation margin, will be made on a daily basis as the price of the underlying financial instrument
fluctuates, making the futures contract more or less valuable, a process known as marking the contract to market. Changes in variation
margin are recorded by the Fund as unrealized gains or losses. At any time prior to expiration of the futures contract, the Fund may elect
to close the position by taking an opposite position that will operate to terminate its position in the futures contract. A final determination
of variation margin is then made, additional cash is required to be paid by or released to the Fund, and the Fund realizes a gain or loss.
In the event of the bankruptcy or insolvency of an FCM that holds margin on behalf of the Fund, the Fund may be entitled to the return
of margin owed to it only in</p>


<!-- Field: Page; Sequence: 56; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">proportion to the amount received by the FCM&#8217;s other customers,
potentially resulting in losses to the Fund. Futures transactions also involve brokerage costs.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund also may buy and write options on the futures
contracts in which it may invest (&#8220;futures options&#8221;) and may buy or write straddles, which consist of a call and a put option
on the same futures contract. A futures option gives the purchaser of such option the right, in return for the premium paid, to assume
a long position (call) or short position (put) in a futures contract at a specified exercise price at any time during the period of the
option. Upon exercise of a call futures option, the purchaser acquires a long position in the futures contract and the writer is assigned
the opposite short position. Upon the exercise of a put futures option, the opposite is true.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Interest Rate Futures Contracts and Options Thereon</i>.
The Fund may purchase or sell interest rate futures contracts to take advantage of or to protect the Fund against fluctuations in interest
rates affecting the value of debt securities which the Fund holds or intends to acquire. For example, if interest rates are expected to
increase, the Fund might sell futures contracts on debt securities, the values of which historically have a high degree of positive correlation
to the values of the Fund&#8217;s portfolio securities. Such a sale would have an effect similar to selling an equivalent value of the
Fund&#8217;s portfolio securities. If interest rates increase, the value of the Fund&#8217;s portfolio securities will decline, but the
value of the futures contracts to the Fund will increase at approximately an equivalent rate thereby keeping the net asset value of the
Fund from declining as much as it otherwise would have. The Fund could accomplish similar results by selling debt securities with longer
maturities and investing in debt securities with shorter maturities when interest rates are expected to increase. However, since the futures
market may be more liquid than the cash market, the use of futures contracts as a risk management technique allows the Fund to maintain
a defensive position without having to sell its portfolio securities.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Similarly, the Fund may purchase interest rate futures
contracts when it is expected that interest rates may decline. The purchase of futures contracts for this purpose constitutes a hedge
against increases in the price of debt securities (caused by declining interest rates) which the Fund intends to acquire. Since fluctuations
in the value of appropriately selected futures contracts should approximate that of the debt securities that will be purchased, the Fund
can take advantage of the anticipated rise in the cost of the debt securities without actually buying them. Subsequently, the Fund can
make its intended purchase of the debt securities in the cash market and liquidate its futures position.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The purchase of a call option on a futures contract
is similar in some respects to the purchase of a call option on an individual security. Depending on the pricing of the option compared
to either the price of the futures contract upon which it is based or the price of the underlying debt securities, it may or may not be
less risky than ownership of the futures contract or underlying debt securities. As with the purchase of futures contracts, when the Fund
is not fully invested it may purchase a call option on a futures contract to hedge against a market advance due to declining interest
rates.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The purchase of a put option on a futures contract
is similar to the purchase of protective put options on portfolio securities. The Fund will purchase a put option on a futures contract
to hedge the Fund&#8217;s portfolio against the risk of rising interest rates and a consequent reduction in the value of portfolio securities.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The writing of a call option on a futures contract
constitutes a partial hedge against declining prices of the securities which are deliverable upon exercise of the futures contract. If
the futures price at expiration of the option is below the exercise price, the Fund will retain the full amount of the option premium
which provides a partial hedge against any decline that may have occurred in the Fund&#8217;s portfolio holdings. The writing of a put
option on a futures contract constitutes a partial hedge against increasing prices of the securities that are deliverable upon exercise
of the futures contract. If the futures price at expiration of the option is higher than the exercise price, the Fund will retain the
full amount of the option premium, which provides a partial hedge against any increase in the price of debt securities that the Fund intends
to purchase. If a put or call option the Fund has written is exercised, the Fund will incur a loss which will be reduced by the amount
of the premium it received. Depending on the degree of correlation between changes in the value of its portfolio securities and changes
in the value of its futures positions, the Fund&#8217;s losses from options on futures it has written may to some extent be reduced or
increased by changes in the value of its portfolio securities.</p>


<!-- Field: Page; Sequence: 57; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Currency Futures and Options Thereon</i>. Generally,
foreign currency futures contracts and options thereon are similar to the interest rate futures contracts and options thereon discussed
previously. By entering into currency futures and options thereon, the Fund will seek to establish the rate at which it will be entitled
to exchange U.S. dollars for another currency at a future time. By selling currency futures, the Fund will seek to establish the number
of dollars it will receive at delivery for a certain amount of a foreign currency. In this way, whenever the Fund anticipates a decline
in the value of a foreign currency against the U.S. dollar, the Fund can attempt to &#8220;lock in&#8221; the U.S. dollar value of some
or all of the securities held in its portfolio that are denominated in that currency. By purchasing currency futures, the Fund can establish
the number of dollars it will be required to pay for a specified amount of a foreign currency in a future month. Thus, if the Fund intends
to buy securities in the future and expects the U.S. dollar to decline against the relevant foreign currency during the period before
the purchase is effected, the Fund can attempt to &#8220;lock in&#8221; the price in U.S. dollars of the securities it intends to acquire.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The purchase of options on currency futures will
allow the Fund, for the price of the premium and related transaction costs it must pay for the option, to decide whether or not to buy
(in the case of a call option) or to sell (in the case of a put option) a futures contract at a specified price at any time during the
period before the option expires. If the Adviser, in purchasing an option, has been correct in its judgment concerning the direction in
which the price of a foreign currency would move against the U.S. dollar, the Fund may exercise the option and thereby take a futures
position to hedge against the risk it had correctly anticipated or close out the option position at a gain that will offset, to some extent,
currency exchange losses otherwise suffered by the Fund. If exchange rates move in a way the Fund did not anticipate, however, the Fund
will have incurred the expense of the option without obtaining the expected benefit; any such movement in exchange rates may also thereby
reduce rather than enhance the Fund&#8217;s profits on its underlying securities transactions.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Securities Index Futures Contracts and Options
Thereon</i>. Purchases or sales of securities index futures contracts are used for hedging purposes to attempt to protect the Fund&#8217;s
current or intended investments from broad fluctuations in stock or bond prices. For example, the Fund may sell securities index futures
contracts in anticipation of or during a market decline to attempt to offset the decrease in market value of the Fund&#8217;s securities
portfolio that might otherwise result. If such decline occurs, the loss in value of portfolio securities may be offset, in whole or part,
by gains on the futures position. When the Fund is not fully invested in the securities market and anticipates a significant market advance,
it may purchase securities index futures contracts in order to gain rapid market exposure that may, in part or entirely, offset increases
in the cost of securities that the Fund intends to purchase. As such purchases are made, the corresponding positions in securities index
futures contracts will be closed out. The Fund may write put and call options on securities index futures contracts for hedging purposes.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Swaps</i>. Swap agreements are two party contracts
entered into primarily by institutional investors for periods ranging from a few weeks to more than one year. In a standard &#8220;swap&#8221;
transaction, two parties agree to exchange the returns (or differentials in rates of return) earned or realized on particular predetermined
investments or instruments. The gross returns to be exchanged or &#8220;swapped&#8221; between the parties are calculated with respect
to a &#8220;notional amount&#8221; (<i>i.e.</i>, the dollar amount invested at a particular interest rate, in a particular foreign currency,
or in a &#8220;basket&#8221; of securities representing a particular index). The &#8220;notional amount&#8221; of the swap agreement is
only a basis on which to calculate the obligations that the parties to a swap agreement have agreed to exchange. The Fund&#8217;s obligations
(or rights) under a swap agreement generally will be equal only to the &#8220;net amount&#8221; to be paid or received under the agreement
based on the relative values of the positions held by each party to the agreement. The Fund&#8217;s obligations under a swap agreement
will be accrued daily (offset against any amounts owing to the Fund) and any accrued but unpaid net amounts owed to a swap counterparty
will be covered by marking as segregated liquid, unencumbered assets.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Credit Default Swaps</i>. The Fund may enter into
credit default swap agreements and similar agreements. Among other purposes, credit default swaps provide investment exposure to changes
in credit spreads and relative interest rates. The credit default swap agreement or similar instrument may have as reference obligations
one or more securities that are not currently held by the Fund (including a &#8220;basket&#8221; of securities representing an index).
The protection &#8220;buyer&#8221; in a credit default contract may be obligated to pay the protection &#8220;seller&#8221; an upfront
payment or a periodic stream of payments over the term of the contract provided generally that no credit event on a reference obligation
has occurred. If a credit event occurs, the seller generally must pay the buyer the &#8220;par value&#8221; (full notional value) of the
swap in exchange for an equal face amount of deliverable obligations of the reference entity described in the swap, or the seller may
be required to deliver the related net cash amount, if the swap is cash settled.</p>


<!-- Field: Page; Sequence: 58; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">The Fund may be either the buyer or seller in the transaction. If the
Fund is a buyer and no credit event occurs, the Fund recovers nothing if the swap is held through its termination date. However, if a
credit event occurs, the Fund may elect to receive the full notional value of the swap in exchange for delivery of an equal face amount
of deliverable obligations of the reference entity that may have little or no value. As a seller, the Fund generally receives an upfront
payment or a fixed rate of income throughout the term of the swap, which typically is between six months and three years; provided that
there is no credit event. If a credit event occurs, generally the seller must pay the buyer the full notional value of the swap in exchange
for an equal face amount of deliverable obligations of the reference entity that may have little or no value.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Total Return Swaps</i>. The Fund may enter into
total return swaps. Total return swaps are used as substitutes for owning a particular physical security, or the securities comprising
a given market index, or to obtain exposure in markets where no physical securities are available such as an interest rate index. Total
return refers to the payment (or receipt) of the total return on the security, index or other instrument underlying the swap, which is
then exchanged for the receipt (or payment) of a floating interest rate. Total return swaps provide the Fund with the additional flexibility
of gaining exposure to a particular security or index by using the most cost-effective vehicle available. Total return swaps provide the
Fund with the opportunity to actively manage the cash maintained by the Fund as a result of not having to purchase the actual securities
or other instruments underlying the swap. The cash backing total return swaps is actively managed to seek to earn a return in excess of
the floating rate paid on the swap.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Interest Rate Swaps</i>. Interest rate swaps involve
the exchange by the Fund with another party of respective commitments to pay or receive interest (<i>e.g.</i>, an exchange of fixed rate
payments for floating rate payments).</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Currency Swaps</i>. Currency swaps involve the
exchange of the two parties&#8217; respective commitments to pay or receive fluctuations with respect to a notional amount of two different
currencies (<i>e.g.</i>, an exchange of payments with respect to fluctuations in the value of the U.S. dollar relative to the Japanese
yen).</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Swaptions</i>. The Fund may enter into &#8220;swaptions,&#8221;
which are options on swap agreements. A swaption is a contract that gives a counterparty the right (but not the obligation) to enter into
a new swap agreement or to shorten, extend, cancel or otherwise modify an existing swap agreement, at some designated future time on specified
terms. The Fund may write (sell) and purchase put and call swaptions. Depending on the terms of the particular option agreement, the Fund
generally will incur a greater degree of risk when it writes a swaption than it will incur when it purchases a swaption. When the Fund
purchases a swaption, it risks losing only the amount of the premium it has paid should it decide to let the option expire unexercised.
When the Fund writes a swaption, upon exercise of the option the Fund will become obligated according to the terms of the underlying agreement.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Credit-Linked Securities</i>. Credit-linked securities
are issued by a limited purpose trust or other vehicle that, in turn, invests in a derivative or basket of derivatives, such as credit
default swaps, interest rate swaps and other securities, in order to provide exposure to certain fixed income markets. Like an investment
in a bond, investments in these credit-linked securities represent the right to receive periodic income payments (in the form of distributions)
and payment of principal at the end of the term of the security. However, these payments are conditioned on the issuer&#8217;s receipt
of payments from, and the issuer&#8217;s potential obligations to, the counterparties to the derivatives and other securities in which
the issuer invests. For instance, the issuer may sell one or more credit default swaps, under which the issuer would receive a stream
of payments over the term of the swap agreements provided that no event of default has occurred with respect to the referenced debt obligation
upon which the swap is based. If a default occurs, the stream of payments may stop and the issuer would be obligated to pay the counterparty
the par (or other agreed-upon value) of the referenced debt obligation. This, in turn, would reduce the amount of income and principal
that the Fund would receive. The Fund&#8217;s investments in these instruments are indirectly subject to the risks associated with derivatives,
including, among others, counterparty risk, credit risk and leverage risk. There may be no established trading market for these securities.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Limitations on the Purchase and Sale of Futures
Contracts, Certain Options, and Swaps</i>. Pursuant to amendments by the Commodity Futures Trading Commission (&#8220;CFTC&#8221;) to
Rule&#160;4.5 under the Commodity Exchange Act (&#8220;CEA&#8221;), the Adviser has filed a notice of exemption from registration as a
&#8220;commodity pool operator&#8221; with respect to the Fund. The Fund and the Adviser are therefore not subject to registration or
regulation as a commodity pool operator under the CEA. In addition, certain trading restrictions are applicable to the Fund as a result
of this status.</p>


<!-- Field: Page; Sequence: 59; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">These trading restrictions permit the Fund to engage in &#8220;commodity
interest&#8221; transactions (generally, transactions in futures, certain options, certain currency transactions, and certain types of
swaps) that include (i) &#8220;bona fide hedging&#8221; transactions, as that term is defined and interpreted by the CFTC and its staff,
without regard to the percentage of the Fund&#8217;s assets committed to margin and options premiums and (ii) non-bona fide hedging transactions;
provided that the Fund does not enter into such non-bona fide hedging transactions if, immediately thereafter, either (a) the sum of the
amount of initial margin deposits on the Fund&#8217;s existing futures positions or swaps positions and option or swaption premiums would
exceed 5% of the market value of the Fund&#8217;s liquidating value, after taking into account unrealized profits and unrealized losses
on any such transactions, or (b) the aggregate net notional value of the Fund&#8217;s commodity interest transactions would not exceed
100% of the market value of the Fund&#8217;s liquidating value, after taking into account unrealized profits and unrealized losses on
any such transactions. In addition to meeting one of the foregoing trading limitations, the Fund may not market itself as a commodity
pool or otherwise as a vehicle for trading in the futures, options or swaps markets. Therefore, in order to claim the Rule&#160;4.5 exemption,
the Fund is limited in its ability to invest in commodity futures, options, and certain types of swaps (including securities futures,
broad based stock index futures, and financial futures contracts). If the Adviser was required to register as a commodity pool operator
with respect to the Fund, compliance with additional registration and regulatory requirements would increase Fund expenses. Other potentially
adverse regulatory initiatives could also develop.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Special Risk Considerations Relating to Futures
and Options Thereon</i>. The Fund&#8217;s ability to establish and close out positions in futures contracts and options thereon will be
subject to the development and maintenance of liquid markets. Although the Fund generally will purchase or sell only those futures contracts
and options thereon for which there appears to be a liquid market, there is no assurance that a liquid market on an exchange will exist
for any particular futures contract or option thereon at any particular time. In the event no liquid market exists for a particular futures
contract or option thereon in which the Fund maintains a position, it will not be possible to effect a closing transaction in that contract
or to do so at a satisfactory price and the Fund would have to either make or take delivery under the futures contract or, in the case
of a written option, wait to sell the underlying securities until the option expires or is exercised or, in the case of a purchased option,
exercise the option. In the case of a futures contract or an option thereon which the Fund has written and which the Fund is unable to
close, the Fund would be required to maintain margin deposits on the futures contract or option thereon and to make variation margin payments
until the contract is closed.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Successful use of futures contracts and options thereon
and forward contracts by the Fund is subject to the ability of the Adviser to predict correctly movements in the direction of interest
and foreign currency rates. If the Adviser&#8217;s expectations are not met, the Fund will be in a worse position than if a hedging strategy
had not been pursued. For example, if the Fund has hedged against the possibility of an increase in interest rates that would adversely
affect the price of securities in its portfolio and the price of such securities increases instead, the Fund will lose part or all of
the benefit of the increased value of its securities because it will have offsetting losses in its futures positions. In addition, in
such situations, if the Fund has insufficient cash to meet daily variation margin requirements, it may have to sell securities to meet
the requirements. These sales may be, but will not necessarily be, at increased prices which reflect the rising market. The Fund may have
to sell securities at a time when it is disadvantageous to do so.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Additional Risks of Foreign Options, Futures Contracts,
Options on Futures Contracts and Forward Contracts</i>. Options, futures contracts and options thereon and forward contracts on securities
and currencies may be traded on foreign exchanges. Such transactions may not be regulated as effectively as similar transactions in the
United States, may not involve a clearing mechanism and related guarantees, and are subject to the risk of governmental actions affecting
trading in, or the prices of, foreign securities. The value of such positions also could be adversely affected by (i) other complex foreign
political, legal and economic factors, (ii) lesser availability than in the U.S. of data on which to make trading decisions, (iii) delays
in the Fund&#8217;s ability to act upon economic events occurring in the foreign markets during non-business hours in the United States,
(iv) the imposition of different exercise and settlement terms and procedures and margin requirements than in the United States and (v)
lesser trading volume.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Exchanges on which options, futures and options on
futures are traded may impose limits on the positions that the Fund may take in certain circumstances.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>1940 Act Considerations. </i>To the extent the terms of such transactions
obligate the Fund to make payments, the Fund earmarks or segregates cash or liquid securities in an amount at least equal to the current
value of the amount then</p>


<!-- Field: Page; Sequence: 60; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">payable by the Fund under the terms of such transactions or otherwise
cover such transactions in accordance with applicable interpretations of the staff of the SEC. To the extent the terms of such transactions
obligate the Fund to deliver particular securities to extinguish the Fund&#8217;s obligations under such transactions, the Fund may &#8220;cover&#8221;
its obligations under such transactions by either (i) owning the securities or collateral underlying such transactions or (ii) having
an absolute and immediate right to acquire such securities or collateral without additional cash consideration (or, if additional cash
consideration is required, having earmarked or segregated cash or liquid securities). Such segregation or cover is intended to provide
the Fund with available assets to satisfy its obligations under such transactions. As a result of such segregation or cover, the Fund&#8217;s
obligations under such transactions will not be considered senior securities representing indebtedness for purposes of the 1940 Act, or
included in calculating the aggregate amount of the Fund&#8217;s financial leverage.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Rule&#160;18f-4 under the 1940 Act, the Derivatives
Rule, permits the Fund to enter into derivatives transactions and certain other transactions notwithstanding the restrictions on the issuance
of &#8220;senior securities&#8221; under Section&#160;18 of the 1940 Act. The Fund has adopted a derivatives risk management program which
includes value-at-risk modeling, stress tests, backtests, and additional disclosures to the SEC in compliance with Rule&#160;18f-4 under
the 1940 Act. The requirements of the rule and the Fund&#8217;s derivatives risk management program may restrict the Fund&#8217;s ability
to engage in certain derivatives transactions and/or increase the cost of such transactions, which could adversely affect the performance
of the Fund.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>Synthetic Investments</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">As an alternative to holding investments directly,
the Fund may also obtain investment exposure to investments in which the Fund may invest directly through the use of derivative instruments.
The Fund may utilize swaps, options, forwards, notional principal contracts or other derivative instruments to replicate, modify or replace
the economic attributes associated with an investment in which the Fund may invest directly. To the extent that the Fund invests in synthetic
investments with economic characteristics similar to convertible securities or other income producing securities investments, the value
of such investments will be counted for purposes of the Fund&#8217;s policy of investing at least 80% of its Managed Assets in convertible
securities or other income producing securities investments.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>Contingent Convertible Securities</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">One type of convertible security in which the Fund
may invest is contingent convertible securities, sometimes referred to as &#8220;CoCos.&#8221; CoCos are a form of hybrid debt security
issued by banking institutions that are intended to either automatically convert into equity or have their principal written down upon
the occurrence of certain &#8220;trigger events,&#8221; which may include a decline in the issuer&#8217;s capital below a specified threshold
level, increase in the issuer&#8217;s risk weighted assets, the share price of the issuer falling to a particular level for a certain
period of time and certain regulatory events. CoCos&#8217; unique equity conversion or principal write-down features are tailored to the
issuing banking institution and its regulatory requirements.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">CoCos are a newer form of instrument and the regulatory
environment for these instruments continues to evolve. Because the market for such securities is evolving, it is uncertain how the larger
market for CoCos would react to a trigger event, coupon cancellation, write-down of par value or coupon suspension (as described below)
applicable to a single issuer. Following conversion of a CoCo, because the common stock of the issuer may not pay a dividend, investors
in such securities could experience reduced yields or no yields at all.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Loss Absorption Risk</i>. CoCos have fully discretionary
coupons. This means coupons can potentially be cancelled at the banking institution&#8217;s discretion or at the request of the relevant
regulatory authority in order to help the bank absorb losses. The liquidation value of a CoCo may be adjusted downward to below the original
par value or written off entirely under certain circumstances. The write-down of the security&#8217;s par value may occur automatically
and would not entitle holders to institute bankruptcy proceedings against the issuer. In addition, an automatic write-down could result
in a reduced income rate if the dividend or interest payment associated with the security is based on the security&#8217;s par value.
Coupon payments may also be subject to approval by the issuer&#8217;s regulator and may be suspended in the event there are insufficient
distributable reserves. Due to uncertainty surrounding coupon payments, CoCos may be volatile and their price may decline rapidly in the
event that coupon payments are suspended.</p>


<!-- Field: Page; Sequence: 61; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Subordinated Instruments</i>. CoCos will, in the
majority of circumstances, be issued in the form of subordinated debt instruments in order to provide the appropriate regulatory capital
treatment prior to a conversion. Accordingly, in the event of liquidation, dissolution or winding-up of an issuer prior to a conversion
having occurred, the rights and claims of the holders of the CoCos, such as the Fund, against the issuer in respect of or arising under
the terms of the CoCos shall generally rank junior to the claims of all holders of unsubordinated obligations of the issuer. In addition,
if the CoCos are converted into the issuer&#8217;s underlying equity securities following a conversion event (<i>i.e.</i>, a &#8220;trigger&#8221;),
each holder will be subordinated due to their conversion from being the holder of a debt instrument to being the holder of an equity instrument.
Such conversion may be automatic.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Unpredictable Market Value Fluctuate</i>. The
value of CoCos is unpredictable and will be influenced by many factors including, without limitation: (i) the creditworthiness of the
issuer and/or fluctuations in such issuer&#8217;s applicable capital ratios; (ii) supply and demand for the CoCos; (iii) general market
conditions and available liquidity; and (iv) economic, financial and political events that affect the issuer, its particular market or
the financial markets in general.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>Stressed, Distressed and Defaulted Investments</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund may invest in debt securities and other
instruments of companies undergoing, or that have recently completed, bankruptcies, reorganizations, insolvencies, liquidations or other
fundamental changes or similar proceedings or other stressed issuers. In any investment opportunity involving any such type of special
situation, there exists the risk that the contemplated transaction either will be unsuccessful, will take considerable time or will result
in a distribution of cash or new securities, the value of which will be less than the purchase price to the Fund of the securities or
other financial instruments in respect of which such distribution is received. Similarly, if an anticipated transaction does not in fact
occur, the Fund may be required to sell its investment at a loss. The consummation of such transactions can be prevented or delayed by
a variety of factors, including, but not limited to, (i) intervention of a regulatory agency; (ii) market conditions resulting in material
changes in securities prices; (iii) compliance with any applicable bankruptcy, insolvency or securities laws; and (iv) the inability to
obtain adequate financing. Because there is substantial uncertainty concerning the outcome of transactions involving financially troubled
companies in which the Fund may invest, there is a potential risk of loss by the Fund of its entire investment in such companies.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund may invest in debt securities and other
instruments that are in default or at risk of being in default as to the repayment of principal and/or interest at the time of acquisition
by the Fund. The repayment of defaulted obligations is subject to significant uncertainties. Defaulted obligations might be repaid only
after lengthy bankruptcy or other reorganization proceedings, during which the issuer might not make any interest or other payments.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Distressed and defaulted instruments generally present
the same risks as investment in below investment grade instruments. However, in most cases, these risks are of a greater magnitude because
of the uncertainties of investing in an issuer undergoing financial distress. Distressed instruments present a risk of loss of principal
value, including potentially a total loss of value. Distressed instruments may be highly illiquid and the prices at which they may be
sold may represent a substantial discount to what the Adviser believes to be their ultimate value.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>Short-Term Fixed Income Securities</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">For temporary defensive purposes or to keep cash
on hand fully invested, the Fund may invest up to 100% of its Managed Assets in cash equivalents and short-term fixed income securities.
Short-term fixed income investments are defined to include, without limitation, the following:</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">(1)</td><td>U.S. government securities, including bills, notes and bonds differing as to maturity and rates of interest that are either issued
or guaranteed by the U.S. Treasury or by U.S. government agencies or instrumentalities. U.S. government securities include securities
issued by (a) the Federal Housing Administration, Farmers Home Administration, Export-Import Bank of the United States, Small Business
Administration and Government National Mortgage Association, whose securities are supported by the full faith and credit of the United
States; (b) the Federal Home Loan Banks, Federal Intermediate Credit Banks and Tennessee Valley Authority, whose securities are supported
by the right of the agency to borrow from the U.S. Treasury; (c) the Federal National</td></tr></table>


<!-- Field: Page; Sequence: 62; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1in">Mortgage Association, whose securities are supported by the
discretionary authority of the U.S. government to purchase certain obligations of the agency or instrumentality; and (d) the Student Loan
Marketing Association, whose securities are supported only by its credit. While the U.S. government provides financial support to such
U.S. government-sponsored agencies or instrumentalities, no assurance can be given that it always will do so since it is not so obligated
by law. The U.S. government, its agencies and instrumentalities do not guarantee the market value of their securities. Consequently, the
value of such securities may fluctuate.</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">(2)</td><td>Certificates of deposit issued against funds deposited in a bank or a savings and loan association. Such certificates are for a definite
period of time, earn a specified rate of return and are normally negotiable. The issuer of a certificate of deposit agrees to pay the
amount deposited plus interest to the bearer of the certificate on the date specified thereon. Certificates of deposit purchased by the
Fund may not be fully insured by the Federal Deposit Insurance Corporation.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">(3)</td><td>Repurchase agreements.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">(4)</td><td>Commercial paper, which consists of short-term unsecured promissory notes, including variable rate master demand notes issued by corporations
to finance their current operations. Master demand notes are direct lending arrangements between the Fund and a corporation. There is
no secondary market for such notes. However, they are redeemable by the Fund at any time. The Adviser will consider the financial condition
of the corporation (<i>e.g.</i>, earning power, cash flow and other liquidity ratios) and will continuously monitor the corporation&#8217;s
ability to meet all of its financial obligations, because the Fund&#8217;s liquidity might be impaired if the corporation were unable
to pay principal and interest on demand. Investments in commercial paper will be limited to commercial paper rated in the two highest
categories by a major rating agency or are unrated but determined to be of comparable quality by the Adviser and which mature within one
year of the date of purchase or carry a variable or floating rate of interest.</td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>Short Sales</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund may make short sales of securities. A short
sale is a transaction in which the Fund sells a security it does not own in anticipation that the market price of that security will decline.
The Fund may make short sales to hedge positions, for duration and risk management, in order to maintain portfolio flexibility or to enhance
income or gain.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">When the Fund makes a short sale, it must borrow
the security sold short and deliver it to the broker-dealer through which it made the short sale as collateral for its obligation to deliver
the security upon conclusion of the sale. The Fund may have to pay a fee to borrow particular securities and is often obligated to pay
over any payments received on such borrowed securities.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund&#8217;s obligation to replace the borrowed
security will be secured by collateral deposited with the broker-dealer, usually cash, U.S. government securities or other liquid securities.
The Fund will also be required to designate on its books and records similar collateral with its custodian to the extent, if any, necessary
so that the aggregate collateral value is at all times at least equal to the current market value of the security sold short. Depending
on arrangements made with the broker-dealer from which it borrowed the security regarding payment over of any payments received by the
Fund on such security, the Fund may not receive any payments (including interest) on its collateral deposited with such broker-dealer.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">If the price of the security sold short increases
between the time of the short sale and the time the Fund replaces the borrowed security, the Fund will incur a loss; conversely, if the
price declines, the Fund will realize a gain. Any gain will be decreased, and any loss increased, by the transaction costs described above.
Although the Fund&#8217;s gain is limited to the price at which it sold the security short, its potential loss is theoretically unlimited.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund will not make a short sale if, after giving
effect to such sale, the market value of all securities sold short exceeds 25% of the value of its Managed Assets or the Fund&#8217;s
aggregate short sales of a particular class of securities exceeds 25% of the outstanding securities of that class. The Fund may also make
short sales &#8220;against the box&#8221;</p>


<!-- Field: Page; Sequence: 63; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">without respect to such limitations. In this type of short sale, at
the time of the sale, the Fund owns or has the immediate and unconditional right to acquire at no additional cost the identical security.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>When Issued, Delayed Delivery Securities And Forward
Commitments</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund may enter into forward commitments for the
purchase or sale of securities. The Fund may enter into transactions on a &#8220;when issued&#8221; or &#8220;delayed delivery&#8221;
basis, in excess of customary settlement periods for the type of security involved. In some cases, a forward commitment may be conditioned
upon the occurrence of a subsequent event, such as approval and consummation of a merger, corporate reorganization or debt restructuring
(<i>i.e.</i>, a when, as and if issued security). When such transactions are negotiated, the price is fixed at the time of the commitment,
with payment and delivery taking place in the future, generally a month or more after the date of the commitment. While it will only enter
into a forward commitment with the intention of actually acquiring the security, the Fund may sell the security before the settlement
date if it is deemed advisable. Securities purchased under a forward commitment are subject to market fluctuation, and generally no interest
(or dividends) accrues to the Fund prior to the settlement date.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Securities purchased on a when-issued or delayed
delivery basis may expose the Fund to counterparty risk of default as well as the risk that securities may experience fluctuations in
value prior to their actual delivery. The Fund generally will not accrue income with respect to a when-issued or delayed delivery security
prior to its stated delivery date. Purchasing securities on a when-issued or delayed delivery basis can involve the additional risk that
the price or yield available in the market when the delivery takes place may not be as favorable as that obtained in the transaction itself.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>Pay-In-Kind Securities</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund may invest pay-in-kind, or &#8220;PIK,&#8221;
securities. PIK securities are securities which pay interest through the issuance of additional debt or equity securities. Similar to
zero coupon obligations, PIK securities also carry additional risk as holders of these types of securities realize no cash until the cash
payment date unless a portion of such securities is sold and, if the issuer defaults, the Fund may obtain no return at all on its investment.
The market price of PIK securities is affected by interest rate changes to a greater extent, and therefore tends to be more volatile,
than that of securities which pay interest in cash. Additionally, current U.S. federal tax law requires the holder of certain PIK securities
to accrue income with respect to these securities prior to the receipt of cash payments. To maintain its qualification as a regulated
investment company and avoid liability for U.S. federal income and excise taxes, the Fund may be required to distribute income accrued
with respect to these securities and may have to dispose of portfolio securities under disadvantageous circumstances in order to generate
cash to satisfy these distribution requirements.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>Zero Coupon Bonds</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund may invest in zero dividend preferred securities
and zero coupon bonds. These are instruments that typically do not pay interest either for the entire life of the obligation or for an
initial period after the issuance of the obligation. When held to its redemption or maturity, a holder receives the par value (or the
accreted value) of the zero (rate) coupon security, which generates a return equal to the difference between the purchase price and its
redemption or maturity value. A zero dividend preferred security or a zero coupon security is normally issued and traded at a deep discount
from face value. This original issue discount (&#8220;OID&#8221;) approximates the total amount of interest the security will accrue and
compound prior to its redemption or maturity. Because these securities and other OID instruments do not pay cash dividends or interest
at regular intervals, the instruments&#8217; ongoing accruals require ongoing judgments concerning the collectability of stated par value
of the instrument at its redemption or maturity, as well as the value of any associated collateral. As a result, these securities may
be subject to greater value fluctuations and less liquidity in the event of adverse market conditions than comparably rated securities
that pay cash on a current basis. Because zero dividend preferred securities and zero coupon bonds, and OID instruments generally, allow
an issuer to delay the need to generate cash to meet current dividend or interest payments (unless there is a prescribed accumulated funding
of the payment), they may involve greater payment and credit risk than dividend or coupon securities that pay dividends or interest currently
or in cash. In order to maintain its status as a regulated investment company (&#8220;RIC&#8221;), the Fund generally will be required
to distribute dividends to shareholders representing the income of these instruments as it accrues, even though the Fund will not receive
all of the income</p>


<!-- Field: Page; Sequence: 64; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">on a current basis or in cash. Thus, the Fund may have to sell other
investments, including when it may not be advisable to do so, and use the cash proceeds to make income distributions to its shareholders.
For accounting purposes, these cash distributions to shareholders will not treated as a return of capital.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>Exchange-Traded Notes</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Exchange-traded notes (&#8220;ETNs&#8221;) are a
type of senior, unsecured, unsubordinated debt security issued by financial institutions that combines both aspects of bonds and ETFs.
An ETN&#8217;s returns are based on the performance of a market index minus fees and expenses. Similar to ETFs, ETNs are listed on an
exchange and traded in the secondary market. However, unlike an ETF, an ETN can be held until the ETN&#8217;s maturity, at which time
the issuer will pay a return linked to the performance of the market index to which the ETN is linked minus certain fees. Unlike regular
bonds, ETNs do not make periodic interest payments and principal is not protected. ETNs are subject to credit risk and the value of an
ETN may drop due to a downgrade in the issuer&#8217;s credit rating, despite the underlying market benchmark or strategy remaining unchanged.
The value of an ETN may also be influenced by time to maturity, level of supply and demand for the ETN, volatility and lack of liquidity
in underlying assets, changes in the applicable interest rates, changes in the issuer&#8217;s credit rating, and economic, legal, political
or geographic events that affect the referenced underlying asset. When the Fund invests in ETNs it will bear its proportionate share of
any fees and expenses borne by the ETN. The Fund&#8217;s decision to sell its ETN holdings may be limited by the availability of a secondary
market. In addition, although an ETN may be listed on an exchange, the issuer may not be required to maintain the listing and there can
be no assurance that a secondary market will exist for an ETN.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">ETNs are also subject to tax risk. No assurance can
be given that the Internal Revenue Service (&#8220;IRS&#8221;) will accept, or a court will uphold, how the Fund characterizes and treats
ETN investments for tax purposes. Further, the IRS and Congress have considered proposals that would change the timing and character of
income and gains from ETNs.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">An ETN that is tied to a specific market benchmark
or strategy may not be able to replicate and maintain exactly the composition and relative weighting of securities, commodities or other
components in the applicable market benchmark or strategy. Some ETNs that use leverage can, at times, be relatively illiquid, and thus
they may be difficult to purchase or sell at a fair price. Leveraged ETNs are subject to the same risk as other instruments that use leverage
in any form.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The market value of ETN shares may differ from their
market benchmark or strategy. This difference in price may be due to the fact that the supply and demand in the market for ETN shares
at any point in time is not always identical to the supply and demand in the market for the securities, commodities or other components
underlying the market benchmark or strategy that the ETN seeks to track. As a result, there may be times when an ETN share trades at a
premium or discount to its market benchmark or strategy.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>Depositary Receipts</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund&#8217;s investments in non-U.S. issuers
may include investment in depositary receipts, including American Depositary Receipts (&#8220;ADRs&#8221;), European Depositary Receipts
(&#8220;EDRs&#8221;) and Global Depositary Receipts (&#8220;GDRs&#8221;). U.S. dollar-denominated ADRs, which are traded in the United
States on exchanges in off exchange markets, are issued by domestic banks. ADRs represent the right to receive securities of foreign issuers
deposited in a domestic bank or a correspondent bank. ADRs do not eliminate all the risk inherent in investing in the securities of foreign
issuers. However, by investing in ADRs rather than directly in foreign issuers&#8217; stock, the Fund can avoid currency risks during
the settlement period for either purchases or sales. In general, there is a large, liquid market in the United States for many ADRs. The
information available for ADRs is subject to the accounting, auditing and financial reporting standards of the domestic market or exchange
on which they are traded, which standards are more uniform and more exacting than those to which many foreign issuers may be subject.
The Fund also may invest in EDRs, GDRs and in other similar instruments representing securities of foreign companies. EDRs and GDRs are
securities that are typically issued by foreign banks or foreign trust companies, although U.S. banks or U.S. trust companies may issue
them. EDRs and GDRs are structured similarly to the arrangements of ADRs. EDRs, in bearer form, are designed for use in European securities
markets and are not necessarily denominated in the currency of the underlying security.</p>


<!-- Field: Page; Sequence: 65; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Certain depositary receipts, typically those denominated
as unsponsored, require the holders thereof to bear most of the costs of the facilities while issuers of sponsored facilities normally
pay more of the costs thereof. The depository of an unsponsored facility frequently is under no obligation to distribute shareholder communications
received from the issuer of the deposited securities or to pass through the voting rights to facility holders in respect to the deposited
securities, whereas the depository of a sponsored facility typically distributes shareholder communications and passes through voting
rights.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>Warrants and Rights</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund may invest in warrants or rights that entitle
the holder to buy equity securities at a specific price for a specific period of time. The Fund may acquire warrants for equity securities
and debt securities that are acquired as units with debt securities. Warrants are securities permitting, but not obligating, their holder
to subscribe to other securities. Warrants do not carry with them the right to dividends or voting rights with respect to the securities
that they entitle their holder to purchase, and they do not represent any rights in the assets of the issuer. As a result, warrants may
be considered more speculative than certain other types of investments. In addition, the value of a warrant does not necessarily change
with the value of the underlying securities and a warrant ceases to have value if it is not exercised prior to its expiration date.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Collateralized Loan Obligations</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund&#8217;s investments in non-convertible income securities may
include investments in collateralized loan obligation (&#8220;CLO&#8221;) securities. A CLO vehicle generally is an entity that is formed
to hold a portfolio consisting principally (typically, 80% or more of its assets) of loan obligations. The loan obligations within the
CLO vehicle are limited to loans which meet established credit criteria and are subject to concentration limitations in order to limit
a CLO vehicle&#8217;s exposure to a single credit. The transaction documents relating to the issuance of CLO securities impose eligibility
criteria on the assets of the CLO, restrict the ability of the CLO&#8217;s investment manager to trade investments and impose certain
portfolio-wide asset quality requirements.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">A CLO issues various classes or &#8220;tranches&#8221; of securities.
Each tranche has different payment characteristics and different credit ratings. These tranches are generally categorized as senior, mezzanine,
or subordinated/equity, according to their degree of risk. The key feature of the CLO structure is the prioritization of the cash flows
from a pool of securities among the several tranches of the CLO. As interest payments are received, the CLO makes contractual interest
payments to each tranche of debt based on its seniority. If there are funds remaining after each tranche of debt receives its contractual
interest rate and the CLO meets or exceeds required collateral coverage levels (or other similar covenants), the remaining funds may be
paid to the subordinated tranche (often referred to as the &#8220;residual&#8221; or &#8220;equity&#8221; tranche). The contractual provisions
setting out this order of payments are set out in detail in the relevant CLO&#8217;s indenture. These provisions are referred to as the
&#8220;priority of payments&#8221; or the &#8220;waterfall&#8221; and determine the terms of payment of any other obligations that may
be required to be paid ahead of payments of interest and principal on the securities issued by a CLO. In addition, for payments to be
made to each tranche, after the most senior tranche of debt, there are various tests that must be complied with, which are different for
each CLO. CLO securities are generally limited recourse obligations of the CLO payable solely from the underlying assets of the CLO or
the proceeds thereof. Consequently, holders of CLO securities must rely solely on distributions on the underlying assets or proceeds thereof
for payment in respect thereof. The cash flows generated by the underlying obligations held in a CLO&#8217;s portfolio will generally
determine the interest payments on CLO securities. Payments to holders of CLO securities are made in sequential order of priority. CLO
securities may have floating interest rates or fixed interest rates. The rated tranches of CLO securities are generally assigned credit
ratings by one or more nationally recognized statistical rating organizations.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund currently intends to invest in the rated debt tranches of CLOs
and does not currently intend to invest in the subordinated (or &#8220;residual&#8221; or &#8220;equity&#8221;) tranche.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">&#160;</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">INVESTMENT RESTRICTIONS</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund operates under the following restrictions
that constitute fundamental policies that, except as otherwise noted, cannot be changed without the affirmative vote of the holders of
a majority of the outstanding voting</p>


<!-- Field: Page; Sequence: 66; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">securities of the Fund voting together as a single class, which is
defined by the 1940 Act as the lesser of (i) 67% or more of the Fund&#8217;s voting securities present at a meeting, if the holders of
more than 50% of the Fund&#8217;s outstanding voting securities are present or represented by proxy; or (ii) more than 50% of the Fund&#8217;s
outstanding voting securities. These restrictions provide that the Fund shall not:</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">(1)</td><td>invest 25% or more of the value of its Managed Assets in any one industry; provided that this limitation does not apply to government
securities;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">(2)</td><td>with respect to 75% of its Managed Assets, invest more than 5% of the value of its Managed Assets in the securities of any single
issuer or purchase more than 10% of the outstanding voting securities of any one issuer;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">(3)</td><td>issue senior securities or borrow money other than as permitted by the Investment Company Act of 1940 (the &#8220;1940 Act&#8221;),
or pledge its assets other than to secure such issuances or in connection with Strategic Transactions and other investment strategies;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">(4)</td><td>make loans of money or property to any person, except through loans of portfolio securities, the purchase of convertible securities
and non-convertible income securities consistent with the Fund&#8217;s investment objective and policies or the entry into repurchase
agreements;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">(5)</td><td>underwrite the securities of other issuers, except to the extent that in connection with the disposition of portfolio securities or
the sale of its own securities the Fund may be deemed to be an underwriter;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">(6)</td><td>purchase or sell real estate, except that the Fund may invest in securities of companies that deal in real estate or are engaged in
the real estate business, including real estate investment trusts, and securities secured by real estate or interests therein and the
Fund may hold and sell real estate or mortgages on real estate acquired through default, liquidation or other distributions of an interest
in real estate as a result of the Fund&#8217;s ownership of such securities; or</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">(7)</td><td>purchase or sell commodities or commodity contracts for any purposes except as, and to the extent, permitted by applicable law without
the Fund becoming subject to registration with the Commodity Futures Trading Commission as a commodity pool.</td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Currently, under the 1940 Act, the Fund generally
is not permitted to engage in borrowings unless immediately after a borrowing the value of the Fund&#8217;s total assets less liabilities
(other than the borrowing) is at least 300% of the principal amount of the borrowing (<i>i.e.</i>, the principal amount may not exceed
33 <span style="background-color: white"><sup>1&#160;</sup>/<sub>&#160;3</sub></span>% of the Fund&#8217;s total assets). In addition,
the Fund is not permitted to declare any cash dividend or other distribution on common shares unless, at the time of declaration, the
value of the Fund&#8217;s total assets, less liabilities other than borrowings, is at least 300% of the principal amount of its borrowing.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Currently, under the 1940 Act, the Fund may generally
not lend money or property to any person, directly or indirectly, if the person controls or is under common control with the Fund, except
for a loan from the Fund to a company that owns all of the outstanding securities of the Fund, except directors&#8217; and qualifying
shares.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">For purposes of the foregoing, &#8220;majority of
the outstanding,&#8221; when used with respect to particular shares of the Fund (whether voting together as a single class or voting as
separate classes), means (i) 67% or more of such shares present at a meeting, if the holders of more than 50% of such shares are present
or represented by proxy, or (ii) more than 50% of such shares, whichever is less.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Unless otherwise indicated, all limitations applicable
to the Fund&#8217;s investments apply only at the time a transaction is entered into.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Currently, under the 1940 Act, a &#8220;senior security&#8221;
does not include any promissory note or evidence of indebtedness where the loan is for temporary purposes only and in an amount not exceeding
5% of the value of the total assets of</p>


<!-- Field: Page; Sequence: 67; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">the issuer at the time the loan is made. A loan is presumed to be for
temporary purposes if it is repaid within sixty days and is not extended or renewed.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund would be deemed to &#8220;concentrate&#8221;
in a particular industry if it invested 25% or more of its total assets in that industry. The Fund&#8217;s industry concentration policy
does not preclude it from focusing investments in issuers in a group of related industrial sectors (such as different types of utilities).</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Currently, to the extent the Fund covers its commitment
under a reverse repurchase agreement, derivative instrument or other borrowing instrument by the segregation of liquid assets, equal in
value to the amount of the Fund&#8217;s commitment, or by entering into offsetting transactions or by owning other positions covering
its obligations, the instrument will not be considered a &#8220;senior security&#8221; for purposes of the asset coverage requirements
otherwise applicable to borrowings by the Fund.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund interprets its policies with respect to
borrowing and lending to permit such activities as may be lawful for the Fund, to the full extent permitted by the 1940 Act or by exemption
from the provisions of the 1940 Act under an exemptive order of the SEC.</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">MANAGEMENT OF THE FUND</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Board of Trustees</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">The information contained under the heading &#8220;Other Information&#8212;Trustees&#8221;
in the Fund&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm">Annual Report</a>
is incorporated herein by reference.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Trustee Qualifications</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The information contained under the heading &#8220;The
Proposal: To Elect Trustees&#8212;Trustee Experiences, Qualifications, and Skills&#8221; in the Fund&#8217;s <a href="https://www.sec.gov/Archives/edgar/data/1219120/000182126824000183/gug87836avk.htm">Proxy
Statement</a> is incorporated herein by reference.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Executive Officers</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The information contained under the heading &#8220;Other
Information&#8212;Officers&#8221; in the Fund&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm">Annual
Report</a> is incorporated herein by reference.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Board Leadership Structure</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The information contained under the heading &#8220;The
Proposal: To Elect Trustees&#8212;Board Leadership Structure&#8221; in the Fund&#8217;s <a href="https://www.sec.gov/Archives/edgar/data/1219120/000182126824000183/gug87836avk.htm">Proxy
Statement</a> is incorporated herein by reference.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Board Committees</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The information contained under the headings
&#8220;The Proposal: To Elect Trustees&#8212;Board Committees&#8221; and "The Proposal: To Elect Trustees&#8212;Board Meetings" in
the Fund&#8217;s <a href="https://www.sec.gov/Archives/edgar/data/1219120/000182126824000183/gug87836avk.htm">Proxy Statement</a> is
incorporated herein by reference.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt"><b>Board&#8217;s Role in Risk Oversight</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 10pt; text-indent: 0in">The information contained under the heading
&#8220;The Proposal: To Elect Trustees&#8212;Board&#8217;s Role in Risk Oversight&#8221; in the Fund&#8217;s <a href="https://www.sec.gov/Archives/edgar/data/1219120/000182126824000183/gug87836avk.htm">Proxy
Statement</a> is incorporated herein by reference.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Remuneration of Trustees and Officers</b></p>


<!-- Field: Page; Sequence: 68; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The information contained under the heading &#8220;The
Proposal: To Elect Trustees&#8212;Trustee Compensation&#8221; in the Fund&#8217;s <a href="https://www.sec.gov/Archives/edgar/data/1219120/000182126824000183/gug87836avk.htm">Proxy
Statement</a> is incorporated herein by reference.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>Trustee Share Ownership</b>&#160;</p>



<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">The information contained under the heading &#8220;The Proposal: To
Elect Trustees&#8212;Trustee and Officer Beneficial Ownership of Securities&#8221; in the Fund&#8217;s Proxy Statement is incorporated
herein by reference.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Indemnification of Officers and Trustees; Limitations on Liability</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund&#8217;s Declaration of Trust and By-Laws
(collectively, the &#8220;Governing Documents&#8221;) provide that the Fund will indemnify its Trustees and officers and may indemnify
its employees or agents against liabilities and expenses incurred in connection with litigation in which they may be involved because
of their positions with the Fund, to the fullest extent permitted by law. However, nothing in the Governing Documents protects or indemnifies
a Trustee, officer, employee or agent of the Fund against any liability to which such person would otherwise be subject in the event of
such person&#8217;s willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct of his
or her position.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Adviser</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Pursuant to an investment advisory agreement between the Fund and the
Adviser (the &#8220;Investment Advisory Agreement&#8221;), the Fund pays the Adviser a management fee, payable monthly.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Under the terms of the Investment Advisory Agreement, the Adviser is
responsible for the day-to-day management of the Fund&#8217;s portfolio of investments, which includes buying and selling securities for
the Fund, as well as investment research.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Investment Advisory Agreement had an initial term of two years and
thereafter remains in effect from year to year if approved annually (i) by the Board of Trustees or by the holders of a majority of the
Fund&#8217;s outstanding voting securities and (ii) by a majority of the Trustees who are not &#8220;interested persons&#8221; (as defined
in the 1940 Act)</p>


<!-- Field: Page; Sequence: 69; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">of the Fund or the Adviser, by vote cast in person at a meeting called
for the purpose of voting on such approval. The Investment Advisory Agreement terminates automatically on its assignment and may be terminated
without penalty on 60 days written notice at the option of either party thereto or by a vote of a majority of the Fund&#8217;s outstanding
shares, which is defined by the 1940 Act as the lesser of (i) 67% or more of the Fund&#8217;s voting securities present at a meeting,
if the holders of more than 50% of the Fund&#8217;s outstanding voting securities are present or represented by proxy; or (ii) more than
50% of the Fund&#8217;s outstanding voting securities.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Investment Advisory Agreement provides that, in the absence of willful
misfeasance, bad faith, gross negligence or reckless disregard for its obligations and duties thereunder, Advent is not liable for any
error or judgment or mistake of law or for any loss suffered by the Fund. Pursuant to the Investment Advisory Agreement, Advent has granted
the right to use the name &#8220;Advent&#8221; in the name of the Fund.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The table below sets forth information about the total management fees
paid by the Fund to Advent.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 10pt 0 0"><b>Advisory Fees Paid to Advent</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 22%; padding-right: 4.3pt; padding-left: 4.3pt">
    <p style="border-bottom: Black 0.5pt solid; font: 9pt Times New Roman, Times, Serif; margin: 0"><b>For the Fiscal Year Ended</b></p></td>
    <td style="width: 31%; padding-right: 4.3pt; padding-left: 4.3pt; text-align: center">&#160;</td>
    <td style="width: 47%; padding-right: 4.3pt; padding-left: 4.3pt">
    <p style="border-bottom: Black 0.5pt solid; font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Paid to Advent</b></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 4.3pt; padding-left: 4.3pt; text-align: center"><span style="font-size: 9pt">October&#160;31, 2023</span></td>
    <td style="padding-right: 4.3pt; padding-left: 4.3pt">&#160;</td>
    <td rowspan="3" style="padding-right: 4.3pt; padding-left: 4.3pt">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center">$4,197,461</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center">$4,716,909</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center">$5,434,775</p></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 4.3pt; padding-left: 4.3pt; text-align: center"><span style="font-size: 9pt">October&#160;31, 2022</span></td>
    <td style="padding-right: 4.3pt; padding-left: 4.3pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 4.3pt; padding-left: 4.3pt; text-align: center"><span style="font-size: 9pt">October&#160;31, 2021</span></td>
    <td style="padding-right: 4.3pt; padding-left: 4.3pt">&#160;</td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>&#160;</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Portfolio Managers</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The information contained under &#8220;Item&#160;8.
Portfolio Managers of Closed-End Management Investment Companies&#8221; of the Fund&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm">Annual
Report</a> is incorporated herein by reference.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>Fund Administration Agreement</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Fund administration services are provided to the
Fund by MUFG Investor Services (US), LLC (&#8220;MUFG&#8221;), pursuant to a fund administration agreement between the Fund and MUFG.
The Fund pays MUFG a contractual fund administration fee for these services, payable monthly at the annual rate set forth as a percentage
of the average daily Managed Assets of the Fund in the table below.</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td colspan="2" style="padding-top: 1pt; padding-bottom: 1pt"><b><span style="text-decoration: underline">Fund Administration Fee</span></b></td>
    <td style="padding-top: 1pt; padding-bottom: 1pt">&#160;</td></tr>
  <tr>
    <td style="border-bottom: Black 1pt solid; width: 67%; padding-top: 1pt; padding-bottom: 1pt"><b>Managed Assets</b></td>
    <td style="border-bottom: Black 1pt solid; width: 25%; padding-top: 1pt; padding-bottom: 1pt"><b>Rate</b></td>
    <td style="width: 8%; padding-top: 1pt; padding-bottom: 1pt">&#160;</td></tr>
  <tr>
    <td style="padding-top: 1pt; padding-bottom: 1pt">First $200,000,000</td>
    <td style="padding-top: 1pt; padding-bottom: 1pt">0.0275%</td>
    <td style="padding-top: 1pt; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding-top: 1pt; padding-bottom: 1pt">Next $300,000,000</td>
    <td style="padding-top: 1pt; padding-bottom: 1pt">0.0200%</td>
    <td style="padding-top: 1pt; padding-bottom: 1pt">&#160;</td></tr>
  <tr>
    <td style="padding-top: 1pt; padding-bottom: 1pt">Next $500,000,000</td>
    <td style="padding-top: 1pt; padding-bottom: 1pt">0.0150%</td>
    <td style="padding-top: 1pt; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding-top: 1pt; padding-bottom: 1pt">Over $1,000,000,000</td>
    <td style="padding-top: 1pt; padding-bottom: 1pt">0.0100%</td>
    <td style="padding-top: 1pt; padding-bottom: 1pt">&#160;</td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>Servicing Agreement</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Pursuant to a Servicing Agreement between the Fund
and Guggenheim Funds Distributors, LLC (&#8220;GFD&#8221;) (the &#8220;GFD Servicing Agreement&#8221;), the Fund pays GFD a servicing
fee of 0.21% of the average value of the Fund&#8217;s Managed Assets, payable monthly.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Under the terms of the GFD Servicing Agreement, GFD
provides the Fund a variety of services, including (i) replying to requests for information concerning the Fund from shareholders or prospective
shareholders, brokers or the public; (ii) aiding in the secondary market support of the Fund through regular written and oral communications
with the Fund&#8217;s NYSE designated market maker, the closed-end fund analyst community and various information providers specializing
in the dissemination of closed-end fund information; (iii) coordinating and overseeing activities of the Fund&#8217;s administrator; (iv)
developing and maintaining a website for the Fund and (v) overseeing, in</p>


<!-- Field: Page; Sequence: 70; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">consultation with, and as agreed by, Advent matters relating to the
conduct and administration of meetings of the Board and committees thereof.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The GFD Servicing Agreement remains in effect from
year to year if approved annually by the Board of Trustees.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The GFD Servicing Agreement is terminable (a) by
the Fund, without penalty, on thirty (30) days&#8217; written notice, by a vote of a majority of the Fund&#8217;s Board of Trustees, or
(b) on sixty (60) days&#8217; written notice by GFD. The GFD Servicing Agreement shall automatically terminate in the event of its assignment
as the term is defined in the 1940 Act. In addition, either party to the GFD Servicing Agreement may also terminate the GFD Servicing
Agreement in the event the other party has materially breached the GFD Servicing Agreement in the event that the breach is not cured within
ten (10) days after receipt by the breaching party of written notice of the breach.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The GFD Servicing Agreement provides that, in the
absence of willful misconduct, bad faith, gross negligence or reckless disregard for its obligations and duties thereunder, GFD is not
liable for any error or judgment or mistake of law or for any loss suffered by the Fund.</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">PORTFOLIO TRANSACTIONS</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Subject to policies established by the Board of Trustees,
the Adviser is responsible for placing purchase and sale orders and the allocation of brokerage on behalf of the Fund.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Adviser will employ a variety of criteria in
selecting brokers to execute trades for the account of the Fund, and will, at all times, seek best execution of such trades. The Adviser
is responsible for selecting the broker or dealer used in each investment transaction for the Fund. When a transaction is effected on
an exchange, the Adviser seeks to use brokers whose commissions it considers to be fair and reasonable without necessarily determining
that the lowest possible commissions are paid in all circumstances. The Adviser also considers the relative creditworthiness of counterparties,
including brokers and dealers, when choosing a broker or dealer as counterparty in respect of investment transactions.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Adviser does not currently utilize &#8220;soft-dollar&#8221;
arrangements, pursuant to which brokers provide research services to the Adviser in return for allocating brokerage transactions. However,
the Adviser may from time to time receive or be offered research services from brokers at no stated cost or requirement to execute transactions,
and may trade with such brokers.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt"><b>Commissions Paid</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt">The Fund paid approximately the following commissions to brokers
during the fiscal years shown:</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 64%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt"><b>Fiscal Year Ended October&#160;31:</b></span></td>
    <td style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b><span style="text-decoration: underline">All Brokers</span></b></span></td>
    <td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b><span style="text-decoration: underline">Affiliated Brokers</span></b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">2023</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$191,572</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$0</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">2022</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$613,105</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$0</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">2021</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$236,222</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$0</span></td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 72%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt"><b>Fiscal Year Ended October&#160;31, 2023 Percentages:</b></span></td>
    <td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Commissions with affiliate to total Transactions:</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">0%</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Value of Brokerage Transactions with affiliate to total transactions:</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">0%</span></td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">During the fiscal period ended October&#160;31, 2023,
the Fund paid $191,572 in brokerage commissions on transactions totaling $648,072,562 to brokers selected primarily on the basis of research
services provided to the Adviser.</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">TAX MATTERS</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">This section and the discussion in the Prospectus
(see &#8220;Tax Matters&#8221;) provide a summary of certain U.S. federal income tax considerations generally applicable to the Fund,
U.S. Shareholders (as defined in the Prospectus) and Non-U.S. Shareholders (as defined in the Prospectus) that acquire common shares (collectively,
the &#8220;Shareholders&#8221;) and that hold such shares as capital assets within the meaning of the Internal Revenue Code of 1986, as
amended</p>


<!-- Field: Page; Sequence: 71; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">(the &#8220;Code&#8221;) (generally, property held for investment).
This summary does not discuss the consequences of an investment in the Rights. The tax consequences of such an investment will be discussed
in a relevant Prospectus Supplement. The discussion is based upon the Code, U.S. Treasury Regulations, judicial authorities, published
positions of the IRS and other applicable authorities, all as in effect on the date hereof and all of which are subject to change or differing
interpretations (possibly with retroactive effect). This summary does not address all of the potential U.S. federal income tax consequences
that may be applicable to the Fund or to all categories of investors, some of which may be subject to special tax rules. No ruling has
been or will be sought from the IRS regarding any matter discussed herein. No assurance can be given that the IRS would not assert, or
that a court would not sustain, a position contrary to any of the tax aspects set forth below. <b>Prospective investors should consult
their tax advisors as to the U.S. federal income tax consequences of acquiring, holding and disposing of common shares, as well as the
effects of state, local and non-U.S. tax laws.</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Taxation of the Fund</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund has elected to be treated, and intends to
qualify each year, as a RIC under Subchapter M of the Code. Accordingly, the Fund must, among other things, (i) derive in each taxable
year at least 90% of its gross income from (a) dividends, interest (including tax-exempt interest), payments with respect to certain securities
loans, and gains from the sale or other disposition of stock, securities or foreign currencies, or other income (including gain from options,
futures and forward contracts) derived with respect to its business of investing in such stock, securities or foreign currencies and (b)
net income derived from interests in &#8220;qualified publicly traded partnerships&#8221; (as defined in the Code); and (ii) diversify
its holdings so that, at the end of each quarter of each taxable year (a) at least 50% of the market value of the Fund&#8217;s total assets
is represented by cash and cash items, U.S. government securities, the securities of other RICs and other securities, with such other
securities limited, in respect of any one issuer, to an amount not greater than 5% of the value of the Fund&#8217;s total assets and not
more than 10% of the outstanding voting securities of such issuer and (b) not more than 25% of the market value of the Fund&#8217;s total
assets is invested in the securities (other than U.S. government securities and the securities of other RICs) of (I) any one issuer, (II)
any two or more issuers that the Fund controls and that are determined to be engaged in the same business or similar or related trades
or businesses or (III) any one or more &#8220;qualified publicly traded partnerships.&#8221; Generally, a qualified publicly traded partnership
includes a partnership the interests of which are traded on an established securities market or readily tradable on a secondary market
(or the substantial equivalent thereof) and that derives less than 90% of its gross income from the items described in (i)(a) above.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">As long as the Fund qualifies as a RIC, the Fund
generally will not be subject to U.S. federal income tax on income and gains that the Fund distributes to its shareholders; provided that
it distributes each taxable year at least 90% of the sum of (i) the Fund&#8217;s investment company taxable income (which includes, among
other items, dividends, interest, the excess of any net short-term capital gain over net long-term capital loss, and other taxable income,
other than any net capital gain (defined below), reduced by deductible expenses) determined without regard to the deduction for dividends
and distributions paid and (ii) the Fund&#8217;s net tax-exempt interest (the excess of its gross tax-exempt interest over certain disallowed
deductions) (the &#8220;Annual Distribution Requirement&#8221;). The Fund intends to distribute substantially all of such income each
year. The Fund will be subject to income tax at regular corporate rates on any taxable income or gains that it does not distribute to
its shareholders.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Code imposes a 4% nondeductible excise tax on
the Fund to the extent the Fund does not distribute by the end of any calendar year at least the sum of (i) 98% of its ordinary income
(not taking into account any capital gain or loss) for the calendar year and (ii) 98.2% of its capital gain in excess of its capital loss
(adjusted for certain ordinary losses) for a one-year period generally ending on October&#160;31 of the calendar year (unless an election
is made to use the Fund&#8217;s taxable year) (the &#8220;Excise Tax Avoidance Requirements&#8221;). In addition, the minimum amounts
that must be distributed in any year to avoid the excise tax will be increased or decreased to reflect any under-distribution or over-distribution,
as the case may be, from the previous year. For purposes of the excise tax, the Fund will be deemed to have distributed any income on
which it paid U.S. federal income tax in the taxable year ending within the calendar year. While the Fund intends to distribute any income
and capital gain in the manner necessary to minimize imposition of the 4% nondeductible excise tax, there can be no assurance that sufficient
amounts of the Fund&#8217;s taxable income and capital gain will be distributed to avoid entirely the imposition of the excise tax. In
that event, the Fund will be liable for the excise tax only on the amount by which it does not meet the foregoing distribution requirement.</p>


<!-- Field: Page; Sequence: 72; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">If for any taxable year the Fund does not qualify
as a RIC, all of its taxable income (including its net capital gain, which consists of the excess of its net long-term capital gain over
its net short-term capital loss) will be subject to tax at regular corporate rates without any deduction for distributions to its shareholders,
and such distributions will be taxable to the Shareholders as ordinary dividends to the extent of the Fund&#8217;s current and accumulated
earnings and profits. Such dividends, however, would be eligible (i) to be treated as &#8220;qualified dividend income&#8221; in the case
of Shareholders taxed as individuals and (ii) for the dividends received deduction in the case of corporate Shareholders, subject, in
each case, to certain holding period and other requirements. To qualify again to be taxed as a RIC in a subsequent year, the Fund would
generally be required to distribute to its shareholders its earnings and profits attributable to non-RIC years. If the Fund fails to qualify
as a RIC for a period greater than two taxable years, the Fund may be required to recognize and pay tax on any net built-in gains with
respect to certain of its assets (<i>i.e.</i>, the excess of the aggregate gains, including items of income, over aggregate losses that
would have been realized with respect to such assets if the Fund had been liquidated) or, alternatively, to elect to be subject to taxation
on such built-in gain recognized for a period of five years, in order to qualify as a RIC in a subsequent year. The remainder of this
discussion assumes that the Fund qualifies as a RIC.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Taxation of the Fund&#8217;s Investments</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Certain of the Fund&#8217;s investment practices
are subject to special and complex U.S. federal income tax provisions (including mark-to-market, constructive sale, straddle, wash sale,
short sale and other rules) that may, among other things, (i) disallow, suspend or otherwise limit the allowance of certain losses or
deductions, including the dividends received deduction, (ii) convert lower taxed long-term capital gains or &#8220;qualified dividend
income&#8221; into higher taxed short-term capital gains or ordinary income, (iii) convert ordinary loss or a deduction into capital loss
(the deductibility of which is more limited), (iv) cause the Fund to recognize income or gain without a corresponding receipt of cash,
(v) adversely affect the time as to when a purchase or sale of stock or securities is deemed to occur, (vi) adversely alter the characterization
of certain complex financial transactions and (vii) produce income that will not be &#8220;qualified&#8221; income for purposes of the
90% annual gross income requirement described above. These U.S. federal income tax provisions could therefore affect the amount, timing
and character of distributions to Shareholders. The Fund intends to monitor its transactions and may make certain tax elections and may
be required to dispose of securities to mitigate the effect of these provisions and prevent disqualification of the Fund as a RIC. Additionally,
the Fund may be required to limit its activities in derivative instruments in order to enable the Fund to maintain its RIC status.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">If the Fund acquires shares in a &#8220;passive foreign
investment company&#8221; (a &#8220;PFIC&#8221;), the Fund may be subject to U.S. federal income tax on a portion of any &#8220;excess
distribution&#8221; or gain from the disposition of such shares even if such income is distributed as a taxable dividend by the Fund to
Shareholders. Additional charges in the nature of interest may be imposed on the Fund in respect of deferred taxes arising from such distributions
or gains. If the Fund invests in a PFIC and elects to treat the PFIC as a &#8220;qualified electing fund&#8221; under the Code (a &#8220;QEF&#8221;),
in lieu of the foregoing requirements, the Fund will be required to include in income each year a portion of the ordinary earnings and
net capital gain of the QEF, even if such income is not distributed to the Fund. Alternatively, the Fund can elect to mark to market at
the end of each taxable year the Fund&#8217;s shares in a PFIC; in this case, the Fund will recognize as ordinary income any increase
in the value of such shares, and as ordinary loss any decrease in such value to the extent it does not exceed prior increases included
in income. The Fund&#8217;s ability to make either election will depend on factors beyond the Fund&#8217;s control. Under either election,
the Fund may be required to recognize in a year income in excess of the Fund&#8217;s distributions from PFICs and the Fund&#8217;s proceeds
from dispositions of PFIC stock during that year, and such income will nevertheless be subject to the Annual Distribution Requirement
and will be taken into account for purposes of the 4% excise tax.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">If the Fund holds 10% or more of the shares in a
foreign corporation that is treated as a controlled foreign corporation (&#8220;CFC&#8221;), the Fund may be treated as receiving a deemed
distribution (taxable as ordinary income) each year from such foreign corporation in an amount equal to the Fund&#8217;s pro rata share
of the corporation&#8217;s income for the taxable year (including both ordinary earnings and capital gains), whether or not the corporation
makes an actual distribution during such year. In general, a foreign corporation will be classified as a CFC if more than 50% of the shares
of the corporation, measured by reference to combined voting power or value, is owned (directly, indirectly or by attribution) by U.S.
shareholders. A U.S. shareholder, for this purpose, is any U.S. person that possesses (directly, indirectly or by attribution) 10% or
more of the combined voting power or value of all classes of shares of a corporation. If the Fund is treated as receiving a deemed distribution
from a CFC, the Fund will be required to</p>


<!-- Field: Page; Sequence: 73; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">include such distribution in its investment company taxable income
regardless of whether the Fund receives any actual distributions from such CFC, and the Fund must distribute such income to satisfy the
Annual Distribution Requirement and the Excise Tax Avoidance Requirement.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Certain types of income received by the Fund from
REITs, real estate mortgage investment conduits (&#8220;REMICs&#8221;), taxable mortgage pools or other investments may cause the Fund
to designate some or all of its distributions as &#8220;excess inclusion income.&#8221; To Shareholders such excess inclusion income will
(i) constitute taxable income, as &#8220;unrelated business taxable income&#8221; (&#8220;UBTI&#8221;) for those Shareholders who would
otherwise be tax-exempt such as individual retirement accounts, 401(k) accounts, Keogh plans, pension plans and certain charitable entities,
(ii) not be offset against net operating losses for tax purposes, (iii) not be eligible for reduced U.S. withholding for Non-U.S. Shareholders
even from tax treaty countries and (iv) cause the Fund to be subject to tax if certain &#8220;disqualified organizations,&#8221; as defined
by the Code (which includes charitable remainder trusts), are Shareholders.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund may invest a portion of its net assets in
below investment grade securities, commonly known as &#8220;junk&#8221; securities. Investments in these types of securities may present
special tax issues for the Fund. U.S. federal income tax rules are not entirely clear about issues such as when the Fund may cease to
accrue interest, original issue discount or market discount, when and to what extent deductions may be taken for bad debts or worthless
securities, how payments received on obligations in default should be allocated between principal and income and whether exchanges of
debt instruments in a bankruptcy or workout context are taxable. The Fund intends to address these and other issues, to the extent necessary,
in order to seek to ensure that the Fund distributes sufficient income to preserve its status as a RIC and does not become subject to
U.S. federal income or excise tax.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Certain credit securities acquired by the Fund may
be treated as credit securities that were originally issued at a discount. Generally, the amount of the original issue discount is treated
as interest income and is included in taxable income (and, to the extent allocable to the Fund, is required to be distributed by the Fund
in order to qualify as a RIC or avoid income or excise taxes on undistributed income) over the term of the security, even though payment
of that amount is not received until a later time, usually when the debt instrument matures. If the Fund purchases a debt instrument on
a secondary market at a price lower than its adjusted issue price, the excess of the adjusted issue price over the purchase price is &#8220;market
discount.&#8221; Unless the Fund makes an election to accrue market discount on a current basis, generally, any gain realized on the disposition
of, and any partial payment of principal on, a debt instrument having market discount is treated as ordinary income to the extent the
gain, or principal payment, does not exceed the &#8220;accrued market discount&#8221; on the debt instrument. Market discount generally
accrues in equal daily installments.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund may invest in preferred securities or other
securities the U.S. federal income tax treatment of which may not be clear or may be subject to recharacterization by the IRS. To the
extent the tax treatment of such securities or the income from such securities differs from the tax treatment expected by the Fund, it
could affect the timing or character of income recognized by the Fund, requiring the Fund to purchase or sell securities, or otherwise
change its portfolio, in order to comply with the tax rules applicable to RICs under the Code.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Gain or loss on the sales of securities by the Fund
will generally be long-term capital gain or loss if the securities have been held by the Fund for more than one year. Gain or loss on
the sale of securities held for one year or less will be short-term capital gain or loss.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Because the Fund may invest in foreign securities,
its income from such securities may be subject to non-U.S. taxes. The Fund does not expect to be eligible to elect to &#8220;pass through&#8221;
to Shareholders of the Fund the ability to use the foreign tax deduction or foreign tax credit allocable to it for foreign taxes paid
by the Fund with respect to qualifying taxes.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Income from options on individual stocks written
by the Fund will not be recognized by the Fund for tax purposes until an option is exercised, lapses or is subject to a &#8220;closing
transaction&#8221; (as defined by applicable regulations) pursuant to which the Fund&#8217;s obligations with respect to the option are
otherwise terminated. If the option lapses without exercise or is otherwise subject to a closing transaction, the premiums received by
the Fund from the writing of such options will generally be characterized as short-term capital gain. If an option written by the Fund
is exercised, the Fund will generally recognize gain or loss depending on the exercise price of the option, the option premium, and the
Fund&#8217;s tax basis in the security underlying the option. The character of any gain or loss on the sale</p>


<!-- Field: Page; Sequence: 74; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">of the underlying security as short-term or long-term capital gain
or loss will depend on the holding period of the Fund in the underlying security. In general, distributions received by U.S. Shareholders
of the Fund that are attributable to short-term capital gains recognized by the Fund from option writing activities of the Fund will be
taxed to such U.S. Shareholders as ordinary income and will not be eligible for the reduced tax rate applicable to qualified dividend
income.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Options on indices of securities and sectors of securities
that qualify as &#8220;section&#160;1256 contracts&#8221; will generally be &#8220;marked-to-market&#8221; for U.S. federal income tax
purposes. As a result, the Fund will generally recognize gain or loss on the last day of each taxable year equal to the difference between
the value of the option on that date and the adjusted basis of the option. The adjusted basis of the option will consequently be increased
by such gain or decreased by such loss. Any gain or loss with respect to options on indices and sectors that qualify as &#8220;section&#160;1256
contracts&#8221; will be treated as short-term capital gain or loss to the extent of 40% of such gain or loss and long-term capital gain
or loss to the extent of 60% of such gain or loss. Because the mark-to-market rules may cause the Fund to recognize gain in advance of
the receipt of cash, the Fund may be required to dispose of investments in order to meet its distribution requirements. &#8220;Mark-to-market&#8221;
losses may be suspended or otherwise limited if such losses are part of a straddle or similar transaction.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Taxation of U.S. Shareholders</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund will either distribute or retain for reinvestment
all or part of its net capital gain. If any such gain is retained, the Fund will be subject to regular corporate income tax on such retained
amount. In that event, the Fund may designate the retained amount as undistributed capital gain in a notice to its Shareholders, each
of whom, if subject to U.S. federal income tax on long-term capital gains, (i) would be required to include in income for U.S. federal
income tax purposes as long-term capital gain its share of such undistributed amounts, (ii) would be entitled to credit its proportionate
share of the tax paid by the Fund against its U.S. federal income tax liability and to claim refunds to the extent that the credit exceeds
such liability and (iii) would increase its basis in its shares by the amount of undistributed capital gain included in such Shareholder&#8217;s
gross income net of the tax deemed paid by such Shareholder under clause&#160;(ii).</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Distributions paid to you by the Fund from its net
capital gains, if any, that the Fund properly reports as capital gains dividends (&#8220;capital gain dividends&#8221;) are taxable as
long-term capital gains, regardless of how long you have held your shares. All other dividends paid to you by the Fund (including dividends
from net short-term capital gains) from its current or accumulated earnings and profits (&#8220;ordinary income dividends&#8221;) are
generally subject to tax as ordinary income. Capital gain dividends are not eligible for the dividends received deduction.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Properly reported ordinary income dividends received
by corporate Shareholders generally will be eligible for the dividends received deduction to the extent that the Fund&#8217;s income consists
of dividend income from U.S. corporations and certain holding period and other requirements are satisfied by both the Fund and the corporate
U.S. Shareholders. In the case of U.S. Shareholders who are individuals, any properly reported ordinary income dividends that you receive
from the Fund will generally be eligible for taxation at the rates applicable to long-term capital gains to the extent that (i) the ordinary
income dividend is attributable to &#8220;qualified dividend income&#8221; (<i>i.e.</i>, generally dividends paid by U.S. corporations
and certain qualified foreign corporations) received by the Fund, (ii) the Fund satisfies certain holding period and other requirements
with respect to the stock on which such qualified dividend income was paid and (iii) you satisfy certain holding period and other requirements
with respect to your shares. Dividend income from PFICs and, in general, dividend income from REITs is not eligible for the reduced rate
for qualified dividend income and is taxed as ordinary income. In addition, for dividends to be eligible for the dividends received deduction
or for reduced rates applicable to individuals, the Fund cannot have an option to sell or be under a contractual obligation to sell (pursuant
to a short sale or otherwise) substantially identical stock or securities. Qualified dividend income eligible for these special rules
is not actually treated as capital gains, however, and thus will not be included in the computation of your net capital gain and generally
cannot be used to offset any capital losses. Due to the nature of the Fund&#8217;s investments, the Fund does not expect that a significant
portion of its distributions will be eligible for the dividends received deduction or for the reduced rates applicable to qualified dividend
income.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Under Treasury regulations, for taxable years beginning
before January 1, 2026, properly reported dividends paid by the Fund that are attributable to the Fund&#8217;s &#8220;qualified REIT dividends&#8221;
(generally, ordinary income dividends paid</p>


<!-- Field: Page; Sequence: 75; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">by a REIT, not including capital gain dividends or dividends treated
as qualified dividend income) may be eligible for the 20% deduction described in Section&#160;199A of the Code in the case of non-corporate
U.S. Shareholders; provided that certain holding period and other requirements are met by the Shareholder and the Fund. There can be no
assurance as to what portion, if any, of our distributions will qualify for such deduction. Subject to any future regulatory guidance
to the contrary, any distribution attributable to income from the Fund&#8217;s investments in publicly traded partnerships, if any, will
not qualify for the 20% deduction that could be available to a non-corporate U.S. Shareholder were the Shareholder to own such partnership
interests directly.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Any distributions you receive that are in excess
of the Fund&#8217;s current and accumulated earnings and profits will be treated as a tax-deferred return of capital to the extent of
your adjusted tax basis in your shares, and thereafter as capital gain from the sale of shares (assuming such shares are held as a capital
asset). The amount of any Fund distribution that is treated as a return of capital will reduce your adjusted tax basis in your shares,
thereby increasing your potential gain or reducing your potential loss on any subsequent sale or other disposition of your shares. In
determining the extent to which a distribution will be treated as being made from the Fund&#8217;s earnings and profits, earnings and
profits will be allocated on a pro rata basis first to distributions with respect to the Fund&#8217;s preferred shares, if any, and then
to the Fund&#8217;s common shares.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">U.S. Shareholders may be entitled to offset their
capital gain dividends with capital losses. The Code contains a number of statutory provisions affecting when capital losses may be offset
against capital gain, and limiting the use of losses from certain investments and activities. Accordingly, Shareholders that have capital
losses are urged to consult their tax advisers.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The IRS currently requires a RIC that has two or
more classes of shares outstanding to designate to each such class proportionate amounts of each type of its income (<i>e.g.</i>, ordinary
income, capital gain dividends, qualified dividend income) for each tax year based upon the percentage of total dividends distributed
to each class for such year.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Dividends and other taxable distributions are taxable
to you even though they are reinvested in additional shares of the Fund. Dividends and other distributions paid by the Fund are generally
treated under the Code as received by you at the time the dividend or distribution is made. If, however, the Fund pays you a dividend
in January that was declared in the previous October, November or December and you were the shareholder of record on a specified date
in one of such months, then such dividend will be treated for U.S. federal income tax purposes as being paid by the Fund and received
by you on December&#160;31 of the year in which the dividend was declared. In addition, certain other distributions made after the close
of the Fund&#8217;s taxable year may be &#8220;spilled back&#8221; and treated as paid by the Fund (except for purposes of the 4% nondeductible
excise tax) during such taxable year. In such case, you will be treated as having received such dividends in the taxable year in which
the distributions were actually made.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The price of shares purchased at any time may reflect
the amount of a forthcoming distribution. Those purchasing shares just prior to the record date of a distribution will receive a distribution
which will be taxable to them even as described above though economically it represents in part a return of invested capital.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund will send you information after the end
of each year setting forth the amount and tax status of any distributions paid to you by the Fund.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Except in the case of a redemption, the sale or other
disposition of common shares (including in connection with a termination of the Fund) will generally result in capital gain or loss to
you and will be long-term capital gain or loss if you have held such shares for more than one year at the time of sale. Any loss upon
the sale or other disposition of shares held for six months or less will be treated as long-term capital loss to the extent of any capital
gain dividends received (including amounts credited as an undistributed capital gain dividend) by you with respect to such shares. Any
loss you recognize on a sale or other disposition of shares will be disallowed if you acquire other shares (whether through the automatic
reinvestment of dividends or otherwise) within a 61-day period beginning 30 days before and ending 30 days after your sale or exchange
of shares. In such case, your tax basis in the shares acquired will be adjusted to reflect the disallowed loss.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">In general, a redemption of shares should be treated as a sale or exchange
of such shares under section&#160;302 of the Code, if the distribution of cash (a) is &#8220;substantially disproportionate&#8221; with
respect to the Shareholder, (b) results in a &#8220;complete redemption&#8221; of the Shareholder&#8217;s interest, or (c) is &#8220;not
essentially equivalent to a dividend&#8221; with</p>


<!-- Field: Page; Sequence: 76; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">respect to the Shareholder. A &#8220;substantially disproportionate&#8221;
distribution generally requires a reduction of at least 20% in the Shareholder&#8217;s proportionate interest in the Fund and also requires
the Shareholder to own less than 50% of the voting power of all classes entitled to vote immediately after the redemption. A &#8220;complete
redemption&#8221; of a Shareholder&#8217;s interest generally requires that all common shares and preferred shares of the Fund owned by
such Shareholder be disposed of. A distribution &#8220;not essentially equivalent to a dividend&#8221; requires that there be a &#8220;meaningful
reduction&#8221; in the Shareholder&#8217;s proportionate interest in the Fund, which should result if the Shareholder has a minimal interest
in the Fund, exercises no control over Fund affairs and suffers a reduction in his proportionate interest in the Fund. In determining
whether any of these tests has been met, any common shares and preferred shares actually owned, as well as shares considered to be owned
by the Shareholder by reason of certain constructive ownership rules set forth in section&#160;318 of the Code, generally must be taken
into account.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 0">If the redemption of your shares meets any of these three tests for
&#8220;sale or exchange&#8221; treatment, you will recognize gain or loss equal to the difference between the amount of cash and the fair
market value of other property received pursuant to the transaction and the adjusted tax basis of the sold shares. If none of the tests
described above are met, you may be treated as having received, in whole or in part, a dividend, return of capital or capital gain, depending
on (i) whether there are sufficient earnings and profits to support a dividend and (ii) your tax basis in the relevant shares. The tax
basis in the sold shares will be transferred to any remaining shares held by you in the Fund. In addition, if the redemption of shares
is treated as a &#8220;dividend&#8221; to a shareholder, a constructive dividend under certain provisions of the Code may result to a
non-selling Shareholder whose proportionate interest in the earnings and assets of the Fund has been increased as a result of such transaction.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Adjusted cost basis information for covered securities,
which generally include shares of a RIC, must be reported to the IRS and to taxpayers. Shareholders should contact their financial intermediaries
with respect to reporting of cost basis and available elections for their accounts.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Current U.S. federal income tax law taxes both long-term
and short-term capital gain of corporations at the rates applicable to ordinary income. For non-corporate taxpayers, short-term capital
gain is currently taxed at rates applicable to ordinary income while long-term capital gain generally is taxed at reduced maximum rates.
The deductibility of capital losses is subject to limitations under the Code.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Certain U.S. Shareholders who are individuals, estates
or trusts and whose income exceeds certain thresholds will be required to pay a 3.8% Medicare tax on all or a part of their &#8220;net
investment income,&#8221; which includes dividends received from the Fund and capital gains from the sale or other disposition of common
shares.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Ordinary income dividends, capital gain dividends,
and gain on the disposition of shares also may be subject to state, local or foreign taxes. Shareholders are urged to consult their tax
advisers regarding specific questions about U.S. federal (including the application of the alternative minimum tax rules), state, local
or foreign tax consequences to them of investing in the Fund.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>Taxation of Non-U.S. Shareholders</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The following discussion only applies to Non-U.S.
Shareholders. Whether an investment in Fund shares is appropriate for a Non-U.S. Shareholder will depend upon that Non-U.S. Shareholder&#8217;s
particular circumstances. An investment in shares by a Non-U.S. Shareholder may have adverse tax consequences. Non-U.S. Shareholders should
consult their tax advisors before investing in our shares.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">A Non-U.S. Shareholder generally will be subject
to U.S. federal withholding tax at the rate of 30% (or possibly a lower rate provided by an applicable tax treaty) on ordinary income
dividends (except as discussed below). In general, U.S. federal withholding tax and U.S. federal income tax will not apply to any gain
or income realized by a Non-U.S. Shareholder in respect of any distribution of net capital gain (including amounts credited as an undistributed
capital gain dividend) or upon the sale or other disposition of shares of the Fund. Different tax consequences may result if the Non-U.S.
Shareholder is engaged in a trade or business in the United States or, in the case of an individual, is present in the United States for
183 days or more during a taxable year and certain other conditions are met.</p>


<!-- Field: Page; Sequence: 77; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Dividends properly reported by the Fund are generally
exempt from U.S. federal withholding tax where they (i) are paid in respect of the Fund&#8217;s &#8220;qualified net interest income&#8221;
(generally, the Fund&#8217;s U.S.-source interest income, other than certain contingent interest and interest from obligations of a corporation
or partnership in which the Fund is at least a 10% shareholder, reduced by expenses that are allocable to such income) or (ii) are paid
in respect of the Fund&#8217;s &#8220;qualified short-term capital gains&#8221; (generally, the excess of the Fund&#8217;s net short-term
capital gain over the Fund&#8217;s long-term capital loss for such taxable year). Depending on its circumstances, the Fund may report
all, some or none of its potentially eligible dividends as such qualified net interest income or as qualified short-term capital gains,
and/or treat such dividends, in whole or in part, as ineligible for this exemption from withholding. In order to qualify for this exemption
from withholding, a Non-U.S. Shareholder needs to comply with applicable certification requirements relating to its non-U.S. status (including,
in general, furnishing an IRS Form&#160;W-8BEN, W-8BEN-E or substitute Form). In the case of shares held through an intermediary, the
intermediary may withhold even if the Fund reports the payment as qualified net interest income or qualified short-term capital gain.
Non-U.S. Shareholders should contact their intermediaries with respect to the application of these rules to their accounts. There can
be no assurance as to what portion of the Fund&#8217;s distributions will qualify for favorable treatment as qualified net interest income
or qualified short-term capital gains.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">If the Fund distributes its net capital gains in
the form of deemed rather than actual distributions, a Non-U.S. Shareholder will be entitled to a U.S. federal income tax credit or tax
refund equal to the Non-U.S. Shareholder&#8217;s allocable share of the tax that the Fund pays on the capital gains deemed to have been
distributed. In order to obtain the refund, the Non-U.S. Shareholder must obtain a U.S. taxpayer identification number and file a federal
income tax return even if the Non-U.S. Shareholder is not otherwise required to obtain a U.S. taxpayer identification number or file a
federal income tax return. For a Non-U.S. Shareholder, distributions (both actual and deemed), and gains realized upon the sale of shares
that are effectively connected with a U.S. trade or business (or, where an applicable treaty applies, are attributable to a permanent
establishment in the United States) will generally be subject to U.S. federal income tax at the rates applicable to U.S. persons and for
a corporate Non-U.S. Shareholder may, under certain circumstances, be subject to an additional &#8220;branch profits tax&#8221; at a 30%
rate (or at a lower rate if provided for by an applicable tax treaty). Accordingly, investment in shares may not be appropriate for certain
Non-U.S. Shareholders.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">In addition, withholding at a rate of 30% is required
on dividends in respect of shares held by or through certain foreign financial institutions (including investment funds), unless such
institution enters into an agreement with the Secretary of the Treasury to report, on an annual basis, information with respect to interests
in, and accounts maintained by, the institution to the extent such interests or accounts are held by certain U.S. persons and by certain
non-U.S. entities that are wholly or partially owned by U.S. persons and to withhold on certain payments. Accordingly, the entity through
which shares are held will affect the determination of whether such withholding is required. Similarly, dividends in respect of shares
held by an investor that is a non-financial non-U.S. entity that does not qualify under certain exemptions will be subject to withholding
at a rate of 30%, unless such entity either (i) certifies to the applicable withholding agent that such entity does not have any &#8220;substantial
United States owners&#8221; or (ii) provides certain information regarding the entity&#8217;s &#8220;substantial United States owners,&#8221;
which the applicable withholding agent will in turn provide to the Secretary of the Treasury. The Fund will not pay any additional amounts
to Shareholders in respect of any amounts withheld. An intergovernmental agreement between the United States and an applicable foreign
country, or future Treasury regulations or other guidance, may modify these requirements. Shareholders are encouraged to consult their
tax advisors regarding the possible implications of the legislation on their investment in our shares.</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">GENERAL INFORMATION</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Proxy Voting Policy and Procedures and Proxy Voting Record</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Adviser will be responsible for voting proxies
on securities held in the Fund&#8217;s portfolio. The Adviser&#8217;s Proxy Voting Policy and Procedures are included as Appendix&#160;B
to this Statement of Additional Information.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Information on how the Fund voted proxies relating
to portfolio securities during the most recent twelve-month period ended October&#160;31 will be available without charge, upon request,
by calling (800) 345-7999 or by visiting the Fund&#8217;s website at www.guggenheiminvestments.com/cef/fund/avk. This information is also
available on the SEC&#8217;s website at www.sec.gov.</p>


<!-- Field: Page; Sequence: 78; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Principal Shareholders</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">As of the date of this SAI, to the knowledge of the
Fund, no person beneficially owned more than 5% of the voting securities of any class of equity securities of the Fund.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Independent Registered Public Accounting Firm</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">PricewaterhouseCoopers LLP, 300 Madison Avenue, New
York, New York 10017, is the independent registered public accounting firm of the Fund. The independent registered public accounting firm
is expected to render an opinion annually on the financial statements and financial highlights of the Fund.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund&#8217;s audited financial statements
and financial highlights appearing in the Fund&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm">Annual
Report</a> to shareholders for the fiscal year ended October&#160;31, 2023, including accompanying notes thereto and the report of PricewaterhouseCoopers
LLP thereon, have been incorporated by reference in this SAI in reliance upon the report of such firm given upon their authority as experts
in accounting and auditing.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Codes of Ethics</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund and the Adviser each have adopted its own
code of ethics. The codes of ethics sets forth restrictions on the trading activities of Trustees/directors, officers and employees of
the Fund, the Adviser and their affiliates, as applicable. The codes of ethics of the Fund and the Adviser are on file with the SEC and
can be reviewed and copied at the SEC&#8217;s Public Reference Room in Washington, D.C. Information on the operation of the Public Reference
Room may be obtained by calling the SEC at (202) 551-8090. The codes of ethics are also available on the EDGAR Database on the SEC&#8217;s
Internet site at www.sec.gov, and copies of the code of ethics may be obtained, after paying a duplicating fee, by electronic request
at the following email address: publicinfo@sec.gov, or by writing the SEC&#8217;s Public Reference Section, Washington, D.C. 20549-0102.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Where You Can Find More Information</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund is subject to the informational requirements
of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and the 1940 Act and in accordance therewith files, or will file,
reports and other information with the SEC. Reports, proxy statements and other information filed by the Fund with the SEC pursuant to
the informational requirements of the Exchange&#160;Act and the 1940 Act can be inspected and copied at the public reference facilities
maintained by the SEC, 100&#160;F&#160;Street, N.E., Washington,&#160;D.C. 20549. The SEC maintains a web site at www.sec.gov containing
reports, proxy and information statements and other information regarding registrants, including the Fund, that file electronically with
the SEC.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">This Statement of Additional Information constitutes
part of a Registration Statement filed by the Fund with the SEC under the Securities Act, and the 1940 Act. This Statement of Additional
Information omits certain of the information contained in the Registration Statement, and reference is hereby made to the Registration
Statement and related exhibits for further information with respect to the Fund and the Securities offered hereby. Any statements contained
herein concerning the provisions of any document are not necessarily complete, and, in each instance, reference is made to the copy of
such document filed as an exhibit to the Registration Statement or otherwise filed with the SEC. Each such statement is qualified in its
entirety by such reference. The complete Registration Statement may be obtained from the SEC upon payment of the fee prescribed by its
rules and regulations or free of charge through the SEC&#8217;s website (www.sec.gov).</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><span style="background-color: white">The Fund will
provide without charge to each person, including any beneficial owner, to whom this SAI is delivered, upon written or oral request, a
copy of any and all of the information that has been incorporated by reference in this SAI, the Prospectus or any accompanying Prospectus
Supplement. You may request such information </span>by calling (800) 345-7999 or by writing to Guggenheim Funds Distributors, LLC at 227
West Monroe Street, 7<sup>th</sup> Floor, Chicago, Illinois 60606, or you may obtain a copy (and other information regarding the Fund)
from the SEC&#8217;s website (www.sec.gov). Free copies of the Fund&#8217;s Prospectus, SAI and any incorporated information will also
be available from the Fund&#8217;s website www.guggenheiminvestments.com/cef/fund/avk. <span style="background-color: white">Information
contained</span></p>


<!-- Field: Page; Sequence: 79; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">on the Fund&#8217;s website is not incorporated by reference into this
SAI, the Prospectus or any Prospectus Supplement and should not be considered to be part of this SAI, the Prospectus or any Prospectus
Supplement.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>Incorporation by Reference</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><span style="background-color: white">This Statement of Additional Information
is part of a registration statement that the Fund has filed with the SEC. The Fund is permitted to &#8220;incorporate by reference&#8221;
the information that it files with the SEC, which means that the Fund can disclose important information to you by referring you to those
documents. The information incorporated by reference is an important part of this Prospectus, and later information that the Fund files
with the SEC will automatically update and supersede this information. </span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><span style="background-color: white">The documents listed below, and
any reports and other documents subsequently filed with the SEC pursuant to Rule&#160;30(b)(2) under the 1940 Act and Sections&#160;13(a),
13(c), 14 or 15(d) of the Exchange Act, prior to the termination of the offering, are incorporated by reference into this Prospectus and
deemed to be part of this Prospectus from the date of the filing of such reports and documents:</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the Fund&#8217;s
                                            Statement of Additional Information, dated 	, 2024, filed with this Prospectus (&#8220;SAI&#8221;);</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><span style="background-color: white">the
                                            Fund&#8217;s Annual Report on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm">Form&#160;N-CSR</a>
                                            for the fiscal year ended October&#160;31, 2023, filed with the SEC on December&#160;29,
                                            2023 (&#8220;Annual Report&#8221;);</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><span style="background-color: white">the
                                            Fund&#8217;s Semi-Annual Report on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126824000124/gug87515avk-ncsr.htm">Form
                                            N-CSRS</a> for the period ended April 30, 2024, filed with the SEC on July 3, 2024 (&#8220;Semi-Annual
                                            Report&#8221;);</span><span style="background-color: white"> </span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><span style="background-color: white">the
                                            financial highlights contained within the Fund&#8217;s Annual Report on <a href="https://www.sec.gov/Archives/edgar/data/1219120/000089180419000003/gug75351-ncsr.htm">Form
                                            N-CSR</a> for the fiscal year ended October 31, 2018, filed with the SEC on January 4, 2019;</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><span style="background-color: white">the
                                            Fund&#8217;s definitive proxy statement on <a href="https://www.sec.gov/Archives/edgar/data/1219120/000182126824000183/gug87836avk.htm">Schedule&#160;14A</a> for its 2024 annual meeting
                                            of shareholders, filed with the SEC on August&#160;2, 2024 (&#8220;Proxy Statement&#8221;);
                                            and</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><span style="background-color: white">the
                                            Fund&#8217;s description of common shares contained in its Registration Statement on <a href="https://www.sec.gov/Archives/edgar/data/1219120/000095017203001191/s426975.txt">Form&#160;8-A</a>
                                            (File No.&#160;001-31663) filed with the SEC on April&#160;10, 2003.</span></td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in"><span style="background-color: white">To obtain
copies of these filings, see &#8220;General Information&#8212;Where You Can Find More Information.&#8221;</span></p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">FINANCIAL STATEMENTS</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund&#8217;s audited financial statements and
financial highlights appearing in the Fund&#8217;s Annual Report to shareholders for the year ended October&#160;31, 2023, including accompanying
notes thereto and the report of PricewaterhouseCoopers LLP thereon, as contained in the Fund&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm">Form&#160;N-CSR</a> filed with the SEC
on December&#160;29, 2023, are incorporated by reference in this Statement of Additional Information.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund&#8217;s unaudited financial statements and
financial highlights appearing in the Fund&#8217;s Semi-Annual Report to shareholders for the period ended April 30, 2024, including accompanying
notes thereto, as contained in the Fund&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126824000124/gug87515avk-ncsr.htm">Form&#160;N-CSRS</a> filed with the SEC on July 3, are incorporated by reference in this Statement
of Additional Information.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Shareholder reports are available upon request and
without charge by calling (800) 345-7999 or by writing to Guggenheim Funds Distributors, LLC at 227 West Monroe Street, 7<sup>th</sup>
Floor, Chicago, Illinois 60606.</p>


<!-- Field: Page; Sequence: 80; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right">Appendix&#160;A</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">DESCRIPTION OF SECURITIES RATINGS</p>

<p style="font: 9pt/10.8pt Times New Roman, Times, Serif; margin: 11.85pt 0 0"><b><span style="text-decoration: underline">Moody&#8217;s Investors Service Inc.</span></b></p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 12.9pt 0.05in 0 0">A brief description of the applicable Moody&#8217;s
Investors Service, Inc. (&#8220;Moody&#8217;s&#8221;) rating symbols and their meanings (as published by Moody&#8217;s) follows:</p>

<p style="font: 9pt/11.45pt Times New Roman, Times, Serif; margin: 11.85pt 0 0"><b>Global Rating Scales</b></p>

<p style="font: 9pt/11.45pt Times New Roman, Times, Serif; margin: 12.35pt 0 0">Ratings assigned on Moody&#8217;s global long-term and
short-term rating scales are forward-looking opinions of the relative credit risks of financial obligations issued by non-financial corporates,
financial institutions, structured finance vehicles, project finance vehicles, and public sector entities. Long-term ratings are assigned
to issuers or obligations with an original maturity of one year or more and reflect both on the likelihood of a default on contractually
promised payments and the expected financial loss suffered in the event of default. Short-term ratings are assigned to obligations with
an original maturity of thirteen months or less and reflect both on the likelihood of a default on contractually promised payments.</p>

<p style="font: 9pt/11.45pt Times New Roman, Times, Serif; margin: 0.4pt 0 0; text-indent: 0.5in"><span style="letter-spacing: 0.05pt">&#160;</span></p>

<p style="font: 9pt/11.45pt Times New Roman, Times, Serif; margin: 0.4pt 0 0"><span style="letter-spacing: 0.05pt">Moody&#8217;s differentiates
structured finance ratings from fundamental ratings (<i>i.e.</i>, ratings on nonfinancial corporate, financial institution, and public
sector entities) on the global long-term scale by adding (sf) to all structured finance ratings. The addition of (sf) to structured finance
ratings should eliminate any presumption that such ratings and fundamental ratings at the same letter grade level will behave the same.
The (sf) indicator for structured finance security ratings indicates that otherwise similarly rated structured finance and fundamental
securities may have different risk characteristics. Through its current methodologies, however, Moody&#8217;s aspire to achieve broad
expected equivalence in structured finance and fundamental rating performance when measured over a long period of time.</span></p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 11.85pt 0 0"><b>Global Long-Term Rating Scale</b></p>



<p style="font: 9pt/11.4pt Times New Roman, Times, Serif; margin: 12.15pt 0 0">Aaa&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Obligations rated Aaa are judged to be of the highest quality, subject to the lowest level of credit risk.</p>

<p style="font: 9pt/11.4pt Times New Roman, Times, Serif; margin: 12.15pt 0 0">Aa&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Obligations rated Aa are judged to be of high quality
and are subject to very low credit risk.</p>

<p style="font: 9pt/11.4pt Times New Roman, Times, Serif; margin: 12.1pt 0 0">A&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Obligations
rated A are judged to be upper-medium grade and are subject to low credit risk.</p>

<p style="font: 9pt/11.4pt Times New Roman, Times, Serif; margin: 12.1pt 0 0">Baa&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Obligations rated Baa are judged to be medium-grade
and subject to moderate credit risk and as such may possess certain speculative characteristics.</p>



<p style="font: 9pt/11.4pt Times New Roman, Times, Serif; margin: 12.1pt 0 0">Ba&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Obligations rated Ba are judged to be speculative
and are subject to substantial credit risk.</p>

<p style="font: 9pt/11.4pt Times New Roman, Times, Serif; margin: 12.15pt 0 0">B&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Obligations
rated B are considered speculative and are subject to high credit risk.</p>

<p style="font: 9pt/11.4pt Times New Roman, Times, Serif; margin: 12.1pt 0 0"><span style="letter-spacing: -0.05pt">Caa&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Obligations
rated Caa are judged to be of poor standing and are subject to very high credit risk.</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.5pt Times New Roman, Times, Serif; width: 100%; margin-top: 12.05pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in">Ca</td><td style="padding-right: 0.15in">Obligations rated Ca are highly speculative and are likely in, or very near, default, with some prospect
of recovery of principal and interest.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.5pt Times New Roman, Times, Serif; width: 100%; margin-top: 11.8pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">C</td><td style="padding-right: 0.25in">Obligations rated C are the lowest-rated class of bonds and are typically in default, with little prospect
for recovery of principal or interest.</td></tr></table>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 12.2pt 0 0">Note: Moody&#8217;s appends numerical modifiers 1, 2, and
3 to each generic rating classification from Aa through Caa. The modifier 1 indicates that the obligation ranks in the higher end of its
generic rating category; the modifier 2 indicates a mid-range ranking; and the modifier 3 indicates a ranking in the lower end of that
generic rating</p>


<!-- Field: Page; Sequence: 81; Section: Appendix A; Options: NewSection -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 12.2pt 0 0">category. Additionally, a &#8220;(hyb)&#8221; indicator
is appended to all ratings of hybrid securities issued by banks, insurers, finance companies, and securities firms.*</p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 12.2pt 0 0">* <i>By their terms, hybrid securities allow for the omission
of scheduled dividends, interest, or principal payments, which can potentially result in impairment if such an omission occurs. Hybrid
securities may also be subject to contractually allowable write-downs of principal that could result in impairment. Together with the
hybrid indicator, the long-term obligation rating assigned to a hybrid security is an expression of the relative credit risk associated
with that security.</i></p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 11.85pt 0 0"><b>Medium-Term Note Program Ratings</b></p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 11.95pt 0.25in 0 0">Moody&#8217;s assigns provisional ratings to medium-term
note (MTN) programs and definitive ratings to the individual debt securities issued from them (referred to as drawdowns or notes).</p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 12.1pt 0 0; text-align: justify">MTN program ratings are intended to
reflect the ratings likely to be assigned to drawdowns issued from the program with the specified priority of claim (<i>e.g.</i>, senior
or subordinated). To capture the contingent nature of a program rating, Moody&#8217;s assigns provisional ratings to MTN programs. A provisional
rating is denoted by a (P) in front of the rating and is defined elsewhere in this document.</p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 12.1pt 0 0"><span style="letter-spacing: -0.05pt">The rating assigned
to a drawdown from a rated MTN or bank/deposit note program is definitive in nature, and may differ from the program rating if the drawdown
is exposed to additional credit risks besides the issuer&#8217;s </span>default, such as links to the defaults of other issuers, or has
other structural features that warrant a different rating. In some circumstances, no rating may be assigned to a drawdown.</p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 12.05pt 0.3in 0 0">Moody&#8217;s encourages market participants to contact
Moody&#8217;s Ratings Desks or visit www.moodys.com directly if they have questions regarding ratings for specific notes issued under
a medium-term note program. Unrated notes issued under an MTN program may be assigned an NR (not rated) symbol.</p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 11.95pt 0 0"><b>Global Short-Term Rating Scale</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">P-1&#160;&#160;&#160;&#160;&#160;&#160;&#160;Ratings of Prime-1 reflect a superior ability to repay short-term obligations.</p>



<p style="font: 9pt/11.35pt Times New Roman, Times, Serif; margin: 12.15pt 0 0"><span style="letter-spacing: -0.05pt">P-2&#160;&#160;&#160;&#160;&#160;&#160;&#160;Ratings of
Prime-2 reflect a strong ability to repay short-term obligations.</span></p>

<p style="font: 9pt/11.35pt Times New Roman, Times, Serif; margin: 12.15pt 0 0"><span style="letter-spacing: -0.05pt">P-3&#160;&#160;&#160;&#160;&#160;&#160;&#160;Ratings of
Prime-3 reflect an acceptable ability to repay short-term obligations.</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">NP&#160;&#160;&#160;&#160;&#160;&#160;&#160;Issuers (or supporting institutions)
rated Not Prime do not fall within any of the Prime rating categories.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 12pt 0 0"><b><span style="text-decoration: underline">Standard &amp; Poor&#8217;s </span></b></p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 12.2pt 0 0">A brief description of the applicable Standard &amp; Poor&#8217;s
rating symbols and their meanings (as published by S&amp;P Global Ratings) follows:</p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 11.9pt 0 0"><b>Issue Credit Ratings Definitions</b></p>

<p style="font: 9pt/11.45pt Times New Roman, Times, Serif; margin: 12.4pt 0.1in 0 0"><span style="letter-spacing: -0.1pt">An S&amp;P Global
Ratings issue credit rating is a forward-looking opinion about the creditworthiness of an obligor with respect to a specific financial
obligation, a specific class of financial obligations, or a specific financial program (including ratings on medium-term note programs
and commercial paper programs). It takes into consideration the creditworthiness of guarantors, insurers, or other forms of credit enhancement
on the obligation and takes into account the currency in which the obligation is denominated. The opinion reflects S&amp;P Global Ratings&#8217;
view of the obligor&#8217;s capacity and willingness to meet its financial commitments as they come due, and this opinion may assess terms,
such as collateral security and subordination, which could affect ultimate payment in the event of default.</span></p>


<!-- Field: Page; Sequence: 82; Section: Appendix A -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt/11.45pt Times New Roman, Times, Serif; margin: 12.4pt 0.1in 0 0">Issue credit ratings can be either long-term or short-term.
Short-term issue credit ratings are generally assigned to those obligations considered short-term in the relevant market, typically with
an original maturity of no more than 365 days. Short-term issue credit ratings are also used to indicate the creditworthiness of an obligor
with respect to put features on long-term obligations. S&amp;P Global Ratings would typically assign a long-term issue credit rating to
an obligation with an original maturity of greater than 365 days. However, the ratings S&amp;P Global Ratings assigns to certain instruments
may diverge from these guidelines based on market practices. Medium-term notes are assigned long-term ratings.</p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 11.85pt 0 0"><b>Long-Term Issue Credit Ratings</b></p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 11.95pt 0.6in 0 0">Issue credit ratings are based, in varying degrees,
on S&amp;P Global Ratings&#8217; analysis of the following considerations:</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.55pt Times New Roman, Times, Serif; width: 100%; margin-top: 11.95pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Symbol">&#183;</span></td><td style="padding-right: 0.05in">The likelihood of payment&#8212;the capacity and willingness of the obligor to meet its financial commitment
on an obligation in accordance with the terms of the obligation;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt/12.55pt Times New Roman, Times, Serif; width: 100%; margin-top: 10.95pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Symbol">&#183;</span></td><td>The nature of and provisions of the financial obligation, and the promise we impute; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.5pt Times New Roman, Times, Serif; width: 100%; margin-top: 12.05pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Symbol">&#183;</span></td><td style="padding-right: 0.45in">The protection afforded by, and relative position of, the obligation in the event of a bankruptcy, reorganization,
or other arrangement under the laws of bankruptcy and other laws affecting creditors&#8217; rights.</td></tr></table>

<p style="font: 9pt/11.45pt Times New Roman, Times, Serif; margin: 12.15pt 0 0">An issue rating is an assessment of default risk but may
incorporate an assessment of relative seniority or ultimate recovery in the event of default. Junior obligations are typically rated lower
than senior obligations, to reflect lower priority in bankruptcy, as noted above. (Such differentiation may apply when an entity has both
senior and subordinated obligations, secured and unsecured obligations, or operating company and holding company obligations.)</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.5pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">AAA</td><td style="padding-right: 0.1in">An obligation rated &#8216;AAA&#8217; has the highest rating assigned by S&amp;P Global Ratings. The
obligor&#8217;s capacity to meet its financial commitments on the obligation is extremely strong.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.5pt Times New Roman, Times, Serif; width: 100%; margin-top: 12.05pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">AA</td><td style="padding-right: 0.2in">An obligation rated &#8216;AA&#8217; differs from the highest-rated obligations only to a small degree.
The obligor&#8217;s capacity to meet its financial commitments on the obligation is very strong.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.4pt Times New Roman, Times, Serif; width: 100%; margin-top: 12.05pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">A</td><td style="padding-right: 0.2in">An obligation rated &#8216;A&#8217; is somewhat more susceptible to the adverse effects of changes in
circumstances and economic conditions than obligations in higher-rated categories. However, the obligor&#8217;s capacity to meet its financial
commitments on the obligation is still strong.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.4pt Times New Roman, Times, Serif; width: 100%; margin-top: 12.05pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in"><span style="letter-spacing: -0.05pt">BBB</span></td><td style="padding-right: 0.2in"><span style="letter-spacing: -0.05pt">An obligation rated &#8216;BBB&#8217; exhibits adequate protection
parameters. However, adverse economic conditions or changing circumstances are more likely to lead to a weakened capacity of the obligor
to meet its</span> financial commitments on the obligation.</td></tr></table>

<p style="font: 9pt/11.4pt Times New Roman, Times, Serif; margin: 12.15pt 0 0">BB, B, CCC, CC, and C</p>

<p style="font: 9pt/11.45pt Times New Roman, Times, Serif; margin: 12.05pt 0 0 0.5in">Obligations rated &#8216;BB&#8217;, &#8216;B&#8217;,
&#8216;CCC&#8217;, &#8216;CC&#8217;, and &#8216;C&#8217; are regarded as having significant speculative characteristics. &#8216;BB&#8217;
indicates the least degree of speculation and &#8216;C&#8217; the highest. While such obligations will likely have some quality and protective
characteristics, these may be outweighed by large uncertainties or major exposures to adverse conditions.</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.5pt Times New Roman, Times, Serif; width: 100%; margin-top: 12.05pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">BB</td><td>An obligation rated &#8216;BB&#8217; is less vulnerable to nonpayment than other speculative issues. However, it faces major ongoing
uncertainties or exposure to adverse business, financial, or economic conditions which could lead to the obligor&#8217;s inadequate capacity
to meet its financial commitments on the obligation.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.5pt Times New Roman, Times, Serif; width: 100%; margin-top: 12.05pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">B</td><td style="padding-right: 0.1in">An obligation rated &#8216;B&#8217; is more vulnerable to nonpayment than obligations rated &#8216;BB&#8217;,
but the obligor currently has the capacity to meet its financial commitments on the obligation. Adverse business,</td></tr></table>


<!-- Field: Page; Sequence: 83; Section: Appendix A -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 12.05pt 0.1in 0 0.5in">financial, or economic conditions will likely
impair the obligor&#8217;s capacity or willingness to meet its financial commitments on the obligation.</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.5pt Times New Roman, Times, Serif; width: 100%; margin-top: 12.1pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">CCC</td><td style="padding-right: 0.15in">An obligation rated &#8216;CCC&#8217; is currently vulnerable to nonpayment, and is dependent upon favorable
business, financial, and economic conditions for the obligor to meet its financial commitments on the obligation. In the event of adverse
business, financial, or economic conditions, the obligor is not likely to have the capacity to meet its financial commitments on the obligation.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.5pt Times New Roman, Times, Serif; width: 100%; margin-top: 11.8pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">CC</td><td style="padding-right: 0.15in">An obligation rated &#8216;CC&#8217; is currently highly vulnerable to nonpayment. The &#8216;CC&#8217;
rating is used when a default has not yet occurred but S&amp;P Global Ratings expects default to be a virtual certainty, regardless of
the anticipated time to default.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.5pt Times New Roman, Times, Serif; width: 100%; margin-top: 12.05pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">C</td><td>An obligation rated &#8216;C&#8217; is currently highly vulnerable to nonpayment, and the obligation is expected to have lower relative
seniority or lower ultimate recovery compared to obligations that are rated higher.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.5pt Times New Roman, Times, Serif; width: 100%; margin-top: 12.15pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">D</td><td>An obligation rated &#8216;D&#8217; is in default or in breach of an imputed promise. For non-hybrid capital instruments, the &#8216;D&#8217;
rating category is used when payments on an obligation are not made on the date due, unless S&amp;P Global Ratings believes that such
payments will be made within the next five business days in the absence of a stated grace period or within the earlier of the stated grace
period or 30 calendar days. The &#8216;D&#8217; rating also will be used upon the filing of a bankruptcy petition or the taking of similar
action and where default on an obligation is a virtual certainty, for example due to automatic stay provisions. A rating on an obligation
is lowered to &#8216;D&#8217; if it is subject to a distressed debt restructuring.</td></tr></table>

<p style="font: 9pt/11.4pt Times New Roman, Times, Serif; margin: 11.9pt 0 0">Plus (+) or minus (-)</p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 12pt 0.25in 0 0.5in">The ratings from &#8216;AA&#8217; to &#8216;CCC&#8217;
may be modified by the addition of a plus (+) or minus (-) sign to show relative standing within the major rating categories.</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.5pt Times New Roman, Times, Serif; width: 100%; margin-top: 12.05pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">NR</td><td style="padding-right: 0.25in">NR indicates that a rating has not been assigned or is no longer assigned.</td></tr></table>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 11.9pt 0 0"><b>Short-Term Issue Credit Ratings</b></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.45pt Times New Roman, Times, Serif; width: 100%; margin-top: 12.2pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">A-1</td><td style="padding-right: 0.25in">A short-term obligation rated &#8216;A-1&#8217; is rated in the highest category by S&amp;P Global Ratings.
The obligor&#8217;s capacity to meet its financial commitments on the obligation is strong. Within this category, certain obligations
are designated with a plus sign (+). This indicates that the obligor&#8217;s capacity to meet its financial commitments on these obligations
is extremely strong.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.45pt Times New Roman, Times, Serif; width: 100%; margin-top: 12.2pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">A-2</td><td style="padding-right: 0.25in">A short-term obligation rated &#8216;A-2&#8217; is somewhat more susceptible to the adverse effects
of changes in circumstances and economic conditions than obligations in higher rating categories. However, the obligor&#8217;s capacity
to meet its financial commitments on the obligation is satisfactory.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.5pt Times New Roman, Times, Serif; width: 100%; margin-top: 12.1pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">A-3</td><td style="padding-right: 0.05in">A short-term obligation rated &#8216;A-3&#8217; exhibits adequate protection parameters. However, adverse
economic conditions or changing circumstances are more likely to lead to a weakened capacity of the obligor to meet its financial commitments
on the obligation.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.5pt Times New Roman, Times, Serif; width: 100%; margin-top: 11.8pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in"><span style="letter-spacing: -0.05pt">B</span></td><td style="padding-right: 0.1in"><span style="letter-spacing: -0.05pt">A short-term obligation rated &#8216;B&#8217; is regarded as vulnerable
and has significant speculative characteristics. The obligor currently has the capacity to meet its financial commitments; however, it
faces major ongoing uncertainties which could lead to the obligor&#8217;s inadequate capacity to meet its financial commitments.</span></td></tr></table>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 12pt 0 0">C&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;A short-term obligation
rated &#8216;C&#8217; is currently vulnerable to nonpayment and is dependent upon favorable</p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 0.05pt 0.45in 0 0.5in">business, financial, and economic conditions
for the obligor to meet its financial commitment on the obligation.</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.5pt Times New Roman, Times, Serif; width: 100%; margin-top: 12.15pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">D</td><td style="padding-right: 0.1in">A short-term obligation rated &#8216;D&#8217; is in default or in breach of an imputed promise. For non-hybrid
capital instruments, the &#8216;D&#8217; rating category is used when payments on an obligation are not made on the date</td></tr></table>


<!-- Field: Page; Sequence: 84; Section: Appendix A -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 12.15pt 0.1in 0 0.5in">due, unless S&amp;P Global Ratings believes that
such payments will be made within any stated grace period. However, any stated grace period longer than five business days will be treated
as five business days. The &#8216;D&#8217; rating also will be used upon the filing of a bankruptcy petition or the taking of a similar
action and where default on an obligation is a virtual certainty, for example due to automatic stay provisions. A rating on an obligation
is lowered to &#8216;D&#8217; if it is subject to a distressed debt restructuring.</p>

<p style="font: 9pt/11.45pt Times New Roman, Times, Serif; margin: 11.65pt 0 0"><b>SPUR (Standard &amp; Poor&#8217;s Underlying Rating)</b></p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 12.25pt 0.05in 0 0">A SPUR is an opinion about the stand-alone capacity
of an obligor to pay debt service on a credit-enhanced debt issue, without giving effect to the enhancement that applies to it. These
ratings are published only at the request of the debt issuer or obligor with the designation SPUR to distinguish them from the credit-enhanced
rating that applies to the debt issue. S&amp;P Global Ratings maintains surveillance of an issue with a published SPUR.</p>

<p style="font: 9pt/11.45pt Times New Roman, Times, Serif; margin: 11.9pt 0 0"><b>Dual Ratings</b></p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 12.1pt 0.05in 0 0">Dual ratings may be assigned to debt issues that
have a put option or demand feature. The first component of the rating addresses the likelihood of repayment of principal and interest
as due, and the second component of the rating addresses only the demand feature. The first component of the rating can relate to either
a short-term or long-term transaction and accordingly use either short-term or long-term rating symbols. The second component of the rating
relates to the put option and is assigned a short-term rating symbol (for example, &#8216;AAA/A-1+&#8217; or &#8216;A-1+/A-1&#8217;).
With U.S. municipal short-term demand debt, the U.S. municipal short-term note rating symbols are used for the first component of the
rating (for example, &#8216;SP-1+/A-1+&#8217;).<br/>
<br/>
</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 0"><b><span style="text-decoration: underline">Fitch&#160;Ratings</span></b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 0"><b>Long-Term Credit Ratings </b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 0">Rated entities in a number of sectors, including financial and non-financial
corporations, sovereigns, insurance companies and certain sectors within public finance, are generally assigned Issuer Default Ratings
(&#8220;IDRs&#8221;). IDRs are also assigned to certain entities or enterprises in global infrastructure, project finance and public finance.
IDRs opine on an entity&#8217;s relative vulnerability to default (including by way of a distressed debt exchange) on financial obligations.
The threshold default risk addressed by the IDR is generally that of the financial obligations whose non-payment would best reflect the
uncured failure of that entity. As such, IDRs also address relative vulnerability to bankruptcy, administrative receivership or similar
concepts.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 0">In aggregate, IDRs provide an ordinal ranking of issuers based on
the agency&#8217;s view of their relative vulnerability to default, rather than a prediction of a specific percentage likelihood of default.</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding: 0.25pt; width: 5%">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom; width: 1%">&#160;</td>
    <td style="padding: 0.25pt; width: 94%">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">AAA:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt">Highest credit quality. &#8216;AAA&#8217; ratings denote the lowest expectation of default risk. They are assigned only in cases of exceptionally strong capacity for payment of financial commitments. This capacity is highly unlikely to be adversely affected by foreseeable events.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">AA:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt">Very high credit quality. &#8216;AA&#8217; ratings denote expectations of very low default risk. They indicate very strong capacity for payment of financial commitments. This capacity is not significantly vulnerable to foreseeable events.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">A:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt">High credit quality. &#8216;A&#8217; ratings denote expectations of low default risk. The capacity for payment of financial commitments is considered strong. This capacity may, nevertheless, be more vulnerable to adverse business or economic conditions than is the case for higher ratings.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">BBB:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt">Good credit quality. &#8216;BBB&#8217; ratings indicate that expectations of default risk are currently low. The capacity for payment of financial commitments is considered adequate, but adverse business or economic conditions are more likely to impair this capacity.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">BB:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt">Speculative. &#8216;BB&#8217; ratings indicate an elevated vulnerability to default risk, particularly in the event of adverse changes in business or economic conditions over time; however, business or financial flexibility exists that supports the servicing of financial commitments.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  </table>

<!-- Field: Page; Sequence: 85; Section: Appendix A -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">B:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt">Highly speculative. &#8216;B&#8217; ratings indicate that material default risk is present, but a limited margin of safety remains. Financial commitments are currently being met; however, capacity for continued payment is vulnerable to deterioration in the business and economic environment.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">CCC:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt">Substantial credit risk. Default is a real possibility.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">CC:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt">Very high levels of credit risk. Default of some kind appears probable.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">C:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt">Near default. A default or default-like process has begun, or the issuer is in standstill, or for a closed funding vehicle, payment capacity is irrevocably impaired. Conditions that are indicative of a &#8216;C&#8217; category rating for an issuer include:</span></td></tr>
  </table>
<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 75pt; text-align: center"><span style="font-family: Symbol">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify">the issuer has entered into a grace or cure period following non-payment of a material financial
obligation;</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 75pt; text-align: center"><span style="font-family: Symbol">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify">the issuer has entered into a temporary negotiated waiver or standstill agreement following
a payment default on a material financial obligation;</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 75pt; text-align: center"><span style="font-family: Symbol">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify">the formal announcement by the issuer or their agent of a distressed debt exchange;</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 75pt; text-align: center"><span style="font-family: Symbol">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify">a closed financing vehicle where payment capacity is irrevocably impaired such that it is
not expected to pay interest and/or principal in full during the life of the transaction, but where no payment default is imminent</td>
</tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">RD: Restricted default. &#8216;RD&#8217; ratings indicate an issuer that
in Fitch Ratings&#8217; opinion has experienced:</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 75pt; text-align: center"><span style="font-family: Symbol">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify">an uncured payment default or distressed debt exchange on a bond, loan or other material
financial obligation, but</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 75pt; text-align: center"><span style="font-family: Symbol">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify">has not entered into bankruptcy filings, administration, receivership, liquidation or other
formal winding-up,</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 75pt; text-align: center"><span style="font-family: Symbol">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify">has not otherwise ceased operating. This would include:</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.25in"><span style="font-family: Courier New, Courier, Monospace">o</span></td><td>the selective payment default on a specific class or currency of debt;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.25in"><span style="font-family: Courier New, Courier, Monospace">o</span></td><td>the uncured expiry of any applicable grace period, cure period or default forbearance period following a payment default on a bank
loan, capital markets security or other material financial obligation;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.25in"><span style="font-family: Courier New, Courier, Monospace">o</span></td><td>the extension of multiple waivers or forbearance periods upon a payment default on one or more material financial obligations, either
in series or in parallel; ordinary execution of a distressed debt exchange on one or more material financial obligations.<br/>
<br/>
</td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt; width: 5%"><span style="font-size: 9pt">D:</span></td>
    <td style="padding: 0.25pt"><span style="font-size: 9pt">Default. &#8216;D&#8217; ratings indicate an issuer that in Fitch Ratings&#8217; opinion has entered into bankruptcy filings, administration, receivership, liquidation or other formal winding-up procedure or that has otherwise ceased business. </span></td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 0">Default ratings are not assigned prospectively to entities or their
obligations; within this context, non-payment on an instrument that contains a deferral feature or grace period will generally not be
considered a default until after the expiration of the deferral or grace period, unless a default is otherwise driven by bankruptcy or
other similar circumstance, or by a distressed debt exchange.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 0">In all cases, the assignment of a default rating reflects the agency&#8217;s
opinion as to the most appropriate rating category consistent with the rest of its universe of ratings and may differ from the definition
of default under the terms of an issuer&#8217;s financial obligations or local commercial practice.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 0">&#8220;Imminent&#8221; default, categorized under &#8216;C&#8217;,
typically refers to the occasion where a payment default has been intimated by the issuer and is all but inevitable. This may, for example,
be where an issuer has missed a scheduled payment but (as is typical) has a grace period during which it may cure the payment default.
Another alternative would be where an issuer has formally announced a distressed debt exchange, but the date of the exchange still lies
several days or weeks in the immediate future.</p>


<!-- Field: Page; Sequence: 86; Section: Appendix A -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 0">The modifiers &#8220;+&#8221; or &#8220;-&#8221; may be appended
to a rating to denote relative status within major rating categories. For example, the rating category &#8216;AA&#8217; has three notch-specific
rating levels (&#8216;AA+&#8217;; &#8216;AA&#8217;; &#8216;AA-&#8217;; each a rating level). Such suffixes are not added to &#8216;AAA&#8217;
ratings and ratings below the &#8216;CCC&#8217; category.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0.25in 0 0"><b>Recovery Ratings </b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 0">Recovery Ratings are assigned to selected individual securities and
obligations, most frequently for individual obligations of corporate finance issuers with IDRs in speculative grade categories.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 0">Among the factors that affect recovery rates for securities are the
collateral, the seniority relative to other obligations in the capital structure (where appropriate), and the expected value of the company
or underlying collateral in distress.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 0">The Recovery Rating scale is based on the expected relative recovery
characteristics of an obligation upon the curing of a default, emergence from insolvency or following the liquidation or termination of
the obligor or its associated collateral.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 0">Recovery Ratings are an ordinal scale and do not attempt to precisely
predict a given level of recovery. As a guideline in developing the rating assessments, the agency employs broad theoretical recovery
bands in its ratings approach based on historical averages and analytical judgement, but actual recoveries for a given security may deviate
materially from historical averages.</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding: 0.25pt; width: 4%">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom; width: 1%">&#160;</td>
    <td style="padding: 0.25pt; width: 95%">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">RR1:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt"><i>Outstanding recovery prospects given default.</i> &#8216;RR1&#8217; rated securities have characteristics consistent with securities historically recovering 91%-100% of current principal and related interest.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">RR2:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt"><i>Superior recovery prospects given default.</i> &#8216;RR2&#8217; rated securities have characteristics consistent with securities historically recovering 71%-90% of current principal and related interest.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">RR3:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt"><i>Good recovery prospects given default.</i> &#8216;RR3&#8217; rated securities have characteristics consistent with securities historically recovering 51%-70% of current principal and related interest.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">RR4:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt"><i>Average recovery prospects given default.</i> &#8216;RR4&#8217; rated securities have characteristics consistent with securities historically recovering 31%-50% of current principal and related interest.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">RR5:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt"><i>Below average recovery prospects given default.</i> &#8216;RR5&#8217; rated securities have characteristics consistent with securities historically recovering 11%-30% of current principal and related interest.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">RR6:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt"><i>Poor recovery prospects given default.</i> &#8216;RR6&#8217; rated securities have characteristics consistent with securities historically recovering 0%-10% of current principal and related interest.</span></td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 0.25in 0 0"><b>Short-Term Ratings Assigned to Issuers and Obligations </b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 0">A short-term issuer or obligation rating is based in all cases on
the short-term vulnerability to default of the rated entity and relates to the capacity to meet financial obligations in accordance with
the documentation governing the relevant obligation. Short-term deposit ratings may be adjusted for loss severity. Short-Term Ratings
are assigned to obligations whose initial maturity is viewed as &#8220;short term&#8221; based on market convention. Typically, this means
up to 13 months for corporate, sovereign, and structured obligations and up to 36 months for obligations in U.S. public finance markets.</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding: 0.25pt; width: 3%">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom; width: 1%">&#160;</td>
    <td style="padding: 0.25pt; width: 96%">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">F1:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt">Highest short-term credit quality. Indicates the strongest intrinsic capacity for timely payment of financial commitments; may have an added &#8220;+&#8221; to denote any exceptionally strong credit feature.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">F2:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt">Good short-term credit quality. Good intrinsic capacity for timely payment of financial commitments.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">F3:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt">Fair short-term credit quality. The intrinsic capacity for timely payment of financial commitments is adequate.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">B:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt">Speculative short-term credit quality. Minimal capacity for timely payment of financial commitments, plus heightened vulnerability to near term adverse changes in financial and economic conditions.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">C:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt">High short-term default risk. Default is a real possibility.</span></td></tr>
  </table>

<!-- Field: Page; Sequence: 87; Section: Appendix A -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">RD:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt">Restricted default. Indicates an entity that has defaulted on one or more of its financial commitments, although it continues to meet other financial obligations. Typically applicable to entity ratings only.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">D:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt">Default. Indicates a broad-based default event for an entity, or the default of a short-term obligation.</span></td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 88; Section: Appendix A -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right">Appendix&#160;B</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">PROXY VOTING POLICIES<br/>
FOR THE ADVENT-ADVISED FUNDS</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: center"><b>ADVENT CAPITAL MANAGEMENT, LLC<br/>
PROXY VOTING POLICY AND PROCEDURES</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 10pt 0 0">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Voting Policy</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 10pt 0 0">It is the policy of Advent that in every case where Advent is presented
with the opportunity to exercise voting authority with respect to a Client&#8217;s Securities, Advent will vote all Securities held by
the Client in the best interest of the Client unless under the facts and circumstances the Chief Compliance Officer determines that voting
is not reasonably practicable (such as, but not limited to, where English-language translations of proxy materials are not available).</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 10pt 0 0">Advent believes the best interest of the Client means the Client&#8217;s
best economic interests over the long-term &#8211; that is, the interest of the Client in seeing the value of its investment increase
over time. Advent generally invests in a company only if Advent believes that the company&#8217;s management seeks to serve shareholders&#8217;
best interests. As a result, Advent believes that management decisions and recommendations with respect to solicited issues generally
are likely to be in the shareholders&#8217; and Clients&#8217; best interests.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 10pt 0 0">In the case of social issue proxy proposals, which often range from
divestment from geographical or industrial representation to environmental or other matters, it is the policy of Advent that the merit
of the social issues should not take precedence over financial ones. Advent will consider voting for issues that have redeeming social
merit that neither compromises the company&#8217;s competitive position within an industry, nor adversely impacts the goal of maximizing
shareholder value.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 10pt 0 0">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Duty to Vote Proxies
</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 10pt 0 0">Advent acknowledges that it is part of its fiduciary duty to its
Clients to vote Client proxies, except in cases in which the cost of doing so, in the opinion of Advent, would exceed the expected benefits
to the Client. This may be particularly true in the case of non-U.S. Securities. While the proxy voting process is well established in
the United States and other developed markets with a number of tools and services available to assist an investment manager, voting proxies
of non-US companies located in certain jurisdictions, particularly emerging markets, may involve a number of logistical problems that
may have a detrimental effect on Advent&#8217;s ability to vote such proxies. The logistical problems include, but are not limited to:
(1) proxy statements and ballots being written in a language other than English; (2) untimely and/or inadequate notice of shareholder
meetings; (3) restrictions on the ability of holders outside the issuer&#8217;s jurisdiction of organization to exercise votes; (4) requirements
to vote proxies in person; (5) the imposition of restrictions on the sale of the Securities for a period of time in proximity to the shareholder
meeting; and (6) requirements to provide local agents with power of attorney to facilitate Advent&#8217;s voting instructions. Accordingly,
Advent may conduct a cost-benefit analysis in determining whether to attempt to vote its Clients&#8217; shares at a non-US company&#8217;s
meeting, whereby if it is determined that the cost associated with the attempt to exercise its vote outweighs the benefit Advent believes
its Clients will derive by voting on the company&#8217;s proposal, Advent may decide not to attempt to vote at the meeting.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 10pt 0 0">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Voting Procedure</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 10pt 0 0">Advent does not take investment positions outside of the Clients
it manages and therefore does not anticipate a situation where there would be a conflict between maximizing long-term investment returns
for Clients and interests of Advent. If such a situation should arise involving a Public Security, the Compliance Committee will independently
review and evaluate the proxy proposal and the circumstances surrounding the conflict to determine the vote, which will be in the best
interest of the Client. The Compliance Committee may also determine whether the conflict of interest involving the Public Security will
be disclosed to the Clients (and/or Investors) and whether to obtain consent prior to voting.</p>


<!-- Field: Page; Sequence: 89; Section: Appendix B; Options: NewSection -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 10pt 0 0">The Investment Team will identify a staff member who is responsible
for voting proxies, and in the absence of that person, the General Counsel or another individual designated by the Chief Administrative
Officer will vote proxies. In deciding how to vote a proxy, these persons are permitted but not required to consult with appropriate members
of the Investment Team. They may also consult with the Chief Financial Officer and such other Persons as they deem advisable.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 10pt 0 0">Although the proxy voting process is well established in the United
States, voting the proxies of foreign companies may involve a number of logistical problems that have a detrimental effect on Advent&#8217;s
ability to vote such proxies. The logistical problems include language barriers, untimely or inadequate notice of shareholder meetings,
restrictions on a foreigner&#8217;s ability to exercise votes, and requirements to vote in person. Such proxies are voted on a best-efforts
basis given the above logistical problems.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 10pt 0 0">D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Disclosure to Clients</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 10pt 0 0">Advent will disclose the Proxy Voting Procedures to its Clients.
Advent&#8217;s disclosure will consist of a &#8220;concise summary&#8221; of its proxy voting policies and procedures. This disclosure
will also tell Clients how to get a complete copy of Advent&#8217;s Proxy Voting Procedures. The proxy voting disclosure will be provided
to existing Clients. Advent will provide any Client, upon written request, with a tabulation of how such Client&#8217;s proxies were voted
by Advent.</p>


<!-- Field: Page; Sequence: 90; Section: Appendix B -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">PART&#160;C</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">OTHER INFORMATION</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Item&#160;25. Financial Statements And Exhibits</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-indent: 0in">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial
Statements</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -0.5in">Part&#160;A &#8211; Financial highlights for
the Registrant:</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Fiscal years ended
                                            October 31, 2023, 2022, 2021, 2020 and 2019 are incorporated by reference to the Registrant&#8217;s
                                            Annual Report to shareholders for the year ended October&#160;31, 2023, as contained in the
                                            Registrant&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm">Form&#160;N-CSR</a>
                                            filed with the SEC on December&#160;29, 2023.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Fiscal years ended
                                            October 31, 2018, 2017, 2016, 2015 and 2014 are incorporated by reference to the Registrant&#8217;s
                                            Annual Report to shareholders for the year ended October&#160;31, 2018, as contained in the
                                            Registrant&#8217;s <a href="https://www.sec.gov/Archives/edgar/data/1219120/000089180419000003/gug75351-ncsr.htm">Form&#160;N-CSR</a>
                                            filed with the SEC on January 4, 2019.</td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -0.5in">Part&#160;B - 	Incorporated by reference
in the Statement of Additional Information included herein are the Registrant&#8217;s audited financial statements for the fiscal year
ended October&#160;31, 2023, notes to such financial statements and the report of independent registered public accounting firm thereon,
as contained in the Fund&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm">Form&#160;N-CSR</a>
filed with the Securities and Exchange Commission on December&#160;29, 2023.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -0.5in">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0in">Incorporated by reference in the Statement
of Additional Information included herein are the Registrant&#8217;s unaudited financial statements for the period ended April 30, 2024,
and notes to such financial statements, as contained in the Fund&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126824000124/gug87515avk-ncsr.htm">Form&#160;N-CSRS</a>
filed with the Securities and Exchange Commission on July 3, 2024.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-indent: 0in">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exhibits</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: right"/><td style="width: 0.5in">(a)</td><td style="text-align: justify; width: 0.5in"><a href="https://www.sec.gov/Archives/edgar/data/1219120/000095017203001096/s735080.txt">(i)</a>	</td>
                                                                                  <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1219120/000095017203001096/s735080.txt">Agreement and Declaration of Trust of Registrant(1)</a></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.5in"><a href="https://www.sec.gov/Archives/edgar/data/1219120/000182126824000132/ex99aii.htm">(ii)</a></td><td><a href="https://www.sec.gov/Archives/edgar/data/1219120/000182126824000132/ex99aii.htm">Certificate of Amendment to the Agreement and Declaration of Trust of Registrant, dated September&#160;20, 2005(5)</a></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.5in"><a href="https://www.sec.gov/Archives/edgar/data/1219120/000182126824000132/ex99aiii.htm">(iii)</a></td><td><a href="https://www.sec.gov/Archives/edgar/data/1219120/000182126824000132/ex99aiii.htm">Certificate of Amendment to the Agreement and Declaration of Trust of Registrant, dated June&#160;18, 2019(5)</a></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: right"><a href="ex99b.htm">(b)</a></td><td style="width: 1in"/><td style="text-align: justify"><a href="ex99b.htm">Fourth Amended and Restated By-Laws of Registrant(*)</a></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: right">(c)</td><td style="width: 1in"/><td style="text-align: justify">Not applicable</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: right">(d)</td><td style="width: 1in"/><td style="text-align: justify">Not applicable</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1219120/000104746903014960/a2107494zex-99_e.txt">(e)</a></td><td style="width: 1in"/><td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1219120/000104746903014960/a2107494zex-99_e.txt">Dividend Reinvestment Plan of Registrant(2)</a></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: right">(f)</td><td style="width: 1in"/><td style="text-align: justify">Not applicable</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1219120/000104746903014960/a2107494zex-99_g1.txt">(g)</a></td><td style="width: 1in"/><td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1219120/000104746903014960/a2107494zex-99_g1.txt">Investment Management Agreement between Registrant and Advent Capital Management, LLC(2)</a></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: right">(h)</td><td style="width: 1in"/><td style="text-align: justify">Form of Underwriting/Sales/Dealer Manager Agreement(+)</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: right">(i)</td><td style="width: 1in"/><td style="text-align: justify">Not applicable</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: right">(j)</td><td style="width: 0.5in">&#160;</td>
                                                    <td style="width: 0.5in"><a href="https://www.sec.gov/Archives/edgar/data/1219120/000089180418000120/ex999a.htm">(i)</a></td><td style="text-align: left"><a href="https://www.sec.gov/Archives/edgar/data/1219120/000089180418000120/ex999a.htm">Custodian Agreement between the Registrant and The Bank of New York Mellon, dated May&#160;2, 2003(3)</a></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.5in"><a href="https://www.sec.gov/Archives/edgar/data/1219120/000089180418000120/ex999b.htm">(ii)</a></td><td><a href="https://www.sec.gov/Archives/edgar/data/1219120/000089180418000120/ex999b.htm">Foreign Custody Manager Agreement between the Registrant and The Bank of New York Mellon, dated May&#160;2, 2003(3)</a></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 38pt; text-align: right">(k)</td>
<td style="width: 37pt; text-align: right">&#160;</td><td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1219120/000089180418000120/ex9913ci.htm">(i)(1)</a>	</td>
                                                      <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1219120/000089180418000120/ex9913ci.htm">Transfer Agency and Service Agreement between the Registrant and Computershare Inc., dated December&#160;1, 2015(3)</a></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.5in"><a href="https://www.sec.gov/Archives/edgar/data/1219120/000089180418000120/ex9913cii.htm">(2)</a></td><td><a href="https://www.sec.gov/Archives/edgar/data/1219120/000089180418000120/ex9913cii.htm">Fee and Service Schedule for Stock Transfer Services between the Registrant and Computershare Inc., dated December&#160;1, 2015(3)</a></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.5in"><a href="https://www.sec.gov/Archives/edgar/data/1219120/000089180418000120/ex9913ciii.htm">(3)</a></td><td><a href="https://www.sec.gov/Archives/edgar/data/1219120/000089180418000120/ex9913ciii.htm">First Amendment to the Transfer Agency and Service Agreement between Registrant and Computershare Inc., dated March&#160;20, 2017(3)</a></td></tr></table>


<!-- Field: Page; Sequence: 91 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in; text-align: right">(ii)</td><td style="width: 0.5in"><a href="https://www.sec.gov/Archives/edgar/data/1219120/000089180418000120/ex9913dii.htm">(1)</a></td><td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1219120/000089180418000120/ex9913dii.htm">Fund Administration Agreement between Registrant and MUFG Investor Services (US) LLC, dated June&#160;20, 2013(3)</a></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.5in"><a href="https://www.sec.gov/Archives/edgar/data/1219120/000089180418000120/ex9913di.htm">(2)</a></td><td><a href="https://www.sec.gov/Archives/edgar/data/1219120/000089180418000120/ex9913di.htm">Amendment to the Fund Administration Agreement between the Registrant and MUFG Investor Services (US), LLC, dated September&#160;28, 2016(3)</a></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1219120/000089180418000120/ex9913ei.htm">(iii)</a></td><td style="width: 0.5in"><a href="https://www.sec.gov/Archives/edgar/data/1219120/000089180418000120/ex9913ei.htm">(1)</a></td><td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1219120/000089180418000120/ex9913ei.htm">Fund Accounting Agreement between the Registrant and The Bank of New York Mellon, dated May&#160;2, 2003(3)</a></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.5in"><a href="https://www.sec.gov/Archives/edgar/data/1219120/000089180418000120/ex9913eii.htm">(2)</a></td><td><a href="https://www.sec.gov/Archives/edgar/data/1219120/000089180418000120/ex9913eii.htm">Addendum to the Fund Accounting Agreement between the Registrant and The Bank of New York Mellon, dated June&#160;20, 2003(3)</a></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.5in"><a href="https://www.sec.gov/Archives/edgar/data/1219120/000089180418000120/ex9913a.htm">(iv)</a></td><td><a href="https://www.sec.gov/Archives/edgar/data/1219120/000089180418000120/ex9913a.htm">Servicing Agreement between the Registrant and Guggenheim Funds Distributors, LLC, dated March&#160;18, 2018(3)</a></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 1in">(l)</td><td><a href="ex99l.htm">Opinion and Consent of Skadden, Arps, Slate, Meagher &amp; Flom LLP(*)</a></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 1in">(m)</td><td>Not applicable</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 1in"><a href="ex99n.htm">(n)</a></td><td><a href="ex99n.htm">Consent of PricewaterhouseCoopers LLP(*)</a></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: right"/><td style="width: 1in">(o)</td><td style="text-align: justify">Not applicable</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 1in"><a href="https://www.sec.gov/Archives/edgar/data/1219120/000104746903014960/a2107494zex-99_p.txt">(p)</a></td><td><a href="https://www.sec.gov/Archives/edgar/data/1219120/000104746903014960/a2107494zex-99_p.txt">Subscription Agreement(2)</a></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 1in">(q)</td><td>Not applicable</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">(r)</td><td style="width: 0.5in"><a href="https://www.sec.gov/Archives/edgar/data/1219120/000182126824000132/ex99ri.htm">(i)</a>	</td>
                                                               <td><a href="https://www.sec.gov/Archives/edgar/data/1219120/000182126824000132/ex99ri.htm">Code of Ethics of the Registrant(5)</a></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.5in"><a href="https://www.sec.gov/Archives/edgar/data/1219120/000182126824000132/ex99rii.htm">(ii)</a></td><td><a href="https://www.sec.gov/Archives/edgar/data/1219120/000182126824000132/ex99rii.htm">Code of Ethics of the Adviser(5)</a></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 1in">(s)</td><td><a href="ex99s.htm">Calculation of Filing Fee Table(*)</a></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 1in"><a href="https://www.sec.gov/Archives/edgar/data/1219120/000182126824000132/ex99t.htm">(t)</a></td><td><a href="https://www.sec.gov/Archives/edgar/data/1219120/000182126824000132/ex99t.htm">Power of Attorney(5)</a></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">(z)</td><td style="width: 0.5in"><a href="https://www.sec.gov/Archives/edgar/data/1219120/000182126824000132/ex99zi.htm">(i)</a>	</td>
                                                               <td><a href="https://www.sec.gov/Archives/edgar/data/1219120/000182126824000132/ex99zi.htm">Form of Prospectus Supplement for Common Shares Offering(5)</a></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.5in"><a href="https://www.sec.gov/Archives/edgar/data/1219120/000182126824000132/ex99zii.htm">(iii)</a></td><td><a href="https://www.sec.gov/Archives/edgar/data/1219120/000182126824000132/ex99zii.htm">Form of Prospectus Supplement for Common Rights Offering(5)</a></td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">___________</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">(*)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Filed herewith.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">(**)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To be filed by pre-effective
amendment.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">(+)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To be filed by post-effective amendment.</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(1)</td><td>Incorporated by reference to Pre-Effective Amendment No.&#160;1 to Registrant&#8217;s Registration Statement on Form&#160;N-2 (File
Nos.&#160;333-103329 and 811-21309) filed on April&#160;3, 2003.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(2)</td><td>Incorporated by reference to Pre-Effective Amendment No.&#160;2 to Registrant&#8217;s Registration Statement on Form&#160;N-2 (File
Nos.&#160;333-103329 and 811-21309) filed on April&#160;28, 2003.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(3)</td><td>Incorporated by reference to Registrant&#8217;s Registration Statement on Form&#160;N-14 (File No.&#160;333-224258) filed on April&#160;12,
2018.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(4)</td><td>Incorporated by reference to Registrant&#8217;s Current Report on Form&#160;8-K (File No.&#160;811-21309) filed on November&#160;4,
2019.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(5)</td><td>Incorporated by reference to Registrant's Registration Statement on
                                            Form N-2 (File Nos. 333-280964 and 811-21309) filed on July 23, 2024.</td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Item&#160;26. Marketing Arrangements</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 0.5in; text-indent: 0in">Reference is made to Exhibit (h) to this
Registration Statement to be filed by post-effective amendment.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Item&#160;27. Other Expenses of Issuance and Distribution</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">The following table sets forth the estimated expenses
to be incurred in connection with the offering described in this Registration Statement:</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 77%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Printer/Edgar Filer </span></td>
    <td style="width: 23%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">$20,000</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Legal Counsel</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">$250,000</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">NYSE Fee</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">$40,500</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">SEC Fees</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">$22,140</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">FINRA Fees</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">$23,000</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Independent Registered Public Accounting Firm</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">$140,000</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Miscellaneous</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">$64,500</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 20pt"><span style="font-size: 9pt;">	Total</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt;">$560,140</span></td></tr>
  </table>

<!-- Field: Page; Sequence: 92; Options: NewSection; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Item&#160;28. Persons Controlled by or Under Common Control with
Registrant</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">None</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Item&#160;29. Number of Holders of Securities</b></p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt"><b><span style="text-decoration: underline">Title of Class</span></b></span></td>
    <td style="width: 200px; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>Number
    of Record Shareholders <br/>
    <span style="text-decoration: underline">as of July 31, 2024</span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Common shares of beneficial interest, par value
    $0.001 per share</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">94</span></td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><b>Item&#160;30.
Indemnification</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">Reference is made to Article&#160;V of the Registrant&#8217;s
Amended and Restated Agreement and Declaration of the Registrant, which provides as follows:</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">5.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">No
Personal Liability of Shareholders, Trustees, etc.</span> No Shareholder of the Trust shall be subject in such capacity to any personal liability
whatsoever to any Person in connection with Trust Property or the acts, obligations or affairs of the Trust. Shareholders shall have the
same limitation of personal liability as is extended to stockholders of a private corporation for profit incorporated under the Delaware
General Corporation Law. No Trustee or officer of the Trust shall be subject in such capacity to any personal liability whatsoever to
any Person, save only liability to the Trust or its Shareholders arising from bad faith, willful misfeasance, gross negligence or reckless
disregard for his duty to such Person; and, subject to the foregoing exception, all such Persons shall look solely to the Trust Property
for satisfaction of claims of any nature arising in connection with the affairs of the Trust. If any Shareholder, Trustee or officer,
as such, of the Trust, is made a party to any suit or proceeding to enforce any such liability, subject to the foregoing exception, he
shall not, on account thereof, be held to any personal liability. Any repeal or modification of this Section&#160;5.1 shall not adversely
affect any right or protection of a Trustee or officer of the Trust existing at the time of such repeal or modification with respect to
acts or omissions occurring prior to such repeal or modification.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">5.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Mandatory
Indemnification</span>. (a) The Trust hereby agrees to indemnify each person who at any time serves as a Trustee or officer of the Trust
(each such person being an &#8220;indemnitee&#8221;) against any liabilities and expenses, including amounts paid in satisfaction of judgments,
in compromise or as fines and penalties, and reasonable counsel fees reasonably incurred by such indemnitee in connection with the defense
or disposition of any action, suit or other proceeding, whether civil or criminal, before any court or administrative or investigative
body in which he may be or may have been involved as a party or otherwise or with which he may be or may have been threatened, while acting
in any capacity set forth in this Article&#160;V by reason of his having acted in any such capacity, except with respect to any matter
as to which he shall not have acted in good faith in the reasonable belief that his action was in the best interest of the Trust or, in
the case of any criminal proceeding, as to which he shall have had reasonable cause to believe that the conduct was unlawful; provided,
however, that no indemnitee shall be indemnified hereunder against any liability to any person or any expense of such indemnitee arising
by reason of (i) willful misfeasance, (ii) bad faith, (iii) gross negligence, or (iv) reckless disregard of the duties involved in the
conduct of his position (the conduct referred to in such clauses&#160;(i) through (iv) being sometimes referred to herein as &#8220;disabling
conduct&#8221;). Notwithstanding the foregoing, with respect to any action, suit or other proceeding voluntarily prosecuted by any indemnitee
as plaintiff, indemnification shall be mandatory only if the prosecution of such action, suit or other proceeding by such indemnitee (1)
was authorized by a majority of the Trustees or (2) was instituted by the indemnitee to enforce his or her rights to indemnification hereunder
in a case in which the indemnitee is found to be entitled to such indemnification. The rights to indemnification set forth in this Declaration
shall continue as to a person who has ceased to be a Trustee or officer of the Trust and shall inure to the benefit of his or her heirs,
executors and personal and legal representatives. No amendment or restatement of this Declaration or repeal of any of its provisions shall
limit or eliminate any of the benefits provided to any person who at any time is or was a Trustee or officer of the Trust or otherwise
entitled to indemnification hereunder in respect of any act or omission that occurred prior to such amendment, restatement or repeal.</p>


<!-- Field: Page; Sequence: 93; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Notwithstanding
the foregoing, no indemnification shall be made hereunder unless there has been a determination (i) by a final decision on the merits
by a court or other body of competent jurisdiction before whom the issue of entitlement to indemnification hereunder was brought that
such indemnitee is entitled to indemnification hereunder or, (ii) in the absence of such a decision, by (1) a majority vote of a quorum
of those Trustees who are neither &#8220;interested persons&#8221; of the Trust (as defined in Section&#160;2(a)(19) of the 1940 Act)
nor parties to the proceeding (&#8220;Disinterested Non-Party Trustees&#8221;), that the indemnitee is entitled to indemnification hereunder,
or (2) if such quorum is not obtainable or even if obtainable, if such majority so directs, independent legal counsel in a written opinion
concludes that the indemnitee should be entitled to indemnification hereunder. All determinations to make advance payments in connection
with the expense of defending any proceeding shall be authorized and made in accordance with the immediately succeeding paragraph&#160;(c)
below.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Trust shall make advance payments in connection with the expenses of defending any action with respect to which indemnification might
be sought hereunder if the Trust receives a written affirmation by the indemnitee of the indemnitee&#8217;s good faith belief that the
standards of conduct necessary for indemnification have been met and a written undertaking to reimburse the Trust unless it is subsequently
determined that the indemnitee is entitled to such indemnification and if a majority of the Trustees determine that the applicable standards
of conduct necessary for indemnification appear to have been met. In addition, at least one of the following conditions must be met: (i)
the indemnitee shall provide adequate security for his undertaking, (ii) the Trust shall be insured against losses arising by reason of
any lawful advances, or (iii) a majority of a quorum of the Disinterested Non-Party Trustees, or if a majority vote of such quorum so
direct, independent legal counsel in a written opinion, shall conclude, based on a review of readily available facts (as opposed to a
full trial-type inquiry), that there is substantial reason to believe that the indemnitee ultimately will be found entitled to indemnification.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
rights accruing to any indemnitee under these provisions shall not exclude any other right which any person may have or hereafter acquire
under this Declaration, the By-Laws of the Trust, any statute, agreement, vote of stockholders or Trustees who are &#8220;disinterested
persons&#8221; (as defined in Section&#160;2(a)(19) of the 1940 Act) or any other right to which he or she may be lawfully entitled.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject
to any limitations provided by the 1940 Act and this Declaration, the Trust shall have the power and authority to indemnify and provide
for the advance payment of expenses to employees, agents and other Persons providing services to the Trust or serving in any capacity
at the request of the Trust to the full extent corporations organized under the Delaware General Corporation Law may indemnify or provide
for the advance payment of expenses for such Persons; provided that such indemnification has been approved by a majority of the Trustees.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">5.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">No
Bond Required of Trustees</span>. No Trustee shall, as such, be obligated to give any bond or other security for the performance of any of
his duties hereunder.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">5.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">No
Duty of Investigation; Notice in Trust Instruments, etc.</span> No purchaser, lender, transfer agent or other person dealing with the Trustees
or with any officer, employee or agent of the Trust shall be bound to make any inquiry concerning the validity of any transaction purporting
to be made by the Trustees or by said officer, employee or agent or be liable for the application of money or property paid, loaned, or
delivered to or on the order of the Trustees or of said officer, employee or agent. Every obligation, contract, undertaking, instrument,
certificate, Share, other security of the Trust, and every other act or thing whatsoever executed in connection with the Trust shall be
conclusively taken to have been executed or done by the executors thereof only in their capacity as Trustees under this Declaration or
in their capacity as officers, employees or agents of the Trust. The Trustees may maintain insurance for the protection of the Trust Property,
its Shareholders, Trustees, officers, employees and agents in such amount as the Trustees shall deem adequate to cover possible tort liability,
and such other insurance as the Trustees in their sole judgment shall deem advisable or is required by the 1940 Act.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">5.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Reliance
on Experts, etc.</span> Each Trustee and officer or employee of the Trust shall, in the performance of its duties, be fully and completely
justified and protected with regard to any act or any failure to act resulting from reliance in good faith upon the books of account or
other records of the Trust, upon an opinion of counsel, or upon reports made to the Trust by any of the Trust&#8217;s officers or employees
or by any advisor, administrator, manager, distributor, selected dealer, accountant, appraiser or other expert or consultant selected
with reasonable care by the Trustees, officers or employees of the Trust, regardless of whether such counsel or expert may also be a Trustee.</p>


<!-- Field: Page; Sequence: 94; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">Reference is made to Section&#160;8 and Section&#160;9
of the Investment Management Agreement, between the Registrant and the Adviser, as filed as Exhibit (g) hereto.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">Insofar as indemnification for liability arising
under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing
provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification
is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against
such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of
the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person
in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled
by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Act and will be governed by the final adjudication of such issue.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Item&#160;31. Business and Other Connections of the Adviser</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">Advent Capital Management, LLC, a limited liability
company organized under the laws of Delaware, acts as investment adviser to the Registrant. The Registrant is fulfilling the requirement
of this Item&#160;31 to provide a list of the officers and directors of the Adviser, together with information as to any other business,
profession, vocation or employment of a substantial nature engaged in by the Adviser or those officers and directors during the past two
years, by incorporating by reference the information contained in the Form ADV of the Adviser filed with the commission pursuant to the
Investment Advisers Act of 1940 (Commission File No.&#160;801-60263).</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Item&#160;32. Location of Accounts and Records</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">The Fund&#8217;s accounts, books, and other documents
are currently located at the offices of Advent Capital Management, LLC, 888 Seventh Avenue, 31st Floor, New York, New York 10019, at the
offices of The Bank of New York, 101 Barclay Street, New York, New York 10286 and at the offices of Guggenheim Funds Distributors, LLC,
227 West Monroe Street, 7th Floor, Chicago, Illinois 60606.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Item&#160;33. Management Services</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">Not applicable.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Item&#160;34. Undertakings</b></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">1.</td><td>Not applicable.</td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Not
applicable.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Registrant
undertakes:</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.5in">(a)</td><td>to file, during any period in which offers or sales are being made, a post-effective amendment to the registration statement:</td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in">	(1)	to include any prospectus required
by Section&#160;10(a)(3) of the Securities Act;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in">	(2)	to reflect in the prospectus
any facts or events after the effective date of the registration statement (or the most recent post- effective amendment thereof) which,
individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding
the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed
that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the
form of prospectus filed with the Commission pursuant to Rule&#160;424(b) if, in the aggregate, the changes in volume and price represent
no more than 20% change in the maximum aggregate offering price</p>


<!-- Field: Page; Sequence: 95; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->v<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in">set forth in the &#8220;Calculation of Filing Fee Tables&#8221;
in the effective registration statement; and</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in">(3)	to include any material information
with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information
in the registration statement.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in">Provided, however, that paragraphs a(1), a(2), and a(3) of
this section do not apply if the registration statement is filed pursuant to General Instruction A.2 of this Form and the information
required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission
by the Registrant pursuant to Section&#160;13 or Section&#160;15(d) of the Exchange Act that are incorporated by reference into the registration
statement, or is contained in a form of prospectus filed pursuant to Rule&#160;424(b) that is part of the registration statement.</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.5in">(b)</td><td>that, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to
be a new registration statement relating to the securities offered therein, and the offering of those securities at that time shall be
deemed to be the initial bona fide offering thereof;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.5in">(c)</td><td>to remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
termination of the offering;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.5in">(d)</td><td>that, for the purpose of determining liability under the Securities Act to any purchaser:</td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;if the Registrant
is relying on Rule&#160;430B</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-indent: 0.5in">(A)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each
prospectus filed by the Registrant pursuant to Rule&#160;424(b)(3) shall be deemed to be part of the registration statement as of the
date the filed prospectus was deemed part of and included in the registration statement; and</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-indent: 0.5in">(B)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each
prospectus required to be filed pursuant to Rule&#160;424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on
Rule&#160;430B relating to an offering made pursuant to Rule&#160;415(a)(1)(i), (x), or (xi) for the purpose of providing the information
required by Section&#160;10(a) of the Securities Act shall be deemed to be part of and included in the registration statement as of the
earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities
in the offering described in the prospectus. As provided in Rule&#160;430B, for liability purposes of the issuer and any person that is
at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities
in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part
of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or
prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective
date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement
or made in any such document immediately prior to such effective date; or</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;If the Registrant
is subject to Rule&#160;430C: Each prospectus filed pursuant to Rule&#160;424(b) under the Securities Act as part of a registration statement
relating to an offering, other than registration statements relying on Rule&#160;430B or other than prospectuses filed in reliance on
Rule&#160;430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness.
Provided,</p>


<!-- Field: Page; Sequence: 96; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vi<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in">however, that no statement made in a registration statement
or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the
registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale
prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of
the registration statement or made in any such document immediately prior to such date of first use.</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.5in">(e)</td><td>that for the purpose of determining liability of the Registrant under the Securities Act to any purchaser in the initial distribution
of securities:</td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in">The undersigned Registrant undertakes that in a primary offering
of securities of the undersigned Registrant pursuant to this registration statement, regardless of the underwriting method used to sell
the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications,
the undersigned Registrant will be a seller to the purchaser and will be considered to offer or sell such securities to the purchaser:</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in">(1) &#160;&#160;&#160;&#160;&#160;&#160;&#160;any preliminary
prospectus or prospectus of the undersigned Registrant relating to the offering required to be filed pursuant to Rule&#160;424 under the
Securities Act;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in">(2) &#160;&#160;&#160;&#160;&#160;&#160;&#160;free writing
prospectus relating to the offering prepared by or on behalf of the undersigned Registrant or used or referred to by the undersigned Registrants;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in">(3) &#160;&#160;&#160;&#160;&#160;&#160;&#160;the portion of
any other free writing prospectus or advertisement pursuant to Rule&#160;482 under the Securities Act relating to the offering containing
material information about the undersigned Registrant or its securities provided by or on behalf of the undersigned Registrant; and</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in">(4) &#160;&#160;&#160;&#160;&#160;&#160;&#160;any other communication
that is an offer in the offering made by the undersigned Registrant to the purchaser.</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">4.</td><td>Registrant undertakes that, for the purpose of determining any liability under the Securities Act of 1933, the information omitted
from the form of prospectus filed as part of the Registration Statement in reliance upon Rule&#160;430A and contained in the form of prospectus
filed by the Registrant pursuant to Rule&#160;424(b)(1) will be deemed to be a part of the Registration Statement as of the time it was
declared effective.</td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in">Registrant undertakes that, for the purpose of determining any
liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus will be deemed to be a new
Registration Statement relating to the securities offered therein, and the offering of such securities at that time will be deemed to
be the initial bona fide offering thereof.</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">5.</td><td>Registrant undertakes that, for the purpose of determining any liability under the Securities Act of 1933, each filing of the Registrant&#8217;s
annual report pursuant to Section&#160;13(a) or Section&#160;15(d) of the Securities Exchange Act of 1934 that is incorporated by reference
into the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">6.</td><td>Not applicable.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">7.</td><td>Registrant undertakes to send by first class mail or other means designed to ensure equally prompt delivery, within two business days
of receipt of a written or oral request, any Statement of Additional Information constituting Part&#160;B of this Registration Statement.</td></tr></table>


<!-- Field: Page; Sequence: 97; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vii<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">SIGNATURES</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">As required by the Securities Act of 1933,
as amended, and the Investment Company Act of 1940, as amended, this Registration Statement has been signed on behalf of the Registrant,
in the City of New York, State of New York, on the 29th day of August, 2024.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 0 3in">ADVENT CONVERTIBLE AND INCOME FUND</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-indent: 0.5in">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-indent: 0.5in">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 0 3in">By:	<span style="text-decoration: underline">	_/s/
Tracy V. Maitland__________________	</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 0 3in">Tracy V. Maitland</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 0 3in">President and Chief Executive Officer</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 0 2.5in; text-indent: 0.5in">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">As required by the Securities Act of 1933,
as amended, this Registration Statement has been signed below by the following persons in the capacities set forth below on the 29th day
of August, 2024.</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 43%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Principal Executive Officer:</span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="text-align: left; width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle">&#160;</td>
    <td style="width: 4%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="text-align: left; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-indent: 2.5in"><br/>
    <span style="text-decoration: underline">/s/ Tracy V. Maitland</span>_________</p>
    <p style="font: 9pt Times New Roman, Times, Serif; text-align: left; margin-top: 0; margin-right: 0; margin-bottom: 0">Tracy V. Maitland</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="text-align: left; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle"><span style="font-size: 9pt">Trustee, President and Chief Executive Officer</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Principal Financial Officer:</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="text-align: left; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="text-align: left; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-indent: 2in">&#160;</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline">/s/ Robert White</span>_________</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0">Robert White</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="text-align: left; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle"><span style="font-size: 9pt">Chief Financial Officer and Treasurer</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Trustees:</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="text-align: left; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-indent: 2.5in">&#160;</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline">*</span>________</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0">Randall C. Barnes</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="text-align: left; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle"><span style="font-size: 9pt">Trustee</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-indent: 2.5in">&#160;</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline">*</span>_________</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0">Daniel L. Black</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="text-align: left; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle"><span style="font-size: 9pt">Trustee</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-indent: 2.5in">&#160;</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline">*</span>_________</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0">Derek Medina</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="text-align: left; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle"><span style="font-size: 9pt">Trustee</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-indent: 2.5in">&#160;</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline">*</span>_________</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0">Ronald A. Nyberg</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="text-align: left; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle"><span style="font-size: 9pt">Trustee</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-indent: 2.5in">&#160;</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline">*</span>________</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0">Gerald L. Seizert</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="text-align: left; vertical-align: middle; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Trustee</span></td>
    <td>&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-indent: 2.5in">&#160;</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0">*________</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0">Michael A. Smart</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="text-align: left; vertical-align: middle; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Trustee</span></td>
    <td>&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-indent: 2.5in">&#160;</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0">*_________</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0">Nancy E. Stuebe</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="text-align: left; vertical-align: middle; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Trustee</span></td>
    <td>&#160;</td></tr>
  </table>
<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.5in">*</td><td>Signed by Tony Huang, an attorney-in-fact, pursuant to a power of attorney filed herewith.</td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0pt 0pt 0.75in; text-indent: 0in">By:	<span style="text-decoration: underline">/s/
Tony Huang</span>_________</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0pt 12pt 0.75in; text-indent: 0in">Tony Huang<br/>
Attorney-In-Fact<br/> August 29, 2024</p>


<!-- Field: Page; Sequence: 98; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->viii<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 6pt; text-align: center; text-indent: 0in"><b>Exhibit List</b></p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top; text-align: justify">
<td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 10%"><span style="font-size: 9pt"><a href="ex99b.htm">(b)</a></span></td><td style="text-indent: 5.4pt; text-align: left; width: 90%"><span style="font-size: 9pt"><a href="ex99b.htm">Fourth Amended and Restated By-Laws of Registrant</a></span></td>
</tr></table>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 10%"><span style="font-size: 9pt"><a href="ex99l.htm">(l)</a></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 90%"><span style="font-size: 9pt"><a href="ex99l.htm">Opinion and Consent of Skadden, Arps, Slate, Meagher &amp; Flom LLP</a></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt"><a href="ex99n.htm">(n)</a></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt"><a href="ex99n.htm">Consent of Independent Registered Public Accounting Firm</a></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt"><a href="ex99s.htm">(s)</a></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt"><a href="ex99s.htm">Calculation of Filing Fee Table</a></span></td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: -1in">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>




<p style="margin: 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJydkk1uwjAQhU/AHaysETjhT8qOpilChYJS1J+lSSYwIvFEtkPDkXrL2kGUVVVay5Jlvfe98cjjeV1vRg9YgGJvd8mCbaCsCmGAJZCDApmCdUTzx5DZM4EdaqOENO31AkZkGbDMqBcMhBVa6xE1ZCHjk74/6QdDxsfhcMzWS6/j9IhkjhlIg6JgQmZsrahSCEao0zlhIxqSVJ7aUi+gNJIMmd/jZ/mTBdwP2BMdxQepg2aLReR1uu3qeDNFdWVdcWNAOpLFBZS2nD7T192+Jq21oTKMm8q6IW6Ea+gdhOIDq/o8CHzOh3/hRv/jfH4Ll6A+zKVRlNWpsc0todyC+ian/Efy3v0fbmtHuZTbSefWU60pRTse2Sua/Sq3I4Jyp1f5NMvQZYrCDkNJ8nkvFOjb0698W4fyBHd781vAFwS9yWs= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>3
<FILENAME>ex99b.htm
<DESCRIPTION>FOURTH AMENDED AND RESTATED BY-LAWS OF REGISTRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FOURTH AMENDED AND RESTATED</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">BY-LAWS</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">OF</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Advent
Convertible and Income Fund</B></FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="text-align: center; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in">ARTICLE I Shareholder Meetings</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="text-align: center; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in">&nbsp;</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="width: 90%; text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">Section 1.1&nbsp;&nbsp;&nbsp;Chairman</TD>
    <TD STYLE="width: 10%; text-align: right; padding-top: 0in; padding-bottom: 0pt">3</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">Section 1.2&nbsp;&nbsp;&nbsp;Proxies; Voting</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">3</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">Section 1.3&nbsp;&nbsp;&nbsp;Fixing Record Dates</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">4</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">Section 1.4&nbsp;&nbsp;&nbsp;Inspectors of Election</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">4</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">Section 1.5&nbsp;&nbsp;&nbsp;Records at Shareholder Meetings</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">4</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">Section 1.6&nbsp;&nbsp;&nbsp;Notice of Shareholder Business and Nominations</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">5</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">Section 1.7&nbsp;&nbsp;&nbsp;Special Shareholders Meetings</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">16</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">Section 1.8&nbsp;&nbsp;&nbsp;Conduct of Meetings.</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">17</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">Section 1.9&nbsp;&nbsp;&nbsp;Adjourned Meeting</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">18</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">&nbsp;</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">&nbsp;</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="text-align: center; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in">ARTICLE II Trustees</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="text-align: center; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in">&nbsp;</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">Section 2.1&nbsp;&nbsp;&nbsp;Annual and Regular Meetings</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">19</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">Section 2.2&nbsp;&nbsp;&nbsp;Chairman</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">19</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">Section 2.3&nbsp;&nbsp;&nbsp;Qualifications</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">19</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">Section 2.4&nbsp;&nbsp;&nbsp;Standard of Care</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">22</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">Section 2.5&nbsp;&nbsp;&nbsp;Governance</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">22</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">Section 2.6&nbsp;&nbsp;&nbsp;Records</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">22</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">&nbsp;</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">&nbsp;</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="text-align: center; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in">ARTICLE III Officers</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="text-align: center; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in">&nbsp;</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">Section 3.1&nbsp;&nbsp;&nbsp;Officers of the Trust</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">22</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">Section 3.2&nbsp;&nbsp;&nbsp;Election and Tenure</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">22</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">Section 3.3&nbsp;&nbsp;&nbsp;Removal of Officers</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">23</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">Section 3.4&nbsp;&nbsp;&nbsp;Bonds and Surety</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">23</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">Section 3.5&nbsp;&nbsp;&nbsp;President, and Vice Presidents</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">23</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">Section 3.6&nbsp;&nbsp;&nbsp;Secretary</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">23</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">Section 3.7&nbsp;&nbsp;&nbsp;Treasurer</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">24</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">Section 3.8&nbsp;&nbsp;&nbsp;Other Officers and Duties</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">24</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="text-align: center; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in">ARTICLE IV Miscellaneous</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="text-align: center; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in">&nbsp;</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in; width: 90%">Section 4.1&nbsp;&nbsp;&nbsp;Depositories</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt; width: 10%">24</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">Section 4.2&nbsp;&nbsp;&nbsp;Signatures</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">24</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">Section 4.3&nbsp;&nbsp;&nbsp;Seal</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">24</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">Section 4.4&nbsp;&nbsp;&nbsp;Disclosure of Holdings</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">25</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">Section 4.5&nbsp;&nbsp;&nbsp;Governing Law</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">25</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">Section 4.6&nbsp;&nbsp;&nbsp;Provisions in Conflict with Law or Regulations</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">25</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">&nbsp;</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">&nbsp;</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="text-align: center; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in">ARTICLE V Stock Transfers</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="text-align: center; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in">&nbsp;</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">Section 5.1&nbsp;&nbsp;&nbsp;Transfer Agents, Registrars and the Like</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">25</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">Section 5.2&nbsp;&nbsp;&nbsp;Transfer of Shares</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">25</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">Section 5.3&nbsp;&nbsp;&nbsp;Registered Shareholders</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">26</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">&nbsp;</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">&nbsp;</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="text-align: center; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in">ARTICLE VI Amendment of By-Laws</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="text-align: center; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in">&nbsp;</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">Section 6.1&nbsp;&nbsp;&nbsp;Amendment and Repeal of By-Laws</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">26</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">&nbsp;</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">&nbsp;</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="text-align: center; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in">ARTICLE VII CHOICE OF FORUM PROVISION</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="text-align: center; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in">&nbsp;</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">Section 7.1&nbsp;&nbsp;&nbsp;Forum for Adjudication of Certain Disputes</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">26</TD></TR>
</TABLE>
<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Advent
Convertible and Income Fund</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>FOURTH AMENDED AND RESTATED BY-LAWS </B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">These Fourth Amended and Restated
By-Laws are made and adopted pursuant to Section 3.9 of the Agreement and Declaration of Trust establishing Advent Convertible and Income
Fund dated as of February 19, 2003, as from time to time amended (hereinafter called the &ldquo;<U>Declaration</U>&rdquo;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">All words and terms capitalized
in these By-Laws and not defined herein shall have the meaning or meanings set forth for such words or terms in the Declaration.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">As used in these By-Laws, the following
term shall have the meanings ascribed to them:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<B><U>12(d) Holder</U>&rdquo;</B>
shall mean any investment fund (as defined herein) or any company or companies controlled by such investment fund which in the aggregate
own beneficially or of record (A) more than three percent (3%) of the outstanding voting Shares of the Trust, (B) securities issued by
the Trust having an aggregate value in excess of five percent (5%) of the total assets of such investment fund and any company or companies
controlled by such investment fund, (C) securities issued by the Trust and by all other investment funds having an aggregate value in
excess of ten percent (10%) of the total assets of the investment fund making such investment and any company or companies controlled
by the investment fund making such investment, or (D) together with other investment funds having the same investment adviser and companies
controlled by such investment funds, more than ten percent (10%) of the total outstanding Shares of the Trust (an investment fund making
such investment(s) and any company or companies controlled by it in the aggregate owning securities in excess of the amounts set forth
in (A), (B), (C) or (D), but excluding any investment fund managed by the Trust&rsquo;s investment adviser or servicing agent or an investment
adviser in a control relationship with the Trust&rsquo;s investment adviser or servicing agent, being referred to as a &ldquo;12(d) Holder&rdquo;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>5% Holder</U>&rdquo;
shall mean an affiliated person of another person within the meaning of section 2(a)(3)(A) or section 2(a)(3)(B) of the 1940 Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>beneficial owner</U>&rdquo;
of a security shall mean any Person who, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise
(A) has or shares: (1) voting power which includes the power to vote, or to direct the voting of, such security; and/or, (2) investment
power which includes the power to dispose, or to direct the disposition, of such security or (B) owns, controls or holds with power to
vote such security. A Person shall be deemed to be the beneficial owner of shares if that Person has the right to acquire beneficial ownership
of such shares at any time, whether or not within sixty days of the date of such determination. &ldquo;Beneficially own,&rdquo; &ldquo;own
beneficially&rdquo; and related terms shall have correlative meaning.</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>control</U>&rdquo;
shall mean the power to exercise a controlling influence over a Person, which in the case of a company means the power to exercise a controlling
influence over the management or policies of such company, unless such power is solely the result of an official position with such company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>control relationship</U>&rdquo;
with respect to any Person shall mean control over such Person, being controlled by such Person or being under common control with such
Person.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>director</U>&rdquo;
shall mean any director of a corporation or any Person performing similar functions with respect to any organization, whether incorporated
or unincorporated, including any natural Person who is a member of a board of trustees of any organization that is a statutory or common-law
trust.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Disclosable Relationship</U>&rdquo;
with respect to another Person means (A) the existence at any time during the current calendar year or at any time within the two most
recently completed calendar years of any agreement, arrangement, understanding (whether written or oral) or practice, including the sharing
of information, decisions or actions, of a Person with such other Person with respect to the Trust or Shares, (B) the beneficial ownership
of securities of any Person known by such Person to beneficially own Shares and of which such Person knows such other Person also beneficially
owns any securities, (C) sharing beneficial ownership of any securities with such other Person, (D) being an immediate family member of
such other Person, (E) the existence at any time during the current calendar year or at any time within the two most recently completed
calendar years of a material business or professional relationship with such other Person or with any Person of which such other Person
is a 5% Holder, officer, director, trustee, general partner, manager, managing member or employee or (F) controlling, being controlled
by or being under common control with such other Person.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<B><U>Exchange Act</U>&rdquo;</B>
shall mean the Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>immediate family
member</U>&rdquo; shall mean any parent, child, spouse, spouse of a parent, spouse of a child, brother or sister (including step and adoptive
relationships).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<B><U>Independent
Trustee</U>&rdquo;</B> shall mean a Trustee that is not an &ldquo;interested person,&rdquo; as defined in Section 2(a)(19) of the 1940
Act, of the Trust.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>investment fund</U>&rdquo;
shall mean any collective investment vehicle, including the Trust, primarily engaged in the business of investing in &quot;investment
securities&quot; (as defined in the 1940 Act).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>nominated or seated</U>&rdquo;
shall have the meaning set forth in Section 2.3 of these By-Laws.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<B><U>Proposed Nominee</U>&rdquo;</B>
shall have the meaning set forth in Section 1.6(a)(iv)(c) of these By-Laws.</P>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<B><U>Proposed Nominee
Associate</U>&rdquo;</B> of any Proposed Nominee shall mean any Person who has a Disclosable Relationship with such Proposed Nominee.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>public announcement</U>&rdquo;
shall include, but not be limited to, disclosure in a press release reported by the Dow Jones News Service, Associated Press or other
national news service or in a document publicly filed by the Trust with the Securities and Exchange Commission pursuant to Section 13,
14 or 15(d) of the Exchange Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Questionnaire</U>&rdquo;
shall mean the Trust&rsquo;s form of annual trustee questionnaire, as supplemented from time to time, containing questions intended to,
among other things, identify and evaluate potential conflicts of interest, obtain information needed to prepare regulatory filings, including
registration statements, annual reports and proxy statements, determine whether a Trustee or a trustee nominee is an &ldquo;interested
person&rdquo; of the Trust (as defined in section 2(a)(19) of the 1940 Act), update records, and otherwise comply with any applicable
laws and regulations.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<B><U>Shareholder
Associate</U>&rdquo;</B> of any Shareholder or beneficial owner of Shares shall mean any Person who has a Disclosable Relationship with
such Shareholder or beneficial owner.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<B><U>Special Meeting
Request</U>&rdquo;</B> shall have the meaning set forth in Section 1.7(b) of these By-Laws.</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">ARTICLE
I<U><BR>
<BR>
Shareholder Meetings</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Section 1.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Chairman</U>. The Trustees may designate a chairman for a meeting of the Shareholders in advance of the meeting, or may delegate
the determination of the chairman for the meeting to any one or more of the Trust&rsquo;s officers. Absent any such designation or delegation,
the Chairman, if any, shall act as chairman at all meetings of the Shareholders and in the Chairman&rsquo;s absence, the Trustee or Trustees
present at such meeting may elect a chairman for the meeting, who may be, but is not required to be, a Trustee. The chairman for the meeting,
whether it be the Chairman or some other individual designated in accordance with this Section 1.1, may preside at the meeting via teleconference
or videoconference.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Section 1.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Proxies; Voting</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shareholders
may vote either in person or by duly executed proxy and each full share represented at the meeting shall have one vote, all as provided
in Article 10 of the Declaration.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to any provision of applicable law, the Declaration, these By-Laws or a resolution of the Trustees specifying a greater or a lesser vote
requirement for the transaction of any item of business at any meeting of Shareholders, an affirmative Majority Shareholder Vote shall
be the act of the Shareholders with respect to any proposal of business brought before a meeting of Shareholders pursuant to Section </P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">1.6(a)(i)(C)
of these By-Laws or Rule 14a-8 under the Exchange Act (or any successor provision of law).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Section 1.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Fixing Record Dates</U>. For the purpose of determining the Shareholders who are entitled to notice of or to vote or act at
any meeting, including any adjournment or postponement thereof, or who are entitled to participate in any dividends, or for any other
proper purpose, the Trustees may from time to time, without closing the transfer books, fix a record date in the manner provided in Section
10.3 of the Declaration. If the Trustees do not prior to any meeting of Shareholders so fix a record date or close the transfer books,
then the date on which mailing of notice of the meeting is commenced or the date upon which the dividend resolution is adopted, as the
case may be, shall be the record date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Section 1.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Inspectors of Election</U>. In advance of any meeting of Shareholders, the Trustees may appoint Inspectors of Election to act
at the meeting or any adjournment or postponement thereof. If Inspectors of Election are not so appointed, the chairman, if any, of any
meeting of Shareholders may appoint Inspectors of Election of the meeting. The number of Inspectors of Election shall be either one or
three. In case any person appointed as Inspector of Election fails to appear or fails or refuses to act, the vacancy may be filled by
appointment made by the Trustees in advance of the convening of the meeting or at the meeting by the chairman of the meeting. The Inspectors
of Election shall determine the number of Shares outstanding, the Shares represented at the meeting, the existence of a quorum, the authenticity,
validity and effect of proxies, shall receive votes, ballots or consents, shall hear and determine all challenges and questions in any
way arising in connection with the right to vote, shall count and tabulate all votes or consents, determine the results, and do such other
acts as may be proper to conduct the election or vote with fairness to all Shareholders. If there are three Inspectors of Election, the
decision, act or certificate of a majority is effective in all respects as the decision, act or certificate of all. On request of the
chairman, if any, of the meeting, the Inspectors of Election shall make a report in writing of any challenge or question or matter determined
by them and shall execute a certificate of any facts found by them.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Section 1.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Records at Shareholder Meetings</U>. At each meeting of the Shareholders, there shall be made available for inspection at a
convenient time and place during normal business hours, if requested by Shareholders for a purpose germane to the meeting, the minutes
of the last previous Annual or Special Meeting of Shareholders of the Trust and a list of the Shareholders of the Trust, as of the record
date of the meeting or the date of closing of transfer books, as the case may be. Such list of Shareholders shall contain the name and
the address of each Shareholder in alphabetical order and the number of Shares owned by such Shareholder, and shall not be required to
contain any other information. Any determination made by the Trustees, or by the Trust&rsquo;s officers pursuant to delegated authority,
as to the convenience of any such time and place, or as to whether any such request is for a purpose germane to the meeting, shall be
deemed conclusive and any Shareholder challenging such determination shall have the burden of proving that the Trustees or the officers,
as the case may be, acted in bad faith in making any such determination.</P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Shareholders shall have such
other rights of inspection of the books and records of the Trust as are granted to shareholders of a Delaware business corporation pursuant
to section 220 of the Delaware General Corporation Law (or any successor provision of law), subject to the procedures and requirements
applicable to shareholders of a Delaware business corporation pursuant to section 220 of the Delaware General Corporation Law (or any
successor provision of law); provided, however, that (i) the Trustees or the officers may require any Person to whom access to the Trust&rsquo;s
books and records is granted to enter into a confidentiality agreement on terms acceptable to the Trustees or the officers in their sole
discretion; (ii) the Trustees or the officers may require any Person to whom access to the Trust&rsquo;s books and records is granted
to pay the reasonable expenses associated with providing any such books and records for inspection; (iii) any such inspection shall be
conducted during normal business hours at the Trust&rsquo;s principal place of business or at such other location or during such other
hours as the Trustees or the officers, in their sole discretion, may direct; and (iv) any determinations made by the Trustees or the officers
related to a request to inspect the Trust&rsquo;s books and records pursuant to the foregoing, including, but not limited to, whether
such request is for a proper purpose, shall be conclusive and any Shareholder challenging such determination shall have the burden of
proving that the Trustees or the officers, as the case may be, acted in bad faith in making any such determination.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Section 1.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Notice of Shareholder Business and Nominations</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Annual Meetings of Shareholders</I>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 0.5in; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Nominations of individuals for election as a Trustee of the Trust and the proposal of other business to be considered by the Shareholders
may be made at an annual meeting of Shareholders only as set forth in this Section 1.6, and only:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1in; text-align: justify; text-indent: 1.5in">(A)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>pursuant to the Trust&rsquo;s notice of meeting (or any supplement thereto) given by or at the direction of the Board of Trustees
or any duly authorized committee thereof,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1in; text-align: justify; text-indent: 1.5in">(B)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>otherwise by or at the direction of the Board of Trustees or any duly authorized committee thereof,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1in; text-align: justify; text-indent: 1.5in">(C)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>by any one or more Shareholders of the Trust who (i) at the date of the giving of the notice provided for in this Section 1.6(a)(i)(C),
individually or in the aggregate, hold of record at least 3% of the Shares entitled to vote at the meeting on such election and have held
such Shares continuously for at least one year, and continuously hold such Shares through and including the time of the annual meeting
(including any adjournment or postponement thereof), (ii) are each a Shareholder of the Trust at the time the notice provided for in this
Section 1.6(a)(i)(C) is delivered to the Secretary of the Trust, on the record date for the determination of Shareholders entitled to
notice of and to vote at such annual meeting of Shareholders, and through and including</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1in; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1in; text-align: justify">the time of the annual meeting (including any
adjournment or postponement thereof), (iii) are each entitled to make nominations or proposals and to vote at the meeting and (iv) comply
with the notice procedures set forth in these By-Laws, or</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1in; text-align: justify; text-indent: 1.5in">(D)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>with respect to business other than a nomination, by Shareholder that has notified the Trust of his, her or its intention to present
a proposal at the annual meeting in compliance with Rule 14a-8 promulgated under the Exchange Act (or any successor provision of law)
and which proposal has been included in a proxy statement that has been prepared by the Trust to solicit proxies for such annual meeting
of shareholders.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 0.5in; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>For any nominations or other business to be properly brought before an annual meeting by a Shareholder pursuant to Section 1.6(a)(i)(C),
the Shareholder must have given timely notice thereof in proper written form to the Secretary of the Trust and any such proposed business
(other than the nominations of individuals for election to the Trust) must constitute a proper matter for Shareholder action.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 0.5in; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>To be timely:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1in; text-align: justify; text-indent: 1.5in">(A)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>except as provided in subsection (B), a Shareholder&rsquo;s notice shall be delivered to the Secretary of the Trust at the principal
executive offices of the Trust (x) not earlier than the close of business on the one hundred fiftieth (150th) day prior to the first anniversary
of the preceding year&rsquo;s annual meeting and (y) not later than the close of business on the one hundred twentieth (120th) day prior
to the first anniversary of the preceding year&rsquo;s annual meeting;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1in; text-align: justify; text-indent: 1.5in">(B)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>in the event that the date of the annual meeting is more than thirty (30) days before or more than seventy (70) days after the
first anniversary of the preceding year&rsquo;s annual meeting, a Shareholder&rsquo;s notice shall be delivered to the Secretary of the
Trust at the principal executive offices of the Trust (x) not earlier than the close of business on the one hundred fiftieth (150th) day
prior to the annual meeting, and (y) not later than the close of business on the later of (i) the one hundred twentieth (120th) day prior
to the annual meeting or (ii) the tenth (10th) day following the day on which public announcement of the date of the annual meeting is
first made by the Trust.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 0.5in; text-align: justify; text-indent: 0in">In no event shall
the public announcement or announcement at the meeting of an adjournment or postponement of an annual meeting commence a new time period
(or extend any time period) for the giving of a Shareholder&rsquo;s notice as described above.</P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 0.5in; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 0.5in; text-align: justify; text-indent: 1.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>To be in proper written form, such Shareholder&rsquo;s notice shall set forth:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1in; text-align: justify; text-indent: 1.5in">(A)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>as to any business that the Shareholder proposes to bring before the meeting, a brief description of the business desired to be
brought before the meeting, the text of the proposal or business (including the text of any resolutions proposed for consideration), the
reasons for conducting such business at the meeting and any material interest in such business of such Shareholder and the beneficial
owner, if any, on whose behalf the proposal is made; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1in; text-align: justify; text-indent: 1.5in">(B)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>as to the Shareholder giving the notice and the beneficial owner, if any, on whose behalf the nomination or proposal is made:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1.5in; text-align: justify; text-indent: 1.5in">(1)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the name and address of such Shareholder, as they appear on the Trust&rsquo;s books, and of such beneficial owner,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1.5in; text-align: justify; text-indent: 1.5in">(2)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the class or series and number of Shares which are owned beneficially and of record by such Shareholder and such beneficial owner
and their respective Shareholder Associates,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1.5in; text-align: justify; text-indent: 1.5in">(3)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the name of each nominee holder of Shares owned beneficially but not of record by such Shareholder and such beneficial owner and
their respective Shareholder Associates, and the number of such Shares held by each such nominee holder,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1.5in; text-align: justify; text-indent: 1.5in">(4)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a description of any agreement, arrangement or understanding (whether written or oral) with respect to the nomination or proposal
between or among such Shareholder and such beneficial owner, any of their respective Shareholder Associates, and any others Person or
Persons, including the Proposed Nominee (including their names) in connection with the proposal of such business and any material interest
of such Person or any Shareholder Associate of such Person, in such business, including any anticipated benefit therefrom to such Person,
or any Shareholder Associate of such Person,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1.5in; text-align: justify; text-indent: 1.5in">(5)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a description of any agreement, arrangement or understanding, whether written or oral (including any derivative or short positions,
profit interests, options, warrants, stock appreciation or similar rights, hedging transactions, and borrowed or loaned shares), that
has been entered into </P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1.5in; text-align: justify">as of the date of the Shareholder&rsquo;s notice by, or on behalf of, such Shareholder and such beneficial owners
or their respective Shareholder Associates, the effect or intent of which is to mitigate loss to, manage risk or benefit of share price
changes for, or increase or decrease the voting power of, such Shareholder or such beneficial owner or their respective Shareholder Associates,
with respect to Shares of the Trust,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1.5in; text-align: justify; text-indent: 1.5in">(6)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a description of all commercial and professional relationships and transactions between or among such Shareholder and such beneficial
owners or their respective Shareholder Associates, and any other Person or Persons known to such Shareholder and such beneficial owners
or their respective Shareholders Associate to have a material interest in the matter that is the subject of such notice,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1.5in; text-align: justify; text-indent: 1.5in">(7)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a representation that the Shareholder is a holder of record of Shares of the Trust entitled to vote at such meeting and intends
to appear in person or by proxy at the meeting to propose such business or nomination,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1.5in; text-align: justify; text-indent: 1.5in">(8)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a representation whether the Shareholder or the beneficial owner, if any, intends or is part of a group which intends (a) to deliver
a proxy statement and/or form of proxy to holders of at least the percentage of the Trust&rsquo;s outstanding Shares required to approve
or adopt the proposal or elect the nominee and/or (b) otherwise to solicit proxies from Shareholders in support of such proposal or nomination,
and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1.5in; text-align: justify; text-indent: 1.5in">(9)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any other information relating to such Shareholder and such beneficial owner that would be required to be disclosed in a proxy
statement or other filing required to be made in connection with the solicitation of proxies by such Person with respect to the proposed
business to be brought by such Person before the Annual Meeting pursuant to Section 14 of the Exchange Act and the rules and regulations
promulgated thereunder, whether or not the Shareholder submitting the notice intends to deliver a proxy statement or solicit proxies.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1in; text-align: justify; text-indent: 1.5in">(C)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>As to each individual whom the Shareholder proposes to nominate for election as a Trustee (a &ldquo;<U>Proposed Nominee</U>&rdquo;)
and each Proposed Nominee Associate of such Proposed Nominee:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1.5in; text-align: justify; text-indent: 1.5in">(1)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the name, age, business address and residence address of such Proposed Nominee and each Proposed Nominee Associate of such Proposed
Nominee,</P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1.5in; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1.5in; text-align: justify; text-indent: 1.5in">(2)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the principal occupation or employment of such Proposed Nominee during the past five years,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1.5in; text-align: justify; text-indent: 1.5in">(3)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>other directorships, trusteeships or comparable positions held during the past five years,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1.5in; text-align: justify; text-indent: 1.5in">(4)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the class or series and number of Shares which are owned beneficially and of record by such Proposed Nominee and each Proposed
Nominee Associate of such Proposed Nominee,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1.5in; text-align: justify; text-indent: 1.5in">(5)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the name of each nominee holder of Shares owned beneficially but not of record by such Proposed Nominee and each Proposed Nominee
Associate of such Proposed Nominee, and the number of such Shares held by each such nominee holder,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1.5in; text-align: justify; text-indent: 1.5in">(6)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a description of any agreement, arrangement or understanding, whether written or oral (including any derivative or short positions,
profit interests, options, warrants, stock appreciation or similar rights, hedging transactions, and borrowed or loaned shares), that
has been entered into as of the date of the Shareholder&rsquo;s notice by, or on behalf of, such Proposed Nominee and each Proposed Nominee
Associate of such Proposed Nominee, the effect or intent of which is to mitigate loss to, manage risk or benefit of share price changes
for, or increase or decrease the voting power of, such Proposed Nominee and each Proposed Nominee Associate of such Proposed Nominee,
with respect to Shares of the Trust,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1.5in; text-align: justify; text-indent: 1.5in">(7)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a description of all agreements, arrangements, or understandings (whether written or oral) between such Proposed Nominee and any
Proposed Nominee Associate of such Proposed Nominee related to such nomination or any, and any material interest of such Proposed Nominee
Associate in, such nomination, including any anticipated benefit therefrom to such Proposed Nominee Associate,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1.5in; text-align: justify; text-indent: 1.5in">(8)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a description of all agreements, arrangements, or understandings (whether written or oral) between such Proposed Nominee or any
Proposed Nominee Associate of such Proposed Nominee and the nominating Shareholder or any Shareholder Associate of such nominating Shareholder
related to such nomination, including with respect to the voting of any matters to come before the Board or any anticipated benefit therefrom
to the Proposed Nominee of any Proposed Nominee Associate of such Proposed Nominee,</P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1.5in; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1.5in; text-align: justify; text-indent: 1.5in">(9)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a description of all commercial and professional relationships and transactions between or among such Proposed Nominee or any Proposed
Nominee Associate, and any other Person or Persons known to such Proposed Nominee or Proposed Nominee Associate to have a material interest
in such nomination,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1.5in; text-align: justify; text-indent: 1.5in">(10)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a representation as to whether such Proposed Nominee is an &ldquo;interested person,&rdquo; as defined under Section 2(a)(19) of
the 1940 Act, together with information regarding such individual that is sufficient, in the discretion of the Board of Trustees or any
committee thereof, to examine such representation,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1.5in; text-align: justify; text-indent: 1.5in">(11)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a representation as to whether such Proposed Nominee meets all applicable legal requirements relevant to service as a Trustee,
including, but not limited to, the rules adopted by the principal listing exchange (if any) upon which Shares are listed, Rule 10A-3 under
the Exchange Act, Article 2-01 of Regulation S-X under the Exchange Act (17 C.F.R. &sect; 210.2-01) (with respect to the Trust&rsquo;s
independent registered public accounting firm) and any other criteria established by the 1940 Act related to service as a director/trustee
of a management investment company or the permitted composition of the board of directors/trustees of a management investment company,
together with information regarding such individual that is sufficient, in the discretion of the Board of Trustees or any committee thereof,
to examine such representation,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1.5in; text-align: justify; text-indent: 1.5in">(12)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a representation that the Proposed Nominee satisfies the Trustee qualifications as set out in these By-Laws, together with information
regarding such individual that is sufficient, in the discretion of the Board of Trustees or any committee thereof, to examine such representation,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1.5in; text-align: justify; text-indent: 1.5in">(13)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any other information relating to such Proposed Nominee that would be required to be disclosed in a proxy statement or other filings
required to be made in connection with solicitations of proxies for election of Trustees in a solicitation subject to Rule 14a-12(c) of
the Exchange Act, whether or not the Shareholder submitting the notice intends to deliver a proxy statement or solicit proxies and whether
or not an election contest is involved, and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1.5in; text-align: justify; text-indent: 1.5in">(14)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>such Proposed Nominee&rsquo;s written consent to being named as a nominee and to serving as a Trustee if elected.</P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1.5in; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1in; text-align: justify; text-indent: 1.5in">(D)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Any notice of a Shareholder&rsquo;s intent to nominate a Proposed Nominee must be accompanied by a certificate executed by the
Proposed Nominee certifying that such Proposed Nominee (a) is not, and will not become a party to, any agreement, arrangement or understanding
(whether written or oral) with any Person other than the Trust in connection with service or action as a Trustee of the Trust that has
not been disclosed to the Trust, (b) will serve as a Trustee of the Trust if elected, and (c) satisfies the Trustee qualifications as
set out in Section 2.3 of these By-Laws.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1in; text-align: justify; text-indent: 1.5in">(E)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Trust may require any Proposed Nominee and/or any Shareholder of record nominating such Proposed Nominee to furnish any such
other information as it may reasonably request regarding any such Proposed Nominee and/or any such Shareholder of record nominating such
Proposed Nominee, and such other information shall be received by the Secretary at the principal executive offices of the Trust not later
than seven (7) calendar days after the first request by or on behalf of the Board of Trustees for such other information was sent to such
Shareholder of record, group of Shareholders of record or Proposed Nominee. Any request for any such other information that is not answered
in a reasonably complete, accurate, diligent and good faith manner, or that is not timely received by the Trust in accordance with this
Section 1.6(a)(iv)(E), will render the nomination ineffective for failure to satisfy the requirements of these By-Laws. If the same request
for such other information is sent to multiple Persons, then the earliest such date and time on which such request for information was
sent shall apply for the purpose of determining compliance with this Section 1.6(a)(iv)(E).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1in; text-align: justify; text-indent: 1.5in">(F)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Trust may require any Proposed Nominee to complete and duly execute the Questionnaire; any Questionnaire that is not completed
in a reasonably complete, diligent, accurate and good faith manner, or that is not duly executed and received by the Secretary of the
Trust at the principal executive offices of the Trust not later than seven (7) calendar days after the Board of Trustees or its designee
first sends the Questionnaire to such Proposed Nominee or any Shareholder(s) of record nominating such Proposed Nominee, will render the
nomination ineffective for failure to satisfy the requirements of these By-Laws. If the Questionnaire is sent to multiple Persons, then
the earliest such date and time on which the Questionnaire was sent shall apply for the purpose of determining compliance with this Section
1.6(a)(iv)(F).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1in; text-align: justify; text-indent: 1.5in">(G)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Trust may require any Proposed Nominee to consent to and cooperate with a background screening conducted by a background screening
company selected by the Board of Trustees or any committee thereof.</P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1in; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1in; text-align: justify; text-indent: 1.5in">(H)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>A Shareholder providing notice of any nomination or other business proposed to be brought before an annual meeting of shareholders
shall further update and supplement such notice, if necessary, so that the information provided or required to be provided in such notice
pursuant to Section 1.6(a)(iv) shall be true and correct as of the record date for determining the Shareholders entitled to receive notice
of the annual meeting of Shareholders and such update and supplement shall be received by the Secretary at the principal executive offices
of the Trust not later than seven (7) calendar days after the record date for determining the Shareholders entitled to receive notice
of the annual meeting of Shareholders.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1in; text-align: justify; text-indent: 1.5in">(I)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If information submitted pursuant to this Section 1.6 by any Shareholder or Proposed Nominee shall be or become inaccurate in any
way, such information shall be deemed not to have been provided in accordance with this Section 1.6. Any such Shareholder or Proposed
Nominee shall notify the Trust in writing of any inaccuracy or change and update such information to cause it to be complete and accurate,
within seven (7) calendar days of becoming aware of such inaccuracy. If a Shareholder or Proposed Nominee fails to provide such written
notification and update within such period, the information that was or becomes inaccurate shall be deemed not to have been provided in
accordance with this Section 1.6 and, accordingly, will render the nomination ineffective for failure to satisfy the requirements of these
By-Laws. Upon written request by the Secretary of the Trust or the Board of Trustees, any such Shareholder or Proposed Nominee shall provide,
within seven (7) calendar days of the sending of such request (or such other period as may be specified in such request), (A) written
verification, satisfactory, in the discretion of the Board of Trustees or any authorized officer of the Trust, to demonstrate the accuracy
of any information submitted by the Shareholder or Proposed Nominee pursuant to this Section 1.6, and (B) a written update of any information
(including, if requested by the Trust, written confirmation by such Shareholder that it continues to intend to bring such nomination)
submitted by the Shareholder or the Proposed Nominee pursuant to this Section 1.6 as of an earlier date. If a Shareholder or Proposed
Nominee fails to provide such written verification or written update within such period, the information as to which written verification
or a written update was requested shall be deemed not to have been provided in accordance with this Section 1.6 and, accordingly, will
render the nomination ineffective for failure to satisfy the requirements of these By-Laws.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1in; text-align: justify; text-indent: 1.5in">(J)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The foregoing notice requirements of this Section 1.6 shall be deemed satisfied by a Shareholder with respect to business other
than a nomination if the Shareholder has notified the Trust of his, her or its intention to present a proposal at an annual or special
meeting in compliance with Rule 14a-8 promulgated under the Exchange</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1in; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1in; text-align: justify">Act (or any successor provision of law) and such Shareholder&rsquo;s
proposal has been included in a proxy statement that has been prepared by the Trust to solicit proxies for such annual or special meeting.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Special Meetings of Shareholders</I>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 0.5in; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Special meetings of Shareholders shall be called only as contemplated by Section 10.1 of the Declaration.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 0.5in; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Only such business shall be conducted at a special meeting of Shareholders as shall have been brought before the meeting pursuant
to the Trust&rsquo;s notice of meeting.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 0.5in; text-align: justify; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Nominations of individuals for election to the Board of Trustees may be made at a special meeting of Shareholders at which Trustees
are to be elected pursuant to the Trust&rsquo;s notice of meeting only as set forth in this Section 1.6, and only:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1in; text-align: justify; text-indent: 1.5in">(A)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>pursuant to the Trust&rsquo;s notice of meeting (or any supplement thereto) given by or at the direction of the Board of Trustees
or any duly authorized committee thereof,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1in; text-align: justify; text-indent: 1.5in">(B)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>otherwise by or at the direction of the Board of Trustees or any duly authorized committee thereof, or</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1in; text-align: justify; text-indent: 1.5in">(C)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>provided that the Board of Trustees has determined that Trustees shall be elected at such special meeting, by one or more Shareholders
of the Trust who (i) at the date of the giving of the notice provided for in this Section 1.6(b)(iii)(C), individually or in the aggregate,
hold of record at least 3% of the Shares entitled to vote at the meeting on such election and have held such Shares continuously for at
least one year, and continuously hold such Shares through and including the time of the annual meeting (including any adjournment or postponement
thereof), (ii) are each a Shareholder of the Trust at the time the notice provided for in this Section 1.6(b)(iii)(C) is delivered to
the Secretary of the Trust, on the record date for the determination of Shareholders entitled to notice of and to vote at such special
meeting of Shareholders, and through and including the time of the annual meeting (including any adjournment or postponement thereof),
(iii) are each entitled to make nominations and to vote at the meeting and (iv) comply with the notice procedures set forth in these By-Laws.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 0.5in; text-align: justify; text-indent: 1.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In the event a special meeting of Shareholders is called pursuant to Section 10.1 of the Declaration for the purpose of electing
one or more Trustees to the Board of Trustees, for any nominations to be properly brought before such special meeting by a Shareholder
pursuant to Section 1.6(b)(iii)(C), the Shareholder must have given timely notice thereof in proper written form to the Secretary of the
Trust.</P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 0.5in; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 0.5in; text-align: justify; text-indent: 1.5in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>To be timely, a Shareholder&rsquo;s notice of a nomination for election to the Board of Trustees at a special meeting of Shareholders
at which Trustees are to be elected pursuant to the Trust&rsquo;s notice of meeting shall be delivered to the Secretary of the Trust at
the principal executive offices of the Trust (x) not earlier than the close of business on the one hundred fiftieth (150<SUP>th</SUP>)
day prior to such special meeting and (y) not later than the close of business on the later of (i) the one hundred twentieth (120<SUP>th</SUP>)
day prior to such special meeting or (ii) the tenth (10<SUP>th</SUP>) day following the day on which public announcement is first made
of the date of the special meeting and of the nominees proposed by the Board of Trustees to be elected at such meeting. In no event shall
the public announcement or announcement at the meeting of an adjournment or postponement of a special meeting commence a new time period
(or extend any time period) for the giving of a Shareholder&rsquo;s notice as described above.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 0.5in; text-align: justify; text-indent: 1.5in">(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>To be in proper written form, such Shareholder&rsquo;s notice shall set forth all information required by Section 1.6(a)(iv).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 0.5in; text-align: justify; text-indent: 1.5in">(vii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>A Shareholder providing notice of any nomination to be brought before a special meeting of Shareholders at which Trustees are to
be elected pursuant to the Trust&rsquo;s notice of meeting shall further update and supplement such notice, if necessary, so that the
information provided or required to be provided in such notice pursuant to Section 1.6(b)(vi) shall be true and correct as of the record
date for determining the Shareholders entitled to receive notice of the special meeting of Shareholders and such update and supplement
shall be delivered to or be mailed and received by the Secretary at the principal executive offices of the Trust not later than seven
(7) calendar days after the record date for determining the Shareholders entitled to receive notice of the special meeting of Shareholders.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 1.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>General</I>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 0.5in; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Only such individuals who are nominated in accordance with the procedures set forth in this Section 1.6 shall be eligible to be
elected at an annual or special meeting of Shareholders of the Trust to serve as Trustees and only such business shall be conducted at
a meeting of Shareholders as shall have been brought before the meeting in accordance with the procedures set forth in this Section 1.6.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 0.5in; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If the Shareholders of any class or series of Shares are entitled separately to elect one or more Trustees, only such Persons who
are holders of record of such class or series of Shares at the time notice is provided pursuant to this Section 1.6 and on the record
date for the determination of Shareholders entitled to notice of and to vote at such annual meeting or special meeting of Shareholders
shall be entitled to nominate individuals for election as a Trustee by such class or series of Shares voting separately.</P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 0.5in; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 0.5in; text-align: justify; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding the foregoing provisions of this Section 1.6, unless otherwise required by law, if the Shareholder (or a qualified
representative of the Shareholder) does not appear at the annual or special meeting of Shareholders of the Trust to present a nomination
or proposed business, such nomination shall be disregarded and such proposed business shall not be transacted, notwithstanding that proxies
in respect of such vote may have been received by the Trust. For purposes of this Section 1.6, to be considered a qualified representative
of the Shareholder, a Person must be a duly authorized officer, manager or partner of such Shareholder or must be authorized by a writing
executed by such Shareholder delivered by such Shareholder to act for such Shareholder as proxy at the meeting of Shareholders and such
Person must produce such writing at the meeting of Shareholders.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 0.5in; text-align: justify; text-indent: 1.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding the foregoing provisions of this Section 1.6, a Shareholder shall also comply with all applicable requirements
of the Exchange Act and the rules and regulations thereunder with respect to the matters set forth in this Section 1.6; provided however,
that any references in these By-laws to the Exchange Act or the rules promulgated thereunder are not intended to and shall not limit any
requirements applicable to nominations or proposals as to any other business to be considered pursuant to this Section 1.6, and compliance
with Sections 1.6(a) and 1.6(b) shall be the exclusive means for a Shareholder to make nominations or submit other business (other than,
as provided in Section 1.6(a)(v), matters brought properly under and in compliance with Rule 14a-8 of the Exchange Act (or any successor
provision of law)).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 0.5in; text-align: justify; text-indent: 1.5in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding anything to the contrary in this Section 1.6 or otherwise in these By-laws, except with respect to nominations
of individuals for election as a Trustee of the Trust or as required by federal law, no proposal of other business may be considered or
brought at a meeting of Shareholders unless such matter has been approved for these purposes by a majority of the Trustees.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 0.5in; text-indent: 1.5in">(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>A notice of one or more Shareholders making a nomination pursuant to Section 1.6(a)(i)(C)(i) or 1.6(b)(iii)(C)(i), as applicable,
shall be accompanied by a:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1in; text-align: justify; text-indent: 1.5in">(A)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>signed statement of each Shareholder giving the notice certifying that (1) all information contained in the notice is true and
complete in all respects, (2) the notice complies with this Section 1.6, and (3) such Shareholder will continue to hold all Shares referenced
in Section 1.6(a)(i)(C)(i) or 1.6(b)(iii)(C)(i), as applicable, through and including the time of the annual meeting (including any adjournment
or postponement thereof);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1in; text-align: justify; text-indent: 1.5in">(B)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>and a signed certificate of each Proposed Nominee (1) certifying that the information contained in the notice regarding such Proposed
Nominee and any Proposed Nominee Associated </P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1in; text-align: justify">Person is true and complete and complies with this Section 1.6 and (2) consenting to being
named in the Shareholder&rsquo;s proxy statement as a nominee and to serving as a Trustee if elected.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 0.5in; text-align: justify; text-indent: 1.5in">(vii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>All judgments and determinations made by the Board of Trustees or the chairman of the meeting, as applicable, under this Section
1.6 (including, without limitation, judgments as to whether any matter or thing is satisfactory to the Board of Trustees and determinations
as to the propriety of a proposed nomination or a proposal of other business for consideration by Shareholders) shall be final and binding
unless determined by a court of competent jurisdiction to have been made in bad faith.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 0.5in; text-indent: 1.5in">(viii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding anything in these By-Laws to the contrary, no business, including nominations, shall be conducted at any annual
or special meeting except in accordance with the procedures set forth in this Section 1.6. The chairman of the annual or special meeting
shall, if the facts warrant, determine and declare to the meeting that business was not properly brought before the meeting in accordance
with the provisions of this Section 1.6, and, if the chairman should determine, the chairman shall so declare to the meeting that any
such business not properly brought before the meeting shall not be considered or transacted.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">Section 1.7<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Special Shareholders Meetings</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Special meetings of Shareholders may be called only by the Board of Trustees (or any duly authorized committee), except a special
meeting shall be called by the Trustees upon the timely receipt by the Secretary of a request in proper written form from one or more
Shareholders acting pursuant to and in accordance with Section 10.1 of the Declaration. Only such business shall be conducted at a special
meeting as shall be specified in the notice of meeting (or any supplement thereto). In fixing a date for any special meeting, the Board
of Trustees (or any duly authorized committee thereof) may consider such factors as it deems relevant, including, without limitation,
the nature of the matters to be considered, the facts and circumstances surrounding any request for the meeting and any plan of the Board
of Trustees to call an annual meeting or a special meeting.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Any Shareholder(s) seeking to request a special meeting shall send written notice to the Secretary (the &ldquo;<U>Special Meeting
Request</U>&rdquo;) by registered mail, return receipt requested, requesting the Secretary to call a special meeting. Proof of the requesting
Shareholder&rsquo;s ownership of Shares at the time of giving the Special Meeting Request must accompany the requesting Shareholder&rsquo;s
Special Meeting Request. The Special Meeting Request shall set forth the purpose of the meeting and the matters proposed to be acted on
at the meeting, shall be signed by one or more Shareholders (or their duly authorized agents), shall bear the date of signature of each
requesting Shareholder (or its duly authorized agent) signing the Special Meeting Request and shall set forth all information that each
such Shareholder and, with respect to the beneficial</P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify"> owners of Shares on whose behalf such request is being made, each such beneficial
owner of Shares would be required to disclose in a proxy statement or other filings required to be made in connection with solicitations
of proxies with respect to the proposed business to be brought before the meeting pursuant to Section 14 of the Exchange Act, whether
or not such Person intends to deliver a proxy statement or solicit proxies, as well as all additional information required by Section
1.6(a)(iv) of these By-Laws. Upon receiving the Special Meeting Request, the Trustees may in their discretion fix a date for the special
meeting, which need not be the same date as that requested in the Special Meeting Request.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 1.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Shareholder(s) providing notice of business proposed to be brought before a special meeting shall further update and supplement
such notice, if necessary, so that the information provided or required to be provided in such notice pursuant to this Section 1.7 shall
be true and correct as of the record date for determining the Shareholders entitled to receive notice of the special meeting and such
update and supplement shall be delivered to or be mailed and received by the Secretary at the principal executive offices of the Trust
not later than five (5) business days after the record date for determining the Shareholders entitled to receive notice of the special
meeting.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 1.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Board of Trustees shall determine the validity of any purported Special Meeting Request received by the Secretary.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 1.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No business shall be conducted at a special meeting of Shareholders except business brought before any such meeting in accordance
with the procedures set forth in this Section 1.7 and in compliance with Section 10.1 of the Declaration. If the chairman of a special
meeting determines that business was not properly brought before such meeting in accordance with the foregoing procedures, the chair shall
declare to the meeting that the business was not properly brought before the meeting and such business shall not be transacted.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 1.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Nothing contained in this Section 1.7 shall be deemed to affect any rights of Shareholders to request inclusion of proposals in
the Trust&rsquo;s proxy statement pursuant to Rule 14a-8 under the Exchange Act (or any successor provision of law).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in">Section 1.8<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Conduct of Meetings.</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Every meeting of Shareholders shall be conducted by an individual appointed by the Board of Trustees to be chairman of the meeting
or, in the absence of such appointment or appointed individual, by the chairman of the Board of Trustees, by one of the officers present
at the meeting, and if no officer is present, by Shareholders by the vote of a majority of the votes cast by Shareholders present in person
or by proxy. The Secretary, or, in the Secretary&rsquo;s absence, an Assistant Secretary, or, in the absence of both the Secretary and
Assistant Secretaries, an individual appointed by the Board of Trustees or, in the absence of such appointment, an individual appointed
by the chairman of the meeting shall act as secretary of the meeting.</P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as otherwise provided by law, the chairman of any meeting of Shareholders shall have the power and duty:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 0.5in; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>to determine whether a nomination or any business proposed to be brought before the meeting was made or proposed, as the case may
be, in accordance with the procedures set forth in Section 1.6 (including whether the Shareholder or beneficial owner, if any, on whose
behalf the nomination or proposal is made solicited (or is part of a group which solicited) or did not so solicit, as the case may be,
proxies in support of such Shareholder&rsquo;s nominee or proposal in compliance with such Shareholder&rsquo;s representation as required
by Section 1.6(a)(iv)(B)(8)), and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 0.5in; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>if any proposed nomination or business was not made or proposed in compliance with Section 1.6, to declare that such nomination
shall be disregarded or that such proposed business shall not be transacted; provided, however, that such nomination or such proposed
business shall not be presumed to be valid in the absence of such a declaration.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 1.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Board of Trustees may adopt by resolution such rules and regulations for the conduct of any meeting of the Shareholders as
it shall deem appropriate. Except to the extent inconsistent with such rules and regulations as adopted by the Board of Trustees, the
chairman of any meeting of Shareholders shall have the right and authority to prescribe such rules, regulations and procedures and to
do all such acts as, in the judgment of such chair, are appropriate for the proper conduct of the meeting. Such rules, regulations or
procedures, whether adopted by the Board of Trustees or prescribed by the chairman of the meeting, may include, without limitation, the
following: (a) the establishment of an agenda or order of business for the meeting; (b) the determination of when the polls shall open
and close for any given matter to be voted on at the meeting; (c) rules and procedures for maintaining order at the meeting and the safety
of those present; (d) limitations on attendance at and participation in the meeting to Shareholders, their duly authorized and constituted
proxies or such other Persons as the chair of the meeting shall determine; (e) restrictions on entry to the meeting after the time fixed
for the commencement thereof; (f) limitations on the time allotted to questions or comments by Shareholders; and (g) the extent to which,
if any, other participants are permitted to speak.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Section 1.9<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Adjourned Meeting</U>. Subject to the requirements of Section 10.3 of the Declaration, any meeting of Shareholders, whether
or not a quorum is present, may be adjourned from time to time by: (a) the vote of the majority of the Shares represented at that meeting,
either in person or by proxy; or (b) by the chairman of the meeting, in his or her discretion. At any adjourned meeting, any business
may be transacted which might have been transacted at the original meeting.</P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">ARTICLE
II<U><BR>
<BR>
Trustees</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Section 2.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Annual and Regular Meetings</U>. Regular meetings of the Trustees may be held without call or notice and shall generally be
held quarterly. Neither the business to be transacted at, nor the purpose of, any meeting of the Board of Trustees need be stated in the
notice or waiver of notice of such meeting, and no notice need be given of action proposed to be taken by unanimous written consent.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Section 2.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Chairman</U>. The Board of Trustees may elect from among its members a Chairman of the Board. The Chairman of the Board, if
any, shall preside over all meetings of the Board of Trustees. In absence of a Chairman, the Trustees present shall elect one of their
number to act as temporary chairman. The Chairman shall have such other responsibilities in furthering the Board&rsquo;s functions as
may be prescribed from time to time by resolution of the Board. The Chairman of the Board, if any, shall be elected by the Board of Trustees
to hold office until his successor shall have been duly elected and shall have qualified, or until his death, or until he shall have resigned,
or have been removed, as herein provided in these by-laws. The Chairman of the Board, if any, may resign at any time by giving written
notice of resignation to the Board of Trustees. Any such resignation shall take effect at the time specified therein or, if the time when
it shall become effective shall not be specified therein, immediately upon its receipt; and, unless otherwise specified therein, the acceptance
of such resignation shall not be necessary to make it effective. The Chairman of the Board, if any, may be removed by the Board of Trustees
with or without cause at any time.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Section 2.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Qualifications</U>. After Shares have been publicly offered, only individuals satisfying the following qualification requirements
applicable to all Trustees may be nominated, elected, appointed, qualified or seated (&ldquo;<U>nominated or seated</U>&rdquo;) to serve
as a Trustee unless a majority of the Trustees then in office shall have determined by resolution that failure to satisfy a particular
qualification requirement will not present undue conflicts or impede the ability of the individual to discharge the duties of a Trustee
or the free flow of information among Trustees or between the Trust&rsquo;s investment adviser, servicing agent and the Board of Trustees:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>An individual nominated or seated as a Trustee shall be at least thirty-five (35) years of age and not older than sixty-five (65)
years of age and not under legal disability,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>An individual nominated or seated as a Trustee shall, at the time the individual is nominated or seated, serve as a director of
no more than 5 companies having securities registered under the Exchange Act or treated as public reporting companies under any comparable
regulatory regime (investment companies having the same investment adviser or investment advisers in a control relationship with each
other shall all be counted as a single company for this purpose),</P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 1.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>An individual nominated or seated as a Trustee shall not be or have been within the last five full calendar years and the current
year an employee, officer, partner, member, manager, managing member, trustee or director (or Person performing similar functions) of
(A) any investment adviser or Person in a control relationship with such investment adviser (other than the Trust&rsquo;s investment adviser
or servicing agent or any investment adviser in a control relationship with the Trust&rsquo;s investment adviser or servicing agent) or
(B) any investment fund or Person in a control relationship with such investment fund (other than the Trust or any investment fund managed
by the Trust&rsquo;s investment adviser or servicing agent or an investment adviser in a control relationship with the Trust&rsquo;s investment
adviser or servicing agent),</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 1.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>An individual nominated or seated as a Trustee shall not have been nominated or seated as a trustee, manager or director of an
investment fund (other than the Trust or any investment fund managed by the Trust&rsquo;s investment adviser or servicing agent or an
investment adviser in a control relationship with the Trust&rsquo;s investment adviser or servicing agent) within the last five full calendar
years and the current year,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 1.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>An individual nominated or seated as a Trustee shall not have been charged (unless such charges were dismissed or the individual
was otherwise exonerated) with a criminal offense involving moral turpitude, dishonesty or breach of trust, or have been convicted or
have pled guilty or <I>nolo contendere</I> with respect to a felony under the laws of the United States or any state thereof,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 1.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>An individual nominated or seated as a Trustee shall not (A) be and shall not have been subject to any censure, order, consent
decree (including consent decrees in which the respondent has neither admitted nor denied the findings) or adverse final action of any
federal, state or foreign governmental or regulatory authority (including self-regulatory organizations), barring or suspending such individual
from participation in or association with any investment-related business or restricting such individual&rsquo;s activities with respect
to any investment-related business, (B) be the subject of any investigation or proceeding that if decided adversely could reasonably be
expected to result in an individual nominated or seated as a Trustee failing to satisfy the requirements of clause (A) of this paragraph,
nor (C) be or have engaged in any conduct which has resulted in, or could have reasonably been expected or would reasonably be expected
to result in, the Commission censuring, placing limitations on the activities, functions, or operations of, suspending, or revoking the
registration of any investment adviser under Section 203(e) or (f) of the Investment Advisers Act of 1940,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 1.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>An individual nominated or seated as a Trustee shall not be and shall not have been the subject of any of the ineligibility provisions
contained in Section 9(a) of the 1940 Act that would result in, or could have reasonably been expected or would reasonably be expected
to result in such individual or a company of which such individual is an affiliated person (as defined in Section 2(a)(3) of the 1940
Act) being ineligible, in the absence of an exemptive order under Section 9(c) of the 1940 Act, to serve or act in the capacity of employee,
officer, director, member of an advisory board, investment adviser, or depositor of any registered investment company, or principal </P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify">underwriter
for any registered investment company, registered unit investment trust, or registered face-amount certificate company,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 1.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>An individual nominated or seated as a Trustee shall not be and shall not have been the subject of any of the ineligibility provisions
contained in Section 9(b) of the 1940 Act that, in the absence of an exemptive order under Section 9(c) of the 1940 Act, would permit,
or could reasonably have been expected or would reasonably be expected to permit the Commission by order to prohibit, conditionally or
unconditionally, either permanently or for a period of time, such individual from serving or acting as an employee, officer, director,
member of an advisory board, investment adviser or depositor of, or principal underwriter for, a registered investment company or affiliated
person (as defined in Section 2(a)(3) of the 1940 Act) of such investment adviser, depositor, or principal underwriter,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>An individual nominated or seated as an Independent Trustee shall not be an &ldquo;interested person,&rdquo; as defined under Section
2(a)(19) of the 1940 Act, of the Trust,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 1.5in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>An individual nominated or seated as a Trustee shall not fail to comply with any other criteria established by the 1940 Act related
to service as a director/trustee of a management investment company and shall not cause (in the case of a nomination, if seated) the Trust&rsquo;s
Board of Trustees to fail to comply with any criteria established by the 1940 Act governing the permitted composition of the board of
directors/trustees of a management investment company,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 1.5in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>An individual nominated or seated as a Trustee shall not, and any immediate family member of such nominee shall not, be employed
or have been employed within the last five full calendar years and the current year by a <B>12(d) Holder</B>, or by any Person who controls,
is controlled by, under common control with or acts in concert with a 12(d) Holder,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 1.5in">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>An individual nominated or seated as a Trustee shall not, and any immediate family member of such nominee shall not, have accepted
directly or indirectly, during the calendar year of the election for which such individual is nominated or seated, or during the immediately
preceding five calendar years, any consulting, advisory, or other compensatory fee from any 12(d) Holder or from any Person who controls,
is controlled by, is under common control with or acts in concert with any 12(d) Holder,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 1.5in">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>An individual nominated or seated as a Trustee shall not, and any immediate family member of such nominee shall not, be, or have
been within the last five full calendar years and the current year, an officer, trustee, director, partner, manager or managing member
(or Person performing similar functions) of any 12(d) Holder or of any Person who controls, is controlled by, is under common control
with or is acting in concert with a 12(d) Holder; and</P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 1.5in">(n)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>An individual nominated or seated as a Trustee, and any immediate family member of such nominee, shall not, and shall not have
within the last five full calendar years and the current year, control or act in concert with any 12(d) Holder or any Person who controls,
is controlled by, is under common control with or is acting in concert with a 12(d) Holder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Section 2.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Standard of Care</U>. It shall be understood that each Trustee, including the Chairman of the Board or any chairman or member
of any committee of the Board created herein or by the Board of Trustees shall have the same level of responsibility to the Trust required
of his or her being a Trustee, regardless of (a) any other position held with the Trust, (b) the Trustee&rsquo;s individual training or
expertise and (c) the role performed by the Trustee on behalf of the Trust in his or her capacity as Trustee even if such role requires
the Trustee to possess specific or unique qualifications under applicable binding law or regulation. The Chairman of the Board or any
chairman or member of any committee of the Board created herein or by the Board of Trustees shall serve in such capacity for the Board
of Trustees and does not serve in such capacity as an officer of the Trust.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Section 2.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Governance</U>. The Board of Trustees may from time to time require all its members and any Proposed Nominee to agree in writing
as to matters of corporate governance, business ethics and confidentiality while such Persons serve as a Trustee, such agreement to be
on the terms and in a form determined satisfactory by the Board of Trustees, as amended and supplemented from time to time in the discretion
of the Board of Trustees.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Section 2.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Records</U>. The results of all actions taken at a meeting of the Trustees, or by the written consent of the number of Trustees
required to take such action, shall be recorded by the person appointed by the Board of Trustees as the meeting secretary.</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">ARTICLE
III<U><BR>
<BR>
Officers</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Section 3.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Officers of the Trust</U>. The officers of the Trust shall consist of a President, a Secretary, a Treasurer and such other officers
or assistant officers as may be elected or authorized by the Trustees. Any two or more of the offices may be held by the same Person,
except that the same person may not be both President and Secretary. No officer of the Trust need be a Trustee.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Section 3.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Election and Tenure</U>. At the initial organization meeting, the Trustees shall elect the President, Secretary, Treasurer and
such other officers as the Trustees shall deem necessary or appropriate in order to carry out the business of the Trust. Such officers
shall serve at the pleasure of the Trustees or until their successors have been duly elected and qualified. The Trustees may fill any
vacancy in office or add any additional officers at any time.</P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Section 3.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Removal of Officers</U>. Any officer may be removed at any time, with or without cause, by action of a majority of the Trustees.
This provision shall not prevent the making of a contract of employment for a definite term with any officer and shall have no effect
upon any cause of action which any officer may have as a result of removal in breach of a contract of employment. Any officer may resign
at any time by notice in writing signed by such officer and delivered or mailed to the President or Secretary, and such resignation shall
take effect immediately upon receipt by the President or Secretary, or at a later date according to the terms of such notice in writing.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Section 3.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Bonds and Surety</U>. Any officer may be required by the Trustees to be bonded for the faithful performance of such officer&rsquo;s
duties in such amount and with such sureties as the Trustees may determine.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Section 3.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>President, and Vice Presidents</U>. Subject to such supervisory powers, if any, as may be given by the Trustees to the Chairman,
if any, the President shall be the chief executive officer of the Trust and, subject to the control of the Trustees, shall have general
supervision, direction and control of the business of the Trust and of its employees and shall exercise such general powers of management
as are usually vested in the office of President of a corporation. Subject to direction of the Trustees, the President shall each have
power in the name and on behalf of the Trust to execute any and all loans, documents, contracts, agreements, deeds, mortgages, registration
statements, applications, requests, filings and other instruments in writing, and to employ and discharge employees and agents of the
Trust. Unless otherwise directed by the Trustees, the President shall each have full authority and power, on behalf of all of the Trustees,
to attend and to act and to vote, on behalf of the Trust at any meetings of business organizations in which the Trust holds an interest,
or to confer such powers upon any other persons, by executing any proxies duly authorizing such persons. The President shall have such
further authorities and duties as the Trustees shall from time to time determine. In the absence or disability of the President, the Vice-Presidents
in order of their rank as fixed by the Trustees or, if more than one and not ranked, the Vice-President designated by the Trustees, shall
perform all of the duties of the President, and when so acting shall have all the powers of and be subject to all of the restrictions
upon the President. Subject to the direction of the Trustees, and of the President, each Vice-President shall have the power in the name
and on behalf of the Trust to execute any and all instruments in writing, and, in addition, shall have such other duties and powers as
shall be designated from time to time by the Trustees or by the President.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Section 3.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Secretary</U>. The Secretary shall maintain the minutes of all meetings of, and record all votes of, Shareholders, Trustees
and the Executive Committee, if any. The Secretary shall be custodian of the seal of the Trust, if any, and the Secretary (and any other
person so authorized by the Trustees) shall affix the seal, or if permitted, facsimile thereof, to any instrument executed by the Trust
which would be sealed by a Delaware business corporation executing the same or a similar instrument and shall attest the seal and the
signature or signatures of the officer or officers executing such instrument on behalf of the Trust. The Secretary shall also perform
any other duties commonly incident to such office in a Delaware business corporation, and shall have such other authorities and duties
as the Trustees shall from time to time determine.</P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Section 3.7<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Treasurer</U>. Except as otherwise directed by the Trustees, the Treasurer shall have the general supervision of the monies,
funds, securities, notes receivable and other valuable papers and documents of the Trust, and shall have and exercise under the supervision
of the Trustees and of the President all powers and duties normally incident to the office. The Treasurer may endorse for deposit or collection
all notes, checks and other instruments payable to the Trust or to its order. The Treasurer shall deposit all funds of the Trust in such
depositories as the Trustees shall designate. The Treasurer shall be responsible for such disbursement of the funds of the Trust as may
be ordered by the Trustees or the President. The Treasurer shall keep accurate account of the books of the Trust&rsquo;s transactions
which shall be the property of the Trust, and which together with all other property of the Trust in the Treasurer&rsquo;s possession,
shall be subject at all times to the inspection and control of the Trustees. Unless the Trustees shall otherwise determine, the Treasurer
shall be the principal accounting officer of the Trust and shall also be the principal financial officer of the Trust. The Treasurer shall
have such other duties and authorities as the Trustees shall from time to time determine.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Section 3.8<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Other Officers and Duties</U>. The Trustees may elect such other officers and assistant officers as they shall from time to
time determine to be necessary or desirable in order to conduct the business of the Trust. Assistant officers shall act generally in the
absence of the officer whom they assist and shall assist that officer in the duties of the office. Each officer, employee and agent of
the Trust shall have such other duties and authority as may be conferred upon such person by the Trustees or delegated to such person
by the President.</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">ARTICLE
IV<U><BR>
<BR>
Miscellaneous</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Section 4.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Depositories</U>. In accordance with Section 7.1 of the Declaration, the funds of the Trust shall be deposited in such custodians
as the Trustees shall designate and shall be drawn out on checks, drafts or other orders signed by such officer, officers, agent or agents
(including the adviser, administrator or manager), as the Trustees may from time to time authorize.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Section 4.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Signatures</U>. All contracts and other instruments shall be executed on behalf of the Trust by its properly authorized officers,
agent or agents, as provided in the Declaration or By-laws or as the Trustees may from time to time by resolution provide.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Section 4.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Seal</U>. The Trust is not required to have any seal, and the adoption or use of a seal shall be purely ornamental and be of
no legal effect. The seal, if any, of the Trust may be affixed to any instrument, and the seal and its attestation may be lithographed,
engraved or otherwise printed on any document with the same force and effect as if it had been imprinted and affixed manually in the same
manner and with the same force and effect as if done by a Delaware business corporation. The presence or absence of a seal shall have
no effect on the validity, enforceability or binding nature of any document or instrument that is otherwise duly authorized, executed
and delivered.</P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Section 4.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Disclosure of Holdings</U>. The holders of Shares or other securities of the Trust shall upon demand disclose to the Trustees
in writing such information with respect to direct and indirect ownership, control over, holding with power to vote or other beneficial
ownership of Shares or other securities of the Trust as the Trustees deem necessary or appropriate.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Section 4.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Governing Law</U>. These By-Laws and the rights of all parties and the validity and construction of every provision hereof shall
be subject to and construed according to the laws of the state of Delaware, although such law shall not be viewed as limiting the powers
otherwise granted to the Trustees hereunder and any ambiguity shall be viewed in favor of such powers.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">Section 4.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Provisions in Conflict with Law or Regulations</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The provisions of these By-Laws are severable, and if the Trustees shall determine, with the advice of counsel, that any of such
provisions is in conflict with the 1940 Act, the regulated investment company provisions of the Code or with other applicable binding
laws and regulations, the conflicting provision shall be deemed never to have constituted a part of these By-Laws; provided, however,
that such determination shall not affect any of the remaining provisions of these By-Laws or render invalid or improper any action taken
or omitted prior to such determination.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If any provision of these By-Laws shall be held invalid or unenforceable in any jurisdiction, such invalidity or unenforceability
shall attach only to such provision in such jurisdiction and shall not in any manner affect such provision in any other jurisdiction or
any other provision of these By-Laws in any jurisdiction.</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">ARTICLE
V<U><BR>
<BR>
Stock Transfers</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Section 5.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Transfer Agents, Registrars and the Like</U>. As provided in Section 6.7 of the Declaration, the Trustees shall have authority
to employ and compensate such transfer agents and registrars with respect to the Shares of the Trust as the Trustees shall deem necessary
or desirable. In addition, the Trustees shall have power to employ and compensate such dividend disbursing agents, warrant agents and
agents for the reinvestment of dividends as they shall deem necessary or desirable. Any of such agents shall have such power and authority
as is delegated to any of them by the Trustees.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Section 5.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Transfer of Shares</U>. The Shares of the Trust shall be transferable on the books of the Trust only upon delivery to the Trustees
or a transfer agent of the Trust of proper documentation as provided in Section 6.8 of the Declaration. The Trust, or its transfer agents,
shall be authorized to refuse any transfer unless and until presentation of such evidence as may be reasonably required to show that the
requested transfer is proper.</P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Section 5.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Registered Shareholders</U>. The Trust may deem and treat the holder of record of any Shares as the absolute owner thereof for
all purposes and shall not be required to take any notice of any right or claim of right of any other Person.</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">ARTICLE
VI<U><BR>
<BR>
Amendment of By-Laws</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Section 6.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Amendment and Repeal of By-Laws</U>. In accordance with Section 3.9 of the Declaration, the Trustees shall have the power to
amend or repeal the By-Laws or adopt new By-Laws at any time. Action by the Trustees with respect to the By-Laws shall be taken by an
affirmative vote of a majority of the Trustees. The Trustees shall in no event adopt By-Laws which are in conflict with the Declaration,
and any apparent inconsistency shall be construed in favor of the related provisions in the Declaration.</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">ARTICLE
VII<U><BR>
<BR>
CHOICE OF FORUM PROVISION</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 1in">Section 7.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Forum for Adjudication of Certain Disputes</U>. Pursuant to Section 3804(e) of the Delaware Act, unless the Trust consents in
writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall be the sole and exclusive forum
for (i) any derivative action or proceeding brought on behalf of the Trust, (ii) any action asserting a claim of breach of a fiduciary
duty owed by any trustee, officer, or employee of the Trust to the Trust or its Shareholders, (iii) any action asserting a claim against
the Trust or any trustee, officer, or employee of the Trust arising pursuant to any provision of the Delaware Statutory Trust Act or the
Trust&rsquo;s Declaration or these By-Laws, or (iv) any action asserting a claim against the Trust or any trustee, officer, or employee
of the Trust governed by the internal affairs doctrine of the State of Delaware; provided, however, that, in the event that the Court
of Chancery of the State of Delaware lacks jurisdiction over any such action or proceeding, the sole and exclusive forum for such action
or proceeding shall be another state or federal court located within the State of Delaware. Failure to enforce the foregoing provisions
would cause the Trust irreparable harm and the Trust shall be entitled to equitable relief, including injunctive relief and specific performance,
to enforce the foregoing provisions. This Section 7.1 does not apply to any claim under the United States federal securities laws.</P>

<P STYLE="text-align: center; font: 12pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 12pt"><FONT STYLE="font-size: 9pt">26</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>4
<FILENAME>ex99l.htm
<DESCRIPTION>CONSENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 17pt EngraversGothic BT,sans-serif; margin: 0; text-align: center"><FONT STYLE="font-variant: small-caps; letter-spacing: 1pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 17pt EngraversGothic BT,sans-serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 85%">&nbsp;</TD>
  <TD STYLE="width: 15%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><P STYLE="font: 17pt EngraversGothic BT,sans-serif; margin: 0; text-align: center"><FONT STYLE="font-variant: small-caps; letter-spacing: 1pt">Skadden,
Arps, Slate, Meagher &amp; Flom llp</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 2pt 0 0; text-align: center">&nbsp;</P>



<P STYLE="text-align: center; margin-top: 0; font: 11pt EngraversGothic BT,sans-serif; margin-bottom: 0"><FONT STYLE="text-transform: uppercase; letter-spacing: 1pt">320 South
canal StReEt</FONT></P>

<P STYLE="font: 11pt EngraversGothic BT,sans-serif; margin: 2pt 0 0; text-align: center"><FONT STYLE="text-transform: uppercase; letter-spacing: 1pt">Chicago,
Illinois 60606-5707</FONT></P>

<P STYLE="font: 4pt EngraversGothic BT,sans-serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase">________</FONT></P>

<P STYLE="font: 4pt EngraversGothic BT,sans-serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 9pt EngraversGothic BT,sans-serif; margin: 2pt 0 0; text-align: center">TEL: (312) 407-0700</P>

<P STYLE="font: 9pt EngraversGothic BT,sans-serif; margin: 2pt 0 0; text-align: center">FAX: (312) 407-0411</P>

<P STYLE="font: 8.5pt Eurostile-WP CY,sans-serif; margin: 2pt 0 0; text-align: center">www.skadden.com</P></TD>
  <TD><P STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FIRM/AFFILIATE OFFICES</P>

<P STYLE="font: 5pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">-----------</P>

<P STYLE="font: 7pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">BOSTON</P>

<P STYLE="font: 7pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">HOUSTON</P>

<P STYLE="font: 7pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">LOS ANGELES<BR>
NEW YORK</P>

<P STYLE="font: 7pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">PALO ALTO</P>

<P STYLE="font: 7pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">WASHINGTON, D.C.</P>

<P STYLE="font: 7pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">WILMINGTON</P>

<P STYLE="font: 5pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">-----------</P>

<P STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">BEIJING</P>

<P STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">BRUSSELS</P>

<P STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FRANKFURT</P>

<P STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">HONG KONG</P>

<P STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">LONDON</P>

<P STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">MUNICH</P>

<P STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">PARIS</P>

<P STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">S&Atilde;O PAULO</P>

<P STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">SEOUL</P>

<P STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">SHANGHAI</P>

<P STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">SINGAPORE</P>

<P STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">TOKYO</P>

<P STYLE="text-align: center; font: 6.5pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0">TORONTO</P></TD></TR>
</TABLE>

<P STYLE="font: 17pt EngraversGothic BT,sans-serif; margin: 0; text-align: center"><FONT STYLE="font-variant: small-caps; letter-spacing: 1pt"></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 30, 2024</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advent
Convertible and Income Fund</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">888
Seventh Avenue, 31st Floor</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10019</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 200pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9;Re:&#9;Advent
Convertible and Income Fund<BR>
&#9;<U>Registration Statement on Form&nbsp;N-2&#9;&#9;</U></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have acted as special United States counsel to Advent Convertible and Income Fund, a statutory trust (the &ldquo;Trust&rdquo;)
created under the Delaware Statutory Trust Act (the &ldquo;DSTA&rdquo;), in connection with the registration statement on Form N-2
filed on July 23, 2024 by the Trust with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) under the Securities
Act of 1933 (the &ldquo;Securities Act&rdquo;), and the Investment Company Act of 1940 (the &ldquo;1940 Act&rdquo;), as amended by
Pre-Effective Amendment No. 1 to be filed by the Trust on the date hereof (such registration statement, as so amended, being herein
referred to as the &ldquo;Registration Statement&rdquo;). The Registration Statement relates to the issuance and sale by the Trust
from time to time, pursuant to Rule 415 of the General Rules and Regulations of the Commission promulgated under the Securities Act
(the &ldquo;Securities Act Rules and Regulations&rdquo;), of an indeterminate number of securities of the Trust, having a maximum
aggregate offering price not exceeding $150,000,000, consisting of: (i) common shares of beneficial interest, par value $0.001 per
share of the Trust (the &ldquo;Common Shares&rdquo;), including an indeterminate number of Common Shares to be issued upon exercise
of any Subscription Rights (as defined below), and (ii) subscription rights to purchase Common Shares (&ldquo;Subscription
Rights&rdquo;), which may be issued under one or more subscription rights certificates (each, a &ldquo;Subscription
Rights Certificate&rdquo;). The Common Shares and Subscription Rights offered pursuant to the Registration Statement are
collectively referred to herein as the &ldquo;Securities&rdquo;.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
opinion is being furnished in accordance with the requirements of sub-paragraph (l) of item 25.2 of part C of Form N-2 under the Securities
Act and the 1940 Act.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
rendering the opinions stated herein, we have examined and relied upon the following:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the notification of registration on Form N-8A (File No. 811-21309) of the Trust filed with the Commission under the 1940 Act on February
19, 2003;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advent
Convertible and Income Fund</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
30, 2024</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
2</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the Registration Statement;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
an executed copy of a certificate of Stephen Ellwood, Secretary of the Trust, dated the date hereof (the &ldquo;Secretary&rsquo;s Certificate&rdquo;);</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
a copy of the Trust&rsquo;s Certificate of Trust (the &ldquo;Certificate of Trust&rdquo;), as certified by the Secretary of State of the State of Delaware as of August 29,
2024 and certified pursuant to the Secretary&rsquo;s Certificate;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
a copy of the Trust&rsquo;s Agreement and Declaration of Trust, by the trustees of the Trust, dated as of February 19, 2003, as amended
by Certificates of Amendment to the Agreement and Declaration of Trust, dated September 20, 2005 and June 18, 2019, by the trustees of
the Trust (as so amended, the &ldquo;Declaration of Trust&rdquo;), certified pursuant to the Secretary&rsquo;s Certificate;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
a copy of the Trust&rsquo;s Fourth Amended and Restated By-Laws, as amended and in effect as of the date hereof, certified pursuant
to the Secretary&rsquo;s Certificate; and</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
copies of certain resolutions adopted by the Board of Trustees of the Trust (the &ldquo;Board of Trustees&rdquo;) on June 11, 2024, relating
to the registration of the Securities and related matters, certified pursuant to the Secretary&rsquo;s Certificate.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
a copy of a certificate, dated the date hereof, from the Secretary of State of the State of Delaware with
respect to the Trust&rsquo;s existence and good standing in the State of Delaware.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have also examined originals or copies, certified or otherwise identified to our satisfaction, of such records of the Trust and such
agreements, certificates and receipts of public officials, certificates of officers or other representatives of the Trust and others,
and such other documents as we have deemed necessary or appropriate as a basis for the opinions stated below.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
our examination, we have assumed the genuineness of all signatures, including electronic signatures, the legal capacity and competency
of all natural persons, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents
submitted to us as facsimile, electronic, certified or photocopied copies, and the authenticity of the originals of such copies. As to
any facts relevant to the opinions stated herein that we did not independently establish or verify, we have relied upon statements and
representations of officers and other representatives of the Trust and others and of public officials, including the facts and conclusions set forth in in the Secretary&rsquo;s
Certificate.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not express any opinion with respect to the laws of any jurisdiction other than the laws of the State of Delaware (the &ldquo;Opined-on
Law&rdquo;). The Securities may be issued from time to time on a delayed or continuous basis, and this opinion is limited to the laws, including the
rules and regulations, as in effect on the date hereof, which laws are subject to change with possible retroactive effect.</FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advent
Convertible and Income Fund</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
30, 2024</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
3</FONT></P>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
used herein, (i) &ldquo;Transaction Documents&rdquo; means the Subscription Rights Certificate and any applicable underwriting
or purchase agreement and (ii) &ldquo;Organizational Documents&rdquo; means those documents listed in paragraphs (d) through (f) above.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
opinions stated in paragraphs 1 and 2 below presume that all of the following (collectively, the &ldquo;general conditions&rdquo;)
shall have occurred prior to the issuance of the Securities referred to therein: (i) the Registration Statement, as finally amended
(including all necessary pre-effective and post-effective amendments), has become effective under the Securities Act; (ii) an
appropriate prospectus supplement with respect to the Securities has been prepared, delivered and filed in compliance with the
Securities Act and the applicable Securities Act Rules and Regulations; (iii) the applicable Transaction Documents shall have been
duly authorized, executed and delivered by the Trust and the other parties thereto, including, if such Securities are to be sold or
otherwise distributed pursuant to a firm commitment underwritten offering, the underwriting agreement or purchase agreement with
respect thereto; (iv) the Board of Trustees, including any duly authorized committee thereof, shall have taken all necessary
statutory trust action to approve the issuance and sale of such Securities and related matters and appropriate officers of the Trust
have taken all related action as directed by or under the direction of the Board of Trustees; and (v) the terms of the applicable
Transaction Documents and the issuance and sale of such Securities have been duly established in conformity with the Organizational
Documents so as not to violate any applicable law or the terms of the Organizational Documents, each as then in effect, or result in
a default under or breach of any agreement or instrument binding upon the Trust, and so as to comply with any requirement or
restriction imposed by any court or governmental body having jurisdiction over the Trust or its properties.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
upon the foregoing and subject to the qualifications and assumptions stated herein, we are of the opinion that:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
With respect to any Common Shares offered by the Trust (the &ldquo;Offered Common Shares&rdquo;), when (a) the general conditions shall
have been satisfied and (b) the Offered Common Shares are registered in the Trust&rsquo;s share registry and delivered upon payment of
the agreed-upon consideration therefor, the Offered Common Shares, when issued and sold or otherwise distributed in accordance with the
provisions of the applicable Transaction Document, will be duly authorized by all requisite statutory trust action on the part of the
Trust under the DSTA and validly issued, fully paid and nonassessable, except as provided in Section 3.8 of the Declaration of Trust.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
With respect to any Subscription Rights offered by the Trust (the &ldquo;Offered Subscription Rights&rdquo;), when (a) the general conditions
shall have been satisfied, (b) the Common Shares relating to such Offered Subscription Rights have been duly authorized for issuance
by the Trust and (c) the Subscription Rights Certificates have been duly executed, delivered and countersigned in accordance
with the provisions of the applicable Subscription Rights Agreement, the Offered Subscription Rights, when issued and sold or otherwise
distributed in accordance with the provisions of the applicable Transaction Document upon payment of the agreed-upon consideration therefor,
will constitute valid and binding obligations</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advent
Convertible and Income Fund</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
30, 2024</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
4</FONT></P>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the Trust, enforceable against the Trust in accordance with their respective terms under
the laws of the State of Delaware.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
opinions stated herein are subject to the following qualifications:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
we do not express any opinion with respect to the effect on the opinions stated herein of any bankruptcy, insolvency,
reorganization, moratorium, fraudulent transfer, preference and other similar laws or governmental orders affecting creditors&rsquo;
rights generally, and the opinions stated herein are limited by such laws and governmental orders and by general principles of
equity (regardless of whether enforcement is sought in equity or at law);</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;we
do not express any opinion with respect to the effect on the opinions stated herein of (i) the compliance or non-compliance of any party
to any of the Transaction Documents with any laws, rules or regulations applicable to such party or (ii) the legal status or legal capacity
of any party to any of the Transaction Documents;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;we
do not express any opinion with respect to any law, rule or regulation that is applicable to any party to any of the Transaction Documents
or the transactions contemplated thereby solely because such law, rule or regulation is part of a regulatory regime applicable to any
such party or any of its affiliates as a result of the specific assets or business operations of such party or such affiliates;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;except
to the extent expressly stated in the opinions contained herein, we have assumed that each of the Transaction Documents constitutes the
valid and binding obligation of each party to such Transaction Document, enforceable against such party in accordance with its terms;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;we
do not express any opinion with respect to the enforceability of any provision contained in any Transaction Document relating to any
indemnification, contribution, non-reliance, exculpation, release, limitation or exclusion of remedies, waiver or other provisions having similar effect that may be contrary to public policy or violative of
federal or state securities laws, rules or regulations, or to the extent any such provision purports to, or has the effect of,
waiving or altering any statute of limitations;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
we do not express any opinion with respect to the enforceability of any provision of any Transaction Document to the extent that such
section purports to bind the Trust to the exclusive jurisdiction of any particular federal court or courts;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
we call to your attention that irrespective of the agreement of the parties to any Transaction Document, a court may decline to hear
a case on grounds of forum non conveniens or other doctrine limiting the availability of such court as a forum for resolution of</FONT></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advent
Convertible and Income Fund</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
30, 2024</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
5</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">disputes;
in addition, we call to your attention that we do not express any opinion with respect to the subject matter jurisdiction of the federal
courts of the United States of America in any action arising out of or relating to any Transaction Document;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
we have assumed that the laws of the State of Delaware will be chosen to govern any Subscription Rights Certificates, and that such choice
of Delaware law is and will be a valid and legal provision;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix) the
opinions stated herein are limited to the agreements and documents specifically identified in the opinions contained herein (the &ldquo;Specified
Documents&rdquo;) without regard to any agreement or other document referenced in any such Specified Document (including agreements or
other documents incorporated by reference or attached or annexed thereto) and without regard to any other agreement or document relating
to any such Specified Document that is not a Transaction Document;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x) we have assumed that any
agent of service will have accepted appointment as agent to receive service of process and call to your attention that we do not express
any opinion if and to the extent such agent shall resign such appointment. Further, we do not express any opinion with respect to the
irrevocability of the designation of such agent to receive service of process;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xi) this
opinion letter shall be interpreted in accordance with customary practice of United States lawyers who regularly give opinions in transactions
of this type; and</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xii)
to the extent that any opinion relates to the enforceability of the choice of Delaware law and choice of Delaware forum provisions contained
in any Transaction Document, the opinions stated herein are rendered solely in reliance upon Delaware Code title 6, section 2708 and
are subject to the qualification that such enforceability may be subject to the exceptions and limitations in Section 2708 as well as
by principles of public policy, comity and constitutionality.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, in rendering the foregoing opinions we have assumed that:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the Organizational Documents are the only governing instruments, as defined under the DSTA, of the Trust; the Trust has, and since the
time of its formation has had, at least one validly admitted and existing trustee of the Trust satisfying the requirements of the DSTA
and (i) no procedures have been instituted for and no other event has occurred, including, without limitation, any action taken by the
Trust or its Board of Trustees or shareholders, as applicable, that would result in the liquidation, dissolution or winding-up of the
Trust, (ii) no event has occurred that has adversely affected the good standing of the Trust under the laws of its jurisdiction of formation,
and the Trust has taken all actions required by the laws of its jurisdiction of formation to maintain such good standing and (iii) no
grounds exist for the revocation or forfeiture of the Trust&rsquo;s Certificate of Trust;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the Trust is duly formed and is validly existing and in good standing under the laws of the jurisdiction of its formation;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the Trust has the statutory trust power and authority to execute, deliver and perform all its obligations under each of the Transaction
Documents;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
neither the execution and delivery by the Trust of the Transaction Documents nor the performance by the Trust of its obligations thereunder,
including the issuance and sale of the applicable Securities: (i) constitutes or will constitute a violation of, or a default under,
any lease, indenture, agreement or other instrument to</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advent
Convertible and Income Fund</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
30, 2024</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
6</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">which
the Trust or its property is subject, (ii) contravenes or will contravene any order or decree of any governmental authority to which
the Trust or its property is subject, or (iii) violates or will violate any law, rule or regulation to which the Trust or its property
is subject (except that we do not make the assumption set forth in this clause (iii) with respect to the Opined-on Law); and</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
neither the execution and delivery by the Trust of the Transaction Documents nor the performance by the Trust of its obligations thereunder,
including the issuance and sale of the applicable Securities, requires or will require the consent, approval, licensing or authorization
of, or any filing, recording or registration with, any governmental authority under any law, rule or regulation of any jurisdiction.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We hereby consent to the reference to our firm under the headings &ldquo;Legal Matters&rdquo; in the prospectus forming part of the Registration Statement. We
also hereby consent to the filing of this opinion with the Commission as an exhibit to the Registration Statement. In giving this consent, we do not thereby admit that we are within the category of persons whose consent is
required under Section 7 of the Securities Act or the Securities Act Rules and Regulations. This opinion is expressed as of the date
hereof unless otherwise expressly stated, and we disclaim any undertaking to advise you of any subsequent changes in the facts
stated or assumed herein or of any subsequent changes in applicable laws.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 24pt 0 0 3.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
truly yours,</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0 3.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Skadden, Arps, Slate, Meagher &amp; Flom LLP</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">KTH</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>5
<FILENAME>ex99n.htm
<DESCRIPTION>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0pt">&nbsp;</P>



<IMG SRC="n2consentletterfinal_829x1x1.jpg" ALT=""><BR>
<P style="text-align: center;">
<U><FONT size=2 face="serif">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</FONT></U></P>
<P style="text-align: left;">
<FONT size=2 face="serif">We hereby consent to the incorporation by reference in this Registration Statement on Form N-2 of our report dated December 21, 2023, relating to the financial statements and financial highlights, which appears in the Advent Convertible and Income Fund&#146;s Annual Report on Form N-CSR for the year ended October 31, 2023. We also consent to the references to us under the headings &#147;Financial Highlights&#148;, &#147;Senior Securities&#148;, &#147;Financial Statements&#148; and &#147;Independent Registered Public Accounting Firm&#148; in such Registration Statement.</FONT></P>
<P style="text-align: left;">
<FONT size=2 face="serif">/s/ PricewaterhouseCoopers LLP</FONT><BR>
<FONT size=2 face="serif">New York, New York</FONT><BR>
<FONT size=2 face="serif">8</FONT><FONT size=2 face="serif">/2</FONT><FONT size=2 face="serif">9</FONT><FONT size=2 face="serif">/2024</FONT></P>

<P STYLE="text-align: left"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<DIV><P STYLE="text-align: left">&nbsp;</P>
<P style="text-align: left;">
<I><FONT size=2 face="serif">PricewaterhouseCoopers LLP, PricewaterhouseCoopers Center, 300 Madison Avenue, New York, NY 10017 T: (646) 471 3000, F: (813) 286 6000, www.pwc.com/us</FONT></I></P>
</DIV>







<P STYLE="margin: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>6
<FILENAME>ex99s.htm
<DESCRIPTION>CALCULATION OF FILING FEE TABLES
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit (s)</B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Calculation of Filing Fee Table</B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>N-2</B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Form Type)</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Advent Convertible and Income Fund</B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Exact Name of Registrant as Specified in its Charter)</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Table 1 &ndash; Newly Registered and Carry Forward
Securities</B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="border: Black 1pt solid; width: 7%; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 7%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt"><B>Security
    Type</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 7%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt"><B>Security
    Class Title</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 7%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt"><B>Fee
    Calculation or Carry Forward Rule</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 7%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt"><B>Amount
    Registered</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 7%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt"><B>Proposed
    Maximum Offering Price Per Unit</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 7%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt"><B>Maximum
    Aggregate Offering Price</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 7%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt"><B>Fee
    Rate</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 16%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt"><B>Amount
    of Registration Fee</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 7%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt"><B>Carry
    Forward Form Type</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 7%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt"><B>Carry
    Forward File Number</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 7%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt"><B>Carry
    Forward Initial Effective Date</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 7%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt"><B>File
    Fee Previously Paid in Connection with Unsold Securities to be Carried Forward</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="13" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt"><B>Newly
    Registered Securities</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt"><FONT STYLE="font-size: 8pt">Fees
    to Be Paid</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">Equity</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">Common
    Shares of Beneficial Interest, $0.001 par value</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">---</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">---</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">---</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">---</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">---</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">---</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">Other</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">Subscription
    Rights for Common Shares</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt"><B>---</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt"><B>---</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt"><B>---</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt"><B>---</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt"><B>---</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt"><B>---</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">Unallocated
    (Universal) Shelf</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">---</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">Rule&nbsp;457(o)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">---</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">---</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">$150,000,000</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">.00014760</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">$22,140.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt"><FONT STYLE="font-size: 8pt">Fees
    Previously Paid</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">---</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">---</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">---</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">---</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">---</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">---</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">$147.60</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 100 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: center; font: 9pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><B>Carry Forward Securities</B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border: Black 1pt solid; width: 7%; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">Carry
    Forward Securities</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 7%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">---</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 7%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">---</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 7%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">---</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 7%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">---</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 7%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 7%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">---</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 7%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 16%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 7%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">---</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 7%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">---</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 7%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">---</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 7%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">---</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="13" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="5" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: right"><FONT STYLE="font-size: 8pt"><B>Total
    Offering Amounts</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">$150,000,000</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">$22,140.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="5" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: right"><FONT STYLE="font-size: 8pt"><B>Total
    Fees Previously Paid</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">$147.60</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="5" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: right"><FONT STYLE="font-size: 8pt"><B>Total
    Fee Offsets</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">$0</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="5" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: right"><FONT STYLE="font-size: 8pt"><B>Net
    Fee Due</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">$21,992.40</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 4pt; padding-bottom: 4pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  </TABLE>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>avk-20240719.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.23b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aAps7xRiXhun8uMZXYsWamNibP9x5F0mZkxsmd2felKHywvATshFykGlZiGobkB -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:fnd="http://xbrl.sec.gov/fnd/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:AVK="http://guggenheiminvestments.com/20240719" elementFormDefault="qualified" targetNamespace="http://guggenheiminvestments.com/20240719">
    <annotation>
      <appinfo>
        <link:linkbaseRef xlink:type="simple" xlink:href="avk-20240719_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="avk-20240719_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="avk-20240719_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/cef/2023" schemaLocation="https://xbrl.sec.gov/cef/2023/cef-2023.xsd" />
    <import namespace="http://xbrl.sec.gov/cef-pre/2023" schemaLocation="https://xbrl.sec.gov/cef/2023/cef-2023_pre.xsd" />
    <import namespace="http://xbrl.sec.gov/fnd/2023" schemaLocation="https://xbrl.sec.gov/fnd/2023/fnd-2023.xsd" />
    <import namespace="http://xbrl.sec.gov/fnd-cef/2023" schemaLocation="https://xbrl.sec.gov/fnd/2023/fnd-cef-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
    <element id="AVK_RiskIntroductionMember" name="RiskIntroductionMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AVK_DistributionRiskMember" name="DistributionRiskMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AVK_RisksAssociatedWithOfferingsOfAdditionalCommonSharesMember" name="RisksAssociatedWithOfferingsOfAdditionalCommonSharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AVK_AdditionalRisksofRightsMember" name="AdditionalRisksofRightsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>avk-20240719_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.23b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/SecurityOnly" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#SecurityOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/AddressTypeOnly" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#AddressTypeOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/RiskOnly" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#RiskOnly" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/AddressTypeOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/RiskOnly">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#cef_AllRisksMember" xlink:label="loc_cefAllRisksMember" />
      <link:loc xlink:type="locator" xlink:href="avk-20240719.xsd#AVK_RiskIntroductionMember" xlink:label="loc_AVKRiskIntroductionMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_AVKRiskIntroductionMember" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="avk-20240719.xsd#AVK_DistributionRiskMember" xlink:label="loc_AVKDistributionRiskMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_AVKDistributionRiskMember" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="avk-20240719.xsd#AVK_RisksAssociatedWithOfferingsOfAdditionalCommonSharesMember" xlink:label="loc_AVKRisksAssociatedWithOfferingsOfAdditionalCommonSharesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_AVKRisksAssociatedWithOfferingsOfAdditionalCommonSharesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="avk-20240719.xsd#AVK_AdditionalRisksofRightsMember" xlink:label="loc_AVKAdditionalRisksofRightsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_AVKAdditionalRisksofRightsMember" xlink:type="arc" order="30" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>avk-20240719_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.23b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="avk-20240719.xsd#AVK_RiskIntroductionMember" xlink:label="AVK_RiskIntroductionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AVK_RiskIntroductionMember" xlink:to="AVK_RiskIntroductionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AVK_RiskIntroductionMember_lbl" xml:lang="en-US">Risk Introduction [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="avk-20240719.xsd#AVK_DistributionRiskMember" xlink:label="AVK_DistributionRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AVK_DistributionRiskMember" xlink:to="AVK_DistributionRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AVK_DistributionRiskMember_lbl" xml:lang="en-US">Distribution Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="avk-20240719.xsd#AVK_RisksAssociatedWithOfferingsOfAdditionalCommonSharesMember" xlink:label="AVK_RisksAssociatedWithOfferingsOfAdditionalCommonSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AVK_RisksAssociatedWithOfferingsOfAdditionalCommonSharesMember" xlink:to="AVK_RisksAssociatedWithOfferingsOfAdditionalCommonSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AVK_RisksAssociatedWithOfferingsOfAdditionalCommonSharesMember_lbl" xml:lang="en-US">Risks Associated With Offerings Of Additional Common Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="avk-20240719.xsd#AVK_AdditionalRisksofRightsMember" xlink:label="AVK_AdditionalRisksofRightsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AVK_AdditionalRisksofRightsMember" xlink:to="AVK_AdditionalRisksofRightsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AVK_AdditionalRisksofRightsMember_lbl" xml:lang="en-US">Additional Risksof Rights [Member]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>avk-20240719_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.23b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/N2Cover" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#N2Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/N2" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#N2" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" xlink:title="995470 - Disclosure - N-2">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#cef_ProspectusLineItems" xlink:label="loc_cefProspectusLineItems" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#cef_AllRisksMember" xlink:label="loc_cefAllRisksMember" />
      <link:loc xlink:type="locator" xlink:href="avk-20240719.xsd#AVK_RiskIntroductionMember" xlink:label="loc_AVKRiskIntroductionMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_AVKRiskIntroductionMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="avk-20240719.xsd#AVK_DistributionRiskMember" xlink:label="loc_AVKDistributionRiskMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_AVKDistributionRiskMember" order="100" />
      <link:loc xlink:type="locator" xlink:href="avk-20240719.xsd#AVK_RisksAssociatedWithOfferingsOfAdditionalCommonSharesMember" xlink:label="loc_AVKRisksAssociatedWithOfferingsOfAdditionalCommonSharesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_AVKRisksAssociatedWithOfferingsOfAdditionalCommonSharesMember" order="200" />
      <link:loc xlink:type="locator" xlink:href="avk-20240719.xsd#AVK_AdditionalRisksofRightsMember" xlink:label="loc_AVKAdditionalRisksofRightsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_AVKAdditionalRisksofRightsMember" order="300" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>n2consentletterfinal_829x1x1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2consentletterfinal_829x1x1.jpg
M_]C_X  02D9)1@ ! 0'_____  #_[@ .061O8F4 9      !_]L 0P ! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@
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M*/%VG(_AZ/4+W3M*E\-Z+X<M-0NM>EOM6:_N=/M;+39Y&LQ/QX_X->[?2?\
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MB>([!+FTGN+9GL=;LQ<P2W,433J7_P 5M/OQ_P">[5_J#?\ !EY_RBT^+_\
MV>I\2_\ U47P+H _KK5%0$+P",<8& ,X P, *.%&,   # KY#\)?\$_?V'_
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3Q?O<3XX,F!7MU%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001821268-24-000261-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001821268-24-000261-xbrl.zip
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M*-9/DGP.]/_F,7#*7L3EOU!+ P04    "  -B1Y9_,?),0L#   0$0  %
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M,FZS7M]L3- 6EX^6@S>M<#G,E9DPU\F*)N:.]F3N;&]'7@!02P,$%     @
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M]552@2\ID<23B;P^#[!*;OO.-&@KPORS<YAMEFRW83?=VD*&5M[\I(."4QA
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MM+MD_]9=TM^X:<MW^I>=N=,'84*F]/=VF[6=!9C)H%.,J2 ;) +W=8H).O2
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MXZ*;^-$GK<X.6H$&%@.Z5JH2*Z,T#-\$:9")KFB$X+V[^ZJ&O\XG\XP[0NW
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MTB&22ZCMF&+VJ?*7U ;]4Z>,*A6C)E5CSV:[V5+XYFLOT4U+T%-5"5M]1&Y
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MUP($EY\>9Y(F;%Z<]!I&X),#2:':([TYDT(W;B&NVHL&7AW=<(12X[!FF[2
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M6JJ@[>"/_1;6@=;&M7#P"X<D'8+TR%$:W/GTJ*RNT[\K7SBU/JK:*Z9*&J7
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M20DT$[4('3-4N0HPAH+4?2PDAIJ<*<^*_3C:7 JVGQ ^R)H^)W #Z:-EME1
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MD&M:=0P8FVC2-1H=;H7KQS(1ES+(E?A';P<\"1&KI-VB015(EP0,24U3N^K
M"W("[AI,5,8:_D;60++$\('ZIA)/IZ F":,+,<S'J9?HF+CK0D]G62JV@$E]
MV$R(8J&"Z,H(YY:&C:?N@(0'P#K 3* V4E6#8,M2VQG5;O$ZY=:N()R< 8T6
M+KC$15$(B$K$/ *$-:WLH<X&M),H;"GIS5!;7[.H>%^.J,I9%7#<;Q-NB&L
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M%= D93G#9P+6=XON0%ZEE:PMOJ#!=E#2UO!=3>\WD0>H?AOZX/2;1J/I=]H
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M[NSP"Q[D?_)A]''P]O\!4$L#!!0    (  V)'EG9KNE*2 ,  $,'   )
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MP^'0R Y1@^9,,U>GBGO'OZ3(V?'@.1U [Y]4IR9HFD.P/!7-X?D?4$L#!!0
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MC2D00.;R@F,], \BZ,4XT7?)M^! 9+PCODF ),\N/N/HRT3IB><.HPFBG[X
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M:<9CTW&'EC-GSKGX2$Z:,JSX6E[^?#22/WOV-J%_>Z%-8LY$FP)V_($U4GO
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M\\E0/3V]W# H<'C4MCL&6?)(=T O;0>>:08;GO1H8'7UOIM36S;0G&OY:K4
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M)=6N0$E32+\S#Z8T 2_LB%=$ %LEZM[Y>@]$3]WK8.T#]E\6GD6]-IR\S8B
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M_Q;]WR/;(L1NI7C$X3)0B*;4[49+V,%2K)M_*""# A:[']"8L,RFQ 3-6)Q
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M@FDU(;NJ.RM'XPFJ)#(-5BEL8IT2]965D/E%<2N!V@DI"L8TCA#(3ITAUWY
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M0=^D8HAO<&.5V+0$/X56I=MGEVX[2>)I8S&%9-I @XY)FGM@IO*B@$PJYPB
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M"BUM^28C<:HA'X);@%REX%[D"(JD;O@')3*D&Y5UU,;YM _C76P$#2_+Y:3
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M Z5,&2N5?R5UKY CE"KQ-QE_:&"%,$(2<9ULV"'YG=55*KL)9TN[.[->4P[
MIRD<^J[KNPY(!U%O:C,MK9T2R%.=*T6'I! OL?NE]D!XQ1$B5=(?C9SLG2O7
M8HYJS$FI JCE^$.J\P4E9(F#QM(C)K@*HL]#22,#O<YK<Z :7F?9APU='YCJ
M?L ^9C>=(@D:/^>H (;PO3( <D.MQH^!S2EHA6,%Y0^J(% %9';Z(A@)7I,W
MCVY(Q<TD!+BS]#H>B7!26-4BNCI)*2!1N!B(IX#;HTB3\I-2%_A$#/X@WN-2
MB9"X#'71PQ2UKM.4%"@"&FSJ5F=4MY <2@#(YB3X?X;.$*QY!KV3[#PN0/1.
M/*F=\N1Y0\DL(^M)5#K*: ^R!-O-&;!BP>\GDUE>&(>,!-[=6LJ *LGRXGZM
MN.$>!9(R$KPA%V%UP)\Z8-"@L4)VS:#44<8W[0;X-HE7D,--4,PL9XG"7LB.
MZA7\"!W5*HVRYKKC@730R[$2A< BR^*B1)03"+>;UG:J/50DV__9HEY4*L.3
MQ@I1JU/I&,P&&)H.47,&@U&"&_BN-\M%[ !C*98.QFDRR:?Y6I/4H?9(>EQ,
MDK<NT7-EQ&F*83]YUH21!0(\PQA/*$$2I;T[4> R-N$ 5XE>.[N+LAS[_!NB
M6"VT F0^=V(L1/CD,Y>30&U!T YSEQ:L#Y38")D#(]GSEB1<U)3.P4V^ !7$
M'FI !9CJ(;GI2'S">QE]7HRT !8WKLZ(2!0F'S3Z$,VWUL"AR"#=9#TR*#DV
M#<*I".H'ML (>Y>W&Y;19^.T 6G:+=6#'#(03CK.&FO&J;"\Y6JZN[6YU5IQ
M.!:^X'9TX*C6<+27D9&X4NI^%'BL8A:L;R".9Z^@1XDTKI&?PV&]*C& K4/*
MTH0RZ'BMF6_V$?5!CX0*JZ!8.WT4G>;R [F%.$V+&"RH%@#P4T%J"$V!"+Y)
M/V0%9V*J]N+1II4.#OPBOR)E%[F("%FL4RC0D80$.H.]R=$N:1IL(3ZAG#03
M>J*VDF-F1W1ET;E(&2@P)'+\ ?G5J<!%<"!0CE)Z)Z(YHR\:A"F)<ZP'P$T4
MG%DE,C%G""="::0>ZUP[B--<.?X!:/$8L54)E0_W?!739RJCD&*RYV.SO77<
M1EM6:XWN.VY[;C4KC"B]LUM!#-?_V,B/%"ZI)4&;X29,2NXT.&U"'W4ZTT>[
M; <#J)R,#,P8YA[VK&P(9LP=EK>S"^M[FK2=( ^>O3\[2=Z\2GXZ^>7DW?%W
M)Y^E6&<!6%M_4*U)!=X&LI3Q!L(VU02GY<6,<UR;#C]S:'O+V-ZH<5_A+<<L
M<-QML!&R,29IXJ57GF86"#2QO;WD=D@M?[>*V;,=<;' ?SRR?QJRTV4/_C1\
MQE7;WY@..HY=@@]#M92K/WP*F*QMPS>6P80STF% TCDD5[U<97:9&_:Q;_?F
M<493SPX"=AMNXL%V=XH%WER3WG^]M,H:G.+2(S$$,O6N;K <("+<;5D[L?\Q
MGRUF$K/Q"*U,E&<G+\3A"?]JE9Z)99R+*5R""RC8*:@=H@##V5V_'17IW-C0
M69\5%WP4XH3W0;Y6B#UM&..C!Q'&%2!!$%]..8Q3N36;3UYSB%'08"[GR"HL
M<X+I_,>#[0?XW_:ID?SW)S&WZWS<7'Z+[K;00[K3Z<NUE[6IY$OHR[9:@#!#
M^]Z#9W:V8WF !]]^\.A9QU^IP_QS*:NPZG@SAN?LPX^:"OX!R[X?'PUX-MQE
M>'\;ONL(';39A37J*O2[@(:",T)W(:9!1\X7[&G2XI/<?XZB&Q@V"9R?[B</
M1Y!I5$:XXHH.XX:]S%4T,[KQOG4%,+OD0(K>.A5M9#D<8"O33K1\F67%K:@1
MAE!N&;M"W<':J3  ?XO[>(T(<:V057JUEC*"@<=1_PP8_R$V=YB@8:)B=,:N
M!0'<G3&R9TEZD 1=TUK*T*3%4L7-S!7NE$^,ZF@3=*A6&</2,9'#FG3MXZT:
M)&ZCXNT9)&10^6D[QAU_!4*%]PD"'7Q]0:"#OT00*"X+.GG]_O'9OV=71[.=
MNP2!]MI!H-U[!8&(/SYXYJM*%)W',#X^EY0=JV--Q5[F=C$0\ ,BU#/D9H,+
MPB59NQNA^W6+Y1ZD3SL^$F6,XE6A#Z1>_/>C5^F+/KC730>E9M5%-GT7F=G?
MF(HE6&_SNA^M:.4.A4T1:!(ZHL:YA@-Q:XM\8,?L@ X4JQ^XN#G 5N]<.7L_
MRD7C?%5WX',FU))\T3LZULG;%+H;0]9_?P-UM3;@(RG@*($34"*,@ 3( 9=2
M4U1NV)U"AD2P!C!;J7I)O F^P@#V*R=CU;XVX+(2]RH4'8$T3UG:#=,IA1@Y
M* ?^2:AU/98IZEI40U(SR'B5OK?Q>ER6)T05LW&8*\B- ^ACM1;&@5=)'%CN
M7<)I,$A5HM9X(NK>6==W!$=UO6&SPG67+GVWH,[$DN/NXT)P\33G/!SR"CAW
M@A@"W+PD#U-2XKB&6HYW-Q*N63P=;66,\FJTF-44)/Z<U"LXE-#S&A>B=L*%
M E1 #6X4( ,B_AMG3BI??0"1$&I?J7:/H^=2\+LU(7ID3#41EVK9,2,C6Q;W
MMPB2;KQW XRF#"X9I;05:#UA #(J>@S*)E"'E:I$1MK05+-ED.S5X/@:?C;>
M"+36;MH'GV1%)3L-^!4<Y@]1=H?/!G39S\WL1/\'N"$."$D$T^'2XQ54AD_0
M;%C;(O?0&MQE"?W0<2V<Y._FU+A.74C-?+ LIXOW;"6OTGR*X2[%;!T3"(\V
M.,&V%46%?$:U5R_:\^3$Z;R99AQ!L#:D;"X$W["J%IS6OY650L=LQ2,_)QU8
MV^@%77Z74Q&%Q*!6-"L$@MC>TS0@BVS<XAZ#9(SRY*65#9!4P>V9#@;)[O;.
M(;;FLQI^,9;X,^IP#?NXI4$.[AAXPS"Y?0+5<M0O2%@&9NN>E:/\O__7[M[>
MTX;^)_F._K>@_ZFP*1CLS[_+ZD/R'!!M+I.', :G6\>KEV*KSOP*^ ]ZP1QW
M9%5@@@=Y#KQ?UC?L( VJ_O;3/3KW<N;L=I@Z\,=/\^=L'8+KIMNILXM>G<!E
M!_/?G*2S?+JTAM]R-BRG:$P=[3UU?BYR_3S;V3HZ^D:G9QQL8F7+#!+NX9X\
M%,)*B*9V#S;^ZV\[3P;6'(+_3P-%[J/_?[.[-_OLS:MWR?]KAWER\ T4?Y#H
MA&W_K_^RF[JW>E<_!T<ZQF2D*KTN(D49+N#VUM[V-V!56NY:6!TYQTJQ"@H-
MV5I4;48UQ]!+"==)H4OU*8GXLL'#P3I"7O "*43%(JP ;#.;MO@AR"!19'T;
M9<J:HM2E3>QP">PNYB:9K,\*"O1E@'2"S6!=@:N87*Z0"R1G1L)?&=;SRPS7
M4@%RLTO5&=J!"U 8:LQT#15PQ-EO7KOB\"1*I?AE2=>V'\"<5((NJ>V5 \/2
MZ;G2S]G]0;2Z4LN4?C5@H(.YX0\J^BB]G:,G<$ZL:BBT/)^QU9J=P<YP$M6C
M-I.MMF]AY2+C'E@JP*Z_/ATGP-E6H3LV*(EXE/K6DJJF2ZIB)R^NTX0Y@B,U
MI9Q:O2-272-]A.U+\VDVIH@)NA+PPSB)0(ET]\53^$!GXP T,CI&L"U)T"?Z
MRC72:]T1A+ZPVYH5$92*=ET%E:S6#KB*<CU]RZB.2>*V0E6(8'0CV'TZ1G-B
MH%P$;:T3QHR]VT'#T)VCAQ>N1ZEHHQNF[?,&/C!=^I0KC#2YA(&@0U7BFNO"
M*:K:&:J:Y#0TF34\,YH"_J7K'(<[*JVX7>6347U[VA4H4K?6[<E//K/U<XQ;
M<6SY\M3N%^H0^Y+O<6VG]+>=@\-D!G6_8%%X5Y>A HZ"X=_<[L8LB1B5.'#&
M*6)_.O]9)TML"0V5AE/G'R$/L+D$37P,1?7!S'G*C[<'1X^/!CM[NP.YV:X%
M7@8F%0@1%Y+69:%V3@=;3PZ_$0 3BB;)A)6G+YR3T7-*.N=TN"="]UZ%*X^_
MOIC%X[]$S.(PBEGL_VM9'F?IQ=[\3C&+_7;,8J\=L[AS,LXVW&_X/P@C1_=\
MDV/+[SAAH:=Z8#TY.F0JIBNS(Y2$@53V.D(>E8(4XQNMB$STGF,J+:G"U-,!
MY65@_CKH?!!:Z6EQR65[,*4Z2@QN+G4%L]&)]:2=4GO@@M/L?:MH! >K*6>2
MF0J[7]B%K+R*SG_L,BLR:C42<$4 _:'L%=>U YO0LE]80S,$FHTOOPY1YT*
M>?8Y<,EVA!1!$?#&/TL#(40$1ELX(0A_5/@HF&[GOX'5]#E&F 3H4P",+U+*
MP<=\0=7.$K=F".:*O?VD ;<R5PWV8$YK!]=*D9(6S:DT CKVA;C/<X!P'UT6
MN65'M.)Q#O&&^I)G[]4V OU,5?(GI^@"L)C "5V+%:0?CQ<DG6S53%9/VE+
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MOAA=PC,,!V3WX0JS4:G*(!W_MD#CJYZ#X]?^P!EB[K\]\/PXFZ1078)"'V:
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M3[!M+4GD-K(YD-WTC!_8!UY1#UNP#@Q9'80WC*[#\PK!3G7XHB_[+RW2Z1+
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M;?-V7["=8 ]_JG<??YCLS7</\X[.8+T+VGT0= VC-:ZA:YA/9(3 */356S0
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MY5)A0DM*2=].16I1$!30,RWZ[KLA$KG5<C9[VACK!B=&BH)\4U<&(4%ZHB6
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MQ0PNR^CS8AZ\X ]"#Q!<B#IH9ZD(:\!Y<RV[@5E2\PP%NA]$:4-9B2Z)&W7
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ME$72NK*+-+VX0RVD[@+G[#H1+1M9IE-Z<38V]E@%[\7N\V:3?LA@!(>0XCY
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MHM-JE+9XVA Q+/W3)_)ROH_P+ ;UCS#%!JU.S!=5,PP -53&#$&ZR(!8J>V
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MN3*$EH_2#/H#G&>#2O:NL1DCAP\Y7NU\5"Q7T[!8,US9##:UQN[.N*N6C$Z
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M7B;U*HM]R[!&R&D:FU'(<\3EPN%[.@(9.=]5$8*Y,)=*\&!C"V-()"EET&%
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M%+,!<D;7CU^@0$]5].Y;"5_"^\R*[2Y07OU\SK>;=/B"Z/6)=JNPEJGM"T%
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M?S VB@82UPCT>A,<KFEI<W</!+Y)(UI$LT8[=&$C2/ID0\1YG13G+@$WFF.
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M0SKM#8+>R (;9V^14ZELOZ[5^G+29!;NS& #O]!R/7S\54C7*Z@CBL''7^X
M/GSZM<G46\TN7AA\ZY=:KF=?A4B9IL795[8R7TZ0!BKVOY0>W]&ANV<I"C40
MYYJ7^E(K]/W7)DU'"\@05A_()CWZ,7N!E'4+<11-!1",X PC,U]F.8\.'GX5
M\A8OX2\_ C[\PRK[O<8@EMA:&,V$$;QE7_X+F5^_K%G%OZ&W]?,.8SJ;@P>/
MOK[@P:,_1O  W?R'3W;CYW^I>,*.@H71*RJ$0O@5/7Q:S;_Y^;^&G_XQ*[5A
M C]=ZAS6@;<>/=C5FRQA^9=XWY>;&4&;L^-ZCLK^DHE53PF>"!['^E%\S$Y^
M^EP_1F&N?<DQ);.QYT+[TV7SMY_=.=64TTTL9/)UD\5?W<FP=AF;_X][TB85
M\,=_Q7WIY,V7_>--EWU\WX6@KPWRID'@)#SZX,&W\-/F9V,P#=D&T?=-V!6M
M(#&!/OT*_X\;_G8&P<./T,Z#H@"= LA/*<?WH".3AU_$F3.J'*A:BT2;6$9/
MFTOFCIK:B$=(* +YZ6'V]U)KRX4:LK4<[QF@)*>,_KD* .?P?FBU.0[@UZ2G
MP GS^KOCP$('8$OI? FIP.VF(PU"I6I>F=IZ0RX(>H%S(@)]PE'3[R#9>;E<
M]7^&1&8K&@IWV%0T;\;%I/)<S4^'ICS_?D'[([SQ/%2H'Y/<(BINC"1W1\LK
MJ$!Z_"#W1M:C)P-+/VAAW/O=</3B=\CS';]Y_?O)V<4I) ,!<WOZ^OC-JTVP
MHEV.X?];^_^Q165/V%$X81'WY;W<TW!+WVW)1E5(@CV NB*'?=G&4-735D2_
M;4H:9R$0;PJHN%[]\Y$;ZV?40SR;U]>:<*I:QB< YLIKG@YQF-B@4%LQP&@O
M;<$F-WN&UK!0WZD0*J^I&IHHK-HVE$ &25J,KJL21M2U;FBH5%H)8+ 1L@PC
MVJ?E+F3,2NX_M65:][N\?NFVD%FE<3D_.K42@S>%(2L@VJ;V6AJ1>/M&6.;^
M*;52>H<9CH.H9@2U4/9?I'T"W:H0=K:!#Z&K7?*@/82?%R+A@S0*H93N5+NZ
M\)"E 3;B?HIQ.LSU#;0L@_BBJ8C$*)#VQ1[587;D5V2AW/4?W:*+S0L:+1Q5
MIK%R_G7-%50VK0""/XT*O@M@KGGP8#][_.3IP?<__/##?9];*Q;8TN1.@@M'
M;#(@DT>G60TH;('@\5(E5>W,::&=US_#=,J"Z>2LDCP_.8YK+]>\)=F30,0.
M%#[0L-R6\V%M2PG05.[>,LZ)UZCEZAA2+(Y?3O2<DPG1X68W58'H*BGRWKN]
MO3WT)M;A57VSCXRUV';22\)A=DQJ#NL<B0QZ"75:E\1YIKV)0,?Y541V&R1G
M*HLY5FP7/#[F]QCHPO$%2FUZR!]^Y5]HGK_0/'^A>?Y"\_S;I>DO-,]?:)Z_
MT#Q_H7G^(P7I+S3/7VB>?P>:YR\DSV<A>?ZX*)Y[=16WC&A!](H"3>?EHB-F
MX?\G^W\IZ+15J=*3OQ*0_\$)R)W*U*ZJEN^.<V=;AN%=/PR?U<U5,<= #U(*
MORBGQ2TR\OO3L$1R[@ZHY;Y$O(87C&-7Y]GIZ]]/SB]>F=#-?2WB<$5VB!FW
M0A$R6E*L;Z@.,^5(Z\K1];P"<DV*^1?8,5#:,?0C8G';;6QYT"5C,W1GQ:R>
M7Q%QK?\7)0,FS <!;X)J62FH#-U^C0!@-+*\DGNC_X1YW=&8PL^;JGT_S#5Y
MYRL:7;\M)H]TZLN5[;@*G9':A*JO;K [>?B6%?"-RW^?46QH4E\">P $0G8#
MA-I"!?AEHSQ*U:;]5G)<):8K=>,PMIC1'-(IU^7X2HC-8+-M#D\X;K!,V[0?
M"_1TYLMX .JL+)JY4/9!H??\FG)@D&QSE&QC+FFB-UD[N#N>)8D[CJ=3YS[@
MB(6N/5[$D%L>$ UF9U B0G<%X"-LEN&TWQ33I3D1<//#;R5(#UT.H%$'#"'\
M-)'CT,4AHN5=-TO#5>FH.2P<[=MBP?_#?YDL.[#OJ-U%@60/_&UD4NM_ZG?V
M%KA3*4DY6H7/B%'6_#CYIM-O)C.+B0I+[-]-*9$#:&>&5U )/P5>KM'4[UU)
MO)SU9'(@7[4+@<W#"_,79.B01SA^1 XI6?HC/17)':$/"8)#@ +QLNQN2V[C
MU-W6&9-2"(L"=%TID6,3" C*AE@%4+Q&U\DDEQTU23+#=*A+PM;;-CZ6G1&[
M 9?8I'DVJ\?\5UY6UEU(5PYDT: E4\KQ;F@@<Z\H@E[+72H\08(!$Q.TKU&
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MQN[A+2]N5CXX [,;5&&L@YGYQUSO2S;E8];=X15DCY)*/AZ-<4U$(9^U]-'
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M&.B@XHL&$'"*:BYB! IO9)-!P,A3BEI,<1'4#ZYM_7WG"K_5X-6)*MX+>$6
M(Y@/$*58S0=,TRT2$W(5F40$=UOE A-)1;Q+H86\?O%RY,E*</(;]',\G34W
MBVIW3L6@J4"]U1P%O?@ZBQ>!A]<+0.*^#HU0GP/74[.\U\CL3]7/I^+OGL$5
M*^?U."I*D,C5!<36@?^N^OG015'=R!^!.$L<4AF(8+'K6HQO"K7N&<%INM31
M<45+I>L%\^0=CEUUXLID45%/=EQ>=M;;2&#O=*-R$ AJ%@(NXA!:5X>&B #L
M28(#36G;H2OVWM[!&-;%)>DO D)2H]'E8>QMJ'?Q_DU7 ^84="XR/%'>RV2]
M2-P@;%PW%#V"3J1U\KA^UDWKA6R\_1QM=G(L;Q$(1R^=,_XN:ZM9-2V46I0-
M.K"6;J!O>!?%$=P6;SSMK6V\EE%<XL[G"0!]!"1'%&2!<<3!C4&1C'QD+:4
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M0Z,Y"C;6G;T"(4L9:'"2'P0^YBAI5$NR616_Z1!H.ZT-;;-2<KCP0I$YPE^
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M:B<(#S4WL.\OJ"&;JM8.H+>-=WPH?C&*QY_SV>0A>/WL]R"XX62<C$@XQ'Q
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M#:>>CZ=&1_G8"]=*R\L9FL!I$)<E\SU<6!R(EE-LOT2U\-$W,65QK"J&J!>
M5WY67$!X-9R\[&CISSX&(ND-5BNUH+.AJ.*<53BLQ(C4RP<(PR_]Q-XC6HAI
M@_^YG!)C5;Y<G-72Z1.!29!"<H'B1\[9^R/3A-7HH>@!N;!^"&" QS,%4X#
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M"]C)9WK,9+IP>^RG:PPG,6%A.5+#U9JJ/>X'(<?1I(L_*Z.0)6*[)<K3YL;
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M" ;7L4"MN=,?@/0GNUQP 7]G!>?84.ACH:L.0Y58CG[$=0T5:0QB=AZ]=.Q
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M>&]A@ZCEWPR!1V 1@C6.'Z<_MD$$PB6G3 ,G;)O LH?>F!A?#V+P?UZ_42D
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M^GL/];TG-<0B.2DE;0Z1WQ87GA9)!I<T%/J'^EY9=":Y:H0[6Z#Z]69* W$
M[MC8-]N(GX/Q"%[5]GU4RR21>'!"I<!E,UG.(? RH<AV,J90J3GP>C@-5,M
M;=HZXC+NWR2V#=P CH7ZO6 <.I(Q _:Z2YNJ?Z[= C96 BZM2+;DU-PU6.YQ
M$-N][;]F&Y!+]I=;>0Q2P_28^ %%X\*J5]$UK!S6F\C=&^LY9\HZ.6&=MR*@
MR-_K7[(9\["L'G4UW.A=ZS5@>%?B3PB;@O+],1/FL/R445NL#O@6T,MII<<-
M,SW]F#)HKAKP.^MD;1) "SG/BZYZ-*X(^TE]B@"9PRK@OR?\#"&$L?Y'..)9
MI?Y>X<R.T)K EK!I)M,2GB&#+2>:^Y\ (86=IWN4T9&,( ,5\AA,8$OB:&F
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MA,9W)G'?B,#]?96L_?_M?6E7V]:Z\.?J5VAUW7-?.#5@F[GIR5T.0TMN(#E
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M93'U;(V?.<4N,*EV+*N9VZ#4L*0N64/T GS70.*XH/T5A%C]K^SDC\M]9;Q
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M*F"V" ,5<_N>+0:VY\; _YO !7,Y-F1[:B'FHA!SB4_VZOL[6Y7RB^9]-<W
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M,<1M1Y!/5',11-8W%26$<7SEIG&(RY=SMU,$1ZO)4T!(VO4ZBD9 I@0#1CQ
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M              "  2L'  !A=FLM,C R-# W,3E?;&%B+GAM;%!+ 0(4 Q0
M   (  V)'EFG&% UM (  /(,   4              "  5\*  !A=FLM,C R
M-# W,3E?<')E+GAM;%!+ 0(4 Q0    (  V)'ED1GV6)YE<  -(W @ )
M          "  44-  !E>#DY8BYH=&U02P$"% ,4    "  -B1Y94]]@C8X:
M  #&E@  "0              @ %290  97@Y.6PN:'1M4$L! A0#%     @
M#8D>6=FNZ4I( P  0P<   D              ( !!X   &5X.3EN+FAT;5!+
M 0(4 Q0    (  V)'EGK'PWR>P4  &%G   )              "  7:#  !E
M>#DY<RYH=&U02P$"% ,4    "  -B1Y9!^MO"QT6 @!RSPH $P
M    @ $8B0  9W5G.#<Y,39A=FLM;C)A+FAT;5!+!08     "0 ) "$"  !F
%GP(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>gug87916avk-n2a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:AVK="http://guggenheiminvestments.com/20240719"
  xmlns:cef="http://xbrl.sec.gov/cef/2023"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="avk-20240719.xsd" xlink:type="simple"/>
    <context id="AsOf2024-07-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001219120</identifier>
        </entity>
        <period>
            <startDate>2024-07-23</startDate>
            <endDate>2024-07-23</endDate>
        </period>
    </context>
    <context id="From2024-07-232024-07-23_dei_BusinessContactMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001219120</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-23</startDate>
            <endDate>2024-07-23</endDate>
        </period>
    </context>
    <context id="From2024-02-012024-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001219120</identifier>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="From2023-11-012024-01-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001219120</identifier>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2024-01-31</endDate>
        </period>
    </context>
    <context id="From2023-08-012023-10-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001219120</identifier>
        </entity>
        <period>
            <startDate>2023-08-01</startDate>
            <endDate>2023-10-30</endDate>
        </period>
    </context>
    <context id="From2023-05-012023-07-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001219120</identifier>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="From2023-02-012023-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001219120</identifier>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2022-11-012023-01-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001219120</identifier>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="From2022-08-012022-10-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001219120</identifier>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="From2022-05-012022-07-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001219120</identifier>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="From2022-02-012022-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001219120</identifier>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2021-11-012022-01-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001219120</identifier>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="From2024-07-232024-07-23_custom_RiskIntroductionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001219120</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">AVK:RiskIntroductionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-23</startDate>
            <endDate>2024-07-23</endDate>
        </period>
    </context>
    <context id="From2024-07-232024-07-23_custom_DistributionRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001219120</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">AVK:DistributionRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-23</startDate>
            <endDate>2024-07-23</endDate>
        </period>
    </context>
    <context id="From2024-07-232024-07-23_custom_RisksAssociatedWithOfferingsOfAdditionalCommonSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001219120</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">AVK:RisksAssociatedWithOfferingsOfAdditionalCommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-23</startDate>
            <endDate>2024-07-23</endDate>
        </period>
    </context>
    <context id="From2024-07-232024-07-23_custom_AdditionalRisksofRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001219120</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">AVK:AdditionalRisksofRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-23</startDate>
            <endDate>2024-07-23</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-07-23" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-07-23" id="Fact000004">0001219120</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-07-23" id="Fact000014">N-2/A</dei:DocumentType>
    <dei:EntityWellKnownSeasonedIssuer contextRef="AsOf2024-07-23" id="xdx2ixbrl0046">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityFileNumber contextRef="AsOf2024-07-23" id="Fact000010">333-280964</dei:EntityFileNumber>
    <dei:InvestmentCompanyActFileNumber contextRef="AsOf2024-07-23" id="Fact000011">811-21309</dei:InvestmentCompanyActFileNumber>
    <dei:EntityInvCompanyType contextRef="AsOf2024-07-23" id="Fact000012">N-2</dei:EntityInvCompanyType>
    <dei:DocumentRegistrationStatement contextRef="AsOf2024-07-23" id="Fact000013">true</dei:DocumentRegistrationStatement>
    <dei:InvestmentCompanyActRegistration contextRef="AsOf2024-07-23" id="Fact000015">true</dei:InvestmentCompanyActRegistration>
    <dei:InvestmentCompanyRegistrationAmendment contextRef="AsOf2024-07-23" id="Fact000016">true</dei:InvestmentCompanyRegistrationAmendment>
    <dei:InvestmentCompanyRegistrationAmendmentNumber contextRef="AsOf2024-07-23" id="Fact000017">1940</dei:InvestmentCompanyRegistrationAmendmentNumber>
    <dei:EntityRegistrantName contextRef="AsOf2024-07-23" id="Fact000018">ADVENT CONVERTIBLE AND INCOME FUND</dei:EntityRegistrantName>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-07-23" id="Fact000019">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-07-23" id="Fact000020">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-07-23" id="Fact000021">10019</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-07-23" id="Fact000022">(212)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-07-23" id="Fact000023">482-1600</dei:LocalPhoneNumber>
    <dei:ContactPersonnelName
      contextRef="From2024-07-232024-07-23_dei_BusinessContactMember"
      id="Fact000024">Robert J. White</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1
      contextRef="From2024-07-232024-07-23_dei_BusinessContactMember"
      id="Fact000025">31</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="From2024-07-232024-07-23_dei_BusinessContactMember"
      id="Fact000026">st</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3
      contextRef="From2024-07-232024-07-23_dei_BusinessContactMember"
      id="Fact000027">Floor</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown
      contextRef="From2024-07-232024-07-23_dei_BusinessContactMember"
      id="Fact000028">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="From2024-07-232024-07-23_dei_BusinessContactMember"
      id="Fact000029">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="From2024-07-232024-07-23_dei_BusinessContactMember"
      id="Fact000030">10019</dei:EntityAddressPostalZipCode>
    <dei:ApproximateDateOfCommencementOfProposedSaleToThePublic contextRef="AsOf2024-07-23" id="Fact000031">From time to time after the effective date of this Registration Statement.</dei:ApproximateDateOfCommencementOfProposedSaleToThePublic>
    <dei:DividendOrInterestReinvestmentPlanOnly contextRef="AsOf2024-07-23" id="Fact000032">false</dei:DividendOrInterestReinvestmentPlanOnly>
    <dei:DelayedOrContinuousOffering contextRef="AsOf2024-07-23" id="Fact000033">true</dei:DelayedOrContinuousOffering>
    <cef:PrimaryShelfFlag contextRef="AsOf2024-07-23" id="Fact000034">true</cef:PrimaryShelfFlag>
    <dei:EffectiveUponFiling462e contextRef="AsOf2024-07-23" id="Fact000035">false</dei:EffectiveUponFiling462e>
    <dei:AdditionalSecuritiesEffective413b contextRef="AsOf2024-07-23" id="Fact000036">false</dei:AdditionalSecuritiesEffective413b>
    <dei:EffectiveWhenDeclaredSection8c contextRef="AsOf2024-07-23" id="Fact000037">false</dei:EffectiveWhenDeclaredSection8c>
    <dei:NewEffectiveDateForPreviousFiling contextRef="AsOf2024-07-23" id="Fact000038">false</dei:NewEffectiveDateForPreviousFiling>
    <dei:AdditionalSecurities462b contextRef="AsOf2024-07-23" id="Fact000039">false</dei:AdditionalSecurities462b>
    <dei:NoSubstantiveChanges462c contextRef="AsOf2024-07-23" id="Fact000040">false</dei:NoSubstantiveChanges462c>
    <dei:ExhibitsOnly462d contextRef="AsOf2024-07-23" id="Fact000041">false</dei:ExhibitsOnly462d>
    <cef:RegisteredClosedEndFundFlag contextRef="AsOf2024-07-23" id="Fact000042">true</cef:RegisteredClosedEndFundFlag>
    <cef:BusinessDevelopmentCompanyFlag contextRef="AsOf2024-07-23" id="Fact000043">false</cef:BusinessDevelopmentCompanyFlag>
    <cef:IntervalFundFlag contextRef="AsOf2024-07-23" id="Fact000044">false</cef:IntervalFundFlag>
    <cef:PrimaryShelfQualifiedFlag contextRef="AsOf2024-07-23" id="Fact000045">true</cef:PrimaryShelfQualifiedFlag>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-07-23" id="Fact000047">false</dei:EntityEmergingGrowthCompany>
    <cef:NewCefOrBdcRegistrantFlag contextRef="AsOf2024-07-23" id="Fact000048">false</cef:NewCefOrBdcRegistrantFlag>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-07-23" id="Fact000049">888 Seventh Ave., 31st Floor</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2024-07-23" id="Fact000050">New York, New York 10019</dei:EntityAddressAddressLine2>
    <cef:PurposeOfFeeTableNoteTextBlock contextRef="AsOf2024-07-23" id="Fact000051">The following table contains information about the costs and expenses
that common shareholders will bear directly or indirectly. The table is based on the capital structure of the Fund as of April 30, 2024
(except as noted below). The purpose of the table and the example below is to help you understand the fees and expenses that you, as a
common shareholder, would bear directly or indirectly.</cef:PurposeOfFeeTableNoteTextBlock>
    <cef:ShareholderTransactionExpensesTableTextBlock contextRef="AsOf2024-07-23" id="Fact000053">&lt;table cellpadding="0" cellspacing="0" id="xdx_881_ecef--ShareholderTransactionExpensesTableTextBlock_dD_z3KBRlDp5omd" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Shareholder Transaction Expenses"&gt;
&lt;tr style="vertical-align: top; text-align: left; background-color: rgb(204,238,255)"&gt;
  &lt;td style="width: 80%"&gt;	Sales load paid by common shareholders (as a percentage of offering
price)&lt;/td&gt;
  &lt;td style="text-align: right; width: 20%"&gt;-&lt;span id="xdx_909_ecef--SalesLoadPercent_d0_c20240723__20240723_fKDEp_zZ6toKgp8uKl"&gt;-&lt;/span&gt;%&lt;sup&gt;(1)&lt;/sup&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top; text-align: left; background-color: White"&gt;
  &lt;td&gt;	Offering expenses borne by the Fund (as a percentage of offering price)&lt;/td&gt;
  &lt;td style="text-align: right"&gt;-&lt;span id="xdx_90B_ecef--OtherTransactionExpensesPercent_d0_c20240723__20240723_fKDEp_zbfML4Jbsyzg"&gt;-&lt;/span&gt;%&lt;sup&gt;(1)&lt;/sup&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top; text-align: left; background-color: rgb(204,238,255)"&gt;
  &lt;td&gt;	Dividend Reinvestment Plan fees&lt;/td&gt;
  &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecef--DividendReinvestmentAndCashPurchaseFees_dn_c20240723__20240723_fKDIp_zShu8yFN6pX5"&gt;None&lt;/span&gt;&lt;sup&gt;(2)&lt;/sup&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</cef:ShareholderTransactionExpensesTableTextBlock>
    <cef:SalesLoadPercent
      contextRef="AsOf2024-07-23"
      decimals="INF"
      id="Fact000055"
      unitRef="Ratio">-0</cef:SalesLoadPercent>
    <cef:OtherTransactionExpensesPercent
      contextRef="AsOf2024-07-23"
      decimals="INF"
      id="Fact000056"
      unitRef="Ratio">-0</cef:OtherTransactionExpensesPercent>
    <cef:DividendReinvestmentAndCashPurchaseFees
      contextRef="AsOf2024-07-23"
      decimals="0"
      id="Fact000057"
      unitRef="USD">0</cef:DividendReinvestmentAndCashPurchaseFees>
    <cef:AnnualExpensesTableTextBlock contextRef="AsOf2024-07-23" id="Fact000059">&lt;table cellpadding="0" cellspacing="0" id="xdx_881_ecef--AnnualExpensesTableTextBlock_dD_zsixZZo5XI2j" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Annual Expenses"&gt;
  &lt;tr&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;As a Percentage of &lt;br/&gt;
Net Assets Attributable to Common Shares&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Annual Expenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.25in"&gt;&lt;span style="font-size: 9pt"&gt;Management fees&lt;sup&gt;(3) &lt;/sup&gt;	&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&lt;span id="xdx_902_ecef--ManagementFeesPercent_c20240723__20240723_fKDMp_zeAmj4lATutc"&gt;0.95%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.25in"&gt;&lt;span style="font-size: 9pt"&gt;Interest Expense&lt;sup&gt;(4)&lt;/sup&gt; 	&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&lt;span id="xdx_900_ecef--InterestExpensesOnBorrowingsPercent_c20240723__20240723_fKDQp_zrsKgdU6Gk02"&gt;4.21%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other Expenses&lt;sup&gt;(5)&lt;/sup&gt; 	&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&lt;span id="xdx_904_ecef--OtherAnnualExpensesPercent_c20240723__20240723_fKDUp_z7qNvSNtAGwd"&gt;0.83%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.25in"&gt;&lt;span style="font-size: 9pt"&gt;Total annual expenses 	&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&lt;span id="xdx_90D_ecef--TotalAnnualExpensesPercent_c20240723__20240723_zrjvigGKazve"&gt;5.99%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</cef:AnnualExpensesTableTextBlock>
    <cef:ManagementFeesPercent
      contextRef="AsOf2024-07-23"
      decimals="INF"
      id="Fact000061"
      unitRef="Ratio">0.0095</cef:ManagementFeesPercent>
    <cef:InterestExpensesOnBorrowingsPercent
      contextRef="AsOf2024-07-23"
      decimals="INF"
      id="Fact000062"
      unitRef="Ratio">0.0421</cef:InterestExpensesOnBorrowingsPercent>
    <cef:OtherAnnualExpensesPercent
      contextRef="AsOf2024-07-23"
      decimals="INF"
      id="Fact000063"
      unitRef="Ratio">0.0083</cef:OtherAnnualExpensesPercent>
    <cef:TotalAnnualExpensesPercent
      contextRef="AsOf2024-07-23"
      decimals="INF"
      id="Fact000064"
      unitRef="Ratio">0.0599</cef:TotalAnnualExpensesPercent>
    <cef:ManagementFeeNotBasedOnNetAssetsNoteTextBlock contextRef="AsOf2024-07-23" id="Fact000068">The contractual management fee
rate of 0.54% of the Fund&#x2019;s Managed Assets represents an effective management fee rate of 0.95% of net assets attributable to common
shares, assuming leverage of 43.0% of the Fund&#x2019;s Managed Assets (the Fund&#x2019;s outstanding leverage as of April 30, 2024)</cef:ManagementFeeNotBasedOnNetAssetsNoteTextBlock>
    <cef:OtherExpensesNoteTextBlock contextRef="AsOf2024-07-23" id="Fact000071">Other Expenses&#x201d; are based on estimated amounts for the six months ended April 30, 2024.</cef:OtherExpensesNoteTextBlock>
    <cef:ExpenseExampleTableTextBlock contextRef="AsOf2024-07-23" id="Fact000072">
&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 10pt"&gt;The following example illustrates the expenses that you would pay
on a $1,000 investment in common shares, assuming (1) total annual expenses of 5.99% of net assets attributable to common shares, and
(2) a 5% annual return. The example assumes that the estimated Total Annual Expenses set forth in the Annual Expenses table are accurate
and that all dividends and distributions are reinvested at net asset value per common share. Actual expenses may be greater or less than
those assumed. Moreover, the Fund&#x2019;s actual rate of return may be greater or less than the hypothetical 5% return shown in the example.&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;1 Year&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 31%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;3 Years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;5 Years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;10 Years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;span id="xdx_90B_ecef--ExpenseExampleYear01_c20240723__20240723_zihIgongleEg"&gt;$60&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;span id="xdx_908_ecef--ExpenseExampleYears1to3_c20240723__20240723_zwpMArH0TKL2"&gt;$177&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;span id="xdx_90B_ecef--ExpenseExampleYears1to5_c20240723__20240723_zQ9oDX08wgX5"&gt;$292&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;span id="xdx_90D_ecef--ExpenseExampleYears1to10_c20240723__20240723_zaAFgg8cJFac"&gt;$570&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</cef:ExpenseExampleTableTextBlock>
    <cef:ExpenseExampleYear01
      contextRef="AsOf2024-07-23"
      decimals="0"
      id="Fact000073"
      unitRef="USD">60</cef:ExpenseExampleYear01>
    <cef:ExpenseExampleYears1to3
      contextRef="AsOf2024-07-23"
      decimals="0"
      id="Fact000074"
      unitRef="USD">177</cef:ExpenseExampleYears1to3>
    <cef:ExpenseExampleYears1to5
      contextRef="AsOf2024-07-23"
      decimals="0"
      id="Fact000075"
      unitRef="USD">292</cef:ExpenseExampleYears1to5>
    <cef:ExpenseExampleYears1to10
      contextRef="AsOf2024-07-23"
      decimals="0"
      id="Fact000076"
      unitRef="USD">570</cef:ExpenseExampleYears1to10>
    <cef:SeniorSecuritiesTableTextBlock contextRef="AsOf2024-07-23" id="Fact000078">&lt;div id="xdx_88C_ecef--SeniorSecuritiesTableTextBlock_dD_zAYOTBTY2Xlg"&gt;&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;The
                                            following table sets forth information about the Fund&#x2019;s outstanding senior securities
                                            as of the end of each fiscal set forth below. The information in this table for the fiscal
                                            years ended &lt;span style="background-color: white"&gt;October&#160;31, 2023, 2022, 2021, 2020
                                            and 2019 has been audited by &lt;/span&gt;PricewaterhouseCoopers LLP&lt;span style="background-color: white"&gt;,
                                            independent registered public accounting firm for the Fund. The report of &lt;/span&gt;PricewaterhouseCoopers
                                            LLP i&lt;span style="background-color: white"&gt;s included in the Fund&#x2019;s Annual Report to
                                            shareholders for the year ended October 31, 2023, as contained in the Registrant&#x2019;s
                                            &lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm"&gt;Form N-CSR&lt;/a&gt; filed with the SEC on December 29, 2023, and is incorporated herein by reference.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;&lt;span style="background-color: white"&gt;&lt;b&gt;Senior Securities Representing
Indebtedness&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 27%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Fiscal Year Ended&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 38%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Principal &lt;br/&gt;
Amount Outstanding(1)(2)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 35%; padding-right: 5.4pt; padding-left: 0.25in; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Asset Coverage &lt;br/&gt;
Per $1,000 of Principal Amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;October&#160;31, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;$173,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;$3,159&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;October&#160;31, 2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;$173,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;$3,480&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;October&#160;31, 2021&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;$168,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;$5,139&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;October&#160;31, 2020&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;$168,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;$4,300&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;October&#160;31, 2019&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;$210,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;$3,686&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;October&#160;31, 2018&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;$235,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;$3,381&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;October&#160;31, 2017&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;$150,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;$3,356&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;October&#160;31, 2016&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;$170,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;$3,256&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;October&#160;31, 2015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;$170,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;$3,374&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;October&#160;31, 2014&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;$170,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;$3,635&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</cef:SeniorSecuritiesTableTextBlock>
    <cef:SharePriceTableTextBlock contextRef="AsOf2024-07-23" id="Fact000081">&lt;table cellpadding="0" cellspacing="0" id="xdx_880_ecef--SharePriceTableTextBlock_dD_zbG3ufhqacEc" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Share Prices"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Market
    Price&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Corresponding
    Net Asset Value Per Common Share&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Corresponding
    Premium/(Discount) as a Percentage of &lt;br/&gt;
    Net Asset Value&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;&lt;span style="text-decoration: underline"&gt;Fiscal Quarter Ended&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;High&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Low&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;High&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Low&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;High&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Low&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;July 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;$12.85&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;$11.58&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;$12.28&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;$12.06&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;4.64%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;-3.98%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;April&#160;30, 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_900_ecef--HighestPriceOrBid_c20240201__20240430_z4uMbWGvVjva" style="font-size: 9pt"&gt;$12.10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_905_ecef--LowestPriceOrBid_c20240201__20240430_zMhcbO0z9rCk" style="font-size: 9pt"&gt;$11.23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90B_ecef--HighestPriceOrBidNav_c20240201__20240430_zHxUBXxDy2A2" style="font-size: 9pt"&gt;$12.59&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_905_ecef--LowestPriceOrBidNav_c20240201__20240430_zj6EJuQQ4Co8" style="font-size: 9pt"&gt;$11.95&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_901_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_c20240201__20240430_zfkX7NzVc3dd" style="font-size: 9pt"&gt;-3.89%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_900_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_c20240201__20240430_z35rfiYeAHMg" style="font-size: 9pt"&gt;-6.03%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;January&#160;31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_904_ecef--HighestPriceOrBid_c20231101__20240131_zWfReKqL3klb" style="font-size: 9pt"&gt;$11.71&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90C_ecef--LowestPriceOrBid_c20231101__20240131_znc7p8uAHF8h" style="font-size: 9pt"&gt;$9.64&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_907_ecef--HighestPriceOrBidNav_c20231101__20240131_z7bFOUe30hS7" style="font-size: 9pt"&gt;$12.39&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_907_ecef--LowestPriceOrBidNav_c20231101__20240131_zJy8rAP6b1C7" style="font-size: 9pt"&gt;$10.86&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90B_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_c20231101__20240131_zN2Phtro7wsd" style="font-size: 9pt"&gt;-5.49%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90A_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_c20231101__20240131_zQ638F4tdPVg" style="font-size: 9pt"&gt;-11.23%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;October&#160;31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_907_ecef--HighestPriceOrBid_c20230801__20231030_z65QkuS88VB3" style="font-size: 9pt"&gt;$11.96&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_904_ecef--LowestPriceOrBid_c20230801__20231030_zDK9JC2rNn1g" style="font-size: 9pt"&gt;$9.27&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90B_ecef--HighestPriceOrBidNav_c20230801__20231030_z6BvqeDy95Lk" style="font-size: 9pt"&gt;$12.79&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_902_ecef--LowestPriceOrBidNav_c20230801__20231030_zhgGpBQl1ixf" style="font-size: 9pt"&gt;$10.81&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90D_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_c20230801__20231030_zDdlKEujvbbf" style="font-size: 9pt"&gt;-6.49%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_905_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_c20230801__20231030_zGTyfs99uxee" style="font-size: 9pt"&gt;-14.25%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;July&#160;31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_902_ecef--HighestPriceOrBid_c20230501__20230731_zcJTdQQBDwQk" style="font-size: 9pt"&gt;$11.96&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_902_ecef--LowestPriceOrBid_c20230501__20230731_zlXhILcSeh69" style="font-size: 9pt"&gt;$11.01&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_905_ecef--HighestPriceOrBidNav_c20230501__20230731_zZZJausECy4a" style="font-size: 9pt"&gt;$12.89&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90E_ecef--LowestPriceOrBidNav_c20230501__20230731_zSjfqiH7PGxb" style="font-size: 9pt"&gt;$11.99&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_905_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_c20230501__20230731_zKFoYz9DvGKl" style="font-size: 9pt"&gt;-7.21%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_903_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_c20230501__20230731_z18wYAu0BHD9" style="font-size: 9pt"&gt;-8.17%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;April&#160;30, 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_906_ecef--HighestPriceOrBid_c20230201__20230430_z2V2E7YqaGb1" style="font-size: 9pt"&gt;$13.13&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90D_ecef--LowestPriceOrBid_c20230201__20230430_zi70uPkYnFue" style="font-size: 9pt"&gt;$11.06&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_906_ecef--HighestPriceOrBidNav_c20230201__20230430_z3hnkZi7Dh2" style="font-size: 9pt"&gt;$13.60&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90E_ecef--LowestPriceOrBidNav_c20230201__20230430_zjvk11eDzIz2" style="font-size: 9pt"&gt;$11.90&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_902_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_c20230201__20230430_z5Vj2U3Qycs2" style="font-size: 9pt"&gt;-3.46%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90C_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_c20230201__20230430_zCULwQIbe6Of" style="font-size: 9pt"&gt;-7.06%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;January&#160;31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90F_ecef--HighestPriceOrBid_c20221101__20230131_zHHLbUA8I0m5" style="font-size: 9pt"&gt;$12.57&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90E_ecef--LowestPriceOrBid_c20221101__20230131_zFG46Luy6HB1" style="font-size: 9pt"&gt;$10.81&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90C_ecef--HighestPriceOrBidNav_c20221101__20230131_z6bw4cyXe5Hc" style="font-size: 9pt"&gt;$13.23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_908_ecef--LowestPriceOrBidNav_c20221101__20230131_z51NAzC5gLZ5" style="font-size: 9pt"&gt;$12.22&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_906_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_c20221101__20230131_zYiCA5rP8FBi" style="font-size: 9pt"&gt;-4.99%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90C_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_c20221101__20230131_zdcvoNQssIT1" style="font-size: 9pt"&gt;-11.54%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;October&#160;31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90E_ecef--HighestPriceOrBid_c20220801__20221031_zzMDlbzJKwrb" style="font-size: 9pt"&gt;$14.70&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90B_ecef--LowestPriceOrBid_c20220801__20221031_z6si7MtqHu3c" style="font-size: 9pt"&gt;$10.43&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_901_ecef--HighestPriceOrBidNav_c20220801__20221031_zmtMhP0AMLWj" style="font-size: 9pt"&gt;$14.15&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90B_ecef--LowestPriceOrBidNav_c20220801__20221031_zEdoV40X7MH" style="font-size: 9pt"&gt;$11.73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90D_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_c20220801__20221031_z7NK3Q6diEP7" style="font-size: 9pt"&gt;3.89%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_901_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_c20220801__20221031_zrU5Fqruq8M1" style="font-size: 9pt"&gt;-11.08%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;July&#160;31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90F_ecef--HighestPriceOrBid_c20220501__20220731_zw5L6wOQvZtc" style="font-size: 9pt"&gt;$14.53&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90A_ecef--LowestPriceOrBid_c20220501__20220731_zrnlgPKJSQEi" style="font-size: 9pt"&gt;$11.75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_906_ecef--HighestPriceOrBidNav_c20220501__20220731_z2VmpkWqG0g3" style="font-size: 9pt"&gt;$15.08&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_904_ecef--LowestPriceOrBidNav_c20220501__20220731_zSIa2K58vfmc" style="font-size: 9pt"&gt;$12.38&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_900_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_c20220501__20220731_zJOr16qWOvci" style="font-size: 9pt"&gt;-3.65%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90B_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_c20220501__20220731_zTQT2G5R8Wxl" style="font-size: 9pt"&gt;-5.09%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;April&#160;30, 2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_900_ecef--HighestPriceOrBid_c20220201__20220430_z73PEurZSRne" style="font-size: 9pt"&gt;$16.87&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_900_ecef--LowestPriceOrBid_c20220201__20220430_zRbSehzl8Go4" style="font-size: 9pt"&gt;$14.18&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_905_ecef--HighestPriceOrBidNav_c20220201__20220430_zFsEgRxXhcp3" style="font-size: 9pt"&gt;$16.73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_907_ecef--LowestPriceOrBidNav_c20220201__20220430_zpm3Ij8V6ICb" style="font-size: 9pt"&gt;$14.99&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_904_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_c20220201__20220430_zOVwTdAsv3Qj" style="font-size: 9pt"&gt;0.84%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_907_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_c20220201__20220430_zak2vfZ39uI4" style="font-size: 9pt"&gt;-5.40%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;January&#160;31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90F_ecef--HighestPriceOrBid_c20211101__20220131_z4xnNJ9lTUFl" style="font-size: 9pt"&gt;$19.39&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90D_ecef--LowestPriceOrBid_c20211101__20220131_zKOh415XjV4f" style="font-size: 9pt"&gt;$15.59&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90C_ecef--HighestPriceOrBidNav_c20211101__20220131_zWBDlLHwhkbh" style="font-size: 9pt"&gt;$20.31&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_901_ecef--LowestPriceOrBidNav_c20211101__20220131_zYL6SkJTdeX1" style="font-size: 9pt"&gt;$16.62&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90B_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_c20211101__20220131_zneeC22xEuk4" style="font-size: 9pt"&gt;-4.53%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_902_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_c20211101__20220131_zVzRt3pRA7D7" style="font-size: 9pt"&gt;-6.20%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</cef:SharePriceTableTextBlock>
    <cef:HighestPriceOrBid
      contextRef="From2024-02-012024-04-30"
      decimals="INF"
      id="Fact000083"
      unitRef="USDPShares">12.10</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2024-02-012024-04-30"
      decimals="INF"
      id="Fact000084"
      unitRef="USDPShares">11.23</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2024-02-012024-04-30"
      decimals="INF"
      id="Fact000085"
      unitRef="USDPShares">12.59</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2024-02-012024-04-30"
      decimals="INF"
      id="Fact000086"
      unitRef="USDPShares">11.95</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-02-012024-04-30"
      decimals="INF"
      id="Fact000087"
      unitRef="Ratio">-0.0389</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-02-012024-04-30"
      decimals="INF"
      id="Fact000088"
      unitRef="Ratio">-0.0603</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2023-11-012024-01-31"
      decimals="INF"
      id="Fact000089"
      unitRef="USDPShares">11.71</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2023-11-012024-01-31"
      decimals="INF"
      id="Fact000090"
      unitRef="USDPShares">9.64</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2023-11-012024-01-31"
      decimals="INF"
      id="Fact000091"
      unitRef="USDPShares">12.39</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2023-11-012024-01-31"
      decimals="INF"
      id="Fact000092"
      unitRef="USDPShares">10.86</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-11-012024-01-31"
      decimals="INF"
      id="Fact000093"
      unitRef="Ratio">-0.0549</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-11-012024-01-31"
      decimals="INF"
      id="Fact000094"
      unitRef="Ratio">-0.1123</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2023-08-012023-10-30"
      decimals="INF"
      id="Fact000095"
      unitRef="USDPShares">11.96</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2023-08-012023-10-30"
      decimals="INF"
      id="Fact000096"
      unitRef="USDPShares">9.27</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2023-08-012023-10-30"
      decimals="INF"
      id="Fact000097"
      unitRef="USDPShares">12.79</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2023-08-012023-10-30"
      decimals="INF"
      id="Fact000098"
      unitRef="USDPShares">10.81</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-08-012023-10-30"
      decimals="INF"
      id="Fact000099"
      unitRef="Ratio">-0.0649</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-08-012023-10-30"
      decimals="INF"
      id="Fact000100"
      unitRef="Ratio">-0.1425</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2023-05-012023-07-31"
      decimals="INF"
      id="Fact000101"
      unitRef="USDPShares">11.96</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2023-05-012023-07-31"
      decimals="INF"
      id="Fact000102"
      unitRef="USDPShares">11.01</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2023-05-012023-07-31"
      decimals="INF"
      id="Fact000103"
      unitRef="USDPShares">12.89</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2023-05-012023-07-31"
      decimals="INF"
      id="Fact000104"
      unitRef="USDPShares">11.99</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-05-012023-07-31"
      decimals="INF"
      id="Fact000105"
      unitRef="Ratio">-0.0721</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-05-012023-07-31"
      decimals="INF"
      id="Fact000106"
      unitRef="Ratio">-0.0817</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2023-02-012023-04-30"
      decimals="INF"
      id="Fact000107"
      unitRef="USDPShares">13.13</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2023-02-012023-04-30"
      decimals="INF"
      id="Fact000108"
      unitRef="USDPShares">11.06</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2023-02-012023-04-30"
      decimals="INF"
      id="Fact000109"
      unitRef="USDPShares">13.60</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2023-02-012023-04-30"
      decimals="INF"
      id="Fact000110"
      unitRef="USDPShares">11.90</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-02-012023-04-30"
      decimals="INF"
      id="Fact000111"
      unitRef="Ratio">-0.0346</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-02-012023-04-30"
      decimals="INF"
      id="Fact000112"
      unitRef="Ratio">-0.0706</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2022-11-012023-01-31"
      decimals="INF"
      id="Fact000113"
      unitRef="USDPShares">12.57</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2022-11-012023-01-31"
      decimals="INF"
      id="Fact000114"
      unitRef="USDPShares">10.81</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2022-11-012023-01-31"
      decimals="INF"
      id="Fact000115"
      unitRef="USDPShares">13.23</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2022-11-012023-01-31"
      decimals="INF"
      id="Fact000116"
      unitRef="USDPShares">12.22</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2022-11-012023-01-31"
      decimals="INF"
      id="Fact000117"
      unitRef="Ratio">-0.0499</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2022-11-012023-01-31"
      decimals="INF"
      id="Fact000118"
      unitRef="Ratio">-0.1154</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2022-08-012022-10-31"
      decimals="INF"
      id="Fact000119"
      unitRef="USDPShares">14.70</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2022-08-012022-10-31"
      decimals="INF"
      id="Fact000120"
      unitRef="USDPShares">10.43</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2022-08-012022-10-31"
      decimals="INF"
      id="Fact000121"
      unitRef="USDPShares">14.15</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2022-08-012022-10-31"
      decimals="INF"
      id="Fact000122"
      unitRef="USDPShares">11.73</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2022-08-012022-10-31"
      decimals="INF"
      id="Fact000123"
      unitRef="Ratio">0.0389</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2022-08-012022-10-31"
      decimals="INF"
      id="Fact000124"
      unitRef="Ratio">-0.1108</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2022-05-012022-07-31"
      decimals="INF"
      id="Fact000125"
      unitRef="USDPShares">14.53</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2022-05-012022-07-31"
      decimals="INF"
      id="Fact000126"
      unitRef="USDPShares">11.75</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2022-05-012022-07-31"
      decimals="INF"
      id="Fact000127"
      unitRef="USDPShares">15.08</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2022-05-012022-07-31"
      decimals="INF"
      id="Fact000128"
      unitRef="USDPShares">12.38</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2022-05-012022-07-31"
      decimals="INF"
      id="Fact000129"
      unitRef="Ratio">-0.0365</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2022-05-012022-07-31"
      decimals="INF"
      id="Fact000130"
      unitRef="Ratio">-0.0509</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2022-02-012022-04-30"
      decimals="INF"
      id="Fact000131"
      unitRef="USDPShares">16.87</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2022-02-012022-04-30"
      decimals="INF"
      id="Fact000132"
      unitRef="USDPShares">14.18</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2022-02-012022-04-30"
      decimals="INF"
      id="Fact000133"
      unitRef="USDPShares">16.73</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2022-02-012022-04-30"
      decimals="INF"
      id="Fact000134"
      unitRef="USDPShares">14.99</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2022-02-012022-04-30"
      decimals="INF"
      id="Fact000135"
      unitRef="Ratio">0.0084</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2022-02-012022-04-30"
      decimals="INF"
      id="Fact000136"
      unitRef="Ratio">-0.0540</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2021-11-012022-01-31"
      decimals="INF"
      id="Fact000137"
      unitRef="USDPShares">19.39</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2021-11-012022-01-31"
      decimals="INF"
      id="Fact000138"
      unitRef="USDPShares">15.59</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2021-11-012022-01-31"
      decimals="INF"
      id="Fact000139"
      unitRef="USDPShares">20.31</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2021-11-012022-01-31"
      decimals="INF"
      id="Fact000140"
      unitRef="USDPShares">16.62</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2021-11-012022-01-31"
      decimals="INF"
      id="Fact000141"
      unitRef="Ratio">-0.0453</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2021-11-012022-01-31"
      decimals="INF"
      id="Fact000142"
      unitRef="Ratio">-0.0620</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:InvestmentObjectivesAndPracticesTextBlock contextRef="AsOf2024-07-23" id="Fact000157">INVESTMENT OBJECTIVE AND POLICIES&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;&lt;span style="-sec-ix-redline: true"&gt;The information contained
                                            under the headings &#x201c;Investment Objective, Policies and Principal Risks&#x2014;Investment
                                            Objective and Policies,&#x201d; &#x201c;About the Fund Manager&#x2014;Investment Philosophy&#x201d;
                                            and &#x201c;About the Fund Manager&#x2014;Investment Process&#x201d; in the Fund&#x2019;s &lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm"&gt;Annual Report&lt;/a&gt; is incorporated herein by reference.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center"&gt;THE FUND&#x2019;S INVESTMENTS&lt;/p&gt;&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;The Fund&#x2019;s investment portfolio may consist of investments in
the following types of securities. There is no guarantee that the fund will buy all of the types of securities or use all of the investment
techniques that are described herein.&lt;/p&gt;&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;&lt;i&gt;Convertible and Non-Convertible Securities Allocation&lt;/i&gt;. Under
normal market conditions, the Fund invests at least 80% of its Managed Assets (as defined in this Prospectus) in a diversified portfolio
of convertible securities and non-convertible income producing securities. Under normal market conditions, the Fund will invest at least
30% of its Managed Assets in convertible securities and may invest up to 70% of its Managed Assets in non-convertible income securities.
The Fund may invest without limitation in convertible securities.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in"&gt;&lt;span style="text-decoration: underline"&gt;Convertible Securities&lt;/span&gt;. A convertible security is a
bond, debenture, note, stock or other similar security that may be converted into or exchanged for a prescribed amount of common stock
or other equity security of the same or a different issuer within a particular period of time at a specified price or formula. A convertible
security may also be structured so that it is convertible at the option of the holder or the issuer, or subject to mandatory conversion.
Before conversion, convertible securities have characteristics similar to nonconvertible debt securities in that they ordinarily provide
a stream of income with generally higher yields than those of common stock of the same or similar issuers. Convertible securities are
senior in rank to common stock in a corporation&#x2019;s capital structure and, therefore, generally entail less risk than the corporation&#x2019;s
common stock, although the extent to which such risk is reduced depends in large measure upon the degree to which the convertible security
sells above its value as a fixed income security.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in"&gt;The Fund believes that the characteristics of convertible
securities make them appropriate investments for an investment company seeking a high level of total return on its assets. These characteristics
include the potential for capital appreciation if the value of the underlying common stock increases, the relatively high yield received
from dividend or interest payments as compared to common stock dividends and decreased risks of decline in value, relative to the underlying
common stock due to their fixed income nature. As a result of the conversion feature, however, the interest rate or dividend preference
on a convertible security is generally less than would be the case if the securities were not convertible. During periods of rising interest
rates, it is possible that the potential for capital gain on a convertible security may be less than that of a common stock equivalent
if the yield on the convertible security is at a level that causes it to sell at a discount.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in"&gt;Every convertible security may be valued, on a theoretical
basis, as if it did not have a conversion privilege. This theoretical value is determined by the yield it provides in comparison with
the yields of other securities of comparable character and quality that do not have a conversion privilege. This theoretical value, which
may change with prevailing interest rates, the credit rating of the issuer and other pertinent factors, often referred to as the &#x201c;investment
value,&#x201d; represents the security&#x2019;s theoretical price support level.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in"&gt;&#x201c;Conversion value&#x201d; is the amount a convertible
security would be worth in market value if it were to be exchanged for the underlying equity security pursuant to its conversion privilege.
Conversion value fluctuates directly with the price of the underlying equity security, usually common stock. If, because of low prices
for the common stock, the conversion value is substantially below the investment value, the price of the convertible security is governed
principally by the factors described in the preceding paragraph. If the conversion value rises near or above its investment value, the
price of the convertible security generally will rise above its investment value and, in addition, will sell at some premium over its
conversion value. This premium represents the price investors are willing to pay for the privilege of&lt;/p&gt;&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in"&gt;purchasing a fixed-income security with a possibility of capital
appreciation due to the conversion privilege. Accordingly, the conversion value of a convertible security is subject to equity risk, that
is, the risk that the price of an equity security will fall due to general market and economic conditions, perceptions regarding the industry
in which the issuer participates or the issuing company&#x2019;s particular circumstances. If the appreciation potential of a convertible
security is not realized, its conversion value premium may not be recovered.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in"&gt;&lt;span style="text-decoration: underline"&gt;Non-Convertible Income Securities&lt;/span&gt;. The Fund may also
invest in income securities other than convertible securities that are expected to periodically accrue or generate income for their holders.
Such income securities include (i) fixed income securities such as bonds, debentures, notes, preferred stock, short-term discounted Treasury
Bills or certain securities of the U.S. government sponsored instrumentalities, as well as money market mutual funds that invest in those
securities, which, in the absence of an applicable exemptive order, will not be affiliated with the Adviser, and (ii) common and preferred
stocks of issuers that have historically paid periodic dividends. Fixed income securities obligate the issuer to pay to the holder of
the security a specified return, which may be either fixed or reset periodically in accordance with the terms of the security. Fixed income
securities generally are senior to an issuer&#x2019;s common stock and their holders generally are entitled to receive amounts due before
any distributions are made to common stockholders. Common stocks, on the other hand, generally do not obligate an issuer to make periodic
distributions to holders.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in"&gt;The market value of fixed income securities, especially those
that provide a fixed rate of return, may be expected to rise and fall inversely with interest rates and in general is affected by the
credit rating of the issuer, the issuer&#x2019;s performance and perceptions of the issuer in the market place. The market value of callable
or redeemable fixed income securities may also be affected by the issuer&#x2019;s call and redemption rights. In addition, it is possible
that the issuer of fixed income securities may not be able to meet its interest or principal obligations to holders. Further, holders
of non-convertible fixed income securities do not participate in any capital appreciation of the issuer.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in"&gt;The Fund may also invest in obligations of government sponsored
instrumentalities. Unlike non-U.S. government securities, obligations of certain agencies and instrumentalities of the U.S. government,
such as the Government National Mortgage Association, are supported by the &#x201c;full faith and credit&#x201d; of the U.S. government;
others, such as those of the Export-Import Bank of the U.S., are supported by the right of the issuer to borrow from the U.S. Treasury;
others, such as those of the Federal National Mortgage Association, are supported by the discretionary authority of the U.S. government
to purchase the agency&#x2019;s obligations; and still others, such as those of the Student Loan Marketing Association, are supported only
by the credit of the instrumentality. No assurance can be given that the U.S. government would provide financial support to U.S. government
sponsored instrumentalities if it is not obligated to do so by law. Although the Fund may invest in all types of obligations of agencies
and instrumentalities of the U.S. government, the Fund currently intends to invest only in obligations that are supported by the &#x201c;full
faith and credit&#x201d; of the U.S. government.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in"&gt;The Fund also may invest in common stock of issuers that have
historically paid periodic dividends or otherwise made distributions to common stockholders. Unlike fixed income securities, dividend
payments generally are not guaranteed and so may be discontinued by the issuer at its discretion or because of the issuer&#x2019;s inability
to satisfy its liabilities. Further, an issuer&#x2019;s history of paying dividends does not guarantee that it will continue to pay dividends
in the future. In addition to dividends, under certain circumstances the holders of common stock may benefit from the capital appreciation
of the issuer.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in"&gt;Common stocks represent the residual ownership interest in
the issuer and holders of common stock are entitled to the income and increase in the value of the assets and business of the issuer after
all of its debt obligations and obligations to preferred shareholders are satisfied. Common stocks generally have voting rights.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in"&gt;Common stocks fluctuate in price in response to many factors
including historical and prospective earnings of the issuer, the value of its assets, general economic conditions, interest rates, investor
perceptions and market liquidity.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in"&gt;&lt;span style="text-decoration: underline"&gt;Synthetic Convertible Securities&lt;/span&gt;. The Fund may also
invest in &#x201c;synthetic&#x201d; convertible securities, which, for purposes of its investment policies, the Fund considers to be convertible
securities. A synthetic convertible&lt;/p&gt;&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in"&gt;security may be created by the Fund or by a third party by
combining separate securities that possess the two principal characteristics of a traditional convertible security: an income producing
component and a convertible component. Synthetic convertible securities differ from convertible securities whose conversion privilege
may be evidenced by warrants attached to the security or acquired as part of a unit with the security. The income-producing component
is achieved by investing in non-convertible, income-producing securities such as bonds, preferred stocks and money market instruments.
The convertible component is achieved by investing in securities or instruments such as warrants or options to buy common stock at a certain
exercise price, or options on a stock index. Unlike a traditional convertible security, which is a single security having a single market
value, a synthetic convertible comprises two or more separate securities, each with its own market value. Because the &#x201c;market value&#x201d;
of a synthetic convertible security is the sum of the values of its income producing component and its convertible component, the value
of a synthetic convertible security may respond differently to market fluctuations than a traditional convertible security. The Fund also
may purchase synthetic convertible securities created by other parties, including convertible structured notes. Convertible structured
notes are income-producing debentures linked to equity. Convertible structured notes have the attributes of a convertible security; however,
the issuer of the convertible note (typically an investment bank), rather than the issuer of the underlying common stock into which the
note is convertible, assumes credit risk associated with the underlying investment and the Fund in turn assumes credit risk associated
with the issuer of the convertible note.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;&lt;i&gt;Covered Call Option Strategy&lt;/i&gt;. The Fund may use a strategy of
writing (selling) covered call options on the securities held in the portfolio, thus generating option writing premiums. The objective
of this strategy is to generate current gains from option premiums to enhance distributions payable to common shareholders. The Fund may
write (sell) covered call options on up to 25% of the securities held in its portfolio.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;&lt;i&gt;Options&lt;/i&gt;. An option on a security is a contract that gives the
holder of the option, in return for a premium, the right to buy from (in the case of a call) or sell to (in the case of a put) the writer
of the option the security underlying the option at a specified exercise or &#x201c;strike&#x201d; price. The writer of an option on a security
has the obligation upon exercise of the option to deliver the underlying security upon payment of the exercise price or to pay the exercise
price upon delivery of the underlying security. Certain options, known as &#x201c;American style&#x201d; options may be exercised at any
time during the term of the option. Other options, known as &#x201c;European style&#x201d; options, may be exercised only on the expiration
date of the option.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;If an option written by the Fund expires unexercised, the Fund realizes
on the expiration date a capital gain equal to the premium received by the Fund at the time the option was written. If an option purchased
by the Fund expires unexercised, the Fund realizes a capital loss equal to the premium paid. Prior to the earlier of exercise or expiration,
an exchange-traded option may be closed out by an offsetting purchase or sale of an option of the same series (type, underlying security,
exercise price and expiration). There can be no assurance, however, that a closing purchase or sale transaction can be effected when the
Fund desires. The Fund may sell put or call options it has previously purchased, which could result in a net gain or loss depending on
whether the amount realized on the sale is more or less than the premium and other transaction costs paid on the put or call option when
purchased. The Fund will realize a capital gain from a closing purchase transaction if the cost of the closing option is less than the
premium received from writing the option, or, if it is more, the Fund will realize a capital loss. If the premium received from a closing
sale transaction is more than the premium paid to purchase the option, the Fund will realize a capital gain or, if it is less, the Fund
will realize a capital loss. Net gains from the Fund&#x2019;s option strategy will be short-term capital gains which, for U.S. federal
income tax purposes, will constitute net investment company taxable income.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;As part of its strategy, the Fund may not sell &#x201c;naked&#x201d; call
options on individual securities, (&lt;i&gt;i.e.&lt;/i&gt;, options representing more shares of the stock than are held in the portfolio). A call
option written by the Fund on a security is &#x201c;covered&#x201d; if the Fund owns the security or instrument underlying the call or has
an absolute and immediate right to acquire that security or instrument without additional cash consideration (or, if additional cash consideration
is required, cash or other assets determined to be liquid by the Adviser (in accordance with procedures established by the Board of Trustees)
in such amount are segregated by the Fund&#x2019;s custodian) upon conversion or exchange of other securities held by the Fund. A call
option is also covered if the Fund holds a call on the same security as the call written where the exercise price of the call held is
(i) equal to or less than the exercise price of the call written, or (ii) greater than the exercise price of the call written, provided
the difference is maintained by the Fund in segregated assets determined to be liquid by the Adviser as described above.&lt;/p&gt;&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;Put options are contracts that give the holder of the option, in return
for a premium, the right to sell to the writer of the option the security underlying the option at a specified exercise price at a specific
time or times during the term of the option. These strategies may produce a considerably higher return than the Fund&#x2019;s primary strategy
of covered call writing, but involve a higher degree of risk and potential volatility.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;The Fund will write (sell) put options on individual securities only
if the put option is &#x201c;covered.&#x201d; A put option written by the Fund on a security is &#x201c;covered&#x201d; if the Fund segregates
or earmarks assets determined to be liquid by the Adviser, as described above, equal to the exercise price. A put option is also covered
if the Fund holds a put on the same security as the put written where the exercise price of the put held is (i) equal to or greater than
the exercise price of the put written, or (ii) less than the exercise price of the put written, provided the difference is maintained
by the Fund in segregated or earmarked assets determined to be liquid by the Adviser, as described above.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;The Fund may sell put and call options on indices of securities. Options
on an index differ from options on securities because (i) the exercise of an index option requires cash payments and does not involve
the actual purchase or sale of securities, (ii) the holder of an index option has the right to receive cash upon exercise of the option
if the level of the index upon which the option is based is greater, in the case of a call, or less, in the case of a put, than the exercise
price of the option and (iii) index options reflect price-fluctuations in a group of securities or segments of the securities market rather
than price fluctuations in a single security.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;&lt;i&gt;Illiquid Securities&lt;/i&gt;. The Fund may invest no more than 20% of
its Managed Assets in illiquid securities. Illiquid securities include securities legally restricted as to resale, such as commercial
paper issued pursuant to Section&#160;4(a)(2) of the Securities Act and securities eligible for resale pursuant to Rule&#160;144A thereunder.
Section&#160;4(a)(2) and Rule&#160;144A securities may, however, be treated as liquid by the Adviser pursuant to procedures adopted by
the Board of Trustees, which require consideration of factors such as trading activity, availability of market quotations and number of
dealers willing to purchase the security. If the Fund invests in Rule&#160;144A securities, the level of portfolio illiquidity may be
increased to the extent that eligible buyers become uninterested in purchasing such securities.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;It may be difficult to sell such securities at a price representing
the fair value until such time as such securities may be sold publicly. Where registration is required, a considerable period may elapse
between a decision to sell the securities and the time when it would be permitted to sell. Thus, the Fund may not be able to obtain as
favorable a price as that prevailing at the time of the decision to sell. The Fund may also acquire securities through private placements
under which it may agree to contractual restrictions on the resale of such securities. Such restrictions might prevent their sale at a
time when such sale would otherwise be desirable.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;As described below, the Fund may invest a portion of its assets in privately
offered convertible securities or similar instruments that may be illiquid.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;&lt;i&gt;Foreign Securities&lt;/i&gt;. The Fund may invest without limitation in
foreign securities. Investing in foreign securities may provide increased diversification by adding securities from various foreign countries
(i) that offer different investment opportunities, (ii) that generally are affected by different economic trends and (iii) whose stock
markets may not be correlated with U.S. markets. At the same time, these opportunities and trends involve risks that may not be encountered
in U.S. investments.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;The following considerations comprise both risks and opportunities not
typically associated with investing in U.S. securities: fluctuations in exchange rates of foreign currencies; possible imposition of exchange
control regulations or currency restrictions that would prevent cash from being brought back to the United States; less public information
with respect to issuers of securities; less government supervision of stock exchanges, securities brokers and issuers of securities; lack
of uniform accounting, auditing and financial reporting standards; lack of uniform settlement periods and trading practices; less liquidity
and frequently greater price volatility in foreign markets than in the United States; possible imposition of foreign taxes; the possibility
of expropriation or confiscatory taxation, seizure or nationalization of foreign bank deposits or other assets; the adoption of foreign
government restrictions and other adverse political, social or diplomatic developments that could affect investment; difficulty in obtaining
or enforcing a court judgment abroad; sometimes less advantageous legal, operational and financial protections applicable to foreign sub-custodial
arrangements; and the historically lower level of responsiveness of foreign management to shareholder concerns (such as dividends and
return on investment).&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;The Fund may purchase sponsored American Depository Receipts (&#x201c;ADRs&#x201d;)
or U.S. dollar denominated securities of foreign issuers. ADRs are receipts issued by U.S. banks or trust companies in respect of securities
of foreign issuers held on deposit for use in the U.S. securities markets.&lt;/p&gt;&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;&lt;span style="background-color: white"&gt;The risks described above for
foreign securities, including the risks of nationalization and expropriation of assets, are typically increased to the extent that the
Fund invests in companies headquartered in developing, or emerging market, countries. Investments in securities of companies headquartered
in such countries may be considered speculative and subject to certain special risks. The political and economic structures in many of
these countries may be in their infancy and developing rapidly, and such countries may lack the social, political and economic characteristics
of more developed countries. Certain of these countries have in the past failed to recognize private property rights and have at times
nationalized and expropriated the assets of private companies. Some countries have inhibited the conversion of their currency to another.
The currencies of certain emerging market countries have experienced devaluation relative to the U.S. dollar, and future devaluations
may adversely affect the value of the Fund&#x2019;s assets denominated in such currencies. Some emerging market countries have experienced
substantial rates of inflation for many years. Continued inflation may adversely affect the economies and securities markets of such countries.
In addition, unanticipated political or social developments may affect the value of the Fund&#x2019;s investments in these countries and
the availability of the Fund of additional investments in these countries. The small size, limited trading volume and relative inexperience
of the securities markets in these countries may make the Fund&#x2019;s investments in such countries illiquid and more volatile than investments
in more developed countries, and the Fund may be required to establish special custodial or other arrangements before making investments
in these countries. There may be little financial or accounting information available with respect to companies located in these countries,
and it may be difficult as a result to assess the value or prospects of an investment in such companies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;&lt;i&gt;Equity Securities&lt;/i&gt;. Equity securities, such as common stock, generally
represent an ownership interest in a company. The Fund may invest up to 20% of its Managed Assets in non-convertible equity securities.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;&lt;i&gt;Lower Grade Securities&lt;/i&gt;. The Fund may invest a significant portion
of its assets in securities rated below investment grade, such as those rated Ba or lower by Moody&#x2019;s Investors Service, Inc. (&#x201c;Moody&#x2019;s&#x201d;)
and BB or lower by Standard &amp;amp; Poor&#x2019;s (&#x201c;S&amp;amp;P&#x201d;) or securities comparably rated by other rating agencies or in unrated
securities determined by Advent to be of comparable quality. Lower grade securities are commonly referred to as &#x201c;junk bonds.&#x201d;
Both the convertible securities and the income-producing securities in which the Fund will invest may be lower grade securities.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;Prices of&#160;lower&#160;grade&#160;securities are more sensitive to
negative developments, such as a decline in the issuer&#x2019;s revenues or a general economic downturn, than are the prices of higher
grade&#160;securities.&#160;Lower grade&#160;securities tend to be less liquid than investment grade securities. The market value&#160;of&#160;lower
grade&#160;securities may be more volatile than the market value of investment grade securities and generally tends to reflect the market&#x2019;s
perception of the creditworthiness of the issuer and short-term market developments to a greater extent than investment grade securities,
which primarily reflect fluctuations in general levels of interest rates.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;Ratings are relative and subjective, and not absolute standards of quality.
Securities ratings are based largely on the issuer&#x2019;s historical financial condition and the rating agencies&#x2019; analysis at the
time of rating. Consequently, the rating assigned to any particular security is not necessarily a reflection of the issuer&#x2019;s current
financial condition.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;The Fund may purchase securities of companies that are experiencing
significant financial or business difficulties, including companies involved in bankruptcy or other reorganization and liquidation proceedings.
Although such investments may result in significant financial returns to the Fund, they involve a substantial degree of risk. The level
of analytical sophistication, both financial and legal, necessary for successful investments in issuers experiencing significant business
and financial difficulties is unusually high. There can be no assurance that the Fund will correctly evaluate the value of the assets
collateralizing its investments or the prospects for a successful reorganization or similar action. In any reorganization or liquidation
proceeding relating to a portfolio investment, the Fund may lose all or part of its investment or may be required to accept collateral
with a value less than the amount of the Fund&#x2019;s initial investment.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;As a part of its investments&#160;in&#160;lower&#160;grade&#160;securities,
the Fund may invest in the securities of issuers in default. By investing in the securities of issuers in default, the Fund bears the
risk that these issuers will not continue to honor their obligations or emerge from bankruptcy protection or that the value of these securities
will not otherwise appreciate.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;In addition to using statistical rating agencies and other sources,
the Adviser will also perform its own analysis of issuers in seeking investments that it believes to be underrated (and thus higher yielding)
in light of the financial condition of the issuer. Its analysis of issuers may include, among other things, current and anticipated cash
flow and borrowing requirements, value of assets in relation to historical cost, strength of management, responsiveness to&lt;/p&gt;&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;business conditions, credit standing and current anticipated results
of operations. In selecting investments for the Fund, the Adviser may also consider general business conditions, anticipated changes in
interest rates and the outlook for specific industries.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;Subsequent to its purchase by the Fund, an issue of securities may cease
to be rated or its rating may be reduced. In addition, it is possible that statistical rating agencies might change their ratings of a
particular issue to reflect subsequent events on a timely basis. Moreover, such ratings do not assess the risk of a decline in market
value. None of these events will require the sale of the securities by the Fund, although the Adviser will consider these events in determining
whether the Fund should continue to hold the securities.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;The market&#160;for&#160;lower&#160;grade&#160;and comparable unrated
securities has at various times, particularly during times of economic recession, experienced substantial reductions in market value and
liquidity. Past recessions have adversely affected the value of such securities as well as the ability of certain issuers of such securities
to repay principal and pay interest thereon or to refinance such securities. The market for those securities could react in a similar
fashion in the event of any future economic recession.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;&lt;i&gt;Preferred Stock&lt;/i&gt;. The Fund may invest in preferred stock. The
preferred stock in which the Fund typically will invest will be convertible securities. Preferred shares are equity securities, but they
have many characteristics of fixed income securities, such as a fixed dividend payment rate and/or a liquidity preference over the issuer&#x2019;s
common shares. However, because preferred stocks are equity securities, they may be more susceptible to risks traditionally associated
with equity investments than the Fund&#x2019;s fixed income securities.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;&lt;i&gt;Private Securities&lt;/i&gt;. The Fund may invest up to 15% of its Managed
Assets in privately offered convertible securities, privately offered non-convertible income securities and any attached or related privately
offered warrants or equity-linked securities (collectively, &#x201c;private securities&#x201d;), which may include securities of private
companies and privately issued securities of public companies. Advent does not expect to invest more than 2.5% of the Fund&#x2019;s Managed
Assets in any single private security at the time of investment. The Fund invests primarily in private securities to seek to enhance the
Fund&#x2019;s current income. Therefore, the Fund will invest in a private security only if the expected yield on such security at the
time of investment exceeds the yield of specified public convertible and high yield bond benchmarks (currently the ICE BofAML All U.S.
Convertibles Index and ICE BofAML US High Yield Total Return Index). The Fund is not required to dispose of private securities in the
event that relative yields change after the time of investment. Any private securities investments will increase the percentage of the
Fund&#x2019;s assets invested in illiquid securities. In order to provide for further diversification, Advent intends to limit the number
of private securities transactions the Fund makes in any given year and deploy the Fund&#x2019;s overall allocation to private securities
over the course of several years.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;&lt;i&gt;Derivative Transactions&lt;/i&gt;. The Fund may purchase and sell derivative
instruments such as exchange-listed and over-the-counter put and call options on securities, financial futures, equity, fixed-income and
interest rate indices, and other financial instruments, purchase and sell financial futures contracts and options thereon, enter into
various interest rate transactions such as swaps, caps, floors or collars and enter into various currency transactions such as currency
forward contracts, currency futures contracts, currency swaps or options on currency or currency futures or credit transactions and credit
default swaps. The Fund also may purchase derivative instruments that combine features of these instruments and purchase securities for
delayed settlement. See &#x201c;The Fund&#x2019;s Investments&#x2014;Derivatives&#x201d; in the Statement of Additional Information.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;&lt;i&gt;Other Investment Companies&lt;/i&gt;. The Fund may invest in the securities
of other investment companies to the extent that such investments are consistent with the Fund&#x2019;s investment objective and policies
and permissible under the 1940 Act. The Fund may invest in mutual funds, closed-end funds and exchange-traded funds. Under the 1940 Act,
the Fund generally may invest only up to 10% of its total assets in the aggregate in shares of other investment companies and only up
to 5% of its total assets in any one investment company, provided the investment does not represent more than 3% of the voting stock of
the acquired investment company at the time such shares are purchased. However, pursuant to certain exemptions set forth in the 1940 Act,
the Fund may invest in excess of this limitation provided that certain conditions are met. Investments in other investment companies involve
operating expenses and fees at the other investment company level that are in addition to the expenses and fees borne by the Fund and
are borne indirectly by common shareholders. For purposes of the Fund&#x2019;s policy of investing at least 80% of its Managed Assets in
convertible securities and other income producing securities, the Fund will include the value of its investments in other investment companies
that invest primarily in convertible securities and/or other income producing securities.&lt;/p&gt;&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;&lt;i&gt;Defensive and Temporary Investments&lt;/i&gt;. Under unusual market or
economic conditions or for temporary defensive purposes, the Fund may invest up to 100% of its total assets in securities issued or guaranteed
by the U.S. government or its instrumentalities or agencies, certificates of deposit, bankers&#x2019; acceptances and other bank obligations,
commercial paper rated in the highest category by a nationally recognized statistical rating organization or other fixed income securities
deemed by the Adviser to be consistent with a defensive posture, or may hold cash, including money market funds.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;&lt;i&gt;Repurchase Agreements&lt;/i&gt;. The Fund may enter into repurchase agreements
with broker-dealers, member banks of the Federal Reserve System and other financial institutions. Repurchase agreements may be seen as
loans by the Fund collateralized by underlying debt securities. Under the terms of a typical repurchase agreement, the Fund would acquire
an underlying debt obligation for a relatively short period (usually not more than one week) subject to an obligation of the seller to
repurchase, and the Fund to resell, the obligation at an agreed price and time. This arrangement results in a fixed rate of return to
the Fund that is not subject to market fluctuations during the holding period. The Fund bears a risk of loss in the event that the other
party to a repurchase agreement defaults on its obligations and the Fund is delayed in or prevented from exercising its rights to dispose
of the collateral securities, including the risk of a possible decline in the value of the underlying securities during the period in
which it seeks to assert these rights. The Adviser, acting under the supervision of the Board of Trustees, reviews the creditworthiness
of those banks and dealers with which the Fund enters into repurchase agreements to evaluate these risks, and monitors on an ongoing basis
the value of the securities subject to repurchase agreements to ensure that the value is maintained at the required level. The Fund will
not enter into repurchase agreements with the Adviser or any of its affiliates.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;&lt;i&gt;Lending of Portfolio Securities&lt;/i&gt;. The Fund may lend portfolio
securities to registered broker-dealers or other institutional investors deemed by the Adviser to be of good standing under agreements
which require that the loans be secured continuously by collateral in cash, cash equivalents or U.S. Treasury bills maintained on a current
basis at an amount at least equal to the market value of the securities loaned. The Fund continues to receive the equivalent of the interest
or dividends paid by the issuer on the securities loaned as well as the benefit of an increase and the detriment of any decrease in the
market value of the securities loaned and would also receive compensation based on investment of the collateral. The Fund would not, however,
have the right to vote any securities having voting rights during the existence of the loan, but would call the loan in anticipation of
an important vote to be taken among holders of the securities or of the giving or withholding of consent on a material matter affecting
the investment. As with other extensions of credit, there are risks of delay in recovery or even loss of rights in the collateral should
the borrower of the securities fail financially. At no time would the value of the securities loaned exceed 35% of the value of the Fund&#x2019;s
total assets.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;&lt;i&gt;Portfolio Turnover Rate&lt;/i&gt;. Portfolio turnover rate is not considered
a limiting factor in the execution of investment decisions for the Fund.&lt;/p&gt;

&lt;p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center"&gt;USE OF LEVERAGE&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;The Fund may utilize leverage up to the limits imposed by the 1940 Act.
Under the 1940 Act, the Fund may utilize financial leverage in the form of indebtedness in an aggregate amount up to 33 &lt;span style="background-color: white"&gt;&lt;sup&gt;1&#160;&lt;/sup&gt;/&lt;sub&gt;&#160;3&lt;/sub&gt;&lt;/span&gt;%
of the Fund&#x2019;s Managed Assets (including the proceeds of such leverage) immediately after incurring such indebtedness. Under the
1940 Act, the Fund may utilize leverage in the form of preferred shares in an aggregate amount of up to 50% of the Fund&#x2019;s total
assets (including the proceeds of such leverage) immediately after such issuance. The Fund may also invest in reverse repurchase agreements
to the maximum extent permitted by the SEC and/or SEC staff rules, guidance or positions. &lt;span style="background-color: white"&gt;In addition,
the Fund may engage in certain derivatives transactions that have economic characteristics similar to leverage to the extent permitted
by the SEC and/or SEC staff rules, guidance or positions.&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;Borrowings&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"&gt;The Fund is authorized to borrow or issue debt securities
for financial leveraging purposes and for temporary purposes such as the settlement of transactions. The Fund may utilize indebtedness
to the maximum extent permitted under the 1940 Act. Under the 1940 Act, a fund generally is not permitted to issue commercial paper or
notes or engage in other borrowings unless, immediately after the borrowing, the fund would have asset coverage (as defined in the 1940
Act) of at least 300%, &lt;i&gt;i.e.&lt;/i&gt;, the value of the fund&#x2019;s total assets less liabilities other than the principal amount represented
by commercial paper, notes or other borrowings, is at least 300% of such principal amount. In&lt;/p&gt;&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0"&gt;addition, other than with respect to privately arranged borrowings,
the Fund is not permitted to declare any cash dividend or other distribution on the common shares unless, at the time of such declaration,
the value of the Fund&#x2019;s total assets, less liabilities other than the principal amount represented by borrowings, is at least 300%
of such principal amount after deducting the amount of such dividend or other distribution. If the Fund borrows, the Fund intends, to
the extent possible, to prepay all or a portion of the principal amount of any outstanding commercial paper, notes or other borrowings
to the extent necessary to maintain the required asset coverage.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"&gt;The terms of any such borrowings may require a Fund
to pay a fee to maintain a line of credit, such as a commitment fee, or to maintain minimum average balances with a lender. Any such requirements
would increase the cost of such borrowings over the stated interest rate. Such lenders would have the right to receive interest on and
repayment of principal of any such borrowings, which right will be senior to those of the common shareholders. Any such borrowings may
contain provisions limiting certain activities of the Fund, including the payment of dividends to common shareholders in certain circumstances.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"&gt;Certain types of borrowings subject the Fund to covenants
in credit agreements relating to asset coverage and portfolio composition requirements. Certain borrowings also may subject the Fund to
certain restrictions on investments imposed by guidelines of one or more rating agencies, which may issue ratings for such borrowings.
Such guidelines may impose asset coverage or portfolio composition requirements that are more stringent than those imposed by the 1940
Act.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"&gt;The 1940 Act grants to the holders of senior securities
representing indebtedness, other than with respect to privately arranged borrowings, certain voting rights in the event of default in
the payment of interest on or repayment of principal. Failure to maintain certain asset coverage requirements under the 1940 Act could
result in an event of default and entitle the debt holders to elect a majority of the Board of Trustees.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"&gt;&lt;i&gt;Credit Agreement&lt;/i&gt;. The Fund has entered into
a senior secured credit agreement, dated December&#160;15, 2017, as amended from time to time through the date hereof, between the Fund
and Soci&#xe9;t&#xe9; G&#xe9;n&#xe9;rale, New York Branch (the &#x201c;Credit Agreement&#x201d;). Under the terms of the Credit
Agreement, the Fund may borrow up to the following amounts:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 12pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;1.88% fixed rate 5-year maturity (December 15, 2025)	$19,000,000&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 12pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;SOFR + 0.95% floating rate			$139,000,000&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"&gt;An undrawn commitment fee of 0.30% per annum is charged
on the difference between the $139,000,000 floating rate loan commitment and the amount borrowed. In the event that the Fund terminates
a credit agreement prior to the contractually agreed-upon date, the Fund may be charged a breakage fee by the counterparty to compensate
for the early termination.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"&gt;The Fund&#x2019;s borrowings under the Credit Agreement
are collateralized by portfolio assets. The Credit Agreement includes usual and customary covenants. These covenants impose on the Fund
asset coverage requirements, collateral requirements, investment strategy requirements, and certain financial obligations. These covenants
place limits or restrictions on the Fund&#x2019;s ability to (i) enter into additional indebtedness with a party other than Soci&#xe9;t&#xe9;
G&#xe9;n&#xe9;rale, (ii) change its fundamental investment policies, or (iii) pledge to any other party, other than to the counterparty,
securities owned or held by the Fund over which the counterparty has a lien. In addition, the Fund is required to deliver financial information
to the counterparty within established deadlines, maintain an asset coverage ratio (as defined in Section&#160;18(g) of the 1940 Act)
of at least 300%, comply with the rules of the stock exchange on which its shares are listed, and maintain its classification as a &#x201c;closed-end
management investment company&#x201d; as defined in the 1940 Act.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"&gt;As of April 30, 2024, there was $157 million outstanding
in connection with the Credit Agreement. The average daily amount of borrowings under the credit agreement during the six months ended
April 30, 2024 was $160,868,132, with a related weighted average interest rate of 5.97%. The maximum amount outstanding during the six
months ended April 30, 2024 was $173,000,000.&lt;/p&gt;&lt;p style="font: bold 9pt Times New Roman, Times, Serif; margin: 10pt 0 0 0.5in; text-indent: -0.5in"&gt;Reverse Repurchase Agreements&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;Under a reverse repurchase agreement, the Fund sells a portfolio instrument
to another party, such as a bank or broker-dealer, in return for cash. At the same time, the Fund agrees to repurchase the instrument
at an agreed-upon time and price, which reflects an interest payment. Such agreements have the economic effect of borrowings. Proceeds
of the sale will be invested in additional instruments for the Fund, and the income from these investments will generate income for the
Fund. If such income does not exceed the income, capital appreciation and gain or loss that would have been realized on the securities
sold as part of the reverse repurchase transaction, the use of this technique will diminish the investment performance of the Fund compared
with what the performance would have been without the use of reverse repurchase transactions. With respect to any reverse repurchase agreement,
the Fund&#x2019;s Managed Assets shall include any proceeds from the sale of an asset of the Fund to a counterparty in such a transaction,
in addition to the value of the underlying asset as of the relevant measuring date.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;Reverse repurchase agreements involve the risks that the interest income
earned on the investment of the proceeds will be less than the interest expense and expenses associated with the repurchase agreement,
that the market value of the securities sold by the Fund may decline below the price at which the Fund is obligated to repurchase such
securities and that the securities may not be returned to the Fund. There is no assurance that reverse repurchase agreements can be successfully
employed. In connection with reverse repurchase agreements, the Fund will also be subject to counterparty risk with respect to the purchaser
of the securities. If the broker/dealer to whom the Fund sells securities becomes insolvent, the Fund&#x2019;s right to purchase or repurchase
securities may be restricted.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;For the six months ended April 30, 2024, the average daily balance for
which reverse repurchase agreements were outstanding amounted to $157,000,000 (exclusive of interest payable), with a related weighted
average interest rate of 4.80%. As of April 30, 2024, there were $157,021,361 (inclusive of interest payable) in reverse repurchase agreements
outstanding.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;Rule&#160;18f-4 under the 1940 Act (the &#x201c;Derivatives Rule&#x201d;)
permits the Fund to enter into derivatives transactions and certain other transactions notwithstanding the restrictions on the issuance
of &#x201c;senior securities&#x201d; under Section&#160;18 of the 1940 Act. The Derivatives Rule requires registered investment companies
that enter into derivatives transactions and certain other transactions that create future payment or delivery obligations to, among other
things, (i) comply with a value-at-risk leverage limit, and (ii) adopt and implement a derivatives risk management program. The Fund has
elected to treat reverse repurchase agreements as derivatives for purposes of complying with Rule&#160;18f-4.&lt;/p&gt;

&lt;p style="font: bold 9pt Times New Roman, Times, Serif; margin: 10pt 0 0 0.5in; text-indent: -0.5in"&gt;Preferred Shares&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;The Fund&#x2019;s Declaration of Trust (as defined herein) provides that
the Board of Trustees may authorize and issue preferred shares with rights as determined by the Board of Trustees, by action of the Board
of Trustees without prior approval of common shareholders.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;Common shareholders have no preemptive right to purchase any preferred
shares that might be issued. Any such preferred share offering would be subject to the limits imposed by the 1940 Act. Any preferred shares
issued by the Fund would have special voting rights and a liquidation preference over the common shares. Issuance of preferred shares
would constitute leverage and would entail special risks to the common shareholders.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;Under the 1940 Act, the Fund may not issue preferred shares unless,
immediately after such issuance, it has an &#x201c;asset coverage&#x201d; of at least 200% of the liquidation value of the outstanding preferred
shares (&lt;i&gt;i.e.&lt;/i&gt;, such liquidation value may not exceed 50% of the value of the Fund&#x2019;s total assets). For these purposes, &#x201c;asset
coverage&#x201d; means the ratio of (i) total assets less all liabilities and indebtedness not represented by &#x201c;senior securities&#x201d;
to (ii) the amount of &#x201c;senior securities representing indebtedness&#x201d; plus the &#x201c;involuntary liquidation preference&#x201d;
of the preferred shares. &#x201c;Senior security&#x201d; generally means any bond, note, or similar security evidencing indebtedness and
any class of shares having priority over any other class as to distribution of assets or payment of dividends. &#x201c;Senior security
representing indebtedness&#x201d; means any &#x201c;senior security&#x201d; other than equity shares. The &#x201c;involuntary liquidation
preference&#x201d; of the preferred shares is the amount that holders of preferred shares would be entitled to receive in the event of
an involuntary liquidation of the Fund in preference to the common shares.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;If preferred shares are outstanding, two of the Fund&#x2019;s Trustees
will be elected by the holders of preferred shares, voting separately as a class. The remaining Trustees of the Fund will be elected by
common shareholders and preferred shareholders voting together as a single class. In the unlikely event the Fund failed to pay dividends
on preferred shares for two years, preferred shareholders would be entitled to elect a majority of the Trustees of the Fund.&lt;/p&gt;&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;The Fund is not permitted to declare any dividend (except a dividend
payable in common shares), or to declare any other distribution on the common shares, or to purchase any common shares, unless the preferred
shares have at the time of the declaration of any such dividend or other distribution, or at the time of any such purchase of common shares,
an asset coverage of at least 200% after deducting the amount of such dividend, distribution or purchase price.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;In addition, the Fund may be subject to certain restrictions imposed
by guidelines of one or more rating agencies that may issue ratings for preferred shares issued by the Fund. These guidelines may impose
asset coverage or portfolio composition requirements that are more stringent than those imposed on the Fund by the 1940 Act.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 0; background-color: white"&gt;If preferred shares are issued, the terms
of any preferred shares issued are expected to include asset coverage maintenance provisions which will require the redemption of the
preferred shares in the event&#160;of&#160;non-compliance&#160;by&#160;the Fund and may also prohibit dividends and other distributions
on the common shares in such circumstances. In order to meet redemption requirements, the Fund may have to liquidate portfolio securities.
Such liquidations and redemptions would cause the Fund to incur related transaction costs and could result in capital losses to the Fund.
Prohibitions on dividends and other distributions on the common shares could impair the Fund&#x2019;s ability to qualify as a regulated
investment company under the Code.&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;Derivatives&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;The Fund may engage in certain derivatives transactions that have economic
characteristics similar to leverage.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;To the extent the terms of such transactions obligate the Fund to make
payments, the Fund earmarks or segregates cash or liquid securities in an amount at least equal to the current value of the amount then
payable by the Fund under the terms of such transactions or otherwise cover such transactions in accordance with applicable interpretations
of the staff of the SEC. To the extent the terms of such transactions obligate the Fund to deliver particular securities to extinguish
the Fund&#x2019;s obligations under such transactions, the Fund may &#x201c;cover&#x201d; its obligations under such transactions by either
(i) owning the securities or collateral underlying such transactions or (ii) having an absolute and immediate right to acquire such securities
or collateral without additional cash consideration (or, if additional cash consideration is required, having earmarked or segregated
cash or liquid securities). Such segregation or cover is intended to provide the Fund with available assets to satisfy its obligations
under such transactions. As a result of such segregation or cover, the Fund&#x2019;s obligations under such transactions will not be considered
senior securities representing indebtedness for purposes of the 1940 Act, or included in calculating the aggregate amount of the Fund&#x2019;s
financial leverage.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;Rule&#160;18f-4 under the 1940 Act, the Derivatives Rule, permits the
Fund to enter into derivatives transactions and certain other transactions notwithstanding the restrictions on the issuance of &#x201c;senior
securities&#x201d; under Section&#160;18 of the 1940 Act. The Fund has adopted a derivatives risk management program which includes value-at-risk
modeling, stress tests, backtests, and additional disclosures to the SEC in compliance with Rule&#160;18f-4 under the 1940 Act. The requirements
of the rule and the Fund&#x2019;s derivatives risk management program may restrict the Fund&#x2019;s ability to engage in certain derivatives
transactions and/or increase the cost of such transactions, which could adversely affect the performance of the Fund.&lt;/p&gt;</cef:InvestmentObjectivesAndPracticesTextBlock>
    <cef:EffectsOfLeverageTextBlock contextRef="AsOf2024-07-23" id="Fact000161">Effects of Leverage&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;Assuming that the Fund utilizes leverage representing approximately
43.0% of the Fund&#x2019;s Managed Assets (the Fund&#x2019;s outstanding leverage as of April 30, 2024) and that the Fund will bear expenses
relating to that leverage at an average annual rate of 5.38%, the income generated by the Fund&#x2019;s portfolio (net of estimated expenses)
must exceed 2.32% in order to cover the expenses specifically related to the Fund&#x2019;s estimated use of leverage. Of course, these
numbers are merely estimates used for illustration. Actual leverage expenses will vary frequently and may be significantly higher or lower
than the rate estimated above.&lt;/p&gt;&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;The following table is furnished in response to requirements of the
SEC. It is designed to illustrate the effect of leverage on common share total return, assuming investment portfolio total returns (comprised
of income and changes in the value of securities held in the Fund&#x2019;s portfolio) of (10)%, (5)%, 0%, 5% and 10%. These assumed investment
portfolio returns are hypothetical figures and are not necessarily indicative of the investment portfolio returns experienced or expected
to be experienced by the Fund. The table further reflects the use of leverage representing 43.0% of the Fund&#x2019;s total managed assets
and the Fund&#x2019;s currently projected annual leverage expense of 5.38%.&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; padding-left: 21.75pt"&gt;Assumed Portfolio Total Return (net of expenses)&lt;/td&gt;
    &lt;td style="width: 10%; text-align: center"&gt;(10.00)%&lt;/td&gt;
    &lt;td style="width: 10%; text-align: center"&gt;(5.00)%&lt;/td&gt;
    &lt;td style="width: 9%; text-align: center"&gt;0.00%&lt;/td&gt;
    &lt;td style="width: 7%; text-align: center"&gt;5.00%&lt;/td&gt;
    &lt;td style="width: 9%; text-align: center"&gt;10.00%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-left: 21.75pt"&gt;Common Share Total Return&lt;/td&gt;
    &lt;td style="text-align: center"&gt;(21.63)%&lt;/td&gt;
    &lt;td style="text-align: center"&gt;(12.85)%&lt;/td&gt;
    &lt;td style="text-align: center"&gt;(4.07)%&lt;/td&gt;
    &lt;td style="text-align: center"&gt;4.71%&lt;/td&gt;
    &lt;td style="text-align: center"&gt;13.49%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;Common Share Total Return is composed of two elements: the common share
distributions paid by the Fund (the amount of which is largely determined by the net investment income of the Fund) and gains or losses
on the value of the securities the Fund owns. As required by SEC rules, the table assumes that the Fund is more likely to suffer capital
losses than to enjoy capital appreciation. For example, a total return of 0% assumes that the tax-exempt interest the Fund receives on
its investments is entirely offset by losses in the value of those securities.&lt;/p&gt;</cef:EffectsOfLeverageTextBlock>
    <cef:RiskTextBlock
      contextRef="From2024-07-232024-07-23_custom_RiskIntroductionMember"
      id="Fact000162">&lt;span style="-sec-ix-redline: true"&gt;The
information contained under the heading &#x201c;Investment Objective, Policies and Principal Risks&#x2014;Principal Risks&#x201d; in the
Fund&#x2019;s &lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm"&gt;Annual Report&lt;/a&gt; is
incorporated herein by reference. Investors should consider the specific risk factors and special considerations associated with investing
in the Fund. An investment in the Fund is subject to investment risk, including the possible loss of your entire investment. A Prospectus
Supplement relating to an offering of the Fund&#x2019;s securities may identify additional risk associated with such offering.&lt;/span&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock
      contextRef="From2024-07-232024-07-23_custom_DistributionRiskMember"
      id="Fact000163">
&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;&lt;b&gt;Distribution Risk&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;The Fund&#x2019;s net investment income can vary significantly over time;
however, the Fund seeks to maintain a more stable monthly distribution per share. The distributions paid by the Fund for any particular
month may be more or less than the amount of net investment income for that monthly period. The Fund may distribute more than the entire
amount of the net investment income earned in a particular period, in which case all or a portion of a distribution may be a return of
capital. &lt;b&gt;The Fund&#x2019;s distributions have historically included, and may in the future include, a significant portion of return
of capital. For the fiscal year ended October&#160;31, 2023, the Fund&#x2019;s distributions were comprised of approximately 28.04% ordinary
income and 71.96% return of capital. &lt;/b&gt;Accordingly, shareholders should not assume that the source of a distribution from the Fund is
net income or profit, and the Fund&#x2019;s distributions should not be used as a measure of performance or confused with yield or income.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;&lt;span style="-sec-ix-redline: true"&gt;Return of capital is the return of a portion of the shareholder&#x2019;s
original investment up to the amount of the Common Shareholder&#x2019;s tax basis in their Common Shares, which would reduce such tax
basis. Although a return of capital may not be taxable, it will generally increase the Common Shareholder&#x2019;s potential gain or reduce
the Common Shareholder&#x2019;s potential loss on any subsequent sale or other disposition of Common Shares. In any given year, there
can be no guarantee the Fund&#x2019;s investment returns will exceed the amount of distributions which may increase taxes payable by a
Common Shareholder or reduce a Common Shareholder&#x2019;s loss deduction in connection with such sale or other disposition. To the extent
the amount of distributions paid to shareholders in cash exceeds the total net investment returns of the Fund, the assets of the Fund
will decline, which may have the effect of increasing the Fund&#x2019;s expense ratio. In addition, in order to make such distributions,
the Fund may have to sell a portion of its investment portfolio at a time when independent investment judgment might not dictate such
action.&lt;/span&gt;&lt;/p&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock
      contextRef="From2024-07-232024-07-23_custom_RisksAssociatedWithOfferingsOfAdditionalCommonSharesMember"
      id="Fact000164">
&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;&lt;b&gt;Risks Associated with Offerings of Additional Common Shares&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;The voting power of current common shareholders will be diluted to the
extent that current common shareholders do not purchase common shares in any future offerings of common shares or do not purchase sufficient
common shares to maintain their percentage interest. If the Fund is unable to invest the proceeds of such offering as intended, the Fund&#x2019;s
per common share distribution may decrease and the Fund may not participate in market advances to the same extent as if such proceeds
were fully invested as planned.&lt;/p&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock
      contextRef="From2024-07-232024-07-23_custom_AdditionalRisksofRightsMember"
      id="Fact000166">
&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;&lt;b&gt;Additional Risks of Rights&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;There are additional risks associated with an offering of Rights. Shareholders
who do not exercise their Rights may, at the completion of such an offering, own a smaller proportional interest in the Fund than if they
exercised their Rights. As a result of such an offering, a shareholder may experience dilution in net asset value per share if the subscription
price per share is below the net asset value per share on the expiration date. If the subscription price per share is below the net asset
value per share of the Fund&#x2019;s common shares on the expiration date, a shareholder will experience an immediate dilution of the aggregate
net asset value of such shareholder&#x2019;s common shares if the shareholder does not participate in such an offering and the shareholder
will experience a reduction in the net asset value per share of such shareholder&#x2019;s common shares whether or not the shareholder
participates in such an offering. Such a reduction in net asset value per share may have the effect of reducing market price of the common
share. The Fund cannot state precisely the extent of this dilution (if any) if the shareholder does not exercise such shareholder&#x2019;s
Rights because the Fund does not know what the net asset value per share will be when the offer expires or what&lt;/p&gt;&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;proportion of the Rights will be exercised. If the subscription price
is substantially less than the then current net asset value per common share at the expiration of a rights offering, such dilution could
be substantial. Any such dilution or accretion will depend upon whether (i) such shareholders participate in the Rights offering and (ii)
the Fund&#x2019;s net asset value per common share is above or below the subscription price on the expiration date of the Rights offering.
In addition to the economic dilution described above, if a common shareholder does not exercise all of their rights, the common shareholder
will incur voting dilution as a result of this rights offering. This voting dilution will occur because the common shareholder will own
a smaller proportionate interest in the Fund after the rights offering than prior to the rights offering. There is a risk that changes
in market conditions may result in the underlying common shares purchasable upon exercise of the subscription rights being less attractive
to investors at the conclusion of the subscription period. This may reduce or eliminate the value of the subscription rights. If investors
exercise only a portion of the rights, the number of common shares issued may be reduced, and the common shares may trade at less favorable
prices than larger offerings for similar securities. Subscription rights issued by the Fund may be transferable or non-transferable rights.
In a non-transferable rights offering, common shareholders who do not wish to exercise their rights will be unable to sell their rights.
In a transferrable rights offering, the Fund will use its best efforts to ensure an adequate trading market for the rights; however, investors
may find that there is no market to sell rights they do not wish to exercise.&lt;/p&gt;</cef:RiskTextBlock>
    <cef:CapitalStockTableTextBlock contextRef="AsOf2024-07-23" id="Fact000174">DESCRIPTION OF CAPITAL STRUCTURE&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;The Fund is a statutory trust organized under the laws of the state
of Delaware. The following is a brief description of the terms of the common shares, indebtedness and preferred shares which may be issued
by the Fund. This description does not purport to be complete and is qualified by reference to the Fund&#x2019;s Agreement and Declaration
of Trust (the &#x201c;Declaration of Trust&#x201d;) and By-Laws (collectively, the &#x201c;Governing Documents&#x201d;).&lt;/p&gt;&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Common Shares&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;Pursuant to the Declaration of Trust, the Fund is authorized to issue
unlimited common shares, par value $0.001 per share. Each common share has one vote and, when issued and paid for in accordance with the
terms of this offering, will be fully paid and non-assessable. All common shares are equal as to dividends, assets and voting privileges
and have no conversion, preemptive or other subscription rights.&lt;/p&gt;&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;The Fund&#x2019;s currently outstanding common shares are, and common
shares offered by this Prospectus will be, listed on the NYSE under the symbol &#x201c;AVK.&#x201d;&lt;/p&gt;&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;The Fund will not issue certificates for common shares.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;&lt;i&gt;Issuance of Additional Common Shares. &lt;/i&gt;Any additional offerings
of common shares will require approval by the Board of Trustees. The provisions of the 1940 Act, including Section&#160;23(b) of the 1940
Act, generally require that the public offering price (less underwriting commissions and discounts) of common shares sold by a closed-end
investment company must equal or exceed the net asset value of such company&#x2019;s common shares (calculated within 48 hours of the pricing
of such offering), except, in pertinent part, (i) with the consent of a majority of its common shareholders; or (ii) in connection with
an offering to the holders of one or more classes of its capital stock.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;The Fund may, from time to time, seek the consent of common shareholders
to permit the issuance and sale by the Fund of common shares at a price below the Fund&#x2019;s then-current net asset value, subject to
certain conditions. If such consent is obtained, the Fund may, contemporaneous with and in no event more than one year following the receipt
of such consent, sell common shares at price below net asset value in accordance with any conditions adopted in connection with the giving
of such consent. Additional information regarding any consent of common shareholders obtained by the Fund and the applicable conditions
imposed on the issuance and sale by the Fund of common shares at a price below net asset value will be disclosed in the Prospectus Supplement
relating to any such offering of common shares at a price below net asset value. Until such consent of common shareholders, if any, is
obtained, the Fund may not sell common shares at a price below net asset value. Because the Fund&#x2019;s advisory fee is based upon average
Managed Assets, the Adviser&#x2019;s interest in recommending the issuance and sale of common shares at a price below net asset value may
conflict with the interests of the Fund and its common shareholders.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;The Fund may also issue and sell common shares at a price below the
Fund&#x2019;s then-current net asset value in connection with an offering to the holders of its common shares pursuant to the issuance
of subscription rights. See &#x201c;Description of Subscription Rights.&#x201d;&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Preferred Shares&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;The Fund&#x2019;s Declaration of Trust provides that the Board of Trustees
may authorize and issue preferred shares with rights as determined by the Board of Trustees, by action of the Board of Trustees without
prior approval of the holders of the common shares.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;Common shareholders have no preemptive right to purchase any preferred
shares that might be issued. Any such preferred share offering would be subject to the limits imposed by the 1940 Act. Any preferred shares
issued by the Fund would have special voting rights and a liquidation preference over the common shares. Issuance of preferred shares
would constitute leverage and would entail special risks to the common shareholders.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;Under the 1940 Act, the Fund may not issue preferred shares unless,
immediately after such issuance, it has an &#x201c;asset coverage&#x201d; of at least 200% of the liquidation value of the outstanding preferred
shares (&lt;i&gt;i.e.&lt;/i&gt;, such liquidation value may not exceed 50% of the value of the Fund&#x2019;s total assets). For these purposes, &#x201c;asset
coverage&#x201d; means the ratio of (i) total assets less all liabilities and indebtedness not represented by &#x201c;senior securities&#x201d;
to (ii) the amount of &#x201c;senior securities representing indebtedness&#x201d; plus the &#x201c;involuntary liquidation preference&#x201d;
of the preferred shares. &#x201c;Senior security&#x201d; generally means any bond, note, or similar security evidencing indebtedness and
any class of shares having priority over any other class as to distribution of assets or payment of dividends. &#x201c;Senior security
representing indebtedness&#x201d; means any &#x201c;senior security&#x201d; other than equity shares. The &#x201c;involuntary liquidation
preference&#x201d; of the preferred shares is the amount that holders of preferred shares would be entitled to receive in the event of
an involuntary liquidation of the Fund in preference to the common shares.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;If preferred shares are outstanding, two of the Fund&#x2019;s Trustees
will be elected by the holders of preferred shares, voting separately as a class. The remaining Trustees of the Fund will be elected by
common shareholders and preferred shares voting together as a single class. In the unlikely event the Fund failed to pay dividends on
preferred shares for two years, preferred shares would be entitled to elect a majority of the Trustees of the Fund.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;The Fund is not permitted to declare any dividend (except a dividend
payable in common shares), or to declare any other distribution on the common shares, or to purchase any common shares, unless the preferred
shares have at the time of the declaration of any such dividend or other distribution, or at the time of any such purchase of common shares,
an asset coverage of at least 200% after deducting the amount of such dividend, distribution or purchase price. In addition, the Fund
may be subject to certain restrictions imposed by guidelines of one or more rating&lt;/p&gt;&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;agencies that may issue ratings for preferred shares issued by the Fund.
These guidelines may impose asset coverage or portfolio composition requirements that are more stringent than those imposed on the Fund
by the 1940 Act.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Indebtedness&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"&gt;The Fund is authorized to borrow or issue debt securities
for financial leveraging purposes and for temporary purposes such as the settlement of transactions. The Fund may utilize indebtedness
to the maximum extent permitted under the 1940 Act. Under the 1940 Act, a fund generally is not permitted to issue commercial paper or
notes or engage in other borrowings unless, immediately after the borrowing, the fund would have asset coverage (as defined in the 1940
Act) of at least 300%, &lt;i&gt;i.e.&lt;/i&gt;, the value of the fund&#x2019;s total assets less liabilities other than the principal amount represented
by commercial paper, notes or other borrowings, is at least 300% of such principal amount. In addition, other than with respect to privately
arranged borrowings, the Fund is not permitted to declare any cash dividend or other distribution on the common shares unless, at the
time of such declaration, the value of the Fund&#x2019;s total assets, less liabilities other than the principal amount represented by
borrowings, is at least 300% of such principal amount after deducting the amount of such dividend or other distribution. If the Fund borrows,
the Fund intends, to the extent possible, to prepay all or a portion of the principal amount of any outstanding commercial paper, notes
or other borrowings to the extent necessary to maintain the required asset coverage.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"&gt;The terms of any such borrowings may require the
Fund to pay a fee to maintain a line of credit, such as a commitment fee, or to maintain minimum average balances with a lender. Any such
requirements would increase the cost of such borrowings over the stated interest rate. Such lenders would have the right to receive interest
on and repayment of principal of any such borrowings, which right will be senior to those of the common shareholders. Any such borrowings
may contain provisions limiting certain activities of the Fund, including the payment of dividends to common shareholders in certain circumstances.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"&gt;Certain types of borrowings subject the Fund to covenants
in credit agreements relating to asset coverage and portfolio composition requirements. Certain borrowings also may subject the Fund to
certain restrictions on investments imposed by guidelines of one or more rating agencies, which may issue ratings for such borrowings.
Such guidelines may impose asset coverage or portfolio composition requirements that are more stringent than those imposed by the 1940
Act.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"&gt;The 1940 Act grants to the holders of senior securities representing
indebtedness, other than with respect to privately arranged borrowings, certain voting rights in the event of default in the payment of
interest on or repayment of principal. Failure to maintain certain asset coverage requirements under the 1940 Act could result in an event
of default and entitle the debt holders to elect a majority of the Board of Trustees.&lt;/p&gt;</cef:CapitalStockTableTextBlock>
    <cef:OutstandingSecuritiesTableTextBlock contextRef="AsOf2024-07-23" id="Fact000176">&lt;table cellpadding="0" cellspacing="0" id="xdx_888_ecef--OutstandingSecuritiesTableTextBlock_ztnItirCHC95" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Outstanding Securities"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 39%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Title of Class&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Amount Authorized&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Amount Held by Fund for its own Account&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Amount Outstanding Exclusive of Amounts held by Fund&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;span id="xdx_908_ecef--OutstandingSecurityTitleTextBlock_c20240723__20240723_zbhSl7iwa7Y6"&gt;Common Shares&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;Unlimited&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;None&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;span id="xdx_907_ecef--OutstandingSecurityAuthorizedShares_c20240723__20240723_zUzeIKXNGSh9"&gt;34,593,769&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</cef:OutstandingSecuritiesTableTextBlock>
    <cef:OutstandingSecurityTitleTextBlock contextRef="AsOf2024-07-23" id="Fact000177">Common Shares</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityAuthorizedShares
      contextRef="AsOf2024-07-23"
      decimals="INF"
      id="Fact000178"
      unitRef="Shares">34593769</cef:OutstandingSecurityAuthorizedShares>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000055"
          xlink:label="Fact000055"
          xlink:type="locator"/>
        <link:footnote id="Footnote000065" xlink:label="Footnote000065" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">If common shares are sold to or through underwriters, a prospectus or prospectus supplement will set forth any applicable sales load
and the estimated offering expenses borne by the Fund.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000055"
          xlink:to="Footnote000065"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000056"
          xlink:label="Fact000056"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000056"
          xlink:to="Footnote000065"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000057"
          xlink:label="Fact000057"
          xlink:type="locator"/>
        <link:footnote id="Footnote000066" xlink:label="Footnote000066" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Common shareholders will incur brokerage charges if they direct Computershare Trust Company, N.A., as Plan Agent for the common shareholders,
to sell their common shares held in a dividend reinvestment account.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000057"
          xlink:to="Footnote000066"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000061"
          xlink:label="Fact000061"
          xlink:type="locator"/>
        <link:footnote id="Footnote000067" xlink:label="Footnote000067" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Fund pays the Adviser an annual management fee, payable monthly in arrears, in an amount equal to 0.54% of the Fund&#x2019;s average
daily Managed Assets. Common shareholders bear the portion of the investment advisory fee attributable to the assets purchased with the
proceeds of leverage, which means that common shareholders effectively bear the entire management fee. <xhtml:span id="xdx_907_ecef--ManagementFeeNotBasedOnNetAssetsNoteTextBlock_c20240723__20240723_zZkZOhKRxHZh">The contractual management fee
rate of 0.54% of the Fund&#x2019;s Managed Assets represents an effective management fee rate of 0.95% of net assets attributable to common
shares, assuming leverage of 43.0% of the Fund&#x2019;s Managed Assets (the Fund&#x2019;s outstanding leverage as of April 30, 2024)</xhtml:span>.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000061"
          xlink:to="Footnote000067"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000062"
          xlink:label="Fact000062"
          xlink:type="locator"/>
        <link:footnote id="Footnote000069" xlink:label="Footnote000069" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes interest payments on borrowed funds and interest expense on reverse repurchase agreements. Interest payments on borrowed
funds is based upon the Fund&#x2019;s outstanding borrowings under the Credit Agreement as of April 30, 2024, in an amount equal to 21.5%
of the Fund&#x2019;s Managed Assets, at an annual interest rate cost to the Fund of 5.97% (the weighted average interest rate paid by the
Fund during the six months ended April 30, 2024). Interest expenses on reverse repurchase agreements is based on the Fund&#x2019;s outstanding
reverse repurchase agreements as of April 30, 2024, representing 21.5% of the Fund&#x2019;s Managed Assets at an annual interest rate cost
to the Fund of 4.80% (the weighted average interest rate cost incurred by the Fund during the six months ended April 30, 2024). The actual
amount of interest expense incurred by the Fund will vary over time in accordance with the amount of borrowings and reverse repurchase
agreements and variations in market interest rates.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000062"
          xlink:to="Footnote000069"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000063"
          xlink:label="Fact000063"
          xlink:type="locator"/>
        <link:footnote id="Footnote000070" xlink:label="Footnote000070" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">&#x201c;<xhtml:span id="xdx_908_ecef--OtherExpensesNoteTextBlock_c20240723__20240723_zojKjAEkfRF2">Other Expenses&#x201d; are based on estimated amounts for the six months ended April 30, 2024.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000063"
          xlink:to="Footnote000070"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139959478529120">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>N-2 - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="10">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 23, 2024</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Jan. 31, 2024</div></th>
<th class="th"><div>Oct. 30, 2023</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">0001219120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInvCompanyType', window );">Entity Inv Company Type</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">N-2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Securities Act File Number</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">333-280964<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_InvestmentCompanyActFileNumber', window );">Investment Company Act File Number</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">811-21309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">N-2/A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_InvestmentCompanyActRegistration', window );">Investment Company Act Registration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_InvestmentCompanyRegistrationAmendment', window );">Investment Company Registration Amendment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_InvestmentCompanyRegistrationAmendmentNumber', window );">Investment Company Registration Amendment Number</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">1940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">ADVENT CONVERTIBLE
AND INCOME FUND<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">888 Seventh Ave., 31st Floor<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">New York, New York 10019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">New York<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">10019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">(212)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">482-1600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_ApproximateDateOfCommencementOfProposedSaleToThePublic', window );">Approximate Date of Commencement of Proposed Sale to Public</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">From time to time
after the effective date of this Registration Statement.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DividendOrInterestReinvestmentPlanOnly', window );">Dividend or Interest Reinvestment Plan Only</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DelayedOrContinuousOffering', window );">Delayed or Continuous Offering</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_PrimaryShelfFlag', window );">Primary Shelf [Flag]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EffectiveUponFiling462e', window );">Effective Upon Filing, 462(e)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AdditionalSecuritiesEffective413b', window );">Additional Securities Effective, 413(b)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EffectiveWhenDeclaredSection8c', window );">Effective when Declared, Section 8(c)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_NewEffectiveDateForPreviousFiling', window );">New Effective Date for Previous Filing</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AdditionalSecurities462b', window );">Additional Securities. 462(b)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_NoSubstantiveChanges462c', window );">No Substantive Changes, 462(c)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_ExhibitsOnly462d', window );">Exhibits Only, 462(d)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_RegisteredClosedEndFundFlag', window );">Registered Closed-End Fund [Flag]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_BusinessDevelopmentCompanyFlag', window );">Business Development Company [Flag]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_IntervalFundFlag', window );">Interval Fund [Flag]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_PrimaryShelfQualifiedFlag', window );">Primary Shelf Qualified [Flag]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_NewCefOrBdcRegistrantFlag', window );">New CEF or BDC Registrant [Flag]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_FeeTableAbstract', window );"><strong>Fee Table [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_ShareholderTransactionExpensesTableTextBlock', window );">Shareholder Transaction Expenses [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_881_ecef--ShareholderTransactionExpensesTableTextBlock_dD_z3KBRlDp5omd" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Shareholder Transaction Expenses">
<tr style="vertical-align: top; text-align: left; background-color: rgb(204,238,255)">
  <td style="width: 80%">	Sales load paid by common shareholders (as a percentage of offering
price)</td>
  <td style="text-align: right; width: 20%">-<span id="xdx_909_ecef--SalesLoadPercent_d0_c20240723__20240723_fKDEp_zZ6toKgp8uKl">-</span>%<sup>(1)</sup></td></tr>
<tr style="vertical-align: top; text-align: left; background-color: White">
  <td>	Offering expenses borne by the Fund (as a percentage of offering price)</td>
  <td style="text-align: right">-<span id="xdx_90B_ecef--OtherTransactionExpensesPercent_d0_c20240723__20240723_fKDEp_zbfML4Jbsyzg">-</span>%<sup>(1)</sup></td></tr>
<tr style="vertical-align: top; text-align: left; background-color: rgb(204,238,255)">
  <td>	Dividend Reinvestment Plan fees</td>
  <td style="text-align: right"><span id="xdx_906_ecef--DividendReinvestmentAndCashPurchaseFees_dn_c20240723__20240723_fKDIp_zShu8yFN6pX5">None</span><sup>(2)</sup></td></tr>
</table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_SalesLoadPercent', window );">Sales Load [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">(0.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_DividendReinvestmentAndCashPurchaseFees', window );">Dividend Reinvestment and Cash Purchase Fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_OtherTransactionExpensesAbstract', window );"><strong>Other Transaction Expenses [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_OtherTransactionExpensesPercent', window );">Other Transaction Expenses [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">(0.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_AnnualExpensesTableTextBlock', window );">Annual Expenses [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_881_ecef--AnnualExpensesTableTextBlock_dD_zsixZZo5XI2j" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Annual Expenses">
  <tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>As a Percentage of <br/>
Net Assets Attributable to Common Shares</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt"><b>Annual Expenses</b></span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 0.25in"><span style="font-size: 9pt">Management fees<sup>(3) </sup>	</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 9pt"><span id="xdx_902_ecef--ManagementFeesPercent_c20240723__20240723_fKDMp_zeAmj4lATutc">0.95%</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 0.25in"><span style="font-size: 9pt">Interest Expense<sup>(4)</sup> 	</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 9pt"><span id="xdx_900_ecef--InterestExpensesOnBorrowingsPercent_c20240723__20240723_fKDQp_zrsKgdU6Gk02">4.21%</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 76%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other Expenses<sup>(5)</sup> 	</span></td>
    <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 9pt"><span id="xdx_904_ecef--OtherAnnualExpensesPercent_c20240723__20240723_fKDUp_z7qNvSNtAGwd">0.83%</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 0.25in"><span style="font-size: 9pt">Total annual expenses 	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 9pt"><span id="xdx_90D_ecef--TotalAnnualExpensesPercent_c20240723__20240723_zrjvigGKazve">5.99%</span></span></td></tr>
  </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_ManagementFeesPercent', window );">Management Fees [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">0.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_InterestExpensesOnBorrowingsPercent', window );">Interest Expenses on Borrowings [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">4.21%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_OtherAnnualExpensesAbstract', window );"><strong>Other Annual Expenses [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_OtherAnnualExpensesPercent', window );">Other Annual Expenses [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.83%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_TotalAnnualExpensesPercent', window );">Total Annual Expenses [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_ExpenseExampleTableTextBlock', window );">Expense Example [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">
<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 10pt">The following example illustrates the expenses that you would pay
on a $1,000 investment in common shares, assuming (1) total annual expenses of 5.99% of net assets attributable to common shares, and
(2) a 5% annual return. The example assumes that the estimated Total Annual Expenses set forth in the Annual Expenses table are accurate
and that all dividends and distributions are reinvested at net asset value per common share. Actual expenses may be greater or less than
those assumed. Moreover, the Fund&#8217;s actual rate of return may be greater or less than the hypothetical 5% return shown in the example.</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>1 Year</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 31%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>3 Years</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>5 Years</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>10 Years</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><span id="xdx_90B_ecef--ExpenseExampleYear01_c20240723__20240723_zihIgongleEg">$60</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><span id="xdx_908_ecef--ExpenseExampleYears1to3_c20240723__20240723_zwpMArH0TKL2">$177</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><span id="xdx_90B_ecef--ExpenseExampleYears1to5_c20240723__20240723_zQ9oDX08wgX5">$292</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><span id="xdx_90D_ecef--ExpenseExampleYears1to10_c20240723__20240723_zaAFgg8cJFac">$570</span></span></td></tr>
  </table>
<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_ExpenseExampleYear01', window );">Expense Example, Year 01</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_ExpenseExampleYears1to3', window );">Expense Example, Years 1 to 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_ExpenseExampleYears1to5', window );">Expense Example, Years 1 to 5</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_ExpenseExampleYears1to10', window );">Expense Example, Years 1 to 10</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_PurposeOfFeeTableNoteTextBlock', window );">Purpose of Fee Table , Note [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">The following table contains information about the costs and expenses
that common shareholders will bear directly or indirectly. The table is based on the capital structure of the Fund as of April 30, 2024
(except as noted below). The purpose of the table and the example below is to help you understand the fees and expenses that you, as a
common shareholder, would bear directly or indirectly.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_OtherExpensesNoteTextBlock', window );">Other Expenses, Note [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Other Expenses&#8221; are based on estimated amounts for the six months ended April 30, 2024.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock', window );">Management Fee not based on Net Assets, Note [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">The contractual management fee
rate of 0.54% of the Fund&#8217;s Managed Assets represents an effective management fee rate of 0.95% of net assets attributable to common
shares, assuming leverage of 43.0% of the Fund&#8217;s Managed Assets (the Fund&#8217;s outstanding leverage as of April 30, 2024)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_FinancialHighlightsAbstract', window );"><strong>Financial Highlights [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_SeniorSecuritiesTableTextBlock', window );">Senior Securities [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><div id="xdx_88C_ecef--SeniorSecuritiesTableTextBlock_dD_zAYOTBTY2Xlg"><p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">The
                                            following table sets forth information about the Fund&#8217;s outstanding senior securities
                                            as of the end of each fiscal set forth below. The information in this table for the fiscal
                                            years ended <span style="background-color: white">October&#160;31, 2023, 2022, 2021, 2020
                                            and 2019 has been audited by </span>PricewaterhouseCoopers LLP<span style="background-color: white">,
                                            independent registered public accounting firm for the Fund. The report of </span>PricewaterhouseCoopers
                                            LLP i<span style="background-color: white">s included in the Fund&#8217;s Annual Report to
                                            shareholders for the year ended October 31, 2023, as contained in the Registrant&#8217;s
                                            <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm">Form N-CSR</a> filed with the SEC on December 29, 2023, and is incorporated herein by reference.</span></span></span></p></div>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span style="background-color: white"><b>Senior Securities Representing
Indebtedness</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 27%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt"><b>Fiscal Year Ended</b></span></td>
    <td style="width: 38%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>Principal <br/>
Amount Outstanding(1)(2)</b></span></td>
    <td style="width: 35%; padding-right: 5.4pt; padding-left: 0.25in; text-align: center"><span style="font-size: 9pt"><b>Asset Coverage <br/>
Per $1,000 of Principal Amount</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">October&#160;31, 2023</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$173,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center"><span style="font-size: 9pt">$3,159</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">October&#160;31, 2022</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$173,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center"><span style="font-size: 9pt">$3,480</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">October&#160;31, 2021</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$168,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center"><span style="font-size: 9pt">$5,139</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">October&#160;31, 2020</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$168,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center"><span style="font-size: 9pt">$4,300</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">October&#160;31, 2019</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$210,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center"><span style="font-size: 9pt">$3,686</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">October&#160;31, 2018</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$235,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center"><span style="font-size: 9pt">$3,381</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">October&#160;31, 2017</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$150,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center"><span style="font-size: 9pt">$3,356</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">October&#160;31, 2016</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$170,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center"><span style="font-size: 9pt">$3,256</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">October&#160;31, 2015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$170,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center"><span style="font-size: 9pt">$3,374</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">October&#160;31, 2014</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$170,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: center"><span style="font-size: 9pt">$3,635</span></td></tr>
  </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_InvestmentObjectivesAndPracticesTextBlock', window );">Investment Objectives and Practices [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">INVESTMENT OBJECTIVE AND POLICIES<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><span style="-sec-ix-redline: true">The information contained
                                            under the headings &#8220;Investment Objective, Policies and Principal Risks&#8212;Investment
                                            Objective and Policies,&#8221; &#8220;About the Fund Manager&#8212;Investment Philosophy&#8221;
                                            and &#8220;About the Fund Manager&#8212;Investment Process&#8221; in the Fund&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm">Annual Report</a> is incorporated herein by reference.</span></p><p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">THE FUND&#8217;S INVESTMENTS</p><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund&#8217;s investment portfolio may consist of investments in
the following types of securities. There is no guarantee that the fund will buy all of the types of securities or use all of the investment
techniques that are described herein.</p><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Convertible and Non-Convertible Securities Allocation</i>. Under
normal market conditions, the Fund invests at least 80% of its Managed Assets (as defined in this Prospectus) in a diversified portfolio
of convertible securities and non-convertible income producing securities. Under normal market conditions, the Fund will invest at least
30% of its Managed Assets in convertible securities and may invest up to 70% of its Managed Assets in non-convertible income securities.
The Fund may invest without limitation in convertible securities.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in"><span style="text-decoration: underline">Convertible Securities</span>. A convertible security is a
bond, debenture, note, stock or other similar security that may be converted into or exchanged for a prescribed amount of common stock
or other equity security of the same or a different issuer within a particular period of time at a specified price or formula. A convertible
security may also be structured so that it is convertible at the option of the holder or the issuer, or subject to mandatory conversion.
Before conversion, convertible securities have characteristics similar to nonconvertible debt securities in that they ordinarily provide
a stream of income with generally higher yields than those of common stock of the same or similar issuers. Convertible securities are
senior in rank to common stock in a corporation&#8217;s capital structure and, therefore, generally entail less risk than the corporation&#8217;s
common stock, although the extent to which such risk is reduced depends in large measure upon the degree to which the convertible security
sells above its value as a fixed income security.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in">The Fund believes that the characteristics of convertible
securities make them appropriate investments for an investment company seeking a high level of total return on its assets. These characteristics
include the potential for capital appreciation if the value of the underlying common stock increases, the relatively high yield received
from dividend or interest payments as compared to common stock dividends and decreased risks of decline in value, relative to the underlying
common stock due to their fixed income nature. As a result of the conversion feature, however, the interest rate or dividend preference
on a convertible security is generally less than would be the case if the securities were not convertible. During periods of rising interest
rates, it is possible that the potential for capital gain on a convertible security may be less than that of a common stock equivalent
if the yield on the convertible security is at a level that causes it to sell at a discount.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in">Every convertible security may be valued, on a theoretical
basis, as if it did not have a conversion privilege. This theoretical value is determined by the yield it provides in comparison with
the yields of other securities of comparable character and quality that do not have a conversion privilege. This theoretical value, which
may change with prevailing interest rates, the credit rating of the issuer and other pertinent factors, often referred to as the &#8220;investment
value,&#8221; represents the security&#8217;s theoretical price support level.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in">&#8220;Conversion value&#8221; is the amount a convertible
security would be worth in market value if it were to be exchanged for the underlying equity security pursuant to its conversion privilege.
Conversion value fluctuates directly with the price of the underlying equity security, usually common stock. If, because of low prices
for the common stock, the conversion value is substantially below the investment value, the price of the convertible security is governed
principally by the factors described in the preceding paragraph. If the conversion value rises near or above its investment value, the
price of the convertible security generally will rise above its investment value and, in addition, will sell at some premium over its
conversion value. This premium represents the price investors are willing to pay for the privilege of</p><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in">purchasing a fixed-income security with a possibility of capital
appreciation due to the conversion privilege. Accordingly, the conversion value of a convertible security is subject to equity risk, that
is, the risk that the price of an equity security will fall due to general market and economic conditions, perceptions regarding the industry
in which the issuer participates or the issuing company&#8217;s particular circumstances. If the appreciation potential of a convertible
security is not realized, its conversion value premium may not be recovered.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in"><span style="text-decoration: underline">Non-Convertible Income Securities</span>. The Fund may also
invest in income securities other than convertible securities that are expected to periodically accrue or generate income for their holders.
Such income securities include (i) fixed income securities such as bonds, debentures, notes, preferred stock, short-term discounted Treasury
Bills or certain securities of the U.S. government sponsored instrumentalities, as well as money market mutual funds that invest in those
securities, which, in the absence of an applicable exemptive order, will not be affiliated with the Adviser, and (ii) common and preferred
stocks of issuers that have historically paid periodic dividends. Fixed income securities obligate the issuer to pay to the holder of
the security a specified return, which may be either fixed or reset periodically in accordance with the terms of the security. Fixed income
securities generally are senior to an issuer&#8217;s common stock and their holders generally are entitled to receive amounts due before
any distributions are made to common stockholders. Common stocks, on the other hand, generally do not obligate an issuer to make periodic
distributions to holders.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in">The market value of fixed income securities, especially those
that provide a fixed rate of return, may be expected to rise and fall inversely with interest rates and in general is affected by the
credit rating of the issuer, the issuer&#8217;s performance and perceptions of the issuer in the market place. The market value of callable
or redeemable fixed income securities may also be affected by the issuer&#8217;s call and redemption rights. In addition, it is possible
that the issuer of fixed income securities may not be able to meet its interest or principal obligations to holders. Further, holders
of non-convertible fixed income securities do not participate in any capital appreciation of the issuer.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in">The Fund may also invest in obligations of government sponsored
instrumentalities. Unlike non-U.S. government securities, obligations of certain agencies and instrumentalities of the U.S. government,
such as the Government National Mortgage Association, are supported by the &#8220;full faith and credit&#8221; of the U.S. government;
others, such as those of the Export-Import Bank of the U.S., are supported by the right of the issuer to borrow from the U.S. Treasury;
others, such as those of the Federal National Mortgage Association, are supported by the discretionary authority of the U.S. government
to purchase the agency&#8217;s obligations; and still others, such as those of the Student Loan Marketing Association, are supported only
by the credit of the instrumentality. No assurance can be given that the U.S. government would provide financial support to U.S. government
sponsored instrumentalities if it is not obligated to do so by law. Although the Fund may invest in all types of obligations of agencies
and instrumentalities of the U.S. government, the Fund currently intends to invest only in obligations that are supported by the &#8220;full
faith and credit&#8221; of the U.S. government.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in">The Fund also may invest in common stock of issuers that have
historically paid periodic dividends or otherwise made distributions to common stockholders. Unlike fixed income securities, dividend
payments generally are not guaranteed and so may be discontinued by the issuer at its discretion or because of the issuer&#8217;s inability
to satisfy its liabilities. Further, an issuer&#8217;s history of paying dividends does not guarantee that it will continue to pay dividends
in the future. In addition to dividends, under certain circumstances the holders of common stock may benefit from the capital appreciation
of the issuer.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in">Common stocks represent the residual ownership interest in
the issuer and holders of common stock are entitled to the income and increase in the value of the assets and business of the issuer after
all of its debt obligations and obligations to preferred shareholders are satisfied. Common stocks generally have voting rights.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in">Common stocks fluctuate in price in response to many factors
including historical and prospective earnings of the issuer, the value of its assets, general economic conditions, interest rates, investor
perceptions and market liquidity.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in"><span style="text-decoration: underline">Synthetic Convertible Securities</span>. The Fund may also
invest in &#8220;synthetic&#8221; convertible securities, which, for purposes of its investment policies, the Fund considers to be convertible
securities. A synthetic convertible</p><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in">security may be created by the Fund or by a third party by
combining separate securities that possess the two principal characteristics of a traditional convertible security: an income producing
component and a convertible component. Synthetic convertible securities differ from convertible securities whose conversion privilege
may be evidenced by warrants attached to the security or acquired as part of a unit with the security. The income-producing component
is achieved by investing in non-convertible, income-producing securities such as bonds, preferred stocks and money market instruments.
The convertible component is achieved by investing in securities or instruments such as warrants or options to buy common stock at a certain
exercise price, or options on a stock index. Unlike a traditional convertible security, which is a single security having a single market
value, a synthetic convertible comprises two or more separate securities, each with its own market value. Because the &#8220;market value&#8221;
of a synthetic convertible security is the sum of the values of its income producing component and its convertible component, the value
of a synthetic convertible security may respond differently to market fluctuations than a traditional convertible security. The Fund also
may purchase synthetic convertible securities created by other parties, including convertible structured notes. Convertible structured
notes are income-producing debentures linked to equity. Convertible structured notes have the attributes of a convertible security; however,
the issuer of the convertible note (typically an investment bank), rather than the issuer of the underlying common stock into which the
note is convertible, assumes credit risk associated with the underlying investment and the Fund in turn assumes credit risk associated
with the issuer of the convertible note.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Covered Call Option Strategy</i>. The Fund may use a strategy of
writing (selling) covered call options on the securities held in the portfolio, thus generating option writing premiums. The objective
of this strategy is to generate current gains from option premiums to enhance distributions payable to common shareholders. The Fund may
write (sell) covered call options on up to 25% of the securities held in its portfolio.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Options</i>. An option on a security is a contract that gives the
holder of the option, in return for a premium, the right to buy from (in the case of a call) or sell to (in the case of a put) the writer
of the option the security underlying the option at a specified exercise or &#8220;strike&#8221; price. The writer of an option on a security
has the obligation upon exercise of the option to deliver the underlying security upon payment of the exercise price or to pay the exercise
price upon delivery of the underlying security. Certain options, known as &#8220;American style&#8221; options may be exercised at any
time during the term of the option. Other options, known as &#8220;European style&#8221; options, may be exercised only on the expiration
date of the option.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">If an option written by the Fund expires unexercised, the Fund realizes
on the expiration date a capital gain equal to the premium received by the Fund at the time the option was written. If an option purchased
by the Fund expires unexercised, the Fund realizes a capital loss equal to the premium paid. Prior to the earlier of exercise or expiration,
an exchange-traded option may be closed out by an offsetting purchase or sale of an option of the same series (type, underlying security,
exercise price and expiration). There can be no assurance, however, that a closing purchase or sale transaction can be effected when the
Fund desires. The Fund may sell put or call options it has previously purchased, which could result in a net gain or loss depending on
whether the amount realized on the sale is more or less than the premium and other transaction costs paid on the put or call option when
purchased. The Fund will realize a capital gain from a closing purchase transaction if the cost of the closing option is less than the
premium received from writing the option, or, if it is more, the Fund will realize a capital loss. If the premium received from a closing
sale transaction is more than the premium paid to purchase the option, the Fund will realize a capital gain or, if it is less, the Fund
will realize a capital loss. Net gains from the Fund&#8217;s option strategy will be short-term capital gains which, for U.S. federal
income tax purposes, will constitute net investment company taxable income.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">As part of its strategy, the Fund may not sell &#8220;naked&#8221; call
options on individual securities, (<i>i.e.</i>, options representing more shares of the stock than are held in the portfolio). A call
option written by the Fund on a security is &#8220;covered&#8221; if the Fund owns the security or instrument underlying the call or has
an absolute and immediate right to acquire that security or instrument without additional cash consideration (or, if additional cash consideration
is required, cash or other assets determined to be liquid by the Adviser (in accordance with procedures established by the Board of Trustees)
in such amount are segregated by the Fund&#8217;s custodian) upon conversion or exchange of other securities held by the Fund. A call
option is also covered if the Fund holds a call on the same security as the call written where the exercise price of the call held is
(i) equal to or less than the exercise price of the call written, or (ii) greater than the exercise price of the call written, provided
the difference is maintained by the Fund in segregated assets determined to be liquid by the Adviser as described above.</p><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Put options are contracts that give the holder of the option, in return
for a premium, the right to sell to the writer of the option the security underlying the option at a specified exercise price at a specific
time or times during the term of the option. These strategies may produce a considerably higher return than the Fund&#8217;s primary strategy
of covered call writing, but involve a higher degree of risk and potential volatility.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund will write (sell) put options on individual securities only
if the put option is &#8220;covered.&#8221; A put option written by the Fund on a security is &#8220;covered&#8221; if the Fund segregates
or earmarks assets determined to be liquid by the Adviser, as described above, equal to the exercise price. A put option is also covered
if the Fund holds a put on the same security as the put written where the exercise price of the put held is (i) equal to or greater than
the exercise price of the put written, or (ii) less than the exercise price of the put written, provided the difference is maintained
by the Fund in segregated or earmarked assets determined to be liquid by the Adviser, as described above.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund may sell put and call options on indices of securities. Options
on an index differ from options on securities because (i) the exercise of an index option requires cash payments and does not involve
the actual purchase or sale of securities, (ii) the holder of an index option has the right to receive cash upon exercise of the option
if the level of the index upon which the option is based is greater, in the case of a call, or less, in the case of a put, than the exercise
price of the option and (iii) index options reflect price-fluctuations in a group of securities or segments of the securities market rather
than price fluctuations in a single security.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Illiquid Securities</i>. The Fund may invest no more than 20% of
its Managed Assets in illiquid securities. Illiquid securities include securities legally restricted as to resale, such as commercial
paper issued pursuant to Section&#160;4(a)(2) of the Securities Act and securities eligible for resale pursuant to Rule&#160;144A thereunder.
Section&#160;4(a)(2) and Rule&#160;144A securities may, however, be treated as liquid by the Adviser pursuant to procedures adopted by
the Board of Trustees, which require consideration of factors such as trading activity, availability of market quotations and number of
dealers willing to purchase the security. If the Fund invests in Rule&#160;144A securities, the level of portfolio illiquidity may be
increased to the extent that eligible buyers become uninterested in purchasing such securities.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">It may be difficult to sell such securities at a price representing
the fair value until such time as such securities may be sold publicly. Where registration is required, a considerable period may elapse
between a decision to sell the securities and the time when it would be permitted to sell. Thus, the Fund may not be able to obtain as
favorable a price as that prevailing at the time of the decision to sell. The Fund may also acquire securities through private placements
under which it may agree to contractual restrictions on the resale of such securities. Such restrictions might prevent their sale at a
time when such sale would otherwise be desirable.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">As described below, the Fund may invest a portion of its assets in privately
offered convertible securities or similar instruments that may be illiquid.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Foreign Securities</i>. The Fund may invest without limitation in
foreign securities. Investing in foreign securities may provide increased diversification by adding securities from various foreign countries
(i) that offer different investment opportunities, (ii) that generally are affected by different economic trends and (iii) whose stock
markets may not be correlated with U.S. markets. At the same time, these opportunities and trends involve risks that may not be encountered
in U.S. investments.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The following considerations comprise both risks and opportunities not
typically associated with investing in U.S. securities: fluctuations in exchange rates of foreign currencies; possible imposition of exchange
control regulations or currency restrictions that would prevent cash from being brought back to the United States; less public information
with respect to issuers of securities; less government supervision of stock exchanges, securities brokers and issuers of securities; lack
of uniform accounting, auditing and financial reporting standards; lack of uniform settlement periods and trading practices; less liquidity
and frequently greater price volatility in foreign markets than in the United States; possible imposition of foreign taxes; the possibility
of expropriation or confiscatory taxation, seizure or nationalization of foreign bank deposits or other assets; the adoption of foreign
government restrictions and other adverse political, social or diplomatic developments that could affect investment; difficulty in obtaining
or enforcing a court judgment abroad; sometimes less advantageous legal, operational and financial protections applicable to foreign sub-custodial
arrangements; and the historically lower level of responsiveness of foreign management to shareholder concerns (such as dividends and
return on investment).</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund may purchase sponsored American Depository Receipts (&#8220;ADRs&#8221;)
or U.S. dollar denominated securities of foreign issuers. ADRs are receipts issued by U.S. banks or trust companies in respect of securities
of foreign issuers held on deposit for use in the U.S. securities markets.</p><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><span style="background-color: white">The risks described above for
foreign securities, including the risks of nationalization and expropriation of assets, are typically increased to the extent that the
Fund invests in companies headquartered in developing, or emerging market, countries. Investments in securities of companies headquartered
in such countries may be considered speculative and subject to certain special risks. The political and economic structures in many of
these countries may be in their infancy and developing rapidly, and such countries may lack the social, political and economic characteristics
of more developed countries. Certain of these countries have in the past failed to recognize private property rights and have at times
nationalized and expropriated the assets of private companies. Some countries have inhibited the conversion of their currency to another.
The currencies of certain emerging market countries have experienced devaluation relative to the U.S. dollar, and future devaluations
may adversely affect the value of the Fund&#8217;s assets denominated in such currencies. Some emerging market countries have experienced
substantial rates of inflation for many years. Continued inflation may adversely affect the economies and securities markets of such countries.
In addition, unanticipated political or social developments may affect the value of the Fund&#8217;s investments in these countries and
the availability of the Fund of additional investments in these countries. The small size, limited trading volume and relative inexperience
of the securities markets in these countries may make the Fund&#8217;s investments in such countries illiquid and more volatile than investments
in more developed countries, and the Fund may be required to establish special custodial or other arrangements before making investments
in these countries. There may be little financial or accounting information available with respect to companies located in these countries,
and it may be difficult as a result to assess the value or prospects of an investment in such companies.</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Equity Securities</i>. Equity securities, such as common stock, generally
represent an ownership interest in a company. The Fund may invest up to 20% of its Managed Assets in non-convertible equity securities.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Lower Grade Securities</i>. The Fund may invest a significant portion
of its assets in securities rated below investment grade, such as those rated Ba or lower by Moody&#8217;s Investors Service, Inc. (&#8220;Moody&#8217;s&#8221;)
and BB or lower by Standard &amp; Poor&#8217;s (&#8220;S&amp;P&#8221;) or securities comparably rated by other rating agencies or in unrated
securities determined by Advent to be of comparable quality. Lower grade securities are commonly referred to as &#8220;junk bonds.&#8221;
Both the convertible securities and the income-producing securities in which the Fund will invest may be lower grade securities.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Prices of&#160;lower&#160;grade&#160;securities are more sensitive to
negative developments, such as a decline in the issuer&#8217;s revenues or a general economic downturn, than are the prices of higher
grade&#160;securities.&#160;Lower grade&#160;securities tend to be less liquid than investment grade securities. The market value&#160;of&#160;lower
grade&#160;securities may be more volatile than the market value of investment grade securities and generally tends to reflect the market&#8217;s
perception of the creditworthiness of the issuer and short-term market developments to a greater extent than investment grade securities,
which primarily reflect fluctuations in general levels of interest rates.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Ratings are relative and subjective, and not absolute standards of quality.
Securities ratings are based largely on the issuer&#8217;s historical financial condition and the rating agencies&#8217; analysis at the
time of rating. Consequently, the rating assigned to any particular security is not necessarily a reflection of the issuer&#8217;s current
financial condition.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund may purchase securities of companies that are experiencing
significant financial or business difficulties, including companies involved in bankruptcy or other reorganization and liquidation proceedings.
Although such investments may result in significant financial returns to the Fund, they involve a substantial degree of risk. The level
of analytical sophistication, both financial and legal, necessary for successful investments in issuers experiencing significant business
and financial difficulties is unusually high. There can be no assurance that the Fund will correctly evaluate the value of the assets
collateralizing its investments or the prospects for a successful reorganization or similar action. In any reorganization or liquidation
proceeding relating to a portfolio investment, the Fund may lose all or part of its investment or may be required to accept collateral
with a value less than the amount of the Fund&#8217;s initial investment.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">As a part of its investments&#160;in&#160;lower&#160;grade&#160;securities,
the Fund may invest in the securities of issuers in default. By investing in the securities of issuers in default, the Fund bears the
risk that these issuers will not continue to honor their obligations or emerge from bankruptcy protection or that the value of these securities
will not otherwise appreciate.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">In addition to using statistical rating agencies and other sources,
the Adviser will also perform its own analysis of issuers in seeking investments that it believes to be underrated (and thus higher yielding)
in light of the financial condition of the issuer. Its analysis of issuers may include, among other things, current and anticipated cash
flow and borrowing requirements, value of assets in relation to historical cost, strength of management, responsiveness to</p><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">business conditions, credit standing and current anticipated results
of operations. In selecting investments for the Fund, the Adviser may also consider general business conditions, anticipated changes in
interest rates and the outlook for specific industries.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Subsequent to its purchase by the Fund, an issue of securities may cease
to be rated or its rating may be reduced. In addition, it is possible that statistical rating agencies might change their ratings of a
particular issue to reflect subsequent events on a timely basis. Moreover, such ratings do not assess the risk of a decline in market
value. None of these events will require the sale of the securities by the Fund, although the Adviser will consider these events in determining
whether the Fund should continue to hold the securities.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The market&#160;for&#160;lower&#160;grade&#160;and comparable unrated
securities has at various times, particularly during times of economic recession, experienced substantial reductions in market value and
liquidity. Past recessions have adversely affected the value of such securities as well as the ability of certain issuers of such securities
to repay principal and pay interest thereon or to refinance such securities. The market for those securities could react in a similar
fashion in the event of any future economic recession.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Preferred Stock</i>. The Fund may invest in preferred stock. The
preferred stock in which the Fund typically will invest will be convertible securities. Preferred shares are equity securities, but they
have many characteristics of fixed income securities, such as a fixed dividend payment rate and/or a liquidity preference over the issuer&#8217;s
common shares. However, because preferred stocks are equity securities, they may be more susceptible to risks traditionally associated
with equity investments than the Fund&#8217;s fixed income securities.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Private Securities</i>. The Fund may invest up to 15% of its Managed
Assets in privately offered convertible securities, privately offered non-convertible income securities and any attached or related privately
offered warrants or equity-linked securities (collectively, &#8220;private securities&#8221;), which may include securities of private
companies and privately issued securities of public companies. Advent does not expect to invest more than 2.5% of the Fund&#8217;s Managed
Assets in any single private security at the time of investment. The Fund invests primarily in private securities to seek to enhance the
Fund&#8217;s current income. Therefore, the Fund will invest in a private security only if the expected yield on such security at the
time of investment exceeds the yield of specified public convertible and high yield bond benchmarks (currently the ICE BofAML All U.S.
Convertibles Index and ICE BofAML US High Yield Total Return Index). The Fund is not required to dispose of private securities in the
event that relative yields change after the time of investment. Any private securities investments will increase the percentage of the
Fund&#8217;s assets invested in illiquid securities. In order to provide for further diversification, Advent intends to limit the number
of private securities transactions the Fund makes in any given year and deploy the Fund&#8217;s overall allocation to private securities
over the course of several years.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Derivative Transactions</i>. The Fund may purchase and sell derivative
instruments such as exchange-listed and over-the-counter put and call options on securities, financial futures, equity, fixed-income and
interest rate indices, and other financial instruments, purchase and sell financial futures contracts and options thereon, enter into
various interest rate transactions such as swaps, caps, floors or collars and enter into various currency transactions such as currency
forward contracts, currency futures contracts, currency swaps or options on currency or currency futures or credit transactions and credit
default swaps. The Fund also may purchase derivative instruments that combine features of these instruments and purchase securities for
delayed settlement. See &#8220;The Fund&#8217;s Investments&#8212;Derivatives&#8221; in the Statement of Additional Information.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Other Investment Companies</i>. The Fund may invest in the securities
of other investment companies to the extent that such investments are consistent with the Fund&#8217;s investment objective and policies
and permissible under the 1940 Act. The Fund may invest in mutual funds, closed-end funds and exchange-traded funds. Under the 1940 Act,
the Fund generally may invest only up to 10% of its total assets in the aggregate in shares of other investment companies and only up
to 5% of its total assets in any one investment company, provided the investment does not represent more than 3% of the voting stock of
the acquired investment company at the time such shares are purchased. However, pursuant to certain exemptions set forth in the 1940 Act,
the Fund may invest in excess of this limitation provided that certain conditions are met. Investments in other investment companies involve
operating expenses and fees at the other investment company level that are in addition to the expenses and fees borne by the Fund and
are borne indirectly by common shareholders. For purposes of the Fund&#8217;s policy of investing at least 80% of its Managed Assets in
convertible securities and other income producing securities, the Fund will include the value of its investments in other investment companies
that invest primarily in convertible securities and/or other income producing securities.</p><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Defensive and Temporary Investments</i>. Under unusual market or
economic conditions or for temporary defensive purposes, the Fund may invest up to 100% of its total assets in securities issued or guaranteed
by the U.S. government or its instrumentalities or agencies, certificates of deposit, bankers&#8217; acceptances and other bank obligations,
commercial paper rated in the highest category by a nationally recognized statistical rating organization or other fixed income securities
deemed by the Adviser to be consistent with a defensive posture, or may hold cash, including money market funds.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Repurchase Agreements</i>. The Fund may enter into repurchase agreements
with broker-dealers, member banks of the Federal Reserve System and other financial institutions. Repurchase agreements may be seen as
loans by the Fund collateralized by underlying debt securities. Under the terms of a typical repurchase agreement, the Fund would acquire
an underlying debt obligation for a relatively short period (usually not more than one week) subject to an obligation of the seller to
repurchase, and the Fund to resell, the obligation at an agreed price and time. This arrangement results in a fixed rate of return to
the Fund that is not subject to market fluctuations during the holding period. The Fund bears a risk of loss in the event that the other
party to a repurchase agreement defaults on its obligations and the Fund is delayed in or prevented from exercising its rights to dispose
of the collateral securities, including the risk of a possible decline in the value of the underlying securities during the period in
which it seeks to assert these rights. The Adviser, acting under the supervision of the Board of Trustees, reviews the creditworthiness
of those banks and dealers with which the Fund enters into repurchase agreements to evaluate these risks, and monitors on an ongoing basis
the value of the securities subject to repurchase agreements to ensure that the value is maintained at the required level. The Fund will
not enter into repurchase agreements with the Adviser or any of its affiliates.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Lending of Portfolio Securities</i>. The Fund may lend portfolio
securities to registered broker-dealers or other institutional investors deemed by the Adviser to be of good standing under agreements
which require that the loans be secured continuously by collateral in cash, cash equivalents or U.S. Treasury bills maintained on a current
basis at an amount at least equal to the market value of the securities loaned. The Fund continues to receive the equivalent of the interest
or dividends paid by the issuer on the securities loaned as well as the benefit of an increase and the detriment of any decrease in the
market value of the securities loaned and would also receive compensation based on investment of the collateral. The Fund would not, however,
have the right to vote any securities having voting rights during the existence of the loan, but would call the loan in anticipation of
an important vote to be taken among holders of the securities or of the giving or withholding of consent on a material matter affecting
the investment. As with other extensions of credit, there are risks of delay in recovery or even loss of rights in the collateral should
the borrower of the securities fail financially. At no time would the value of the securities loaned exceed 35% of the value of the Fund&#8217;s
total assets.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Portfolio Turnover Rate</i>. Portfolio turnover rate is not considered
a limiting factor in the execution of investment decisions for the Fund.</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">USE OF LEVERAGE</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund may utilize leverage up to the limits imposed by the 1940 Act.
Under the 1940 Act, the Fund may utilize financial leverage in the form of indebtedness in an aggregate amount up to 33 <span style="background-color: white"><sup>1&#160;</sup>/<sub>&#160;3</sub></span>%
of the Fund&#8217;s Managed Assets (including the proceeds of such leverage) immediately after incurring such indebtedness. Under the
1940 Act, the Fund may utilize leverage in the form of preferred shares in an aggregate amount of up to 50% of the Fund&#8217;s total
assets (including the proceeds of such leverage) immediately after such issuance. The Fund may also invest in reverse repurchase agreements
to the maximum extent permitted by the SEC and/or SEC staff rules, guidance or positions. <span style="background-color: white">In addition,
the Fund may engage in certain derivatives transactions that have economic characteristics similar to leverage to the extent permitted
by the SEC and/or SEC staff rules, guidance or positions.</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in">Borrowings</td><td></td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund is authorized to borrow or issue debt securities
for financial leveraging purposes and for temporary purposes such as the settlement of transactions. The Fund may utilize indebtedness
to the maximum extent permitted under the 1940 Act. Under the 1940 Act, a fund generally is not permitted to issue commercial paper or
notes or engage in other borrowings unless, immediately after the borrowing, the fund would have asset coverage (as defined in the 1940
Act) of at least 300%, <i>i.e.</i>, the value of the fund&#8217;s total assets less liabilities other than the principal amount represented
by commercial paper, notes or other borrowings, is at least 300% of such principal amount. In</p><p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">addition, other than with respect to privately arranged borrowings,
the Fund is not permitted to declare any cash dividend or other distribution on the common shares unless, at the time of such declaration,
the value of the Fund&#8217;s total assets, less liabilities other than the principal amount represented by borrowings, is at least 300%
of such principal amount after deducting the amount of such dividend or other distribution. If the Fund borrows, the Fund intends, to
the extent possible, to prepay all or a portion of the principal amount of any outstanding commercial paper, notes or other borrowings
to the extent necessary to maintain the required asset coverage.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The terms of any such borrowings may require a Fund
to pay a fee to maintain a line of credit, such as a commitment fee, or to maintain minimum average balances with a lender. Any such requirements
would increase the cost of such borrowings over the stated interest rate. Such lenders would have the right to receive interest on and
repayment of principal of any such borrowings, which right will be senior to those of the common shareholders. Any such borrowings may
contain provisions limiting certain activities of the Fund, including the payment of dividends to common shareholders in certain circumstances.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Certain types of borrowings subject the Fund to covenants
in credit agreements relating to asset coverage and portfolio composition requirements. Certain borrowings also may subject the Fund to
certain restrictions on investments imposed by guidelines of one or more rating agencies, which may issue ratings for such borrowings.
Such guidelines may impose asset coverage or portfolio composition requirements that are more stringent than those imposed by the 1940
Act.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The 1940 Act grants to the holders of senior securities
representing indebtedness, other than with respect to privately arranged borrowings, certain voting rights in the event of default in
the payment of interest on or repayment of principal. Failure to maintain certain asset coverage requirements under the 1940 Act could
result in an event of default and entitle the debt holders to elect a majority of the Board of Trustees.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Credit Agreement</i>. The Fund has entered into
a senior secured credit agreement, dated December&#160;15, 2017, as amended from time to time through the date hereof, between the Fund
and Soci&#233;t&#233; G&#233;n&#233;rale, New York Branch (the &#8220;Credit Agreement&#8221;). Under the terms of the Credit
Agreement, the Fund may borrow up to the following amounts:</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>1.88% fixed rate 5-year maturity (December 15, 2025)	$19,000,000</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>SOFR + 0.95% floating rate			$139,000,000</td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">An undrawn commitment fee of 0.30% per annum is charged
on the difference between the $139,000,000 floating rate loan commitment and the amount borrowed. In the event that the Fund terminates
a credit agreement prior to the contractually agreed-upon date, the Fund may be charged a breakage fee by the counterparty to compensate
for the early termination.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund&#8217;s borrowings under the Credit Agreement
are collateralized by portfolio assets. The Credit Agreement includes usual and customary covenants. These covenants impose on the Fund
asset coverage requirements, collateral requirements, investment strategy requirements, and certain financial obligations. These covenants
place limits or restrictions on the Fund&#8217;s ability to (i) enter into additional indebtedness with a party other than Soci&#233;t&#233;
G&#233;n&#233;rale, (ii) change its fundamental investment policies, or (iii) pledge to any other party, other than to the counterparty,
securities owned or held by the Fund over which the counterparty has a lien. In addition, the Fund is required to deliver financial information
to the counterparty within established deadlines, maintain an asset coverage ratio (as defined in Section&#160;18(g) of the 1940 Act)
of at least 300%, comply with the rules of the stock exchange on which its shares are listed, and maintain its classification as a &#8220;closed-end
management investment company&#8221; as defined in the 1940 Act.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">As of April 30, 2024, there was $157 million outstanding
in connection with the Credit Agreement. The average daily amount of borrowings under the credit agreement during the six months ended
April 30, 2024 was $160,868,132, with a related weighted average interest rate of 5.97%. The maximum amount outstanding during the six
months ended April 30, 2024 was $173,000,000.</p><p style="font: bold 9pt Times New Roman, Times, Serif; margin: 10pt 0 0 0.5in; text-indent: -0.5in">Reverse Repurchase Agreements</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Under a reverse repurchase agreement, the Fund sells a portfolio instrument
to another party, such as a bank or broker-dealer, in return for cash. At the same time, the Fund agrees to repurchase the instrument
at an agreed-upon time and price, which reflects an interest payment. Such agreements have the economic effect of borrowings. Proceeds
of the sale will be invested in additional instruments for the Fund, and the income from these investments will generate income for the
Fund. If such income does not exceed the income, capital appreciation and gain or loss that would have been realized on the securities
sold as part of the reverse repurchase transaction, the use of this technique will diminish the investment performance of the Fund compared
with what the performance would have been without the use of reverse repurchase transactions. With respect to any reverse repurchase agreement,
the Fund&#8217;s Managed Assets shall include any proceeds from the sale of an asset of the Fund to a counterparty in such a transaction,
in addition to the value of the underlying asset as of the relevant measuring date.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Reverse repurchase agreements involve the risks that the interest income
earned on the investment of the proceeds will be less than the interest expense and expenses associated with the repurchase agreement,
that the market value of the securities sold by the Fund may decline below the price at which the Fund is obligated to repurchase such
securities and that the securities may not be returned to the Fund. There is no assurance that reverse repurchase agreements can be successfully
employed. In connection with reverse repurchase agreements, the Fund will also be subject to counterparty risk with respect to the purchaser
of the securities. If the broker/dealer to whom the Fund sells securities becomes insolvent, the Fund&#8217;s right to purchase or repurchase
securities may be restricted.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">For the six months ended April 30, 2024, the average daily balance for
which reverse repurchase agreements were outstanding amounted to $157,000,000 (exclusive of interest payable), with a related weighted
average interest rate of 4.80%. As of April 30, 2024, there were $157,021,361 (inclusive of interest payable) in reverse repurchase agreements
outstanding.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Rule&#160;18f-4 under the 1940 Act (the &#8220;Derivatives Rule&#8221;)
permits the Fund to enter into derivatives transactions and certain other transactions notwithstanding the restrictions on the issuance
of &#8220;senior securities&#8221; under Section&#160;18 of the 1940 Act. The Derivatives Rule requires registered investment companies
that enter into derivatives transactions and certain other transactions that create future payment or delivery obligations to, among other
things, (i) comply with a value-at-risk leverage limit, and (ii) adopt and implement a derivatives risk management program. The Fund has
elected to treat reverse repurchase agreements as derivatives for purposes of complying with Rule&#160;18f-4.</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 10pt 0 0 0.5in; text-indent: -0.5in">Preferred Shares</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund&#8217;s Declaration of Trust (as defined herein) provides that
the Board of Trustees may authorize and issue preferred shares with rights as determined by the Board of Trustees, by action of the Board
of Trustees without prior approval of common shareholders.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Common shareholders have no preemptive right to purchase any preferred
shares that might be issued. Any such preferred share offering would be subject to the limits imposed by the 1940 Act. Any preferred shares
issued by the Fund would have special voting rights and a liquidation preference over the common shares. Issuance of preferred shares
would constitute leverage and would entail special risks to the common shareholders.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Under the 1940 Act, the Fund may not issue preferred shares unless,
immediately after such issuance, it has an &#8220;asset coverage&#8221; of at least 200% of the liquidation value of the outstanding preferred
shares (<i>i.e.</i>, such liquidation value may not exceed 50% of the value of the Fund&#8217;s total assets). For these purposes, &#8220;asset
coverage&#8221; means the ratio of (i) total assets less all liabilities and indebtedness not represented by &#8220;senior securities&#8221;
to (ii) the amount of &#8220;senior securities representing indebtedness&#8221; plus the &#8220;involuntary liquidation preference&#8221;
of the preferred shares. &#8220;Senior security&#8221; generally means any bond, note, or similar security evidencing indebtedness and
any class of shares having priority over any other class as to distribution of assets or payment of dividends. &#8220;Senior security
representing indebtedness&#8221; means any &#8220;senior security&#8221; other than equity shares. The &#8220;involuntary liquidation
preference&#8221; of the preferred shares is the amount that holders of preferred shares would be entitled to receive in the event of
an involuntary liquidation of the Fund in preference to the common shares.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">If preferred shares are outstanding, two of the Fund&#8217;s Trustees
will be elected by the holders of preferred shares, voting separately as a class. The remaining Trustees of the Fund will be elected by
common shareholders and preferred shareholders voting together as a single class. In the unlikely event the Fund failed to pay dividends
on preferred shares for two years, preferred shareholders would be entitled to elect a majority of the Trustees of the Fund.</p><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund is not permitted to declare any dividend (except a dividend
payable in common shares), or to declare any other distribution on the common shares, or to purchase any common shares, unless the preferred
shares have at the time of the declaration of any such dividend or other distribution, or at the time of any such purchase of common shares,
an asset coverage of at least 200% after deducting the amount of such dividend, distribution or purchase price.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">In addition, the Fund may be subject to certain restrictions imposed
by guidelines of one or more rating agencies that may issue ratings for preferred shares issued by the Fund. These guidelines may impose
asset coverage or portfolio composition requirements that are more stringent than those imposed on the Fund by the 1940 Act.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 0; background-color: white">If preferred shares are issued, the terms
of any preferred shares issued are expected to include asset coverage maintenance provisions which will require the redemption of the
preferred shares in the event&#160;of&#160;non-compliance&#160;by&#160;the Fund and may also prohibit dividends and other distributions
on the common shares in such circumstances. In order to meet redemption requirements, the Fund may have to liquidate portfolio securities.
Such liquidations and redemptions would cause the Fund to incur related transaction costs and could result in capital losses to the Fund.
Prohibitions on dividends and other distributions on the common shares could impair the Fund&#8217;s ability to qualify as a regulated
investment company under the Code.</p>

<table cellpadding="0" cellspacing="0" style="font: bold 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in">Derivatives</td><td></td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund may engage in certain derivatives transactions that have economic
characteristics similar to leverage.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">To the extent the terms of such transactions obligate the Fund to make
payments, the Fund earmarks or segregates cash or liquid securities in an amount at least equal to the current value of the amount then
payable by the Fund under the terms of such transactions or otherwise cover such transactions in accordance with applicable interpretations
of the staff of the SEC. To the extent the terms of such transactions obligate the Fund to deliver particular securities to extinguish
the Fund&#8217;s obligations under such transactions, the Fund may &#8220;cover&#8221; its obligations under such transactions by either
(i) owning the securities or collateral underlying such transactions or (ii) having an absolute and immediate right to acquire such securities
or collateral without additional cash consideration (or, if additional cash consideration is required, having earmarked or segregated
cash or liquid securities). Such segregation or cover is intended to provide the Fund with available assets to satisfy its obligations
under such transactions. As a result of such segregation or cover, the Fund&#8217;s obligations under such transactions will not be considered
senior securities representing indebtedness for purposes of the 1940 Act, or included in calculating the aggregate amount of the Fund&#8217;s
financial leverage.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Rule&#160;18f-4 under the 1940 Act, the Derivatives Rule, permits the
Fund to enter into derivatives transactions and certain other transactions notwithstanding the restrictions on the issuance of &#8220;senior
securities&#8221; under Section&#160;18 of the 1940 Act. The Fund has adopted a derivatives risk management program which includes value-at-risk
modeling, stress tests, backtests, and additional disclosures to the SEC in compliance with Rule&#160;18f-4 under the 1940 Act. The requirements
of the rule and the Fund&#8217;s derivatives risk management program may restrict the Fund&#8217;s ability to engage in certain derivatives
transactions and/or increase the cost of such transactions, which could adversely affect the performance of the Fund.</p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_EffectsOfLeverageTextBlock', window );">Effects of Leverage [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Effects of Leverage<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Assuming that the Fund utilizes leverage representing approximately
43.0% of the Fund&#8217;s Managed Assets (the Fund&#8217;s outstanding leverage as of April 30, 2024) and that the Fund will bear expenses
relating to that leverage at an average annual rate of 5.38%, the income generated by the Fund&#8217;s portfolio (net of estimated expenses)
must exceed 2.32% in order to cover the expenses specifically related to the Fund&#8217;s estimated use of leverage. Of course, these
numbers are merely estimates used for illustration. Actual leverage expenses will vary frequently and may be significantly higher or lower
than the rate estimated above.</p><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The following table is furnished in response to requirements of the
SEC. It is designed to illustrate the effect of leverage on common share total return, assuming investment portfolio total returns (comprised
of income and changes in the value of securities held in the Fund&#8217;s portfolio) of (10)%, (5)%, 0%, 5% and 10%. These assumed investment
portfolio returns are hypothetical figures and are not necessarily indicative of the investment portfolio returns experienced or expected
to be experienced by the Fund. The table further reflects the use of leverage representing 43.0% of the Fund&#8217;s total managed assets
and the Fund&#8217;s currently projected annual leverage expense of 5.38%.</p>
<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 55%; padding-left: 21.75pt">Assumed Portfolio Total Return (net of expenses)</td>
    <td style="width: 10%; text-align: center">(10.00)%</td>
    <td style="width: 10%; text-align: center">(5.00)%</td>
    <td style="width: 9%; text-align: center">0.00%</td>
    <td style="width: 7%; text-align: center">5.00%</td>
    <td style="width: 9%; text-align: center">10.00%</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 21.75pt">Common Share Total Return</td>
    <td style="text-align: center">(21.63)%</td>
    <td style="text-align: center">(12.85)%</td>
    <td style="text-align: center">(4.07)%</td>
    <td style="text-align: center">4.71%</td>
    <td style="text-align: center">13.49%</td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Common Share Total Return is composed of two elements: the common share
distributions paid by the Fund (the amount of which is largely determined by the net investment income of the Fund) and gains or losses
on the value of the securities the Fund owns. As required by SEC rules, the table assumes that the Fund is more likely to suffer capital
losses than to enjoy capital appreciation. For example, a total return of 0% assumes that the tax-exempt interest the Fund receives on
its investments is entirely offset by losses in the value of those securities.</p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_SharePriceTableTextBlock', window );">Share Price [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_880_ecef--SharePriceTableTextBlock_dD_zbG3ufhqacEc" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Share Prices">
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt"><b>Market
    Price</b></span></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt"><b>Corresponding
    Net Asset Value Per Common Share</b></span></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt"><b>Corresponding
    Premium/(Discount) as a Percentage of <br/>
    Net Asset Value</b></span></span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="-sec-ix-redline: true"><span style="font-size: 9pt"><b><span style="text-decoration: underline">Fiscal Quarter Ended</span></b></span></span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt"><b>High</b></span></span></td>
    <td style="border-top: Black 1pt solid; width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt"><b>Low</b></span></span></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt"><b>High</b></span></span></td>
    <td style="border-top: Black 1pt solid; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt"><b>Low</b></span></span></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt"><b>High</b></span></span></td>
    <td style="border-top: Black 1pt solid; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt"><b>Low</b></span></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">July 31, 2024</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">$12.85</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">$11.58</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">$12.28</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true">$12.06</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">4.64%</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">-3.98%</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">April&#160;30, 2024</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_900_ecef--HighestPriceOrBid_c20240201__20240430_z4uMbWGvVjva" style="font-size: 9pt">$12.10</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_905_ecef--LowestPriceOrBid_c20240201__20240430_zMhcbO0z9rCk" style="font-size: 9pt">$11.23</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_90B_ecef--HighestPriceOrBidNav_c20240201__20240430_zHxUBXxDy2A2" style="font-size: 9pt">$12.59</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_905_ecef--LowestPriceOrBidNav_c20240201__20240430_zj6EJuQQ4Co8" style="font-size: 9pt">$11.95</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_901_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_c20240201__20240430_zfkX7NzVc3dd" style="font-size: 9pt">-3.89%</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_900_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_c20240201__20240430_z35rfiYeAHMg" style="font-size: 9pt">-6.03%</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">January&#160;31, 2024</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_904_ecef--HighestPriceOrBid_c20231101__20240131_zWfReKqL3klb" style="font-size: 9pt">$11.71</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_90C_ecef--LowestPriceOrBid_c20231101__20240131_znc7p8uAHF8h" style="font-size: 9pt">$9.64</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_907_ecef--HighestPriceOrBidNav_c20231101__20240131_z7bFOUe30hS7" style="font-size: 9pt">$12.39</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_907_ecef--LowestPriceOrBidNav_c20231101__20240131_zJy8rAP6b1C7" style="font-size: 9pt">$10.86</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_90B_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_c20231101__20240131_zN2Phtro7wsd" style="font-size: 9pt">-5.49%</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_90A_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_c20231101__20240131_zQ638F4tdPVg" style="font-size: 9pt">-11.23%</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">October&#160;31, 2023</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_907_ecef--HighestPriceOrBid_c20230801__20231030_z65QkuS88VB3" style="font-size: 9pt">$11.96</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_904_ecef--LowestPriceOrBid_c20230801__20231030_zDK9JC2rNn1g" style="font-size: 9pt">$9.27</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_90B_ecef--HighestPriceOrBidNav_c20230801__20231030_z6BvqeDy95Lk" style="font-size: 9pt">$12.79</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_902_ecef--LowestPriceOrBidNav_c20230801__20231030_zhgGpBQl1ixf" style="font-size: 9pt">$10.81</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_90D_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_c20230801__20231030_zDdlKEujvbbf" style="font-size: 9pt">-6.49%</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_905_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_c20230801__20231030_zGTyfs99uxee" style="font-size: 9pt">-14.25%</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">July&#160;31, 2023</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_902_ecef--HighestPriceOrBid_c20230501__20230731_zcJTdQQBDwQk" style="font-size: 9pt">$11.96</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_902_ecef--LowestPriceOrBid_c20230501__20230731_zlXhILcSeh69" style="font-size: 9pt">$11.01</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_905_ecef--HighestPriceOrBidNav_c20230501__20230731_zZZJausECy4a" style="font-size: 9pt">$12.89</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_90E_ecef--LowestPriceOrBidNav_c20230501__20230731_zSjfqiH7PGxb" style="font-size: 9pt">$11.99</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_905_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_c20230501__20230731_zKFoYz9DvGKl" style="font-size: 9pt">-7.21%</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_903_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_c20230501__20230731_z18wYAu0BHD9" style="font-size: 9pt">-8.17%</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">April&#160;30, 2023</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_906_ecef--HighestPriceOrBid_c20230201__20230430_z2V2E7YqaGb1" style="font-size: 9pt">$13.13</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_90D_ecef--LowestPriceOrBid_c20230201__20230430_zi70uPkYnFue" style="font-size: 9pt">$11.06</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_906_ecef--HighestPriceOrBidNav_c20230201__20230430_z3hnkZi7Dh2" style="font-size: 9pt">$13.60</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_90E_ecef--LowestPriceOrBidNav_c20230201__20230430_zjvk11eDzIz2" style="font-size: 9pt">$11.90</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_902_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_c20230201__20230430_z5Vj2U3Qycs2" style="font-size: 9pt">-3.46%</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_90C_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_c20230201__20230430_zCULwQIbe6Of" style="font-size: 9pt">-7.06%</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">January&#160;31, 2023</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_90F_ecef--HighestPriceOrBid_c20221101__20230131_zHHLbUA8I0m5" style="font-size: 9pt">$12.57</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_90E_ecef--LowestPriceOrBid_c20221101__20230131_zFG46Luy6HB1" style="font-size: 9pt">$10.81</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_90C_ecef--HighestPriceOrBidNav_c20221101__20230131_z6bw4cyXe5Hc" style="font-size: 9pt">$13.23</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_908_ecef--LowestPriceOrBidNav_c20221101__20230131_z51NAzC5gLZ5" style="font-size: 9pt">$12.22</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_906_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_c20221101__20230131_zYiCA5rP8FBi" style="font-size: 9pt">-4.99%</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_90C_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_c20221101__20230131_zdcvoNQssIT1" style="font-size: 9pt">-11.54%</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">October&#160;31, 2022</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_90E_ecef--HighestPriceOrBid_c20220801__20221031_zzMDlbzJKwrb" style="font-size: 9pt">$14.70</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_90B_ecef--LowestPriceOrBid_c20220801__20221031_z6si7MtqHu3c" style="font-size: 9pt">$10.43</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_901_ecef--HighestPriceOrBidNav_c20220801__20221031_zmtMhP0AMLWj" style="font-size: 9pt">$14.15</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_90B_ecef--LowestPriceOrBidNav_c20220801__20221031_zEdoV40X7MH" style="font-size: 9pt">$11.73</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_90D_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_c20220801__20221031_z7NK3Q6diEP7" style="font-size: 9pt">3.89%</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_901_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_c20220801__20221031_zrU5Fqruq8M1" style="font-size: 9pt">-11.08%</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">July&#160;31, 2022</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_90F_ecef--HighestPriceOrBid_c20220501__20220731_zw5L6wOQvZtc" style="font-size: 9pt">$14.53</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_90A_ecef--LowestPriceOrBid_c20220501__20220731_zrnlgPKJSQEi" style="font-size: 9pt">$11.75</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_906_ecef--HighestPriceOrBidNav_c20220501__20220731_z2VmpkWqG0g3" style="font-size: 9pt">$15.08</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_904_ecef--LowestPriceOrBidNav_c20220501__20220731_zSIa2K58vfmc" style="font-size: 9pt">$12.38</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_900_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_c20220501__20220731_zJOr16qWOvci" style="font-size: 9pt">-3.65%</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_90B_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_c20220501__20220731_zTQT2G5R8Wxl" style="font-size: 9pt">-5.09%</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">April&#160;30, 2022</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_900_ecef--HighestPriceOrBid_c20220201__20220430_z73PEurZSRne" style="font-size: 9pt">$16.87</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_900_ecef--LowestPriceOrBid_c20220201__20220430_zRbSehzl8Go4" style="font-size: 9pt">$14.18</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_905_ecef--HighestPriceOrBidNav_c20220201__20220430_zFsEgRxXhcp3" style="font-size: 9pt">$16.73</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_907_ecef--LowestPriceOrBidNav_c20220201__20220430_zpm3Ij8V6ICb" style="font-size: 9pt">$14.99</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_904_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_c20220201__20220430_zOVwTdAsv3Qj" style="font-size: 9pt">0.84%</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_907_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_c20220201__20220430_zak2vfZ39uI4" style="font-size: 9pt">-5.40%</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">January&#160;31, 2022</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_90F_ecef--HighestPriceOrBid_c20211101__20220131_z4xnNJ9lTUFl" style="font-size: 9pt">$19.39</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_90D_ecef--LowestPriceOrBid_c20211101__20220131_zKOh415XjV4f" style="font-size: 9pt">$15.59</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_90C_ecef--HighestPriceOrBidNav_c20211101__20220131_zWBDlLHwhkbh" style="font-size: 9pt">$20.31</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_901_ecef--LowestPriceOrBidNav_c20211101__20220131_zYL6SkJTdeX1" style="font-size: 9pt">$16.62</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_90B_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_c20211101__20220131_zneeC22xEuk4" style="font-size: 9pt">-4.53%</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span id="xdx_902_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_c20211101__20220131_zVzRt3pRA7D7" style="font-size: 9pt">-6.20%</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="-sec-ix-redline: true"><span style="font-size: 9pt">&#160;</span></span></td></tr>
  </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_LowestPriceOrBid', window );">Lowest Price or Bid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.23<span></span>
</td>
<td class="nump">$ 9.64<span></span>
</td>
<td class="nump">$ 9.27<span></span>
</td>
<td class="nump">$ 11.01<span></span>
</td>
<td class="nump">$ 11.06<span></span>
</td>
<td class="nump">$ 10.81<span></span>
</td>
<td class="nump">$ 10.43<span></span>
</td>
<td class="nump">$ 11.75<span></span>
</td>
<td class="nump">$ 14.18<span></span>
</td>
<td class="nump">$ 15.59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_HighestPriceOrBid', window );">Highest Price or Bid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.10<span></span>
</td>
<td class="nump">11.71<span></span>
</td>
<td class="nump">11.96<span></span>
</td>
<td class="nump">11.96<span></span>
</td>
<td class="nump">13.13<span></span>
</td>
<td class="nump">12.57<span></span>
</td>
<td class="nump">14.70<span></span>
</td>
<td class="nump">14.53<span></span>
</td>
<td class="nump">16.87<span></span>
</td>
<td class="nump">19.39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_LowestPriceOrBidNav', window );">Lowest Price or Bid, NAV</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.95<span></span>
</td>
<td class="nump">10.86<span></span>
</td>
<td class="nump">10.81<span></span>
</td>
<td class="nump">11.99<span></span>
</td>
<td class="nump">11.90<span></span>
</td>
<td class="nump">12.22<span></span>
</td>
<td class="nump">11.73<span></span>
</td>
<td class="nump">12.38<span></span>
</td>
<td class="nump">14.99<span></span>
</td>
<td class="nump">16.62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_HighestPriceOrBidNav', window );">Highest Price or Bid, NAV</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.59<span></span>
</td>
<td class="nump">$ 12.39<span></span>
</td>
<td class="nump">$ 12.79<span></span>
</td>
<td class="nump">$ 12.89<span></span>
</td>
<td class="nump">$ 13.60<span></span>
</td>
<td class="nump">$ 13.23<span></span>
</td>
<td class="nump">$ 14.15<span></span>
</td>
<td class="nump">$ 15.08<span></span>
</td>
<td class="nump">$ 16.73<span></span>
</td>
<td class="nump">$ 20.31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_HighestPriceOrBidPremiumDiscountToNavPercent', window );">Highest Price or Bid, Premium (Discount) to NAV [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.89%)<span></span>
</td>
<td class="num">(5.49%)<span></span>
</td>
<td class="num">(6.49%)<span></span>
</td>
<td class="num">(7.21%)<span></span>
</td>
<td class="num">(3.46%)<span></span>
</td>
<td class="num">(4.99%)<span></span>
</td>
<td class="nump">3.89%<span></span>
</td>
<td class="num">(3.65%)<span></span>
</td>
<td class="nump">0.84%<span></span>
</td>
<td class="num">(4.53%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_LowestPriceOrBidPremiumDiscountToNavPercent', window );">Lowest Price or Bid, Premium (Discount) to NAV [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.03%)<span></span>
</td>
<td class="num">(11.23%)<span></span>
</td>
<td class="num">(14.25%)<span></span>
</td>
<td class="num">(8.17%)<span></span>
</td>
<td class="num">(7.06%)<span></span>
</td>
<td class="num">(11.54%)<span></span>
</td>
<td class="num">(11.08%)<span></span>
</td>
<td class="num">(5.09%)<span></span>
</td>
<td class="num">(5.40%)<span></span>
</td>
<td class="num">(6.20%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_CapitalStockTableTextBlock', window );">Capital Stock [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">DESCRIPTION OF CAPITAL STRUCTURE<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund is a statutory trust organized under the laws of the state
of Delaware. The following is a brief description of the terms of the common shares, indebtedness and preferred shares which may be issued
by the Fund. This description does not purport to be complete and is qualified by reference to the Fund&#8217;s Agreement and Declaration
of Trust (the &#8220;Declaration of Trust&#8221;) and By-Laws (collectively, the &#8220;Governing Documents&#8221;).</p><p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><b>Common Shares</b></p><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Pursuant to the Declaration of Trust, the Fund is authorized to issue
unlimited common shares, par value $0.001 per share. Each common share has one vote and, when issued and paid for in accordance with the
terms of this offering, will be fully paid and non-assessable. All common shares are equal as to dividends, assets and voting privileges
and have no conversion, preemptive or other subscription rights.</p><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund&#8217;s currently outstanding common shares are, and common
shares offered by this Prospectus will be, listed on the NYSE under the symbol &#8220;AVK.&#8221;</p><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund will not issue certificates for common shares.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt"><i>Issuance of Additional Common Shares. </i>Any additional offerings
of common shares will require approval by the Board of Trustees. The provisions of the 1940 Act, including Section&#160;23(b) of the 1940
Act, generally require that the public offering price (less underwriting commissions and discounts) of common shares sold by a closed-end
investment company must equal or exceed the net asset value of such company&#8217;s common shares (calculated within 48 hours of the pricing
of such offering), except, in pertinent part, (i) with the consent of a majority of its common shareholders; or (ii) in connection with
an offering to the holders of one or more classes of its capital stock.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt">The Fund may, from time to time, seek the consent of common shareholders
to permit the issuance and sale by the Fund of common shares at a price below the Fund&#8217;s then-current net asset value, subject to
certain conditions. If such consent is obtained, the Fund may, contemporaneous with and in no event more than one year following the receipt
of such consent, sell common shares at price below net asset value in accordance with any conditions adopted in connection with the giving
of such consent. Additional information regarding any consent of common shareholders obtained by the Fund and the applicable conditions
imposed on the issuance and sale by the Fund of common shares at a price below net asset value will be disclosed in the Prospectus Supplement
relating to any such offering of common shares at a price below net asset value. Until such consent of common shareholders, if any, is
obtained, the Fund may not sell common shares at a price below net asset value. Because the Fund&#8217;s advisory fee is based upon average
Managed Assets, the Adviser&#8217;s interest in recommending the issuance and sale of common shares at a price below net asset value may
conflict with the interests of the Fund and its common shareholders.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt">The Fund may also issue and sell common shares at a price below the
Fund&#8217;s then-current net asset value in connection with an offering to the holders of its common shares pursuant to the issuance
of subscription rights. See &#8220;Description of Subscription Rights.&#8221;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><b>Preferred Shares</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund&#8217;s Declaration of Trust provides that the Board of Trustees
may authorize and issue preferred shares with rights as determined by the Board of Trustees, by action of the Board of Trustees without
prior approval of the holders of the common shares.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Common shareholders have no preemptive right to purchase any preferred
shares that might be issued. Any such preferred share offering would be subject to the limits imposed by the 1940 Act. Any preferred shares
issued by the Fund would have special voting rights and a liquidation preference over the common shares. Issuance of preferred shares
would constitute leverage and would entail special risks to the common shareholders.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Under the 1940 Act, the Fund may not issue preferred shares unless,
immediately after such issuance, it has an &#8220;asset coverage&#8221; of at least 200% of the liquidation value of the outstanding preferred
shares (<i>i.e.</i>, such liquidation value may not exceed 50% of the value of the Fund&#8217;s total assets). For these purposes, &#8220;asset
coverage&#8221; means the ratio of (i) total assets less all liabilities and indebtedness not represented by &#8220;senior securities&#8221;
to (ii) the amount of &#8220;senior securities representing indebtedness&#8221; plus the &#8220;involuntary liquidation preference&#8221;
of the preferred shares. &#8220;Senior security&#8221; generally means any bond, note, or similar security evidencing indebtedness and
any class of shares having priority over any other class as to distribution of assets or payment of dividends. &#8220;Senior security
representing indebtedness&#8221; means any &#8220;senior security&#8221; other than equity shares. The &#8220;involuntary liquidation
preference&#8221; of the preferred shares is the amount that holders of preferred shares would be entitled to receive in the event of
an involuntary liquidation of the Fund in preference to the common shares.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">If preferred shares are outstanding, two of the Fund&#8217;s Trustees
will be elected by the holders of preferred shares, voting separately as a class. The remaining Trustees of the Fund will be elected by
common shareholders and preferred shares voting together as a single class. In the unlikely event the Fund failed to pay dividends on
preferred shares for two years, preferred shares would be entitled to elect a majority of the Trustees of the Fund.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund is not permitted to declare any dividend (except a dividend
payable in common shares), or to declare any other distribution on the common shares, or to purchase any common shares, unless the preferred
shares have at the time of the declaration of any such dividend or other distribution, or at the time of any such purchase of common shares,
an asset coverage of at least 200% after deducting the amount of such dividend, distribution or purchase price. In addition, the Fund
may be subject to certain restrictions imposed by guidelines of one or more rating</p><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">agencies that may issue ratings for preferred shares issued by the Fund.
These guidelines may impose asset coverage or portfolio composition requirements that are more stringent than those imposed on the Fund
by the 1940 Act.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><b>Indebtedness</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund is authorized to borrow or issue debt securities
for financial leveraging purposes and for temporary purposes such as the settlement of transactions. The Fund may utilize indebtedness
to the maximum extent permitted under the 1940 Act. Under the 1940 Act, a fund generally is not permitted to issue commercial paper or
notes or engage in other borrowings unless, immediately after the borrowing, the fund would have asset coverage (as defined in the 1940
Act) of at least 300%, <i>i.e.</i>, the value of the fund&#8217;s total assets less liabilities other than the principal amount represented
by commercial paper, notes or other borrowings, is at least 300% of such principal amount. In addition, other than with respect to privately
arranged borrowings, the Fund is not permitted to declare any cash dividend or other distribution on the common shares unless, at the
time of such declaration, the value of the Fund&#8217;s total assets, less liabilities other than the principal amount represented by
borrowings, is at least 300% of such principal amount after deducting the amount of such dividend or other distribution. If the Fund borrows,
the Fund intends, to the extent possible, to prepay all or a portion of the principal amount of any outstanding commercial paper, notes
or other borrowings to the extent necessary to maintain the required asset coverage.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The terms of any such borrowings may require the
Fund to pay a fee to maintain a line of credit, such as a commitment fee, or to maintain minimum average balances with a lender. Any such
requirements would increase the cost of such borrowings over the stated interest rate. Such lenders would have the right to receive interest
on and repayment of principal of any such borrowings, which right will be senior to those of the common shareholders. Any such borrowings
may contain provisions limiting certain activities of the Fund, including the payment of dividends to common shareholders in certain circumstances.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Certain types of borrowings subject the Fund to covenants
in credit agreements relating to asset coverage and portfolio composition requirements. Certain borrowings also may subject the Fund to
certain restrictions on investments imposed by guidelines of one or more rating agencies, which may issue ratings for such borrowings.
Such guidelines may impose asset coverage or portfolio composition requirements that are more stringent than those imposed by the 1940
Act.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The 1940 Act grants to the holders of senior securities representing
indebtedness, other than with respect to privately arranged borrowings, certain voting rights in the event of default in the payment of
interest on or repayment of principal. Failure to maintain certain asset coverage requirements under the 1940 Act could result in an event
of default and entitle the debt holders to elect a majority of the Board of Trustees.</p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_OutstandingSecuritiesTableTextBlock', window );">Outstanding Securities [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_888_ecef--OutstandingSecuritiesTableTextBlock_ztnItirCHC95" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Outstanding Securities">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; width: 39%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>Title of Class</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>Amount Authorized</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>Amount Held by Fund for its own Account</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>Amount Outstanding Exclusive of Amounts held by Fund</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><span id="xdx_908_ecef--OutstandingSecurityTitleTextBlock_c20240723__20240723_zbhSl7iwa7Y6">Common Shares</span> </span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">Unlimited</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">None</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><span id="xdx_907_ecef--OutstandingSecurityAuthorizedShares_c20240723__20240723_zUzeIKXNGSh9">34,593,769</span></span></td></tr>
  </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_OutstandingSecurityTitleTextBlock', window );">Outstanding Security, Title [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Common Shares<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_OutstandingSecurityAuthorizedShares', window );">Outstanding Security, Authorized [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">34,593,769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_RiskAxis=AVK_RiskIntroductionMember', window );">Risk Introduction [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><span style="-sec-ix-redline: true">The
information contained under the heading &#8220;Investment Objective, Policies and Principal Risks&#8212;Principal Risks&#8221; in the
Fund&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm">Annual Report</a> is
incorporated herein by reference. Investors should consider the specific risk factors and special considerations associated with investing
in the Fund. An investment in the Fund is subject to investment risk, including the possible loss of your entire investment. A Prospectus
Supplement relating to an offering of the Fund&#8217;s securities may identify additional risk associated with such offering.</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_RiskAxis=AVK_DistributionRiskMember', window );">Distribution Risk [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">
<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Distribution Risk</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund&#8217;s net investment income can vary significantly over time;
however, the Fund seeks to maintain a more stable monthly distribution per share. The distributions paid by the Fund for any particular
month may be more or less than the amount of net investment income for that monthly period. The Fund may distribute more than the entire
amount of the net investment income earned in a particular period, in which case all or a portion of a distribution may be a return of
capital. <b>The Fund&#8217;s distributions have historically included, and may in the future include, a significant portion of return
of capital. For the fiscal year ended October&#160;31, 2023, the Fund&#8217;s distributions were comprised of approximately 28.04% ordinary
income and 71.96% return of capital. </b>Accordingly, shareholders should not assume that the source of a distribution from the Fund is
net income or profit, and the Fund&#8217;s distributions should not be used as a measure of performance or confused with yield or income.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><span style="-sec-ix-redline: true">Return of capital is the return of a portion of the shareholder&#8217;s
original investment up to the amount of the Common Shareholder&#8217;s tax basis in their Common Shares, which would reduce such tax
basis. Although a return of capital may not be taxable, it will generally increase the Common Shareholder&#8217;s potential gain or reduce
the Common Shareholder&#8217;s potential loss on any subsequent sale or other disposition of Common Shares. In any given year, there
can be no guarantee the Fund&#8217;s investment returns will exceed the amount of distributions which may increase taxes payable by a
Common Shareholder or reduce a Common Shareholder&#8217;s loss deduction in connection with such sale or other disposition. To the extent
the amount of distributions paid to shareholders in cash exceeds the total net investment returns of the Fund, the assets of the Fund
will decline, which may have the effect of increasing the Fund&#8217;s expense ratio. In addition, in order to make such distributions,
the Fund may have to sell a portion of its investment portfolio at a time when independent investment judgment might not dictate such
action.</span></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_RiskAxis=AVK_RisksAssociatedWithOfferingsOfAdditionalCommonSharesMember', window );">Risks Associated With Offerings Of Additional Common Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">
<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Risks Associated with Offerings of Additional Common Shares</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The voting power of current common shareholders will be diluted to the
extent that current common shareholders do not purchase common shares in any future offerings of common shares or do not purchase sufficient
common shares to maintain their percentage interest. If the Fund is unable to invest the proceeds of such offering as intended, the Fund&#8217;s
per common share distribution may decrease and the Fund may not participate in market advances to the same extent as if such proceeds
were fully invested as planned.</p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_RiskAxis=AVK_AdditionalRisksofRightsMember', window );">Additional Risksof Rights [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">
<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Additional Risks of Rights</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">There are additional risks associated with an offering of Rights. Shareholders
who do not exercise their Rights may, at the completion of such an offering, own a smaller proportional interest in the Fund than if they
exercised their Rights. As a result of such an offering, a shareholder may experience dilution in net asset value per share if the subscription
price per share is below the net asset value per share on the expiration date. If the subscription price per share is below the net asset
value per share of the Fund&#8217;s common shares on the expiration date, a shareholder will experience an immediate dilution of the aggregate
net asset value of such shareholder&#8217;s common shares if the shareholder does not participate in such an offering and the shareholder
will experience a reduction in the net asset value per share of such shareholder&#8217;s common shares whether or not the shareholder
participates in such an offering. Such a reduction in net asset value per share may have the effect of reducing market price of the common
share. The Fund cannot state precisely the extent of this dilution (if any) if the shareholder does not exercise such shareholder&#8217;s
Rights because the Fund does not know what the net asset value per share will be when the offer expires or what</p><p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">proportion of the Rights will be exercised. If the subscription price
is substantially less than the then current net asset value per common share at the expiration of a rights offering, such dilution could
be substantial. Any such dilution or accretion will depend upon whether (i) such shareholders participate in the Rights offering and (ii)
the Fund&#8217;s net asset value per common share is above or below the subscription price on the expiration date of the Rights offering.
In addition to the economic dilution described above, if a common shareholder does not exercise all of their rights, the common shareholder
will incur voting dilution as a result of this rights offering. This voting dilution will occur because the common shareholder will own
a smaller proportionate interest in the Fund after the rights offering than prior to the rights offering. There is a risk that changes
in market conditions may result in the underlying common shares purchasable upon exercise of the subscription rights being less attractive
to investors at the conclusion of the subscription period. This may reduce or eliminate the value of the subscription rights. If investors
exercise only a portion of the rights, the number of common shares issued may be reduced, and the common shares may trade at less favorable
prices than larger offerings for similar securities. Subscription rights issued by the Fund may be transferable or non-transferable rights.
In a non-transferable rights offering, common shareholders who do not wish to exercise their rights will be unable to sell their rights.
In a transferrable rights offering, the Fund will use its best efforts to ensure an adequate trading market for the rights; however, investors
may find that there is no market to sell rights they do not wish to exercise.</p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">st<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Floor<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">New York<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">10019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Robert J. White<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="12"></td></tr>
<tr><td colspan="12"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">If common shares are sold to or through underwriters, a prospectus or prospectus supplement will set forth any applicable sales load
and the estimated offering expenses borne by the Fund.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Common shareholders will incur brokerage charges if they direct Computershare Trust Company, N.A., as Plan Agent for the common shareholders,
to sell their common shares held in a dividend reinvestment account.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">The Fund pays the Adviser an annual management fee, payable monthly in arrears, in an amount equal to 0.54% of the Fund&#8217;s average
daily Managed Assets. Common shareholders bear the portion of the investment advisory fee attributable to the assets purchased with the
proceeds of leverage, which means that common shareholders effectively bear the entire management fee. <span id="xdx_907_ecef--ManagementFeeNotBasedOnNetAssetsNoteTextBlock_c20240723__20240723_zZkZOhKRxHZh">The contractual management fee
rate of 0.54% of the Fund&#8217;s Managed Assets represents an effective management fee rate of 0.95% of net assets attributable to common
shares, assuming leverage of 43.0% of the Fund&#8217;s Managed Assets (the Fund&#8217;s outstanding leverage as of April 30, 2024)</span>.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Includes interest payments on borrowed funds and interest expense on reverse repurchase agreements. Interest payments on borrowed
funds is based upon the Fund&#8217;s outstanding borrowings under the Credit Agreement as of April 30, 2024, in an amount equal to 21.5%
of the Fund&#8217;s Managed Assets, at an annual interest rate cost to the Fund of 5.97% (the weighted average interest rate paid by the
Fund during the six months ended April 30, 2024). Interest expenses on reverse repurchase agreements is based on the Fund&#8217;s outstanding
reverse repurchase agreements as of April 30, 2024, representing 21.5% of the Fund&#8217;s Managed Assets at an annual interest rate cost
to the Fund of 4.80% (the weighted average interest rate cost incurred by the Fund during the six months ended April 30, 2024). The actual
amount of interest expense incurred by the Fund will vary over time in accordance with the amount of borrowings and reverse repurchase
agreements and variations in market interest rates.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">&#8220;<span id="xdx_908_ecef--OtherExpensesNoteTextBlock_c20240723__20240723_zojKjAEkfRF2">Other Expenses&#8221; are based on estimated amounts for the six months ended April 30, 2024.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_AnnualExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_AnnualExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_BusinessDevelopmentCompanyFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_BusinessDevelopmentCompanyFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_CapitalStockTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 1<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_CapitalStockTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_DividendReinvestmentAndCashPurchaseFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_DividendReinvestmentAndCashPurchaseFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_EffectsOfLeverageTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_EffectsOfLeverageTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYear01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYear01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to10">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to10</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to5">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to5</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_FeeTableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_FeeTableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_FinancialHighlightsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_FinancialHighlightsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_GeneralDescriptionOfRegistrantAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_GeneralDescriptionOfRegistrantAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_HighestPriceOrBid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_HighestPriceOrBid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_HighestPriceOrBidNav">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instruction 4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_HighestPriceOrBidNav</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_HighestPriceOrBidPremiumDiscountToNavPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instructions 4, 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_HighestPriceOrBidPremiumDiscountToNavPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_InterestExpensesOnBorrowingsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 8<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_InterestExpensesOnBorrowingsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_IntervalFundFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_IntervalFundFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_InvestmentObjectivesAndPracticesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 2<br> -Paragraph b, d<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_InvestmentObjectivesAndPracticesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LowestPriceOrBid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LowestPriceOrBid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LowestPriceOrBidNav">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instruction 4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LowestPriceOrBidNav</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LowestPriceOrBidPremiumDiscountToNavPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instructions 4, 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LowestPriceOrBidPremiumDiscountToNavPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 7<br> -Subparagraph b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ManagementFeesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 7<br> -Subparagraph a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ManagementFeesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_NewCefOrBdcRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_NewCefOrBdcRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherAnnualExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherAnnualExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherAnnualExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherAnnualExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherExpensesNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherExpensesNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherTransactionExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherTransactionExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherTransactionExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherTransactionExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OutstandingSecuritiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OutstandingSecuritiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OutstandingSecurityAuthorizedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 5<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OutstandingSecurityAuthorizedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OutstandingSecurityTitleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 5<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OutstandingSecurityTitleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PrimaryShelfFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PrimaryShelfFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PrimaryShelfQualifiedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PrimaryShelfQualifiedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PurposeOfFeeTableNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PurposeOfFeeTableNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RegisteredClosedEndFundFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RegisteredClosedEndFundFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SalesLoadPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SalesLoadPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SeniorSecuritiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 4<br> -Subsection 3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SeniorSecuritiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SharePriceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph 4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SharePriceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ShareholderTransactionExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ShareholderTransactionExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_TotalAnnualExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 8<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_TotalAnnualExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AdditionalSecurities462b">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AdditionalSecurities462b</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AdditionalSecuritiesEffective413b">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 413<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AdditionalSecuritiesEffective413b</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ApproximateDateOfCommencementOfProposedSaleToThePublic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ApproximateDateOfCommencementOfProposedSaleToThePublic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:dateOrAsapItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DelayedOrContinuousOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form S-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form F-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DelayedOrContinuousOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DividendOrInterestReinvestmentPlanOnly">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form S-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form F-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DividendOrInterestReinvestmentPlanOnly</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EffectiveUponFiling462e">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection e<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EffectiveUponFiling462e</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EffectiveWhenDeclaredSection8c">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Section 8<br> -Subsection c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EffectiveWhenDeclaredSection8c</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInvCompanyType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInvCompanyType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:invCompanyType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ExhibitsOnly462d">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection d<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ExhibitsOnly462d</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyActFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-4<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyActFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyActRegistration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Investment Company Act<br> -Number 270<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyActRegistration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyRegistrationAmendment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Investment Company Act<br> -Number 270<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyRegistrationAmendment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyRegistrationAmendmentNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Investment Company Act<br> -Number 270<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyRegistrationAmendmentNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:sequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_NewEffectiveDateForPreviousFiling">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-4<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_NewEffectiveDateForPreviousFiling</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_NoSubstantiveChanges462c">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_NoSubstantiveChanges462c</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=AVK_RiskIntroductionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=AVK_RiskIntroductionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=AVK_DistributionRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=AVK_DistributionRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=AVK_RisksAssociatedWithOfferingsOfAdditionalCommonSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=AVK_RisksAssociatedWithOfferingsOfAdditionalCommonSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=AVK_AdditionalRisksofRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=AVK_AdditionalRisksofRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>16</ContextCount>
  <ElementCount>70</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>5</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="gug87916avk-n2a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995470 - Disclosure - N-2</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cef/role/N2</Role>
      <ShortName>N-2</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>avk-20240719.xsd</File>
    <File>avk-20240719_def.xml</File>
    <File>avk-20240719_lab.xml</File>
    <File>avk-20240719_pre.xml</File>
    <File doctype="N-2/A" isN2Prospectus="true" isUsgaap="true" original="gug87916avk-n2a.htm">gug87916avk-n2a.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="95">http://xbrl.sec.gov/cef/2023</BaseTaxonomy>
    <BaseTaxonomy items="37">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>27
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "gug87916avk-n2a.htm": {
   "nsprefix": "AVK",
   "nsuri": "http://guggenheiminvestments.com/20240719",
   "dts": {
    "schema": {
     "local": [
      "avk-20240719.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/2006/xbrldi-2006.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/cef/2023/cef-2023.xsd",
      "https://xbrl.sec.gov/cef/2023/cef-2023_pre.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023_lab.xsd",
      "https://xbrl.sec.gov/fnd/2023/fnd-2023.xsd",
      "https://xbrl.sec.gov/fnd/2023/fnd-2023_lab.xsd",
      "https://xbrl.sec.gov/fnd/2023/fnd-cef-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "avk-20240719_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "avk-20240719_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "avk-20240719_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "gug87916avk-n2a.htm"
     ]
    }
   },
   "keyStandard": 70,
   "keyCustom": 0,
   "axisStandard": 2,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 4,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/dei/2023": 4
   },
   "contextCount": 16,
   "entityCount": 1,
   "segmentCount": 5,
   "elementCount": 204,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/cef/2023": 95,
    "http://xbrl.sec.gov/dei/2023": 37
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/cef/role/N2",
     "longName": "995470 - Disclosure - N-2",
     "shortName": "N-2",
     "isDefault": "true",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-07-23",
      "name": "dei:EntityInvCompanyType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gug87916avk-n2a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-07-23",
      "name": "dei:EntityInvCompanyType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gug87916avk-n2a.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "cef_AcquiredFundFeesAndExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundFeesAndExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "cef_AcquiredFundFeesAndExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundFeesAndExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "cef_AcquiredFundFeesEstimatedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundFeesEstimatedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees Estimated, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "cef_AcquiredFundIncentiveAllocationNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundIncentiveAllocationNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Incentive Allocation, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_AcquiredFundTotalAnnualExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundTotalAnnualExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Total Annual Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "AVK_AdditionalRisksofRightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://guggenheiminvestments.com/20240719",
     "localname": "AdditionalRisksofRightsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Risksof Rights [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "cef_AllRisksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AllRisksMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Risks:"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "cef_AnnualCoverageReturnRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualCoverageReturnRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Coverage Return Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "cef_AnnualDividendPayment": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualDividendPayment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_AnnualDividendPaymentCurrent": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualDividendPaymentCurrent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Current"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_AnnualDividendPaymentInitial": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualDividendPaymentInitial",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Initial"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_AnnualExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "cef_AnnualInterestRateCurrentPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualInterestRateCurrentPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Current [Percent]"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_AnnualInterestRateInitialPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualInterestRateInitialPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Initial [Percent]"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_AnnualInterestRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualInterestRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "cef_BasisOfTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "BasisOfTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "cef_BdcFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "BdcFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "BDC File Number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r2",
      "r3"
     ]
    },
    "cef_BusinessDevelopmentCompanyFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "BusinessDevelopmentCompanyFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Development Company [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "CapitalStockLongTermDebtAndOtherSecuritiesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock, Long-Term Debt, and Other Securities [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "cef_CapitalStockTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "CapitalStockTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "auth_ref": []
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r5",
      "r77"
     ]
    },
    "AVK_DistributionRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://guggenheiminvestments.com/20240719",
     "localname": "DistributionRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distribution Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_DistributionServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DistributionServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distribution/Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "cef_DistributionsMayReducePrincipalTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DistributionsMayReducePrincipalTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distributions May Reduce Principal [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "cef_DividendAndInterestExpensesOnShortSalesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DividendAndInterestExpensesOnShortSalesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend and Interest Expenses on Short Sales [Percent]"
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "cef_DividendExpenseOnPreferredSharesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DividendExpenseOnPreferredSharesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Expenses on Preferred Shares [Percent]"
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r5",
      "r77"
     ]
    },
    "cef_DividendReinvestmentAndCashPurchaseFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DividendReinvestmentAndCashPurchaseFees",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Reinvestment and Cash Purchase Fees"
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "cef_EffectsOfLeveragePurposeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "EffectsOfLeveragePurposeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage, Purpose [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "cef_EffectsOfLeverageTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "EffectsOfLeverageTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "cef_EffectsOfLeverageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "EffectsOfLeverageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Act File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "cef_ExpenseExampleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "cef_ExpenseExampleYear01": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleYear01",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Year 01"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_ExpenseExampleYears1to10": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleYears1to10",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 10"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_ExpenseExampleYears1to3": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleYears1to3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 3"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_ExpenseExampleYears1to5": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleYears1to5",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 5"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_FeeTableAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "FeeTableAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Table [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "cef_FinancialHighlightsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "FinancialHighlightsAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "cef_GeneralDescriptionOfRegistrantAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "GeneralDescriptionOfRegistrantAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Description of Registrant [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "cef_HighestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "HighestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "cef_HighestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "HighestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "cef_HighestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "HighestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "cef_IncentiveAllocationMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IncentiveAllocationMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_IncentiveAllocationMinimumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IncentiveAllocationMinimumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Minimum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_IncentiveAllocationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IncentiveAllocationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_IncentiveFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IncentiveFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "cef_InterestExpensesOnBorrowingsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "InterestExpensesOnBorrowingsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expenses on Borrowings [Percent]"
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_InterestRateRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestRateRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Rate Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_IntervalFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IntervalFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interval Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r5",
      "r74",
      "r75",
      "r76"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "cef_InvestmentObjectivesAndPracticesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "InvestmentObjectivesAndPracticesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Objectives and Practices [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "cef_LatestNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LatestNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest NAV (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "cef_LatestPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LatestPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "cef_LatestSharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LatestSharePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Share Price (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "cef_LoanServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LoanServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "cef_LongTermDebtDividendsAndCovenantsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtDividendsAndCovenantsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Dividends and Covenants [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "cef_LongTermDebtIssuanceAndSubstitutionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtIssuanceAndSubstitutionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Issuance and Substitution [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_LongTermDebtPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtPrincipal",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Principal"
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "cef_LongTermDebtRightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtRightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "cef_LongTermDebtStructuringTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtStructuringTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Structuring [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "cef_LongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "cef_LongTermDebtTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "cef_LowestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LowestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "cef_LowestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LowestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "cef_LowestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LowestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ManagementFeeNotBasedOnNetAssetsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fee not based on Net Assets, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_ManagementFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ManagementFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_NetAssetValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetAssetValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NAV Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "cef_NetExpenseOverAssetsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "NetExpenseOverAssetsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Expense over Assets [Percent]"
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "cef_NewCefOrBdcRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "NewCefOrBdcRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New CEF or BDC Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r5",
      "r74",
      "r75",
      "r76"
     ]
    },
    "fnd_NmRule35d1EightyPctInvstmntPlcyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/fnd/2023",
     "localname": "NmRule35d1EightyPctInvstmntPlcyTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 35d-1 Eighty Percent Investment Policy [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r79"
     ]
    },
    "fnd_NmRule35d1TermDfnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/fnd/2023",
     "localname": "NmRule35d1TermDfnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Definition of Rule 35d-1 Term in Fund Name [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r7",
      "r79"
     ]
    },
    "fnd_NmRule35d1TermSlctnCritTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/fnd/2023",
     "localname": "NmRule35d1TermSlctnCritTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selection Criteria for Rule 35d-1 Term in Fund Name [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r7",
      "r79"
     ]
    },
    "cef_NoPublicTradingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "NoPublicTradingTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Public Trading [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "cef_NoTradingHistoryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "NoTradingHistoryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading History [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "cef_OtherAnnualExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "cef_OtherAnnualExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "cef_OtherAnnualExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "cef_OtherAnnualExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "cef_OtherAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "cef_OtherExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "cef_OtherFeederFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherFeederFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Feeder Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "cef_OtherMasterFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherMasterFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Master Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "cef_OtherSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "cef_OtherSecurityDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherSecurityDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "cef_OtherSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "cef_OtherTransactionExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "cef_OtherTransactionExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "cef_OtherTransactionExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "cef_OtherTransactionExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "cef_OtherTransactionExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximum": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionFeesBasisMaximum",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum"
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionFeesBasisMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "cef_OtherTransactionFeesBasisNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionFeesBasisNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "cef_OtherTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "cef_OutstandingSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "cef_OutstandingSecurityAuthorizedShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecurityAuthorizedShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Authorized [Shares]"
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "cef_OutstandingSecurityHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecurityHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "cef_OutstandingSecurityNotHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecurityNotHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Not Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "cef_OutstandingSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "us-gaap_PreferredStockLiquidationPreference": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockLiquidationPreference",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Liquidating Preference"
       }
      }
     },
     "auth_ref": []
    },
    "cef_PreferredStockRestrictionsArrearageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PreferredStockRestrictionsArrearageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Arrearage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "cef_PreferredStockRestrictionsOtherTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PreferredStockRestrictionsOtherTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Other [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "cef_PrimaryShelfFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PrimaryShelfFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_PrimaryShelfQualifiedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PrimaryShelfQualifiedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf Qualified [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_ProspectusLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ProspectusLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_ProspectusTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ProspectusTable",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_PurposeOfFeeTableNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PurposeOfFeeTableNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purpose of Fee Table , Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "cef_RegisteredClosedEndFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RegisteredClosedEndFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registered Closed-End Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_ReturnAtMinusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtMinusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "cef_ReturnAtMinusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtMinusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "cef_ReturnAtPlusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtPlusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "cef_ReturnAtPlusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtPlusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "cef_ReturnAtZeroPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtZeroPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Zero [Percent]"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "cef_RightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "cef_RightsSubjectToOtherThanMajorityVoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RightsSubjectToOtherThanMajorityVoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Subject to Other than Majority Vote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "cef_RiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RiskAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_RiskFactorsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RiskFactorsTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk Factors [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "AVK_RiskIntroductionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://guggenheiminvestments.com/20240719",
     "localname": "RiskIntroductionMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk Introduction [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_RiskTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RiskTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "AVK_RisksAssociatedWithOfferingsOfAdditionalCommonSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://guggenheiminvestments.com/20240719",
     "localname": "RisksAssociatedWithOfferingsOfAdditionalCommonSharesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risks Associated With Offerings Of Additional Common Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_SalesLoadPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SalesLoadPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales Load [Percent]"
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "cef_SecurityDividendsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityDividendsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Dividends [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "cef_SecurityLiabilitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityLiabilitiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liabilities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "cef_SecurityLiquidationRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityLiquidationRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liquidation Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "cef_SecurityObligationsOfOwnershipTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityObligationsOfOwnershipTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Obligations of Ownership [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "cef_SecurityPreemptiveAndOtherRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityPreemptiveAndOtherRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Preemptive and Other Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "cef_SecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "cef_SecurityVotingRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityVotingRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Voting Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "cef_SeniorSecuritiesAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesAmount",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Amount (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "cef_SeniorSecuritiesAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "cef_SeniorSecuritiesAverageMarketValuePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesAverageMarketValuePerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Average Market Value per Unit"
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "cef_SeniorSecuritiesAveragingMethodNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesAveragingMethodNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Averaging Method, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "cef_SeniorSecuritiesCoveragePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesCoveragePerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Coverage per Unit (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "cef_SeniorSecuritiesCvgPerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesCvgPerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Coverage per Unit"
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "cef_SeniorSecuritiesHeadingsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesHeadingsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Headings, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "cef_SeniorSecuritiesHighlightsAnnualizedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesHighlightsAnnualizedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Annualized, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r49",
      "r56"
     ]
    },
    "cef_SeniorSecuritiesHighlightsAuditedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesHighlightsAuditedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Audited, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r50",
      "r56"
     ]
    },
    "cef_SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Involuntary Liquidating Preference per Unit (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "cef_SeniorSecuritiesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r48",
      "r56"
     ]
    },
    "cef_SeniorSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price"
       }
      }
     },
     "auth_ref": []
    },
    "cef_SharePriceTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SharePriceTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "cef_SharePricesNotActualTransactionsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SharePricesNotActualTransactionsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Prices Not Actual Transactions [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "cef_ShareholderTransactionExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ShareholderTransactionExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder Transaction Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_TotalAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "TotalAnnualExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "cef_UnderwritersCompensationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "UnderwritersCompensationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriters Compensation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "cef_WaiversAndReimbursementsOfFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WaiversAndReimbursementsOfFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Waivers and Reimbursements of Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "cef_WarrantsOrRightsCalledAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WarrantsOrRightsCalledAmount",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Amount"
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "cef_WarrantsOrRightsCalledPeriodDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WarrantsOrRightsCalledPeriodDate",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Period [Date]"
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "cef_WarrantsOrRightsCalledTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WarrantsOrRightsCalledTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Title"
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "cef_WarrantsOrRightsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WarrantsOrRightsExercisePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item",
   "Subsection": "8",
   "Paragraph": "2",
   "Subparagraph": "b"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item",
   "Subsection": "8",
   "Paragraph": "2",
   "Subparagraph": "b",
   "Sentence": "instruction",
   "Clause": "2"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "4"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "5"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "6"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "Instruction 2"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "c"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "d"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "a"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "b"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "c"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "e"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "3"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "1"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "2"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "3"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "4"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 1"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a, g, h"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "f"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "g"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "i"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 11"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 4"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 5"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 6"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "a"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "b"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 9"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 2"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 3"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "2"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "3",
   "Subparagraph": "Instruction 2"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "4",
   "Subparagraph": "Instruction 3"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "5"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 1"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 4"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 5"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "2",
   "Paragraph": "b, d"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "a"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "3"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "4"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 2"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 3"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 4"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instructions 4, 5"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "c"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "e"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270",
   "Section": "35d-1"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  }
 }
}
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
